1	O	NN	O	o	_	0	SENT_1	[p1l206t20r220b34],

1	L	NN	O	l	_	0	SENT_2	[p1l101t14r186b115],
2	p	NN	PERCENT	p	nn	3	SENT_2	[p1l196t53r422b119],
3	%	NN	PERCENT	%	dep	1	SENT_2	[p1l196t53r422b119],
4	+	CC	O	+	_	0	SENT_2	[p1l196t53r422b119],
5	|	NN	O	|	dep	1	SENT_2	[p1l444t87r737b114],
6	.	.	O	.	_	0	SENT_2	[p1l444t87r737b114],

1	\	NN	O	\	nn	3	SENT_3	[p1l444t87r737b114],
2	'	''	O	'	_	0	SENT_3	[p1l444t87r737b114],
3	TlCR	NN	O	tlcr	_	0	SENT_3	[p1l444t87r737b114],
4	\	NN	O	\	dep	3	SENT_3	[p1l444t87r737b114],
5	'	''	O	'	_	0	SENT_3	[p1l444t87r737b114],
6	.	.	O	.	_	0	SENT_3	[p1l444t87r737b114],

1	\	NN	O	\	_	0	SENT_4	[p1l444t87r737b114],
2	’	CD	NUMBER	’	num	1	SENT_4	[p1l444t87r737b114],
3	I	PRP	O	I	nsubj	4	SENT_4	[p1l444t87r737b114],
4	‘	VBP	O	‘	rcmod	1	SENT_4	[p1l444t87r737b114],
5	|	CD	NUMBER	|	number	6	SENT_4	[p1l444t87r737b114],
6	(	CD	NUMBER	(	num	11	SENT_4	[p1l444t87r737b114],
7	)	NN	O	)	nn	11	SENT_4	[p1l444t87r737b114],
8	l	NN	O	l	nn	11	SENT_4	[p1l444t87r737b114],
9	\	CD	NUMBER	\	num	11	SENT_4	[p1l444t87r737b114],
10	l.	NN	O	l.	nn	11	SENT_4	[p1l444t87r737b114],
11	~	NN	O	~	dobj	4	SENT_4	[p1l444t87r737b114],
12	\	CD	NUMBER	\	num	15	SENT_4	[p1l444t87r737b114],
13	l.	NNP	O	l.	nn	15	SENT_4	[p1l444t87r737b114],
14	OFFICIAL	NNP	ORGANIZATION	OFFICIAL	nn	15	SENT_4	[p1l105t129r200b147],
15	JOURNAL	NNP	ORGANIZATION	JOURNAL	dep	11	SENT_4	[p1l211t129r307b147],
16	OF	IN	O	of	_	0	SENT_4	[p1l320t129r343b147],
17	THE	DT	O	the	det	19	SENT_4	[p1l354t129r391b147],
18	INTERNATIONAL	NNP	O	INTERNATIONAL	nn	19	SENT_4	[p1l404t129r575b147],
19	ASSOCIATION	NNP	O	ASSOCIATION	prep_of	15	SENT_4	[p1l586t129r728b147],
20	FOR	IN	O	for	_	0	SENT_4	[p1l742t129r779b147],
21	THE	DT	O	the	det	22	SENT_4	[p1l790t129r827b147],
22	STUDY	NN	O	study	prep_for	19	SENT_4	[p1l840t129r905b147],
23	OF	IN	O	of	_	0	SENT_4	[p1l918t129r942b147],
24	THE	DT	O	the	det	28	SENT_4	[p1l953t129r989b147],
25	LIVER	NN	O	liver	nn	28	SENT_4	[p1l1003t129r1059b147],
26	Liver	NN	O	liver	nn	28	SENT_4	[p1l1556t182r1624b206],
27	International	NNP	O	International	nn	28	SENT_4	[p1l1634t182r1821b206],
28	ISSN	NNP	O	ISSN	prep_of	22	SENT_4	[p1l1839t183r1900b206],
29	1478-3223	CD	DURATION	1478-3223	num	28	SENT_4	[p1l1912t183r2056b206],

1	CLINICAL	JJ	O	clinical	amod	2	SENT_5	[p1l99t281r311b311],
2	STUDIES	NNS	O	study	_	0	SENT_5	[p1l329t281r518b311],

1	TNF-oz	JJ	O	tnf-oz	amod	3	SENT_6	[p1l97t368r240b410],
2	genetic	JJ	O	genetic	amod	3	SENT_6	[p1l255t366r453b422],
3	polymorphism	NN	O	polymorphism	_	0	SENT_6	[p1l469t365r857b422],
4	—	NN	O	—	nn	5	SENT_6	[p1l876t367r1104b410],
5	308G/A	NN	O	308g/a	dep	3	SENT_6	[p1l876t367r1104b410],
6	and	CC	O	and	_	0	SENT_6	[p1l1119t365r1217b410],
7	antituberculosis	NN	O	antituberculosis	nn	9	SENT_6	[p1l1233t365r1667b410],
8	drug-induced	JJ	O	drug-induced	amod	9	SENT_6	[p1l1682t365r2037b422],
9	hepatitis	NN	O	hepatitis	dep	3	SENT_6	[p1l100t431r336b487],

1	Sang	NNP	O	Sang	_	0	SENT_7	[p1l98t523r285b558],
2	.	.	O	.	_	0	SENT_7	[p1l98t523r285b558],

1	—	NN	O	—	_	0	SENT_8	[p1l98t523r285b558],
2	.	.	O	.	_	0	SENT_8	[p1l98t523r285b558],

1	Heon	NNP	PERSON	Heon	nn	3	SENT_9	[p1l98t523r285b558],
2	Kim	NNP	PERSON	Kim	nn	3	SENT_9	[p1l301t515r389b555],
3	‘	NNP	O	‘	_	0	SENT_9	[p1l301t515r389b555],
4	,	,	O	,	_	0	SENT_9	[p1l301t515r389b555],
5	Sang	NNP	O	Sang	appos	3	SENT_9	[p1l403t523r592b558],
6	.	.	O	.	_	0	SENT_9	[p1l403t523r592b558],

1	—	NN	O	—	_	0	SENT_10	[p1l403t523r592b558],
2	.	.	O	.	_	0	SENT_10	[p1l403t523r592b558],

1	Heon	NNP	PERSON	Heon	nn	2	SENT_11	[p1l403t523r592b558],
2	Kimz	NNP	PERSON	Kimz	_	0	SENT_11	[p1l607t515r695b555],
3	,	,	O	,	_	0	SENT_11	[p1l607t515r695b555],
4	Ho	NNP	PERSON	Ho	nn	6	SENT_11	[p1l711t523r756b550],
5	Joo	NNP	PERSON	Joo	nn	6	SENT_11	[p1l767t523r826b550],
6	Yoonl	NNP	PERSON	Yoonl	appos	2	SENT_11	[p1l837t515r953b555],
7	,	,	O	,	_	0	SENT_11	[p1l837t515r953b555],
8	Dong	NNP	PERSON	Dong	nn	11	SENT_11	[p1l968t523r1058b558],
9	Ho	NNP	PERSON	Ho	nn	11	SENT_11	[p1l1074t523r1119b550],
10	Shin	NNP	PERSON	Shin	nn	11	SENT_11	[p1l1131t515r1228b555],
11	‘	NNP	O	‘	appos	2	SENT_11	[p1l1131t515r1228b555],
12	,	,	O	,	_	0	SENT_11	[p1l1131t515r1228b555],
13	Sung	NNP	PERSON	Sung	nn	15	SENT_11	[p1l1242t523r1325b558],
14	Soo	NNP	PERSON	Soo	nn	15	SENT_11	[p1l1339t523r1400b550],
15	Park1	NNP	O	Park1	appos	2	SENT_11	[p1l1414t515r1713b557],
16	,	,	O	,	_	0	SENT_11	[p1l1414t515r1713b557],
17	Youn	NNP	PERSON	Youn	appos	2	SENT_11	[p1l1414t515r1713b557],
18	.	.	O	.	_	0	SENT_11	[p1l1414t515r1713b557],

1	—	NN	O	—	_	0	SENT_12	[p1l1414t515r1713b557],
2	.	.	O	.	_	0	SENT_12	[p1l1414t515r1713b557],

1	Seup	NN	MISC	seup	nn	2	SENT_13	[p1l1414t515r1713b557],
2	Kim3	NN	O	kim3	_	0	SENT_13	[p1l1727t515r1815b555],
3	,	,	O	,	_	0	SENT_13	[p1l1727t515r1815b555],
4	Jae	NNP	PERSON	Jae	appos	2	SENT_13	[p1l97t568r247b597],
5	.	.	O	.	_	0	SENT_13	[p1l97t568r247b597],

1	—	NN	O	—	_	0	SENT_14	[p1l97t568r247b597],
2	.	.	O	.	_	0	SENT_14	[p1l97t568r247b597],

1	Seuk	NNP	O	Seuk	_	0	SENT_15	[p1l97t568r247b597],
2	Park3	NN	O	park3	dep	1	SENT_15	[p1l260t562r347b597],
3	and	CC	O	and	_	0	SENT_15	[p1l360t568r422b597],
4	Young	NN	PERSON	young	dep	1	SENT_15	[p1l435t570r633b605],
5	.	.	O	.	_	0	SENT_15	[p1l435t570r633b605],

1	—	NN	O	—	_	0	SENT_16	[p1l435t570r633b605],
2	.	.	O	.	_	0	SENT_16	[p1l435t570r633b605],

1	Koo	NNP	PERSON	Koo	nn	2	SENT_17	[p1l435t570r633b605],
2	Jee3	NNP	O	Jee3	_	0	SENT_17	[p1l644t562r713b597],

1	1	CD	NUMBER	1	_	0	SENT_18	[p1l101t641r108b663],
2	Department	NNP	ORGANIZATION	Department	dep	1	SENT_18	[p1l129t641r285b670],
3	of	IN	ORGANIZATION	of	_	0	SENT_18	[p1l294t639r321b664],
4	Internal	NNP	ORGANIZATION	Internal	nn	45	SENT_18	[p1l331t639r427b664],
5	Medicine	NNP	ORGANIZATION	Medicine	nn	45	SENT_18	[p1l439t639r563b667],
6	,	,	O	,	_	0	SENT_18	[p1l439t639r563b667],
7	Hanyang	NNP	ORGANIZATION	Hanyang	nn	9	SENT_18	[p1l576t641r689b670],
8	University	NNP	ORGANIZATION	University	nn	9	SENT_18	[p1l702t640r827b670],
9	College	NNP	ORGANIZATION	College	dep	45	SENT_18	[p1l837t639r934b670],
10	of	IN	ORGANIZATION	of	_	0	SENT_18	[p1l944t639r970b664],
11	Medicine	NNP	ORGANIZATION	Medicine	nn	17	SENT_18	[p1l981t639r1105b667],
12	,	,	O	,	_	0	SENT_18	[p1l981t639r1105b667],
13	Seoul	NNP	LOCATION	Seoul	appos	17	SENT_18	[p1l1117t639r1194b667],
14	,	,	O	,	_	0	SENT_18	[p1l1117t639r1194b667],
15	Korea	NNP	LOCATION	Korea	appos	17	SENT_18	[p1l1207t641r1281b664],
16	2	CD	NUMBER	2	num	17	SENT_18	[p1l98t684r112b706],
17	Department	NNP	ORGANIZATION	Department	prep_of	9	SENT_18	[p1l129t684r285b713],
18	of	IN	ORGANIZATION	of	_	0	SENT_18	[p1l294t682r321b707],
19	Internal	NNP	ORGANIZATION	Internal	nn	20	SENT_18	[p1l331t682r427b707],
20	Medicine	NNP	ORGANIZATION	Medicine	prep_of	17	SENT_18	[p1l439t682r563b711],
21	,	,	O	,	_	0	SENT_18	[p1l439t682r563b711],
22	Eulji	NNP	ORGANIZATION	Eulji	nn	24	SENT_18	[p1l576t682r625b713],
23	University	NNP	ORGANIZATION	University	nn	24	SENT_18	[p1l637t683r763b713],
24	School	NNP	ORGANIZATION	School	appos	9	SENT_18	[p1l772t682r856b707],
25	of	IN	ORGANIZATION	of	_	0	SENT_18	[p1l867t682r894b707],
26	Medicine	NNP	ORGANIZATION	Medicine	nn	32	SENT_18	[p1l904t682r1029b711],
27	,	,	O	,	_	0	SENT_18	[p1l904t682r1029b711],
28	Seoul	NNP	LOCATION	Seoul	appos	32	SENT_18	[p1l1041t682r1118b711],
29	,	,	O	,	_	0	SENT_18	[p1l1041t682r1118b711],
30	Korea	NNP	LOCATION	Korea	appos	32	SENT_18	[p1l1131t684r1204b707],
31	3	NNP	NUMBER	3	nn	32	SENT_18	[p1l98t727r112b749],
32	Department	NNP	ORGANIZATION	Department	prep_of	24	SENT_18	[p1l129t727r285b756],
33	of	IN	ORGANIZATION	of	_	0	SENT_18	[p1l294t725r321b750],
34	Internal	NNP	ORGANIZATION	Internal	nn	35	SENT_18	[p1l331t725r427b750],
35	Medicine	NNP	ORGANIZATION	Medicine	prep_of	32	SENT_18	[p1l439t725r563b754],
36	,	,	O	,	_	0	SENT_18	[p1l439t725r563b754],
37	Dankook	NNP	ORGANIZATION	Dankook	nn	39	SENT_18	[p1l576t725r692b750],
38	University	NNP	ORGANIZATION	University	nn	39	SENT_18	[p1l703t726r828b756],
39	College	NNP	ORGANIZATION	College	appos	9	SENT_18	[p1l838t725r935b756],
40	of	IN	ORGANIZATION	of	_	0	SENT_18	[p1l945t725r972b750],
41	Medicine	NNP	ORGANIZATION	Medicine	nn	43	SENT_18	[p1l982t725r1107b754],
42	,	,	O	,	_	0	SENT_18	[p1l982t725r1107b754],
43	Cheonan	NNP	LOCATION	Cheonan	prep_of	39	SENT_18	[p1l1119t725r1244b754],
44	,	,	O	,	_	0	SENT_18	[p1l1119t725r1244b754],
45	Korea	NNP	LOCATION	Korea	prep_of	2	SENT_18	[p1l1257t727r1330b750],

1	Keywords	NNPS	O	Keywords	_	0	SENT_19	[p1l99t837r243b868],
2	Abstract	JJ	O	abstract	amod	3	SENT_19	[p1l765t831r928b863],
3	antituberculosisdrugs	NNS	O	antituberculosisdrug	dep	1	SENT_19	[p1l98t880r513b911],
4	—	JJ	O	—	amod	6	SENT_19	[p1l98t880r513b911],
5	genetic	JJ	O	genetic	amod	6	SENT_19	[p1l98t880r513b911],
6	Background	NN	O	background	dep	1	SENT_19	[p1l764t878r965b918],
7	:	:	O	:	_	0	SENT_19	[p1l764t878r965b918],
8	While	IN	O	while	mark	17	SENT_19	[p1l987t878r1087b908],
9	the	DT	O	the	det	10	SENT_19	[p1l1108t878r1159b908],
10	mechanisms	NNS	O	mechanism	nsubj	17	SENT_19	[p1l1179t878r1384b908],
11	underlying	VBG	O	underlie	partmod	10	SENT_19	[p1l1405t878r1585b918],
12	the	DT	O	the	det	13	SENT_19	[p1l1605t878r1656b908],
13	development	NN	O	development	dobj	11	SENT_19	[p1l1677t878r1892b918],
14	of	IN	O	of	_	0	SENT_19	[p1l1913t878r1949b908],
15	drugIoolYmoFPhlSm-hepatitis-tumour	NN	O	drugioolymofphlsm-hepatitis-tumour	nn	16	SENT_19	[p1l1965t878r2055b918, p1l99t923r557b954],
16	necrosis	NN	O	necrosis	prep_of	13	SENT_19	[p1l568t924r670b948],
17	induced	VBD	O	induce	advcl	25	SENT_19	[p1l765t923r899b953],
18	liver	NN	O	liver	nn	19	SENT_19	[p1l917t923r990b953],
19	injury	NN	O	injury	nsubj	22	SENT_19	[p1l1008t924r1108b963],
20	are	VBP	O	be	cop	22	SENT_19	[p1l1126t934r1175b953],
21	not	RB	O	not	neg	22	SENT_19	[p1l1193t929r1249b953],
22	clear	JJ	O	clear	ccomp	17	SENT_19	[p1l1268t923r1353b958],
23	,	,	O	,	_	0	SENT_19	[p1l1268t923r1353b958],
24	there	EX	O	there	expl	25	SENT_19	[p1l1373t923r1456b953],
25	is	VBZ	O	be	dep	1	SENT_19	[p1l1475t924r1499b953],
26	evidence	NN	O	evidence	nsubj	25	SENT_19	[p1l1519t923r1661b953],
27	to	TO	O	to	aux	28	SENT_19	[p1l1679t929r1712b953],
28	suggest	VB	O	suggest	infmod	26	SENT_19	[p1l1732t929r1850b963],
29	that	IN	O	that	complm	44	SENT_19	[p1l1869t923r1934b953],
30	tumor	NN	O	tumor	nsubj	44	SENT_19	[p1l1952t929r2058b953],
31	faCtol	NN	O	factol	nn	33	SENT_19	[p1l97t966r200b991],
32	'	''	O	'	_	0	SENT_19	[p1l97t966r200b991],
33	o	NN	O	o	dep	30	SENT_19	[p1l97t966r200b991],
34	<	JJR	O	<	amod	36	SENT_19	[p1l97t966r200b991],
35	necrosis	NN	O	necrosis	nn	36	SENT_19	[p1l765t969r898b999],
36	factor	NN	O	factor	dep	30	SENT_19	[p1l912t968r1046b999],
37	—	CD	NUMBER	—	num	40	SENT_19	[p1l912t968r1046b999],
38	oc	NN	O	oc	nn	40	SENT_19	[p1l912t968r1046b999],
39	(	NN	O	(	nn	40	SENT_19	[p1l1062t968r1202b1005],
40	TNF	NN	O	tnf	dep	36	SENT_19	[p1l1062t968r1202b1005],
41	—	NN	O	—	nn	43	SENT_19	[p1l1062t968r1202b1005],
42	oc	NN	O	oc	nn	43	SENT_19	[p1l1062t968r1202b1005],
43	)	NN	O	)	dep	36	SENT_19	[p1l1062t968r1202b1005],
44	plays	VBZ	O	play	ccomp	28	SENT_19	[p1l1218t968r1300b1008],
45	an	DT	O	a	det	47	SENT_19	[p1l1315t979r1353b999],
46	important	JJ	O	important	amod	47	SENT_19	[p1l1367t969r1537b1008],
47	role	NN	O	role	dobj	44	SENT_19	[p1l1550t968r1613b999],
48	in	IN	O	in	_	0	SENT_19	[p1l1627t969r1659b998],
49	drug	NN	O	drug	prep_in	47	SENT_19	[p1l1673t968r1763b1008],
50	—	CD	NUMBER	—	num	49	SENT_19	[p1l1673t968r1763b1008],
51	or	CC	O	or	_	0	SENT_19	[p1l1779t979r1814b999],
52	drug	NN	O	drug	dobj	44	SENT_19	[p1l1828t968r1905b1008],
53	metabolite-induced	JJ	O	metabolite-induced	amod	55	SENT_19	[p1l1918t968r2056b999, p1l765t1014r966b1044],
54	immune	JJ	O	immune	amod	55	SENT_19	[p1l979t1015r1119b1044],
55	responses	NNS	O	response	dep	52	SENT_19	[p1l1132t1024r1298b1054],
56	.	.	O	.	_	0	SENT_19	[p1l1132t1024r1298b1054],

1	We	PRP	O	we	nsubj	2	SENT_20	[p1l1312t1016r1368b1044],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_20	[p1l1380t1014r1598b1054],
3	that	IN	O	that	complm	12	SENT_20	[p1l1610t1014r1676b1044],
4	polymorphisms	NNS	O	polymorphism	nsubjpass	12	SENT_20	[p1l1687t1014r1948b1054],
5	in	IN	O	in	_	0	SENT_20	[p1l1962t1015r1994b1044],
6	the	DT	O	the	det	10	SENT_20	[p1l2006t1014r2057b1044],
7	TNF	NN	O	tnf	nn	10	SENT_20	[p1l765t1061r879b1090],
8	—	NN	O	—	nn	10	SENT_20	[p1l765t1061r879b1090],
9	oL	NN	O	ol	nn	10	SENT_20	[p1l765t1061r879b1090],
10	gene	NN	O	gene	prep_in	4	SENT_20	[p1l892t1071r966b1100],
11	are	VBP	O	be	auxpass	12	SENT_20	[p1l979t1071r1028b1090],
12	associated	VBN	O	associate	ccomp	2	SENT_20	[p1l1041t1060r1208b1090],
13	with	IN	O	with	_	0	SENT_20	[p1l1219t1060r1293b1090],
14	anti	JJ	O	anti	amod	16	SENT_20	[p1l1306t1060r1586b1090],
15	—	NN	O	—	nn	16	SENT_20	[p1l1306t1060r1586b1090],
16	tuberculosis	NN	O	tuberculosis	prep_with	12	SENT_20	[p1l1306t1060r1586b1090],
17	drug	NN	O	drug	nn	20	SENT_20	[p1l1600t1060r1677b1100],
18	(	CD	NUMBER	(	num	20	SENT_20	[p1l1692t1060r1951b1096],
19	ATD	NN	ORGANIZATION	atd	nn	20	SENT_20	[p1l1692t1060r1951b1096],
20	)	NN	O	)	dep	16	SENT_20	[p1l1692t1060r1951b1096],
21	.	.	O	.	_	0	SENT_20	[p1l1692t1060r1951b1096],

1	—	NN	O	—	_	0	SENT_21	[p1l1692t1060r1951b1096],
2	.	.	O	.	_	0	SENT_21	[p1l1692t1060r1951b1096],

1	induced	VBN	O	induce	_	0	SENT_22	[p1l1692t1060r1951b1096],
2	hepatitis	NN	O	hepatitis	dobj	1	SENT_22	[p1l1964t1060r2056b1099, p1l765t1107r835b1136],
3	.	.	O	.	_	0	SENT_22	[p1l1964t1060r2056b1099, p1l765t1107r835b1136],

1	Methods	NNS	O	method	nsubj	9	SENT_23	[p1l858t1105r1006b1136],
2	:	:	O	:	_	0	SENT_23	[p1l858t1105r1006b1136],
3	Patients	NNS	O	patient	dep	1	SENT_23	[p1l1029t1107r1160b1136],
4	who	WP	O	who	nsubj	5	SENT_23	[p1l1187t1106r1257b1136],
5	suffered	VBD	O	suffer	rcmod	3	SENT_23	[p1l1286t1105r1417b1136],
6	from	IN	O	from	_	0	SENT_23	[p1l1445t1105r1526b1136],
7	ATD	NN	O	atd	nn	8	SENT_23	[p1l1553t1105r1785b1136],
8	—	NN	O	—	prep_from	5	SENT_23	[p1l1553t1105r1785b1136],
9	induced	VBD	O	induce	_	0	SENT_23	[p1l1553t1105r1785b1136],
10	hepatitis	NN	O	hepatitis	nsubjpass	12	SENT_23	[p1l1812t1105r1953b1145],
11	were	VBD	O	be	auxpass	12	SENT_23	[p1l1980t1116r2057b1136],
12	enrolled	VBN	O	enrol	ccomp	9	SENT_23	[p1l766t1151r901b1182],
13	in	IN	O	in	_	0	SENT_23	[p1l918t1152r950b1181],
14	the	DT	O	the	det	15	SENT_23	[p1l966t1151r1017b1182],
15	study	NN	O	study	prep_in	12	SENT_23	[p1l1034t1151r1131b1191],
16	.	.	O	.	_	0	SENT_23	[p1l1034t1151r1131b1191],

1	ATD	NN	O	atd	nn	2	SENT_24	[p1l1149t1151r1382b1182],
2	—	NN	O	—	nsubj	3	SENT_24	[p1l1149t1151r1382b1182],
3	induced	VBD	O	induce	_	0	SENT_24	[p1l1149t1151r1382b1182],
4	hepatitis	NN	O	hepatitis	nsubjpass	6	SENT_24	[p1l1398t1151r1539b1191],
5	was	VBD	O	be	auxpass	6	SENT_24	[p1l1555t1162r1615b1182],
6	deﬁned	VBN	O	deﬁned	ccomp	3	SENT_24	[p1l1633t1151r1756b1182],
7	as	IN	O	as	_	0	SENT_24	[p1l1773t1162r1803b1182],
8	an	DT	O	a	det	9	SENT_24	[p1l1821t1162r1859b1182],
9	increase	NN	O	increase	prep_as	6	SENT_24	[p1l1876t1152r2008b1182],
10	in	IN	O	in	_	0	SENT_24	[p1l2025t1152r2057b1181],
11	liver	NN	O	liver	nn	13	SENT_24	[p1l765t1197r837b1227],
12	transaminase	NN	O	transaminase	nn	13	SENT_24	[p1l852t1198r1070b1227],
13	levels	NNS	O	level	prep_in	9	SENT_24	[p1l1085t1197r1173b1227],
14	that	WDT	O	that	nsubj	22	SENT_24	[p1l1188t1197r1253b1227],
15	were	VBD	O	be	cop	22	SENT_24	[p1l1267t1208r1344b1227],
16	more	JJR	O	more	mwe	17	SENT_24	[p1l1360t1208r1446b1227],
17	than	IN	O	than	quantmod	19	SENT_24	[p1l1461t1197r1536b1227],
18	three	CD	NUMBER	three	number	19	SENT_24	[p1l1550t1197r1634b1227],
19	times	NNS	O	time	num	22	SENT_24	[p1l1649t1198r1737b1227],
20	the	DT	O	the	det	22	SENT_24	[p1l1753t1197r1804b1227],
21	upper	JJ	O	upper	amod	22	SENT_24	[p1l1819t1208r1917b1236],
22	limit	NN	O	limit	rcmod	9	SENT_24	[p1l1931t1197r2010b1227],
23	of	IN	O	of	_	0	SENT_24	[p1l2026t1197r2062b1227],
24	normal	JJ	O	normal	prep_of	22	SENT_24	[p1l765t1243r894b1273],
25	.	.	O	.	_	0	SENT_24	[p1l765t1243r894b1273],

1	ATD	NN	O	atd	npadvmod	3	SENT_25	[p1l910t1243r1139b1273],
2	—	CD	NUMBER	—	num	1	SENT_25	[p1l910t1243r1139b1273],
3	tolerant	JJ	O	tolerant	amod	4	SENT_25	[p1l910t1243r1139b1273],
4	patients	NNS	O	patient	nsubjpass	6	SENT_25	[p1l1153t1244r1283b1282],
5	were	VBD	O	be	auxpass	6	SENT_25	[p1l1298t1254r1375b1273],
6	used	VBN	O	use	_	0	SENT_25	[p1l1391t1243r1466b1273],
7	as	IN	O	as	_	0	SENT_25	[p1l1481t1254r1512b1273],
8	a	DT	O	a	det	9	SENT_25	[p1l1528t1254r1544b1273],
9	control	NN	O	control	prep_as	6	SENT_25	[p1l1559t1243r1687b1273],
10	.	.	O	.	_	0	SENT_25	[p1l1559t1243r1687b1273],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_26	[p1l1705t1244r1835b1273],
2	were	VBD	O	be	auxpass	3	SENT_26	[p1l1850t1254r1927b1273],
3	treated	VBN	O	treat	_	0	SENT_26	[p1l1942t1243r2057b1273],

1	Correspondence	NN	O	correspondence	_	0	SENT_27	[p1l98t1089r333b1119],
2	Young	NN	O	young	dep	1	SENT_27	[p1l97t1134r248b1163],
3	.	.	O	.	_	0	SENT_27	[p1l97t1134r248b1163],

1	—	NN	O	—	_	0	SENT_28	[p1l97t1134r248b1163],
2	.	.	O	.	_	0	SENT_28	[p1l97t1134r248b1163],

1	Koo	NNP	PERSON	Koo	nn	2	SENT_29	[p1l97t1134r248b1163],
2	Jee	NNP	PERSON	Jee	_	0	SENT_29	[p1l257t1134r304b1161],
3	,	,	O	,	_	0	SENT_29	[p1l257t1134r304b1161],
4	MD	NNP	O	MD	appos	2	SENT_29	[p1l317t1134r369b1161],
5	,	,	O	,	_	0	SENT_29	[p1l317t1134r369b1161],
6	PhD	NNP	O	PhD	appos	2	SENT_29	[p1l382t1132r439b1161],
7	,	,	O	,	_	0	SENT_29	[p1l382t1132r439b1161],
8	Department	NNP	ORGANIZATION	Department	appos	2	SENT_29	[p1l452t1134r608b1163],
9	of	IN	ORGANIZATION	of	_	0	SENT_29	[p1l618t1132r644b1157],
10	Internal	NNP	ORGANIZATION	Internal	nn	11	SENT_29	[p1l99t1176r195b1200],
11	Medicine	NNP	ORGANIZATION	Medicine	prep_of	8	SENT_29	[p1l207t1176r331b1204],
12	,	,	O	,	_	0	SENT_29	[p1l207t1176r331b1204],
13	Dankook	NNP	ORGANIZATION	Dankook	nn	15	SENT_29	[p1l344t1176r460b1200],
14	University	NNP	ORGANIZATION	University	nn	15	SENT_29	[p1l471t1177r596b1207],
15	College	NNP	ORGANIZATION	College	appos	2	SENT_29	[p1l98t1220r196b1250],
16	of	IN	ORGANIZATION	of	_	0	SENT_29	[p1l206t1220r232b1244],
17	Medicine	NNP	ORGANIZATION	Medicine	prep_of	15	SENT_29	[p1l242t1220r367b1248],
18	,	,	O	,	_	0	SENT_29	[p1l242t1220r367b1248],
19	Anseo	NNP	O	Anseo	appos	2	SENT_29	[p1l378t1220r538b1250],
20	—	CD	NUMBER	—	num	19	SENT_29	[p1l378t1220r538b1250],
21	dong	JJ	O	dong	amod	19	SENT_29	[p1l378t1220r538b1250],
22	San	NNP	O	San	dep	21	SENT_29	[p1l549t1221r593b1244],
23	16-5	CD	NUMBER	16-5	num	22	SENT_29	[p1l607t1221r671b1248],
24	,	,	O	,	_	0	SENT_29	[p1l607t1221r671b1248],
25	Cheonan	NNP	LOCATION	Cheonan	appos	2	SENT_29	[p1l99t1263r215b1288],
26	330-715	CD	NUMBER	330-715	num	25	SENT_29	[p1l227t1265r345b1291],
27	,	,	O	,	_	0	SENT_29	[p1l227t1265r345b1291],
28	Korea	NNP	LOCATION	Korea	nn	37	SENT_29	[p1l358t1265r432b1288],
29	Tel.	NNP	O	Tel.	nn	37	SENT_29	[p1l97t1307r141b1331],
30	+82	CD	NUMBER	+82	num	37	SENT_29	[p1l153t1309r388b1331],
31	_	CD	NUMBER	_	number	32	SENT_29	[p1l153t1309r388b1331],
32	41_550_3923	CD	NUMBER	41_550_3923	dep	37	SENT_29	[p1l153t1309r388b1331],
33	with	IN	O	with	_	0	SENT_29	[p1l764t1289r838b1319],
34	ﬁrst	JJ	O	ﬁrst	amod	36	SENT_29	[p1l859t1288r923b1319],
35	line	NN	O	line	nn	36	SENT_29	[p1l943t1289r1003b1319],
36	ATD	NN	ORGANIZATION	atd	prep_with	32	SENT_29	[p1l1022t1290r1103b1318],
37	therapies	NNS	O	therapy	appos	2	SENT_29	[p1l1124t1289r1274b1328],
38	including	VBG	O	include	_	0	SENT_29	[p1l1295t1289r1452b1328],
39	isoniazid	NN	O	isoniazid	nn	45	SENT_29	[p1l1472t1289r1629b1323],
40	,	,	O	,	_	0	SENT_29	[p1l1472t1289r1629b1323],
41	rifampicin	NN	O	rifampicin	dep	45	SENT_29	[p1l1651t1289r1833b1328],
42	,	,	O	,	_	0	SENT_29	[p1l1651t1289r1833b1328],
43	ethambutol	NN	O	ethambutol	dep	45	SENT_29	[p1l1856t1289r2056b1324],
44	,	,	O	,	_	0	SENT_29	[p1l1856t1289r2056b1324],
45	Fax	NN	O	fax	prep_including	37	SENT_29	[p1l99t1352r146b1375],
46	;	:	O	;	_	0	SENT_29	[p1l99t1352r146b1375],
47	+82	CD	NUMBER	+82	number	48	SENT_29	[p1l158t1352r395b1375],
48	_	CD	NUMBER	_	conj_and	37	SENT_29	[p1l158t1352r395b1375],
49	41_556_3256	CD	NUMBER	41_556_3256	dep	48	SENT_29	[p1l158t1352r395b1375],
50	and	CC	O	and	_	0	SENT_29	[p1l766t1334r827b1365],
51	pyrazinamide	NN	O	pyrazinamide	conj_and	37	SENT_29	[p1l847t1334r1082b1374],
52	.	.	O	.	_	0	SENT_29	[p1l847t1334r1082b1374],

1	We	PRP	O	we	nsubj	2	SENT_30	[p1l1103t1337r1160b1364],
2	compared	VBD	O	compare	_	0	SENT_30	[p1l1181t1334r1348b1374],
3	the	DT	O	the	det	5	SENT_30	[p1l1368t1334r1419b1365],
4	genotype	NN	O	genotype	nn	5	SENT_30	[p1l1440t1340r1590b1374],
5	frequencies	NNS	O	frequency	nsubj	9	SENT_30	[p1l1611t1334r1798b1374],
6	of	IN	O	of	_	0	SENT_30	[p1l1819t1334r1856b1365],
7	the	DT	O	the	det	8	SENT_30	[p1l1872t1334r1923b1365],
8	TNF-or	NN	O	tnf-or	prep_of	5	SENT_30	[p1l1943t1336r2057b1364],
9	e-mail	VB	O	e-mail	ccomp	2	SENT_30	[p1l98t1394r184b1419],
10	:	:	O	:	_	0	SENT_30	[p1l98t1394r184b1419],
11	ykjee@dku_edu	NN	O	ykjee@dku_edu	nn	14	SENT_30	[p1l195t1394r394b1425],
12	polymorphism	NN	O	polymorphism	nn	14	SENT_30	[p1l765t1380r1012b1420],
13	—	NN	O	—	nn	14	SENT_30	[p1l1028t1382r1170b1412],
14	308G/A	NN	O	308g/a	nsubj	21	SENT_30	[p1l1028t1382r1170b1412],
15	in	IN	O	in	_	0	SENT_30	[p1l1185t1381r1217b1410],
16	77	CD	NUMBER	77	num	17	SENT_30	[p1l1234t1383r1270b1410],
17	patients	NNS	O	patient	prep_in	14	SENT_30	[p1l1285t1381r1416b1419],
18	with	IN	O	with	_	0	SENT_30	[p1l1431t1380r1505b1410],
19	ATD	NN	O	atd	nn	20	SENT_30	[p1l1519t1380r1751b1410],
20	—	NN	O	—	prep_with	17	SENT_30	[p1l1519t1380r1751b1410],
21	induced	VBD	O	induce	parataxis	2	SENT_30	[p1l1519t1380r1751b1410],
22	hepatitis	NN	O	hepatitis	dobj	21	SENT_30	[p1l1766t1380r1907b1419],
23	and	CC	O	and	_	0	SENT_30	[p1l1923t1380r1984b1410],
24	229	CD	NUMBER	229	num	26	SENT_30	[p1l1999t1383r2056b1410],
25	ATD-tolerant	JJ	O	atd-tolerant	amod	26	SENT_30	[p1l764t1425r992b1455],
26	patients	NNS	O	patient	conj_and	22	SENT_30	[p1l1009t1426r1148b1465],
27	.	.	O	.	_	0	SENT_30	[p1l1009t1426r1148b1465],

1	Results	NNS	O	result	dep	107	SENT_31	[p1l1171t1425r1292b1455],
2	:	:	O	:	_	0	SENT_31	[p1l1171t1425r1292b1455],
3	The	DT	O	the	dep	107	SENT_31	[p1l1315t1425r1378b1455],
4	frequency	NN	O	frequency	dep	107	SENT_31	[p1l1395t1425r1559b1465],
5	of	IN	O	of	dep	107	SENT_31	[p1l1575t1425r1611b1455],
6	carrying	VBG	O	carry	dep	107	SENT_31	[p1l1623t1426r1759b1465],
7	the	DT	O	the	dep	107	SENT_31	[p1l1775t1425r1826b1455],
8	variant	JJ	O	variant	dep	107	SENT_31	[p1l1841t1426r1958b1455],
9	allele	NN	O	allele	dep	107	SENT_31	[p1l1975t1425r2057b1455],
10	Received	VBN	O	receive	dep	107	SENT_31	[p1l99t1476r211b1500],
11	16	CD	DATE	16	dep	107	SENT_31	[p1l225t1477r254b1500],
12	October	NNP	DATE	October	dep	107	SENT_31	[p1l264t1476r369b1500],
13	2011	CD	DATE	2011	dep	107	SENT_31	[p1l379t1477r440b1500],
14	(	NNP	O	(	dep	107	SENT_31	[p1l768t1470r835b1507],
15	AG	NNP	O	AG	dep	107	SENT_31	[p1l768t1470r835b1507],
16	or	CC	O	or	dep	107	SENT_31	[p1l850t1481r885b1500],
17	AA	NNP	O	AA	dep	107	SENT_31	[p1l898t1470r964b1507],
18	)	NN	O	)	dep	107	SENT_31	[p1l898t1470r964b1507],
19	was	VBD	O	be	dep	107	SENT_31	[p1l981t1481r1041b1500],
20	signiﬁcantly	RB	O	signiﬁcantly	dep	107	SENT_31	[p1l1056t1470r1258b1510],
21	higher	JJR	O	higher	dep	107	SENT_31	[p1l1271t1470r1377b1510],
22	in	IN	O	in	dep	107	SENT_31	[p1l1391t1471r1423b1500],
23	patients	NNS	O	patient	dep	107	SENT_31	[p1l1437t1471r1568b1510],
24	with	IN	O	with	dep	107	SENT_31	[p1l1582t1470r1656b1500],
25	ATD	NN	O	atd	dep	107	SENT_31	[p1l1669t1470r1901b1500],
26	—	NN	O	—	dep	107	SENT_31	[p1l1669t1470r1901b1500],
27	induced	VBD	O	induce	dep	107	SENT_31	[p1l1669t1470r1901b1500],
28	hepatitis	NN	O	hepatitis	dep	107	SENT_31	[p1l1916t1470r2057b1510],
29	Accepted	JJ	O	accepted	dep	107	SENT_31	[p1l97t1519r219b1549],
30	5	CD	DATE	5	dep	107	SENT_31	[p1l232t1521r245b1543],
31	November	NNP	DATE	November	dep	107	SENT_31	[p1l256t1519r390b1543],
32	2011	CD	DATE	2011	dep	107	SENT_31	[p1l400t1520r461b1543],
33	compared	VBN	O	compare	dep	107	SENT_31	[p1l766t1515r932b1554],
34	with	IN	O	with	dep	107	SENT_31	[p1l943t1515r1017b1545],
35	ATD	NN	O	atd	dep	107	SENT_31	[p1l1028t1515r1256b1545],
36	—	CD	NUMBER	—	dep	107	SENT_31	[p1l1028t1515r1256b1545],
37	tolerant	JJ	O	tolerant	dep	107	SENT_31	[p1l1028t1515r1256b1545],
38	patients	NNS	O	patient	dep	107	SENT_31	[p1l1268t1516r1398b1554],
39	[	IN	O	[	dep	107	SENT_31	[p1l1415t1515r1528b1551],
40	26.0	CD	PERCENT	26.0	dep	107	SENT_31	[p1l1415t1515r1528b1551],
41	%	NN	PERCENT	%	dep	107	SENT_31	[p1l1415t1515r1528b1551],
42	vs.	CC	O	vs.	dep	107	SENT_31	[p1l1541t1526r1582b1545],
43	15.3	CD	PERCENT	15.3	dep	107	SENT_31	[p1l1599t1518r1708b1550],
44	%	NN	PERCENT	%	dep	107	SENT_31	[p1l1599t1518r1708b1550],
45	,	,	O	,	_	0	SENT_31	[p1l1599t1518r1708b1550],
46	P	NN	O	p	dep	107	SENT_31	[p1l1721t1517r1742b1545],
47	=	JJ	O	=	dep	107	SENT_31	[p1l1755t1528r1777b1538],
48	0.034	CD	NUMBER	0.034	dep	107	SENT_31	[p1l1791t1518r1888b1550],
49	,	,	O	,	_	0	SENT_31	[p1l1791t1518r1888b1550],
50	OR	NN	O	or	dep	107	SENT_31	[p1l1901t1517r1957b1545],
51	(	CD	PERCENT	(	dep	107	SENT_31	[p1l1971t1515r2056b1551],
52	95	CD	PERCENT	95	dep	107	SENT_31	[p1l1971t1515r2056b1551],
53	%	NN	PERCENT	%	dep	107	SENT_31	[p1l1971t1515r2056b1551],
54	CI	NN	O	ci	dep	107	SENT_31	[p1l766t1560r817b1597],
55	)	NN	O	)	dep	107	SENT_31	[p1l766t1560r817b1597],
56	=	JJ	O	=	dep	107	SENT_31	[p1l833t1573r855b1584],
57	1.94	CD	NUMBER	1.94	dep	107	SENT_31	[p1l872t1563r936b1591],
58	(	CD	NUMBER	(	dep	107	SENT_31	[p1l951t1560r1149b1597],
59	1.04	CD	NUMBER	1.04	dep	107	SENT_31	[p1l951t1560r1149b1597],
60	—	NN	O	—	dep	107	SENT_31	[p1l951t1560r1149b1597],
61	3.64	CD	NUMBER	3.64	dep	107	SENT_31	[p1l951t1560r1149b1597],
62	)	CD	NUMBER	)	dep	107	SENT_31	[p1l951t1560r1149b1597],
63	]	NN	O	]	dep	107	SENT_31	[p1l951t1560r1149b1597],
64	and	CC	O	and	dep	107	SENT_31	[p1l1166t1560r1227b1591],
65	the	DT	O	the	dep	107	SENT_31	[p1l1239t1560r1290b1591],
66	frequency	NN	O	frequency	dep	107	SENT_31	[p1l1302t1560r1466b1600],
67	of	IN	O	of	dep	107	SENT_31	[p1l1477t1560r1513b1591],
68	the	DT	O	the	dep	107	SENT_31	[p1l1520t1560r1571b1591],
69	A	NN	O	a	dep	107	SENT_31	[p1l1582t1562r1609b1590],
70	allele	NN	O	allele	dep	107	SENT_31	[p1l1621t1560r1703b1591],
71	was	VBD	O	be	dep	107	SENT_31	[p1l1714t1571r1774b1591],
72	signiﬁcantly	RB	O	signiﬁcantly	dep	107	SENT_31	[p1l1786t1560r1988b1600],
73	difDOHOVIIII/l	NN	O	difdohoviiii/l	dep	107	SENT_31	[p1l1999t1560r2056b1591, p1l99t1602r635b1632],
74	'	''	O	'	_	0	SENT_31	[p1l1999t1560r2056b1591, p1l99t1602r635b1632],
75	I478	NN	O	i478	dep	107	SENT_31	[p1l1999t1560r2056b1591, p1l99t1602r635b1632],
76	'	''	O	'	_	0	SENT_31	[p1l1999t1560r2056b1591, p1l99t1602r635b1632],
77	323I	NN	O	323us	dep	107	SENT_31	[p1l1999t1560r2056b1591, p1l99t1602r635b1632],
78	'	''	O	'	_	0	SENT_31	[p1l1999t1560r2056b1591, p1l99t1602r635b1632],
79	20lI-02597-X	JJ	O	20li-02597-x	dep	107	SENT_31	[p1l1999t1560r2056b1591, p1l99t1602r635b1632],
80	ferent	JJ	O	ferent	dep	107	SENT_31	[p1l766t1606r862b1637],
81	between	IN	O	between	dep	107	SENT_31	[p1l876t1606r1012b1637],
82	the	DT	O	the	dep	107	SENT_31	[p1l1028t1606r1079b1637],
83	two	CD	NUMBER	two	dep	107	SENT_31	[p1l1095t1612r1156b1637],
84	groups	NNS	O	group	dep	107	SENT_31	[p1l1173t1617r1286b1646],
85	[	VBP	O	[	dep	107	SENT_31	[p1l1307t1606r1404b1643],
86	0.143	CD	NUMBER	0.143	dep	107	SENT_31	[p1l1307t1606r1404b1643],
87	vs.	CC	O	vs.	dep	107	SENT_31	[p1l1421t1617r1462b1637],
88	0.079	CD	NUMBER	0.079	dep	107	SENT_31	[p1l1480t1609r1577b1641],
89	,	,	O	,	_	0	SENT_31	[p1l1480t1609r1577b1641],
90	P	NN	O	p	dep	107	SENT_31	[p1l1594t1608r1615b1636],
91	=	JJ	O	=	dep	107	SENT_31	[p1l1633t1619r1655b1630],
92	0.018	CD	NUMBER	0.018	dep	107	SENT_31	[p1l1672t1609r1769b1641],
93	,	,	O	,	_	0	SENT_31	[p1l1672t1609r1769b1641],
94	OR	NN	O	or	dep	107	SENT_31	[p1l1786t1608r1842b1637],
95	(	CD	PERCENT	(	dep	107	SENT_31	[p1l1859t1606r1945b1643],
96	95	CD	PERCENT	95	dep	107	SENT_31	[p1l1859t1606r1945b1643],
97	%	NN	PERCENT	%	dep	107	SENT_31	[p1l1859t1606r1945b1643],
98	CI	NN	O	ci	dep	107	SENT_31	[p1l1963t1606r2015b1643],
99	)	NN	O	)	dep	107	SENT_31	[p1l1963t1606r2015b1643],
100	=	JJ	O	=	dep	107	SENT_31	[p1l2034t1619r2056b1630],
101	1.95	CD	NUMBER	1.95	dep	107	SENT_31	[p1l769t1654r832b1682],
102	(	CD	NUMBER	(	dep	107	SENT_31	[p1l855t1651r1066b1688],
103	1.11	CD	NUMBER	1.11	dep	107	SENT_31	[p1l855t1651r1066b1688],
104	—	NN	O	—	dep	107	SENT_31	[p1l855t1651r1066b1688],
105	3.44	CD	NUMBER	3.44	dep	107	SENT_31	[p1l855t1651r1066b1688],
106	)	CD	NUMBER	)	dep	107	SENT_31	[p1l855t1651r1066b1688],
107	]	NN	O	]	_	0	SENT_31	[p1l855t1651r1066b1688],
108	.	.	O	.	_	0	SENT_31	[p1l855t1651r1066b1688],

1	Conclusion	NN	O	conclusion	_	0	SENT_32	[p1l1092t1651r1278b1682],
2	:	:	O	:	_	0	SENT_32	[p1l1092t1651r1278b1682],
3	These	DT	O	these	det	4	SENT_32	[p1l1300t1651r1396b1682],
4	results	NNS	O	result	nsubj	5	SENT_32	[p1l1415t1651r1520b1682],
5	reveal	VBP	O	reveal	dep	1	SENT_32	[p1l1540t1651r1636b1682],
6	that	IN	O	that	complm	21	SENT_32	[p1l1654t1651r1720b1682],
7	the	DT	O	the	det	10	SENT_32	[p1l1738t1651r1789b1682],
8	TNF	NN	MISC	tnf	nn	10	SENT_32	[p1l1808t1652r1922b1682],
9	—	NN	O	—	nn	10	SENT_32	[p1l1808t1652r1922b1682],
10	oc	NN	O	oc	nsubj	21	SENT_32	[p1l1808t1652r1922b1682],
11	genetic	JJ	O	genetic	amod	14	SENT_32	[p1l1941t1652r2057b1691],
12	polymorphism	NN	O	polymorphism	nn	14	SENT_32	[p1l765t1696r1012b1736],
13	—	NN	O	—	nn	14	SENT_32	[p1l1026t1698r1168b1728],
14	308G/A	NN	O	308g/a	nsubjpass	17	SENT_32	[p1l1026t1698r1168b1728],
15	is	VBZ	O	be	auxpass	17	SENT_32	[p1l1180t1697r1204b1727],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_32	[p1l1218t1696r1419b1736],
17	associated	VBN	O	associate	rcmod	10	SENT_32	[p1l1431t1696r1598b1727],
18	with	IN	O	with	_	0	SENT_32	[p1l1609t1696r1683b1727],
19	ATD	NN	O	atd	nn	20	SENT_32	[p1l1695t1696r1927b1727],
20	—	NN	O	—	prep_with	17	SENT_32	[p1l1695t1696r1927b1727],
21	induced	VBD	O	induce	ccomp	5	SENT_32	[p1l1695t1696r1927b1727],
22	hepatitis	NN	O	hepatitis	dobj	21	SENT_32	[p1l1939t1696r2055b1736, p1l765t1743r811b1773],
23	.	.	O	.	_	0	SENT_32	[p1l1939t1696r2055b1736, p1l765t1743r811b1773],

1	This	DT	O	this	det	3	SENT_33	[p1l830t1742r901b1773],
2	genetic	JJ	O	genetic	amod	3	SENT_33	[p1l920t1743r1035b1782],
3	variant	NN	O	variant	nsubj	8	SENT_33	[p1l1052t1743r1169b1773],
4	may	MD	O	may	aux	8	SENT_33	[p1l1186t1753r1257b1782],
5	be	VB	O	be	cop	8	SENT_33	[p1l1272t1742r1310b1773],
6	a	DT	O	a	det	8	SENT_33	[p1l1328t1753r1345b1773],
7	risk	NN	O	risk	nn	8	SENT_33	[p1l1362t1742r1423b1773],
8	factor	NN	O	factor	_	0	SENT_33	[p1l1440t1742r1535b1773],
9	for	IN	O	for	mark	12	SENT_33	[p1l1553t1742r1601b1773],
10	ATD	NN	O	atd	nn	11	SENT_33	[p1l1616t1742r1849b1773],
11	—	NN	O	—	nsubj	12	SENT_33	[p1l1616t1742r1849b1773],
12	induced	VBD	O	induce	advcl	8	SENT_33	[p1l1616t1742r1849b1773],
13	hepatitis	NN	O	hepatitis	dobj	12	SENT_33	[p1l1866t1742r2007b1782],
14	in	IN	O	in	_	0	SENT_33	[p1l2025t1743r2057b1772],
15	individuals	NNS	O	individual	prep_in	12	SENT_33	[p1l766t1787r949b1817],
16	from	IN	O	from	_	0	SENT_33	[p1l961t1787r1043b1817],
17	Korea	NNP	LOCATION	Korea	prep_from	12	SENT_33	[p1l1055t1789r1161b1817],
18	.	.	O	.	_	0	SENT_33	[p1l1055t1789r1161b1817],

1	Tuberculosis	NN	O	tuberculosis	nsubj	9	SENT_34	[p1l8t1987r487b2055],
2	(	CD	NUMBER	(	num	4	SENT_34	[p1l556t1987r722b2069],
3	TB	NN	O	tb	nn	4	SENT_34	[p1l556t1987r722b2069],
4	)	NN	O	)	dep	1	SENT_34	[p1l556t1987r722b2069],
5	remains	VBZ	O	remain	cop	9	SENT_34	[p1l791t1989r1088b2055],
6	a	DT	O	a	det	9	SENT_34	[p1l1152t2012r1189b2055],
7	major	JJ	O	major	amod	9	SENT_34	[p1l1250t1989r1473b2076],
8	health	NN	O	health	nn	9	SENT_34	[p1l1533t1987r1763b2055],
9	problem	NN	O	problem	_	0	SENT_34	[p1l1824t1987r2143b2075],
10	around	IN	O	around	_	0	SENT_34	[p1l9t2089r281b2157],
11	the	DT	O	the	det	12	SENT_34	[p1l355t2089r470b2157],
12	world	NN	O	world	prep_around	9	SENT_34	[p1l543t2089r781b2157],
13	.	.	O	.	_	0	SENT_34	[p1l543t2089r781b2157],

1	During	IN	O	during	_	0	SENT_35	[p1l861t2092r1131b2178],
2	treatment	NN	O	treatment	prep_during	19	SENT_35	[p1l1204t2102r1573b2157],
3	of	IN	O	of	_	0	SENT_35	[p1l1648t2089r1731b2157],
4	TB	NN	O	tb	prep_of	2	SENT_35	[p1l1795t2092r1901b2156],
5	with	IN	O	with	_	0	SENT_35	[p1l1975t2089r2143b2157],
6	ﬁrst	NN	O	ﬁrst	nn	9	SENT_35	[p1l8t2190r327b2259],
7	—	CD	NUMBER	—	num	9	SENT_35	[p1l8t2190r327b2259],
8	line	NN	O	line	nn	9	SENT_35	[p1l8t2190r327b2259],
9	medications	NNS	O	medication	prep_with	4	SENT_35	[p1l376t2190r831b2259],
10	based	VBN	O	base	partmod	2	SENT_35	[p1l880t2190r1090b2259],
11	on	IN	O	on	_	0	SENT_35	[p1l1140t2215r1235b2259],
12	established	VBN	O	establish	amod	13	SENT_35	[p1l1285t2190r1694b2259],
13	guidelines	NNS	O	guideline	prep_on	10	SENT_35	[p1l1743t2190r2140b2281],
14	,	,	O	,	_	0	SENT_35	[p1l1743t2190r2140b2281],
15	various	JJ	O	various	amod	18	SENT_35	[p1l6t2296r281b2362],
16	adverse	JJ	O	adverse	amod	18	SENT_35	[p1l314t2294r589b2362],
17	drug	NN	O	drug	nn	18	SENT_35	[p1l623t2294r797b2383],
18	reactions	NNS	O	reaction	nsubj	19	SENT_35	[p1l828t2296r1165b2362],
19	(	VBP	O	(	_	0	SENT_35	[p1l1203t2294r1446b2376],
20	ADR	NN	O	adr	nn	21	SENT_35	[p1l1203t2294r1446b2376],
21	)	NN	O	)	nsubj	26	SENT_35	[p1l1203t2294r1446b2376],
22	induced	VBN	O	induce	partmod	21	SENT_35	[p1l1485t2294r1787b2362],
23	by	IN	O	by	_	0	SENT_35	[p1l1816t2294r1908b2383],
24	antituberculosis	NN	O	antituberculosis	nn	25	SENT_35	[p1l1937t2296r2139b2362, p1l8t2396r431b2464],
25	drugs	NNS	O	drug	agent	22	SENT_35	[p1l461t2396r667b2485],
26	(	VBP	O	(	ccomp	19	SENT_35	[p1l702t2396r943b2478],
27	ATD	NN	ORGANIZATION	atd	nn	28	SENT_35	[p1l702t2396r943b2478],
28	)	NN	O	)	nsubj	30	SENT_35	[p1l702t2396r943b2478],
29	often	RB	O	often	advmod	30	SENT_35	[p1l980t2396r1172b2464],
30	result	VBP	O	result	dep	26	SENT_35	[p1l1201t2396r1407b2464],
31	in	IN	O	in	_	0	SENT_35	[p1l1436t2399r1508b2463],
32	serious	JJ	O	serious	amod	33	SENT_35	[p1l1538t2399r1799b2464],
33	morbidities	NNS	O	morbidity	prep_in	30	SENT_35	[p1l1828t2396r2139b2464, p1l8t2499r156b2565],
34	and	CC	O	and	_	0	SENT_35	[p1l203t2496r340b2565],
35	mortalities	NNS	O	mortality	nsubj	36	SENT_35	[p1l384t2496r787b2565],
36	(	VBP	O	(	dep	26	SENT_35	[p1l838t2497r962b2579],
37	1	CD	NUMBER	1	number	38	SENT_35	[p1l838t2497r962b2579],
38	)	CD	NUMBER	)	dobj	36	SENT_35	[p1l838t2497r962b2579],
39	.	.	O	.	_	0	SENT_35	[p1l838t2497r962b2579],

1	Furthermore	RB	O	furthermore	advmod	11	SENT_36	[p1l1012t2497r1514b2576],
2	,	,	O	,	_	0	SENT_36	[p1l1012t2497r1514b2576],
3	serious	JJ	O	serious	advmod	11	SENT_36	[p1l1561t2499r1822b2565],
4	adverse	JJ	O	adverse	amod	5	SENT_36	[p1l1867t2496r2143b2565],
5	reactions	NNS	O	reaction	dep	3	SENT_36	[p1l9t2601r346b2667],
6	to	TO	O	to	_	0	SENT_36	[p1l375t2612r448b2667],
7	ATD	NN	ORGANIZATION	atd	nn	8	SENT_36	[p1l477t2602r659b2666],
8	lead	NN	O	lead	prep_to	3	SENT_36	[p1l690t2599r841b2667],
9	to	TO	O	to	_	0	SENT_36	[p1l870t2612r942b2667],
10	discontinuation	NN	O	discontinuation	prep_to	3	SENT_36	[p1l975t2599r1571b2667],
11	of	IN	O	of	_	0	SENT_36	[p1l1602t2599r1684b2667],
12	TB	NN	O	tb	nn	13	SENT_36	[p1l1702t2602r1809b2666],
13	medications	NNS	O	medication	pobj	11	SENT_36	[p1l1840t2599r2139b2667, p1l7t2704r212b2781],
14	,	,	O	,	_	0	SENT_36	[p1l1840t2599r2139b2667, p1l7t2704r212b2781],

1	thus	RB	O	thus	advmod	2	SENT_37	[p1l256t2702r416b2770],
2	hindering	VBG	O	hinder	_	0	SENT_37	[p1l458t2702r826b2791],
3	the	DT	O	the	det	5	SENT_37	[p1l866t2702r982b2770],
4	scheduled	JJ	O	scheduled	amod	5	SENT_37	[p1l1025t2702r1397b2770],
5	treatment	NN	O	treatment	dobj	2	SENT_37	[p1l1437t2715r1806b2770],
6	and	CC	O	and	_	0	SENT_37	[p1l1848t2702r1986b2770],
7	the	DT	O	the	det	9	SENT_37	[p1l2027t2702r2143b2770],
8	effective	JJ	O	effective	amod	9	SENT_37	[p1l9t2803r314b2871],
9	cure	NN	O	cure	conj_and	5	SENT_37	[p1l346t2828r504b2871],
10	of	IN	O	of	_	0	SENT_37	[p1l538t2803r620b2871],
11	TB	NN	O	tb	prep_of	9	SENT_37	[p1l640t2806r767b2871],
12	.	.	O	.	_	0	SENT_37	[p1l640t2806r767b2871],

1	The	DT	O	the	det	3	SENT_38	[p1l801t2803r944b2871],
2	ATD	NN	O	atd	nn	3	SENT_38	[p1l973t2803r1499b2871],
3	—	NN	O	—	nsubj	4	SENT_38	[p1l973t2803r1499b2871],
4	induced	VBD	O	induce	_	0	SENT_38	[p1l973t2803r1499b2871],
5	hepatitis	NN	O	hepatitis	nsubj	16	SENT_38	[p1l1529t2803r1869b2892],
6	,	,	O	,	_	0	SENT_38	[p1l1529t2803r1869b2892],
7	one	CD	NUMBER	one	nsubj	13	SENT_38	[p1l1904t2828r2039b2871],
8	of	IN	O	of	_	0	SENT_38	[p1l2071t2803r2153b2871],
9	the	DT	O	the	det	12	SENT_38	[p1l7t2906r123b2974],
10	major	JJ	O	major	amod	12	SENT_38	[p1l159t2908r381b2996],
11	ATD	NN	O	atd	nn	12	SENT_38	[p1l413t2906r940b2975],
12	—	NN	O	—	prep_of	7	SENT_38	[p1l413t2906r940b2975],
13	induced	VBD	O	induce	rcmod	5	SENT_38	[p1l413t2906r940b2975],
14	ADR	NNP	MISC	ADR	dobj	13	SENT_38	[p1l972t2910r1179b2985],
15	,	,	O	,	_	0	SENT_38	[p1l972t2910r1179b2985],
16	ranges	VBZ	O	range	ccomp	4	SENT_38	[p1l1218t2930r1455b2996],
17	from	IN	O	from	_	0	SENT_38	[p1l1492t2905r1677b2974],
18	asymptomatic	JJ	O	asymptomatic	amod	19	SENT_38	[p1l1713t2920r2138b2996, p1l9t3011r140b3076],
19	elevations	NNS	O	elevation	prep_from	16	SENT_38	[p1l177t3008r545b3076],
20	of	IN	O	of	_	0	SENT_38	[p1l584t3008r666b3076],
21	liver	NN	O	liver	nn	22	SENT_38	[p1l690t3008r854b3076],
22	transaminases	NNS	O	transaminase	prep_of	19	SENT_38	[p1l889t3010r1416b3076],
23	to	TO	O	to	_	0	SENT_38	[p1l1452t3021r1525b3076],
24	acute	JJ	O	acute	amod	26	SENT_38	[p1l1565t3022r1760b3076],
25	liver	NN	O	liver	nn	26	SENT_38	[p1l1795t3008r1959b3076],
26	failure	NN	O	failure	prep_to	16	SENT_38	[p1l1995t3008r2139b3076, p2l8t49r149b104],
27	,	,	O	,	_	0	SENT_38	[p1l1995t3008r2139b3076, p2l8t49r149b104],

1	necessitating	VBG	O	necessitate	amod	4	SENT_39	[p2l188t27r665b115],
2	liver	NN	O	liver	nn	4	SENT_39	[p2l701t24r864b93],
3	transplantation	NN	O	transplantation	nn	4	SENT_39	[p2l901t24r1478b114],
4	(	NN	O	(	_	0	SENT_39	[p2l1521t25r1646b107],
5	2	CD	NUMBER	2	num	6	SENT_39	[p2l1521t25r1646b107],
6	)	NN	O	)	dep	4	SENT_39	[p2l1521t25r1646b107],
7	.	.	O	.	_	0	SENT_39	[p2l1521t25r1646b107],

1	While	IN	O	while	mark	5	SENT_40	[p2l1684t24r1910b93],
2	some	DT	O	some	det	4	SENT_40	[p2l1948t49r2143b93],
3	position	NN	O	position	nn	4	SENT_40	[p2l7t130r317b217],
4	articles	NNS	O	article	nsubj	5	SENT_40	[p2l352t128r612b196],
5	recommend	VBP	O	recommend	advcl	25	SENT_40	[p2l647t128r1101b196],
6	systemic	JJ	O	systemic	amod	7	SENT_40	[p2l1135t130r1450b218],
7	steps	NNS	O	step	nsubj	16	SENT_40	[p2l1485t142r1664b217],
8	for	IN	O	for	_	0	SENT_40	[p2l1699t128r1807b196],
9	the	DT	O	the	det	10	SENT_40	[p2l1839t128r1954b196],
10	prevention	NN	O	prevention	prep_for	7	SENT_40	[p2l1989t152r2139b217, p2l6t234r293b299],
11	and	CC	O	and	_	0	SENT_40	[p2l323t231r460b299],
12	management	NN	O	management	conj_and	10	SENT_40	[p2l489t245r977b320],
13	of	IN	O	of	_	0	SENT_40	[p2l1006t231r1088b299],
14	ATD	NN	O	atd	nn	15	SENT_40	[p2l1105t231r1630b299],
15	—	NN	O	—	prep_of	10	SENT_40	[p2l1105t231r1630b299],
16	induced	VBD	O	induce	ccomp	5	SENT_40	[p2l1105t231r1630b299],
17	hepatitis	NN	O	hepatitis	dobj	16	SENT_40	[p2l1658t231r1978b319],
18	(	CD	NUMBER	(	number	19	SENT_40	[p2l2014t231r2140b313],
19	3	CD	NUMBER	3	num	20	SENT_40	[p2l2014t231r2140b313],
20	)	NN	O	)	dep	16	SENT_40	[p2l2014t231r2140b313],
21	,	,	O	,	_	0	SENT_40	[p2l2014t231r2140b313],
22	it	PRP	O	it	nsubjpass	25	SENT_40	[p2l8t335r60b400],
23	is	VBZ	O	be	auxpass	25	SENT_40	[p2l101t335r154b400],
24	still	RB	O	still	advmod	25	SENT_40	[p2l197t332r329b400],
25	difﬁcult	VBN	O	difﬁcult	_	0	SENT_40	[p2l371t332r664b400],
26	to	TO	O	to	aux	27	SENT_40	[p2l704t346r778b400],
27	predict	VB	O	predict	xcomp	25	SENT_40	[p2l821t332r1086b421],
28	the	DT	O	the	det	29	SENT_40	[p2l1125t332r1241b400],
29	development	NN	O	development	dobj	27	SENT_40	[p2l1284t332r1771b421],
30	of	IN	O	of	_	0	SENT_40	[p2l1813t332r1895b400],
31	ATDinduced	NN	O	atdinduced	nn	32	SENT_40	[p2l1923t335r2139b399, p2l8t435r311b503],
32	hepatitis	NN	O	hepatitis	prep_of	29	SENT_40	[p2l351t435r671b523],
33	prior	RB	O	prior	_	0	SENT_40	[p2l713t437r905b523],
34	to	TO	O	to	_	0	SENT_40	[p2l945t448r1019b503],
35	the	DT	O	the	det	36	SENT_40	[p2l1063t435r1178b503],
36	administration	NN	O	administration	prep_prior_to	27	SENT_40	[p2l1221t435r1781b503],
37	of	IN	O	of	_	0	SENT_40	[p2l1824t435r1906b503],
38	ATD	NN	ORGANIZATION	atd	prep_of	36	SENT_40	[p2l1935t438r2139b503],
39	.	.	O	.	_	0	SENT_40	[p2l1935t438r2139b503],

1	The	DT	O	the	det	2	SENT_41	[p2l8t537r150b605],
2	pathomechanisms	NNS	O	pathomechanism	nsubj	6	SENT_41	[p2l206t537r889b625],
3	of	IN	O	of	_	0	SENT_41	[p2l948t537r1030b605],
4	ATD	NN	O	atd	nn	5	SENT_41	[p2l1073t537r1599b605],
5	—	NN	O	—	prep_of	2	SENT_41	[p2l1073t537r1599b605],
6	induced	VBD	O	induce	_	0	SENT_41	[p2l1073t537r1599b605],
7	hepatitis	NN	O	hepatitis	nsubjpass	11	SENT_41	[p2l1655t537r1974b625],
8	are	VBP	O	be	auxpass	11	SENT_41	[p2l2033t562r2143b605],
9	not	RB	O	not	neg	11	SENT_41	[p2l8t652r134b707],
10	well	RB	O	well	advmod	11	SENT_41	[p2l180t638r330b707],
11	understood	VBN	O	understand	ccomp	6	SENT_41	[p2l378t638r811b707],
12	yet	RB	O	yet	advmod	11	SENT_41	[p2l857t652r985b729],
13	.	.	O	.	_	0	SENT_41	[p2l857t652r985b729],

1	The	DT	O	the	det	3	SENT_42	[p2l1038t638r1180b707],
2	prevailing	VBG	O	prevail	amod	3	SENT_42	[p2l1228t638r1603b729],
3	theory	NN	O	theory	nsubj	4	SENT_42	[p2l1650t638r1895b729],
4	holds	VBZ	O	hold	_	0	SENT_42	[p2l1940t638r2142b707],
5	that	IN	O	that	complm	17	SENT_42	[p2l7t742r155b810],
6	hepatotoxicity	NN	O	hepatotoxicity	nsubj	17	SENT_42	[p2l203t742r747b832],
7	because	IN	O	because	prep	6	SENT_42	[p2l790t742r1079b810],
8	of	IN	O	of	_	0	SENT_42	[p2l1131t742r1213b810],
9	reactive	JJ	O	reactive	amod	10	SENT_42	[p2l1253t744r1539b810],
10	metabolites	NNS	O	metabolite	prep_of	11	SENT_42	[p2l1589t742r2020b810],
11	of	IN	O	of	pobj	7	SENT_42	[p2l2071t741r2153b810],
12	ATD	NN	ORGANIZATION	atd	pobj	11	SENT_42	[p2l6t848r210b923],
13	,	,	O	,	_	0	SENT_42	[p2l6t848r210b923],
14	especially	RB	O	especially	advmod	11	SENT_42	[p2l277t845r633b934],
15	INH	NNP	MISC	INH	dep	11	SENT_42	[p2l694t850r882b923],
16	,	,	O	,	_	0	SENT_42	[p2l694t850r882b923],
17	plays	VBZ	O	play	ccomp	4	SENT_42	[p2l948t845r1134b934],
18	a	DT	O	a	det	20	SENT_42	[p2l1200t869r1237b913],
19	major	JJ	O	major	amod	20	SENT_42	[p2l1299t847r1522b934],
20	role	NN	O	role	dobj	17	SENT_42	[p2l1585t845r1726b913],
21	in	IN	O	in	_	0	SENT_42	[p2l1791t847r1863b912],
22	ATDinduced	JJ	O	atdinduced	amod	23	SENT_42	[p2l1923t848r2139b912, p2l8t946r311b1015],
23	hepatitis	NN	O	hepatitis	prep_in	17	SENT_42	[p2l348t946r667b1036],
24	(	CD	NUMBER	(	number	25	SENT_42	[p2l713t947r838b1029],
25	4	CD	NUMBER	4	num	26	SENT_42	[p2l713t947r838b1029],
26	)	NN	O	)	dep	17	SENT_42	[p2l713t947r838b1029],
27	.	.	O	.	_	0	SENT_42	[p2l713t947r838b1029],

1	This	DT	O	this	det	2	SENT_43	[p2l880t946r1041b1015],
2	theory	NN	O	theory	nsubjpass	5	SENT_43	[p2l1080t946r1324b1037],
3	is	VBZ	O	be	auxpass	5	SENT_43	[p2l1360t949r1414b1015],
4	also	RB	O	also	advmod	5	SENT_43	[p2l1454t946r1594b1015],
5	supported	VBN	O	support	_	0	SENT_43	[p2l1636t946r2018b1036],
6	by	IN	O	by	prep	5	SENT_43	[p2l2054t946r2146b1037],

1	Liver	NN	O	liver	nn	3	SENT_44	[p2l10t1208r124b1254],
2	International	NNP	O	International	nn	3	SENT_44	[p2l144t1207r463b1254],
3	(	NNP	O	(	nsubjpass	21	SENT_44	[p2l484t1207r649b1262],
4	2012	CD	DATE	2012	num	9	SENT_44	[p2l484t1207r649b1262],
5	)	CD	NUMBER	)	num	9	SENT_44	[p2l484t1207r649b1262],
6	©	CD	NUMBER	©	num	9	SENT_44	[p2l6t1283r51b1329],
7	2011	CD	DATE	2011	num	9	SENT_44	[p2l68t1284r188b1329],
8	John	NNP	ORGANIZATION	John	nn	9	SENT_44	[p2l216t1282r332b1329],
9	Wiley	NNP	ORGANIZATION	Wiley	dep	3	SENT_44	[p2l352t1282r493b1340],
10	&	CC	ORGANIZATION	&	_	0	SENT_44	[p2l512t1284r549b1329],
11	Sons	NNP	ORGANIZATION	Sons	nn	12	SENT_44	[p2l568t1284r685b1329],
12	N5	NNP	O	N5	nsubjpass	21	SENT_44	[p2l703t1284r787b1329],
13	the	DT	O	the	det	14	SENT_44	[p2l7t1364r123b1432],
14	ﬁnding	NN	O	ﬁnding	dep	12	SENT_44	[p2l179t1364r448b1453],
15	that	WDT	O	that	dobj	18	SENT_44	[p2l501t1364r649b1432],
16	ATD	NN	O	atd	nn	17	SENT_44	[p2l701t1364r1227b1432],
17	—	NN	O	—	nsubj	18	SENT_44	[p2l701t1364r1227b1432],
18	induced	VBD	O	induce	rcmod	3	SENT_44	[p2l701t1364r1227b1432],
19	hepatitis	NN	O	hepatitis	dobj	18	SENT_44	[p2l1280t1364r1600b1452],
20	is	VBZ	O	be	auxpass	21	SENT_44	[p2l1656t1366r1710b1432],
21	associated	VBN	O	associate	_	0	SENT_44	[p2l1767t1364r2143b1432],
22	with	IN	O	with	_	0	SENT_44	[p2l6t1466r173b1534],
23	genetic	JJ	O	genetic	amod	24	SENT_44	[p2l211t1469r474b1555],
24	polymorphisms	NNS	O	polymorphism	prep_with	21	SENT_44	[p2l509t1466r1100b1555],
25	in	IN	O	in	_	0	SENT_44	[p2l1139t1468r1211b1533],
26	drug	NN	O	drug	nn	28	SENT_44	[p2l1250t1466r1424b1555],
27	metabolizing	VBG	O	metabolize	amod	28	SENT_44	[p2l1460t1466r1948b1555],
28	enzumes	NNS	O	enzume	prep_in	24	SENT_44	[p2l1986t1490r2139b1534, p2l9t1592r224b1636],
29	:	:	O	:	_	0	SENT_44	[p2l1986t1490r2139b1534, p2l9t1592r224b1636],
30	N	NN	O	n	dep	37	SENT_44	[p2l263t1567r982b1658],
31	—	CD	NUMBER	—	num	32	SENT_44	[p2l263t1567r982b1658],
32	acetyltransferase	NN	O	acetyltransferase	dep	30	SENT_44	[p2l263t1567r982b1658],
33	2	CD	NUMBER	2	number	34	SENT_44	[p2l1019t1574r1057b1635],
34	(	CD	NUMBER	(	dep	32	SENT_44	[p2l1100t1568r1387b1650],
35	NAT2	NN	O	nat2	dep	37	SENT_44	[p2l1100t1568r1387b1650],
36	)	CD	NUMBER	)	num	35	SENT_44	[p2l1100t1568r1387b1650],
37	(	NN	O	(	dep	44	SENT_44	[p2l1434t1568r1526b1650],
38	5	CD	NUMBER	5	num	37	SENT_44	[p2l1434t1568r1526b1650],
39	,	,	O	,	_	0	SENT_44	[p2l1434t1568r1526b1650],
40	6	CD	NUMBER	6	num	41	SENT_44	[p2l1564t1567r1660b1650],
41	)	NN	O	)	appos	37	SENT_44	[p2l1564t1567r1660b1650],
42	,	,	O	,	_	0	SENT_44	[p2l1564t1567r1660b1650],
43	cytochrome	NN	O	cytochrome	appos	37	SENT_44	[p2l1699t1567r2143b1657],
44	P450	NN	O	p450	dep	49	SENT_44	[p2l9t1676r191b1739],
45	(	CD	NUMBER	(	num	44	SENT_44	[p2l248t1671r473b1753],
46	CYP	NN	O	cyp	nn	49	SENT_44	[p2l248t1671r473b1753],
47	)	CD	NUMBER	)	num	49	SENT_44	[p2l248t1671r473b1753],
48	2E1	NN	O	2e1	nn	49	SENT_44	[p2l530t1676r660b1738],
49	(	NN	O	(	dep	56	SENT_44	[p2l723t1671r849b1753],
50	7	CD	NUMBER	7	num	51	SENT_44	[p2l723t1671r849b1753],
51	)	NN	O	)	dep	49	SENT_44	[p2l723t1671r849b1753],
52	,	,	O	,	_	0	SENT_44	[p2l723t1671r849b1753],
53	glutathione	NN	O	glutathione	nn	54	SENT_44	[p2l902t1671r1329b1760],
54	S	NN	O	s	appos	51	SENT_44	[p2l1381t1671r1859b1739],
55	—	CD	NUMBER	—	num	56	SENT_44	[p2l1381t1671r1859b1739],
56	transferase	NN	O	transferase	dep	58	SENT_44	[p2l1381t1671r1859b1739],
57	(	CD	NUMBER	(	num	58	SENT_44	[p2l1914t1671r2137b1753],
58	GST	NN	O	gst	dep	60	SENT_44	[p2l1914t1671r2137b1753],
59	)	CD	NUMBER	)	num	60	SENT_44	[p2l1914t1671r2137b1753],
60	M1	NN	O	m1	dep	68	SENT_44	[p2l8t1778r127b1840],
61	(	CD	NUMBER	(	number	62	SENT_44	[p2l178t1773r304b1855],
62	8	CD	NUMBER	8	num	63	SENT_44	[p2l178t1773r304b1855],
63	)	NN	O	)	dep	60	SENT_44	[p2l178t1773r304b1855],
64	,	,	O	,	_	0	SENT_44	[p2l178t1773r304b1855],
65	GSTT1	NN	O	gstt1	appos	63	SENT_44	[p2l346t1776r603b1841],
66	(	CD	NUMBER	(	num	65	SENT_44	[p2l654t1773r753b1855],
67	9	CD	NUMBER	9	num	68	SENT_44	[p2l654t1773r753b1855],
68	)	NN	O	)	dep	74	SENT_44	[p2l654t1773r753b1855],
69	and	CC	O	and	_	0	SENT_44	[p2l799t1773r937b1841],
70	manganese	NN	O	manganese	nn	72	SENT_44	[p2l975t1798r1388b1862],
71	superoxide	NN	O	superoxide	nn	72	SENT_44	[p2l1426t1773r1836b1861],
72	dismu	NN	O	dismu	conj_and	68	SENT_44	[p2l1877t1773r2140b1841],
73	—	CD	NUMBER	—	num	74	SENT_44	[p2l1877t1773r2140b1841],
74	tase	NN	O	tase	dep	80	SENT_44	[p2l8t1888r148b1943],
75	(	CD	NUMBER	(	num	76	SENT_44	[p2l195t1875r570b1957],
76	MnSOD	NN	O	mnsod	dep	74	SENT_44	[p2l195t1875r570b1957],
77	)	CD	NUMBER	)	number	78	SENT_44	[p2l195t1875r570b1957],
78	(	CD	NUMBER	(	dep	76	SENT_44	[p2l624t1875r794b1957],
79	10	CD	NUMBER	10	num	80	SENT_44	[p2l624t1875r794b1957],
80	)	NN	O	)	dep	21	SENT_44	[p2l624t1875r794b1957],
81	.	.	O	.	_	0	SENT_44	[p2l624t1875r794b1957],

1	However	RB	O	however	advmod	10	SENT_45	[p2l840t1880r1197b1954],
2	,	,	O	,	_	0	SENT_45	[p2l840t1880r1197b1954],
3	the	DT	O	the	det	5	SENT_45	[p2l1241t1874r1356b1943],
4	genetic	JJ	O	genetic	amod	5	SENT_45	[p2l1399t1877r1662b1965],
5	effects	NNS	O	effect	nsubj	23	SENT_45	[p2l1704t1874r1933b1943],
6	relevant	JJ	O	relevant	amod	5	SENT_45	[p2l1977t1874r2139b1943, p2l6t1991r170b2046],
7	to	TO	O	to	_	0	SENT_45	[p2l210t1991r283b2046],
8	ATD	NN	O	atd	nn	9	SENT_45	[p2l324t1978r850b2046],
9	—	NN	O	—	prep_to	6	SENT_45	[p2l324t1978r850b2046],
10	induced	VBD	O	induce	_	0	SENT_45	[p2l324t1978r850b2046],
11	hepatitis	NN	O	hepatitis	nsubj	19	SENT_45	[p2l890t1978r1209b2066],
12	in	IN	O	in	_	0	SENT_45	[p2l1252t1980r1325b2045],
13	the	DT	O	the	det	15	SENT_45	[p2l1365t1978r1481b2046],
14	previous	JJ	O	previous	amod	15	SENT_45	[p2l1521t1980r1843b2066],
15	studies	NNS	O	study	prep_in	11	SENT_45	[p2l1886t1978r2143b2046],
16	are	VBP	O	be	cop	19	SENT_45	[p2l9t2105r119b2148],
17	not	RB	O	not	neg	19	SENT_45	[p2l152t2094r277b2148],
18	so	RB	O	so	advmod	19	SENT_45	[p2l310t2105r385b2148],
19	large	JJ	O	large	ccomp	10	SENT_45	[p2l419t2080r597b2169],
20	and	CC	O	and	_	0	SENT_45	[p2l630t2080r768b2148],
21	do	VBP	O	do	aux	23	SENT_45	[p2l800t2080r892b2148],
22	not	RB	O	not	neg	23	SENT_45	[p2l927t2094r1053b2148],
23	explain	VB	O	explain	conj_and	10	SENT_45	[p2l1085t2080r1354b2168],
24	all	PDT	O	all	predet	26	SENT_45	[p2l1388t2080r1472b2148],
25	the	DT	O	the	det	26	SENT_45	[p2l1503t2080r1618b2148],
26	events	NNS	O	event	dobj	23	SENT_45	[p2l1651t2093r1900b2148],
27	.	.	O	.	_	0	SENT_45	[p2l1651t2093r1900b2148],

1	Some	DT	O	some	det	3	SENT_46	[p2l1937t2084r2143b2148],
2	clinical	JJ	O	clinical	amod	3	SENT_46	[p2l9t2181r274b2250],
3	characteristics	NNS	O	characteristic	nsubj	10	SENT_46	[p2l343t2181r871b2250],
4	and	CC	O	and	_	0	SENT_46	[p2l943t2181r1080b2250],
5	genetics	NNS	O	genetics	nn	6	SENT_46	[p2l1149t2184r1444b2272],
6	study	NN	O	study	nsubj	10	SENT_46	[p2l1515t2181r1720b2272],
7	of	IN	O	of	_	0	SENT_46	[p2l1786t2181r1869b2250],
8	ATDinduced	NN	O	atdinduced	nn	9	SENT_46	[p2l1924t2184r2140b2249, p2l9t2285r311b2353],
9	hepatitis	NN	O	hepatitis	prep_of	3	SENT_46	[p2l338t2285r658b2373],
10	provide	VBP	O	provide	_	0	SENT_46	[p2l686t2285r974b2373],
11	evidences	NNS	O	evidence	dobj	10	SENT_46	[p2l1003t2285r1356b2353],
12	that	WDT	O	that	dobj	16	SENT_46	[p2l1385t2285r1533b2353],
13	immune	JJ	O	immune	amod	14	SENT_46	[p2l1561t2287r1878b2353],
14	mechanisms	NNS	O	mechanism	nsubjpass	16	SENT_46	[p2l1907t2285r2139b2353, p2l9t2390r265b2455],
15	are	VBP	O	be	auxpass	16	SENT_46	[p2l314t2412r423b2455],
16	involved	VBN	O	involve	rcmod	11	SENT_46	[p2l470t2387r790b2455],
17	in	IN	O	in	_	0	SENT_46	[p2l837t2389r909b2454],
18	the	DT	O	the	det	22	SENT_46	[p2l954t2387r1069b2455],
19	pathogenesis	NN	O	pathogenesis	nn	22	SENT_46	[p2l1115t2387r1595b2476],
20	(	NN	O	(	nn	22	SENT_46	[p2l1647t2387r1817b2469],
21	11	CD	NUMBER	11	num	22	SENT_46	[p2l1647t2387r1817b2469],
22	)	NN	O	)	prep_in	16	SENT_46	[p2l1647t2387r1817b2469],
23	:	:	O	:	_	0	SENT_46	[p2l1647t2387r1817b2469],
24	a	DT	O	a	det	25	SENT_46	[p2l1869t2412r1906b2455],
25	delay	NN	O	delay	conj_and	11	SENT_46	[p2l1952t2387r2146b2476],
26	between	IN	O	between	_	0	SENT_46	[p2l6t2488r314b2557],
27	drug	NN	O	drug	nn	28	SENT_46	[p2l348t2488r522b2579],
28	administration	NN	O	administration	prep_between	25	SENT_46	[p2l556t2488r1114b2557],
29	and	CC	O	and	_	0	SENT_46	[p2l1148t2488r1285b2557],
30	the	DT	O	the	det	31	SENT_46	[p2l1317t2488r1432b2557],
31	onset	NN	O	onset	conj_and	11	SENT_46	[p2l1466t2502r1664b2557],
32	of	IN	O	of	_	0	SENT_46	[p2l1697t2488r1779b2557],
33	hepatitis	NN	O	hepatitis	prep_of	31	SENT_46	[p2l1800t2488r2140b2578],
34	,	,	O	,	_	0	SENT_46	[p2l1800t2488r2140b2578],
35	some	DT	O	some	det	36	SENT_46	[p2l9t2616r203b2660],
36	cases	NNS	O	case	appos	33	SENT_46	[p2l243t2616r423b2660],
37	presenting	VBG	O	present	partmod	36	SENT_46	[p2l461t2594r855b2682],
38	features	NNS	O	feature	dobj	37	SENT_46	[p2l892t2592r1182b2660],
39	of	IN	O	of	_	0	SENT_46	[p2l1222t2591r1304b2660],
40	hypersensitivity	NN	O	hypersensitivity	nn	41	SENT_46	[p2l1331t2592r1924b2682],
41	reactions	NNS	O	reaction	prep_of	38	SENT_46	[p2l1959t2616r2139b2660, p2l8t2698r192b2763],
42	(	JJ	O	(	amod	36	SENT_46	[p2l267t2695r496b2777],
43	fever	NN	O	fever	tmod	42	SENT_46	[p2l267t2695r496b2777],
44	,	,	O	,	_	0	SENT_46	[p2l267t2695r496b2777],
45	skin	NN	O	skin	nn	46	SENT_46	[p2l568t2695r720b2763],
46	rash	NN	O	rash	conj_and	43	SENT_46	[p2l789t2695r943b2763],
47	and	CC	O	and	_	0	SENT_46	[p2l1012t2695r1150b2763],
48	eosinophilia	NN	O	eosinophilia	nn	49	SENT_46	[p2l1220t2695r1732b2783],
49	)	NN	O	)	conj_and	43	SENT_46	[p2l1220t2695r1732b2783],
50	,	,	O	,	_	0	SENT_46	[p2l1220t2695r1732b2783],
51	common	JJ	O	common	amod	52	SENT_46	[p2l1805t2720r2143b2763],
52	occurrence	NN	O	occurrence	conj_and	36	SENT_46	[p2l9t2821r420b2865],
53	of	IN	O	of	_	0	SENT_46	[p2l482t2796r564b2865],
54	‘	CD	NUMBER	‘	num	57	SENT_46	[p2l617t2796r1062b2886],
55	adaptation	NN	O	adaptation	nn	57	SENT_46	[p2l617t2796r1062b2886],
56	’	NN	O	’	nn	57	SENT_46	[p2l617t2796r1062b2886],
57	response	NN	O	response	prep_of	52	SENT_46	[p2l1127t2821r1453b2886],
58	to	TO	O	to	_	0	SENT_46	[p2l1513t2810r1586b2865],
59	ATD	NN	ORGANIZATION	atd	prep_to	57	SENT_46	[p2l1646t2799r1829b2864],
60	during	IN	O	during	_	0	SENT_46	[p2l1893t2796r2144b2887],
61	rechallenge	NN	O	rechallenge	prep_during	59	SENT_46	[p2l9t2900r428b2990],
62	and	CC	O	and	_	0	SENT_46	[p2l487t2900r624b2968],
63	the	DT	O	the	det	64	SENT_46	[p2l680t2900r795b2968],
64	association	NN	O	association	appos	33	SENT_46	[p2l853t2902r1266b2968],
65	with	IN	O	with	_	0	SENT_46	[p2l1321t2900r1488b2968],
66	speciﬁc	NN	O	speciﬁc	nn	69	SENT_46	[p2l1546t2899r1820b2989],
67	human	JJ	O	human	amod	69	SENT_46	[p2l1876t2900r2143b2968],
68	leucocyte	NN	O	leucocyte	nn	69	SENT_46	[p2l7t3002r357b3093],
69	antigen	NN	O	antigen	prep_with	64	SENT_46	[p2l413t3005r688b3093],
70	(	CD	NUMBER	(	num	73	SENT_46	[p2l749t3002r987b3085],
71	HLA	NN	O	hlum	nn	73	SENT_46	[p2l749t3002r987b3085],
72	)	NN	O	)	nn	73	SENT_46	[p2l749t3002r987b3085],
73	alleles	NNS	O	allele	nsubj	74	SENT_46	[p2l1051t3002r1268b3071],
74	(	VBP	O	(	rcmod	64	SENT_46	[p2l1330t3003r1500b3085],
75	12	CD	NUMBER	12	num	76	SENT_46	[p2l1330t3003r1500b3085],
76	)	CD	NUMBER	)	dobj	74	SENT_46	[p2l1330t3003r1500b3085],
77	.	.	O	.	_	0	SENT_46	[p2l1330t3003r1500b3085],

1	Thus	RB	O	thus	advmod	7	SENT_47	[p2l1560t3002r1768b3082],
2	,	,	O	,	_	0	SENT_47	[p2l1560t3002r1768b3082],
3	immune	JJ	O	immune	amod	4	SENT_47	[p2l1826t3005r2143b3071],
4	mechanism	NN	O	mechanism	nsubj	7	SENT_47	[p2l9t3106r439b3174],
5	could	MD	O	could	aux	7	SENT_47	[p2l488t3106r696b3174],
6	be	VB	O	be	cop	7	SENT_47	[p2l741t3106r826b3174],
7	one	CD	NUMBER	one	_	0	SENT_47	[p2l875t3130r1009b3174],
8	of	IN	O	of	_	0	SENT_47	[p2l1058t3105r1140b3174],
9	the	DT	O	the	det	10	SENT_47	[p2l1176t3106r1292b3174],
10	pathomechanisms	NNS	O	pathomechanism	prep_of	7	SENT_47	[p2l1339t3106r2022b3194],
11	of	IN	O	of	_	0	SENT_47	[p2l2072t3106r2154b3174],
12	ATD	NN	O	atd	nn	13	SENT_47	[p2l6t3208r531b3276],
13	—	NN	O	—	prep_of	10	SENT_47	[p2l6t3208r531b3276],
14	induced	VBD	O	induce	partmod	13	SENT_47	[p2l6t3208r531b3276],
15	hepatitis	NN	O	hepatitis	dobj	14	SENT_47	[p2l558t3208r897b3296],
16	.	.	O	.	_	0	SENT_47	[p2l558t3208r897b3296],

1	Tumour	NN	MISC	tumour	nn	3	SENT_48	[p2l111t3312r428b3377],
2	necrosis	NN	O	necrosis	nn	3	SENT_48	[p2l469t3311r768b3377],
3	factor-oz	NN	O	factor-oz	_	0	SENT_48	[p2l810t3309r1114b3377],
4	(	CD	NUMBER	(	num	6	SENT_48	[p2l1159t3309r1475b3392],
5	TNF-oz	NN	O	tnf-oz	nn	6	SENT_48	[p2l1159t3309r1475b3392],
6	)	NN	O	)	nsubj	10	SENT_48	[p2l1159t3309r1475b3392],
7	is	VBZ	O	be	cop	10	SENT_48	[p2l1522t3311r1576b3377],
8	an	DT	O	a	det	10	SENT_48	[p2l1619t3334r1706b3377],
9	inﬂammatory	JJ	O	inﬂammatory	amod	10	SENT_48	[p2l1748t3309r2139b3377, p2l8t3425r163b3501],
10	cytokine	NN	O	cytokine	rcmod	3	SENT_48	[p2l220t3412r536b3501],
11	produced	VBN	O	produce	partmod	10	SENT_48	[p2l596t3412r956b3500],
12	by	IN	O	by	_	0	SENT_48	[p2l1013t3412r1105b3501],
13	monocytes	NNS	O	monocyte	agent	11	SENT_48	[p2l1161t3425r1586b3501],
14	,	,	O	,	_	0	SENT_48	[p2l1161t3425r1586b3501],
15	macrophages	NNS	O	macrophage	appos	13	SENT_48	[p2l1649t3412r2143b3501],

1	TNF	NN	O	tnf	nn	4	SENT_49	[p3l7t34r205b88],
2	—	NN	O	—	nn	4	SENT_49	[p3l7t34r205b88],
3	oc	NN	O	oc	nn	4	SENT_49	[p3l7t34r205b88],
4	polymorphism	NN	O	polymorphism	_	0	SENT_49	[p3l230t31r719b103],
5	and	CC	O	and	_	0	SENT_49	[p3l747t31r872b88],
6	ATD-induced	JJ	O	atd-induced	amod	7	SENT_49	[p3l897t31r1345b88],
7	hepatitis	NN	O	hepatitis	conj_and	4	SENT_49	[p3l1374t31r1671b103],
8	and	CC	O	and	_	0	SENT_49	[p3l10t273r148b341],
9	activated	VBN	O	activate	amod	11	SENT_49	[p3l194t273r528b341],
10	T	NN	O	t	nn	11	SENT_49	[p3l573t275r626b340],
11	cells	NNS	O	cell	conj_and	4	SENT_49	[p3l674t273r846b341],
12	.	.	O	.	_	0	SENT_49	[p3l674t273r846b341],

1	Previous	JJ	O	previous	amod	2	SENT_50	[p3l896t275r1219b341],
2	studies	NNS	O	study	nsubj	4	SENT_50	[p3l1268t273r1523b341],
3	have	VBP	O	have	aux	4	SENT_50	[p3l1569t273r1739b340],
4	suggested	VBN	O	suggest	_	0	SENT_50	[p3l1786t273r2144b362],
5	that	IN	O	that	complm	7	SENT_50	[p3l8t375r156b443],
6	TNF-OL	NN	O	tnf-ol	nsubj	7	SENT_50	[p3l188t378r446b443],
7	plays	VBZ	O	play	ccomp	4	SENT_50	[p3l477t375r664b464],
8	an	DT	O	a	det	10	SENT_50	[p3l698t400r785b443],
9	important	JJ	O	important	amod	10	SENT_50	[p3l819t378r1202b463],
10	role	NN	O	role	dobj	7	SENT_50	[p3l1235t375r1377b443],
11	in	IN	O	in	_	0	SENT_50	[p3l1410t378r1482b442],
12	the	DT	O	the	det	13	SENT_50	[p3l1514t375r1630b443],
13	pathogenesis	NN	O	pathogenesis	prep_in	10	SENT_50	[p3l1662t375r2143b464],
14	of	IN	O	of	_	0	SENT_50	[p3l10t476r92b545],
15	DILI	NNP	O	DILI	prep_of	13	SENT_50	[p3l127t482r303b544],
16	by	IN	O	by	_	0	SENT_50	[p3l348t476r440b567],
17	enhancing	VBG	O	enhance	prepc_by	7	SENT_50	[p3l482t476r870b567],
18	inﬂammatory	JJ	O	inﬂammatory	amod	20	SENT_50	[p3l914t476r1434b567],
19	cytokine	NN	O	cytokine	nn	20	SENT_50	[p3l1477t476r1793b567],
20	production	NN	O	production	dobj	17	SENT_50	[p3l1839t476r2140b566, p3l8t582r160b648],
21	and	CC	O	and	_	0	SENT_50	[p3l194t580r331b647],
22	mediating	VBG	O	mediate	prepc_by	7	SENT_50	[p3l364t580r743b669],
23	direct	JJ	O	direct	amod	25	SENT_50	[p3l776t580r989b648],
24	hepatocyte	NN	O	hepatocyte	nn	25	SENT_50	[p3l1021t580r1425b669],
25	injury	NN	O	injury	dobj	22	SENT_50	[p3l1460t582r1686b669],
26	(	CD	NUMBER	(	num	28	SENT_50	[p3l1721t580r2028b662],
27	13-15	CD	NUMBER	13-15	num	28	SENT_50	[p3l1721t580r2028b662],
28	)	NN	O	)	dobj	17	SENT_50	[p3l1721t580r2028b662],
29	.	.	O	.	_	0	SENT_50	[p3l1721t580r2028b662],

1	In	IN	O	in	_	0	SENT_51	[p3l2066t585r2144b647],
2	humans	NNS	O	human	prep_in	21	SENT_51	[p3l8t682r329b761],
3	,	,	O	,	_	0	SENT_51	[p3l8t682r329b761],
4	the	DT	O	the	det	6	SENT_51	[p3l375t682r491b750],
5	G/A	NN	O	g/a	nn	6	SENT_51	[p3l537t686r690b753],
6	transition	NN	O	transition	nsubj	21	SENT_51	[p3l732t684r1099b750],
7	308	CD	NUMBER	308	num	8	SENT_51	[p3l1145t689r1272b750],
8	nucleotides	NNS	O	nucleotide	npadvmod	9	SENT_51	[p3l1321t682r1745b750],
9	upstream	RB	O	upstream	advmod	6	SENT_51	[p3l1792t695r2143b770],
10	from	IN	O	from	_	0	SENT_51	[p3l9t783r193b852],
11	the	DT	O	the	det	14	SENT_51	[p3l225t783r340b852],
12	transcription	NN	O	transcription	nn	14	SENT_51	[p3l372t786r862b873],
13	initiation	NN	O	initiation	nn	14	SENT_51	[p3l895t786r1244b852],
14	site	NN	O	site	prep_from	6	SENT_51	[p3l1278t786r1400b852],
15	in	IN	O	in	_	0	SENT_51	[p3l1433t786r1506b851],
16	the	DT	O	the	det	20	SENT_51	[p3l1537t783r1653b852],
17	TNF	NN	O	tnf	nn	20	SENT_51	[p3l1685t786r1943b852],
18	—	NN	O	—	nn	20	SENT_51	[p3l1685t786r1943b852],
19	oL	NN	O	ol	nn	20	SENT_51	[p3l1685t786r1943b852],
20	gene	NN	O	gene	prep_in	14	SENT_51	[p3l1975t808r2144b874],
21	showed	VBD	O	show	_	0	SENT_51	[p3l10t887r290b955],
22	signiﬁcant	JJ	O	signiﬁcant	amod	23	SENT_51	[p3l335t887r722b977],
23	association	NN	O	association	dobj	21	SENT_51	[p3l766t889r1179b955],
24	with	IN	O	with	_	0	SENT_51	[p3l1220t887r1387b955],
25	various	JJ	O	various	amod	27	SENT_51	[p3l1427t889r1703b955],
26	inﬂammatory	JJ	O	inﬂammatory	amod	27	SENT_51	[p3l1747t887r2139b955, p3l8t1004r164b1079],
27	diseases	NNS	O	disease	prep_with	21	SENT_51	[p3l195t990r485b1058],
28	and	CC	O	and	_	0	SENT_51	[p3l521t990r659b1058],
29	immune	JJ	O	immune	amod	30	SENT_51	[p3l693t992r1010b1058],
30	disorders	NNS	O	disorder	nsubj	31	SENT_51	[p3l1046t990r1388b1058],
31	(	VBP	O	(	conj_and	21	SENT_51	[p3l1430t990r1600b1072],
32	16	CD	NUMBER	16	num	33	SENT_51	[p3l1430t990r1600b1072],
33	)	CD	NUMBER	)	dobj	31	SENT_51	[p3l1430t990r1600b1072],
34	.	.	O	.	_	0	SENT_51	[p3l1430t990r1600b1072],

1	Furthermore	RB	O	furthermore	advmod	10	SENT_52	[p3l1639t990r2142b1069],
2	,	,	O	,	_	0	SENT_52	[p3l1639t990r2142b1069],
3	TNF	NN	O	tnf	nn	4	SENT_52	[p3l8t1094r267b1160],
4	—	NN	O	—	nsubj	10	SENT_52	[p3l8t1094r267b1160],
5	oc	NN	O	oc	nn	7	SENT_52	[p3l8t1094r267b1160],
6	—	NN	O	—	nn	7	SENT_52	[p3l321t1095r678b1163],
7	308G/A	NN	O	308g/a	dep	4	SENT_52	[p3l321t1095r678b1163],
8	is	VBZ	O	be	cop	10	SENT_52	[p3l727t1094r780b1160],
9	closely	RB	O	closely	advmod	10	SENT_52	[p3l832t1091r1080b1182],
10	related	JJ	O	related	_	0	SENT_52	[p3l1127t1091r1380b1160],
11	to	TO	O	to	_	0	SENT_52	[p3l1429t1105r1502b1160],
12	hypersensitivity	NN	O	hypersensitivity	nn	13	SENT_52	[p3l1553t1091r2147b1182],
13	reactions	NNS	O	reaction	prep_to	10	SENT_52	[p3l9t1197r346b1263],
14	to	TO	O	to	_	0	SENT_52	[p3l427t1208r500b1263],
15	carbamazepine	NN	O	carbamazepine	nn	16	SENT_52	[p3l585t1195r1146b1283],
16	(	NN	O	(	prep_to	10	SENT_52	[p3l1232t1195r1402b1277],
17	17	CD	NUMBER	17	num	18	SENT_52	[p3l1232t1195r1402b1277],
18	)	NN	O	)	dep	16	SENT_52	[p3l1232t1195r1402b1277],
19	.	.	O	.	_	0	SENT_52	[p3l1232t1195r1402b1277],

1	Therefore	RB	O	therefore	advmod	5	SENT_53	[p3l1487t1194r1873b1273],
2	,	,	O	,	_	0	SENT_53	[p3l1487t1194r1873b1273],
3	it	PRP	O	it	nsubjpass	5	SENT_53	[p3l1957t1197r2008b1263],
4	is	VBZ	O	be	auxpass	5	SENT_53	[p3l2089t1197r2143b1263],
5	hypothesized	VBN	O	hypothesize	_	0	SENT_53	[p3l8t1297r502b1386],
6	that	IN	O	that	complm	13	SENT_53	[p3l539t1297r686b1365],
7	TNF	NN	O	tnf	nn	8	SENT_53	[p3l724t1300r982b1365],
8	—	NN	O	—	nsubj	13	SENT_53	[p3l724t1300r982b1365],
9	oL	NN	O	ol	nn	11	SENT_53	[p3l724t1300r982b1365],
10	—	CD	NUMBER	—	num	11	SENT_53	[p3l1025t1301r1382b1368],
11	308G/A	NNP	O	308G/A	dep	8	SENT_53	[p3l1025t1301r1382b1368],
12	would	MD	O	would	aux	13	SENT_53	[p3l1417t1297r1653b1365],
13	increase	VB	O	increase	ccomp	5	SENT_53	[p3l1691t1300r1990b1365],
14	the	DT	O	the	det	15	SENT_53	[p3l2028t1297r2143b1365],
15	risk	NN	O	risk	dobj	13	SENT_53	[p3l9t1398r147b1467],
16	of	IN	O	of	_	0	SENT_53	[p3l181t1398r264b1467],
17	DILI	NNP	O	DILI	prep_of	15	SENT_53	[p3l290t1404r466b1466],
18	caused	VBN	O	cause	partmod	17	SENT_53	[p3l505t1398r754b1467],
19	by	IN	O	by	_	0	SENT_53	[p3l788t1398r881b1489],
20	inﬂammatory	JJ	O	inﬂammatory	amod	21	SENT_53	[p3l913t1398r1433b1489],
21	diseases	NNS	O	disease	agent	18	SENT_53	[p3l1467t1398r1757b1467],
22	and	CC	O	and	_	0	SENT_53	[p3l1795t1398r1933b1467],
23	drug	NN	O	drug	nn	24	SENT_53	[p3l1970t1398r2144b1489],
24	hypersensitivity	NN	O	hypersensitivity	agent	18	SENT_53	[p3l8t1502r617b1591],
25	.	.	O	.	_	0	SENT_53	[p3l8t1502r617b1591],

1	While	IN	O	while	mark	4	SENT_54	[p3l649t1502r875b1569],
2	some	DT	O	some	det	3	SENT_54	[p3l907t1526r1101b1569],
3	researchers	NNS	O	researcher	nsubj	4	SENT_54	[p3l1133t1502r1545b1570],
4	reported	VBD	O	report	advcl	44	SENT_54	[p3l1577t1502r1898b1590],
5	a	DT	O	a	det	6	SENT_54	[p3l1930t1526r1968b1569],
6	lack	NN	O	lack	nsubj	15	SENT_54	[p3l1996t1502r2146b1569],
7	of	IN	O	of	_	0	SENT_54	[p3l10t1604r92b1672],
8	associations	NNS	O	association	prep_of	6	SENT_54	[p3l147t1606r592b1672],
9	between	IN	O	between	_	0	SENT_54	[p3l655t1604r964b1672],
10	TNF-or	JJ	O	tnf-or	amod	11	SENT_54	[p3l1028t1607r1286b1672],
11	polymorphisms	NNS	O	polymorphism	prep_between	8	SENT_54	[p3l1348t1604r1939b1693],
12	and	CC	O	and	_	0	SENT_54	[p3l2007t1604r2144b1672],
13	acetaminophen	NN	O	acetaminophen	nn	14	SENT_54	[p3l10t1705r929b1795],
14	—	NN	O	—	prep_between	8	SENT_54	[p3l10t1705r929b1795],
15	induced	VBD	O	induce	ccomp	4	SENT_54	[p3l10t1705r929b1795],
16	hepatotoxicity	NN	O	hepatotoxicity	iobj	15	SENT_54	[p3l954t1705r1499b1796],
17	(	CD	NUMBER	(	number	18	SENT_54	[p3l1527t1706r1671b1788],
18	18	CD	NUMBER	18	num	19	SENT_54	[p3l1527t1706r1671b1788],
19	)	NN	O	)	dobj	15	SENT_54	[p3l1527t1706r1671b1788],
20	and	CC	O	and	_	0	SENT_54	[p3l1706t1705r1843b1774],
21	various	JJ	O	various	amod	25	SENT_54	[p3l1867t1708r2143b1774],
22	drug	NN	O	drug	nn	25	SENT_54	[p3l10t1809r475b1898],
23	—	NN	O	—	nn	25	SENT_54	[p3l10t1809r475b1898],
24	related	JJ	O	related	amod	25	SENT_54	[p3l10t1809r475b1898],
25	DILI	NNP	O	DILI	conj_and	19	SENT_54	[p3l506t1814r682b1876],
26	(	CD	NUMBER	(	number	27	SENT_54	[p3l719t1809r891b1890],
27	19	CD	NUMBER	19	num	28	SENT_54	[p3l719t1809r891b1890],
28	)	NN	O	)	dep	25	SENT_54	[p3l719t1809r891b1890],
29	,	,	O	,	_	0	SENT_54	[p3l719t1809r891b1890],
30	the	DT	O	the	det	31	SENT_54	[p3l924t1809r1039b1876],
31	relationship	NN	O	relationship	dobj	15	SENT_54	[p3l1071t1809r1516b1897],
32	between	IN	O	between	_	0	SENT_54	[p3l1547t1809r1855b1876],
33	TNF	NN	O	tnf	nn	35	SENT_54	[p3l1886t1811r2145b1876],
34	—	NN	O	—	nn	35	SENT_54	[p3l1886t1811r2145b1876],
35	oL	NN	O	ol	prep_between	31	SENT_54	[p3l1886t1811r2145b1876],
36	—	CD	NUMBER	—	num	37	SENT_54	[p3l14t1915r371b1982],
37	308G/A	NNP	O	308G/A	nsubjpass	44	SENT_54	[p3l14t1915r371b1982],
38	and	CC	O	and	_	0	SENT_54	[p3l433t1911r571b1979],
39	ATD-induced	JJ	O	atd-induced	amod	40	SENT_54	[p3l630t1911r1156b1979],
40	hepatitis	NN	O	hepatitis	nsubjpass	44	SENT_54	[p3l1217t1911r1536b1999],
41	has	VBZ	O	have	aux	44	SENT_54	[p3l1599t1911r1719b1979],
42	not	RB	O	not	neg	44	SENT_54	[p3l1783t1924r1909b1979],
43	been	VBN	O	be	auxpass	44	SENT_54	[p3l1968t1911r2143b1979],
44	investigated	VBN	O	investigate	_	0	SENT_54	[p3l9t2012r473b2103],
45	.	.	O	.	_	0	SENT_54	[p3l9t2012r473b2103],

1	In	IN	O	in	_	0	SENT_55	[p3l508t2018r587b2080],
2	the	DT	O	the	det	4	SENT_55	[p3l616t2012r731b2081],
3	present	JJ	DATE	present	amod	4	SENT_55	[p3l761t2026r1034b2102],
4	study	NN	O	study	prep_in	7	SENT_55	[p3l1065t2012r1285b2103],
5	,	,	O	,	_	0	SENT_55	[p3l1065t2012r1285b2103],
6	we	PRP	O	we	nsubj	7	SENT_55	[p3l1316t2037r1417b2081],
7	examined	VBD	O	examine	_	0	SENT_55	[p3l1449t2012r1812b2081],
8	whether	IN	O	whether	complm	17	SENT_55	[p3l1839t2012r2144b2081],
9	the	DT	O	the	det	12	SENT_55	[p3l8t2116r123b2184],
10	TNF	NN	O	tnf	nn	12	SENT_55	[p3l164t2118r422b2183],
11	—	NN	O	—	nn	12	SENT_55	[p3l164t2118r422b2183],
12	oL	NN	O	ol	nsubjpass	17	SENT_55	[p3l164t2118r422b2183],
13	polymorphism	NN	O	polymorphism	nn	15	SENT_55	[p3l462t2116r1020b2205],
14	—	NN	O	—	nn	15	SENT_55	[p3l1067t2119r1424b2186],
15	308G/A	NN	O	308g/a	dep	12	SENT_55	[p3l1067t2119r1424b2186],
16	is	VBZ	O	be	auxpass	17	SENT_55	[p3l1465t2118r1518b2184],
17	associated	VBN	O	associate	ccomp	7	SENT_55	[p3l1561t2116r1938b2184],
18	with	IN	O	with	_	0	SENT_55	[p3l1976t2116r2144b2183],
19	ATD-induced	JJ	MISC	atd-induced	amod	20	SENT_55	[p3l6t2218r531b2286],
20	hepatitis	NN	O	hepatitis	prep_with	17	SENT_55	[p3l558t2218r878b2306],
21	in	IN	O	in	_	0	SENT_55	[p3l907t2220r978b2285],
22	a	DT	O	a	det	24	SENT_55	[p3l1007t2242r1044b2286],
23	Korean	JJ	LOCATION	korean	amod	24	SENT_55	[p3l1071t2223r1343b2286],
24	population	NN	O	population	prep_in	20	SENT_55	[p3l1370t2218r1805b2306],
25	.	.	O	.	_	0	SENT_55	[p3l1370t2218r1805b2306],

1	Methods	NNS	O	method	_	0	SENT_56	[p3l13t2476r376b2545],

1	Subjects	NNS	O	subject	_	0	SENT_57	[p3l9t2635r305b2720],

1	Patients	NNS	O	patient	_	0	SENT_58	[p3l9t2788r306b2854],
2	with	IN	O	with	_	0	SENT_58	[p3l332t2786r500b2854],
3	newly	RB	O	newly	amod	51	SENT_58	[p3l527t2786r746b2875],
4	diagnosed	VBN	O	diagnose	dep	3	SENT_58	[p3l772t2786r1149b2875],
5	pulmonary	JJ	O	pulmonary	amod	6	SENT_58	[p3l1176t2786r1596b2875],
6	TB	NN	O	tb	dobj	4	SENT_58	[p3l1620t2789r1726b2853],
7	and	CC	O	and	_	0	SENT_58	[p3l1757t2786r1923b2857],
8	/	:	O	/	punct	28	SENT_58	[p3l1757t2786r1923b2857],
9	or	CC	O	or	dep	28	SENT_58	[p3l1929t2810r2008b2854],
10	TB	NN	O	tb	nn	11	SENT_58	[p3l2035t2789r2142b2853],
11	pleuritis	NN	O	pleuritis	nsubjpass	28	SENT_58	[p3l8t2888r316b2976],
12	who	WP	O	who	nsubjpass	14	SENT_58	[p3l342t2888r501b2956],
13	were	VBD	O	be	auxpass	14	SENT_58	[p3l529t2913r703b2956],
14	treated	VBN	O	treat	rcmod	11	SENT_58	[p3l729t2888r990b2956],
15	with	IN	O	with	_	0	SENT_58	[p3l1014t2888r1181b2956],
16	ﬁrst-line	JJ	O	ﬁrst-line	amod	17	SENT_58	[p3l1209t2888r1527b2956],
17	ATD	NN	ORGANIZATION	atd	prep_with	14	SENT_58	[p3l1553t2891r1757b2966],
18	,	,	O	,	_	0	SENT_58	[p3l1553t2891r1757b2966],
19	including	VBG	O	include	_	0	SENT_58	[p3l1788t2888r2144b2977],
20	isoniazid	NN	O	isoniazid	prep_including	14	SENT_58	[p3l9t2990r365b3069],
21	,	,	O	,	_	0	SENT_58	[p3l9t2990r365b3069],
22	rifampin	NN	O	rifampin	prep_including	14	SENT_58	[p3l401t2989r748b3079],
23	,	,	O	,	_	0	SENT_58	[p3l401t2989r748b3079],
24	ethambutol	NN	O	ethambutol	prep_including	14	SENT_58	[p3l786t2990r1220b3058],
25	and	CC	O	and	_	0	SENT_58	[p3l1254t2990r1392b3058],
26	pyrazinamide	NN	O	pyrazinamide	prep_including	14	SENT_58	[p3l1424t2990r1937b3080],
27	were	VBD	O	be	auxpass	28	SENT_58	[p3l1969t3014r2143b3058],
28	enrolled	VBN	O	enrol	conj_and	6	SENT_58	[p3l10t3093r315b3161],
29	into	IN	O	into	_	0	SENT_58	[p3l377t3095r525b3161],
30	two	CD	NUMBER	two	num	31	SENT_58	[p3l589t3106r725b3161],
31	groups	NNS	O	group	prep_into	28	SENT_58	[p3l790t3117r1045b3182],
32	of	IN	O	of	_	0	SENT_58	[p3l1109t3093r1191b3161],
33	patients	NNS	O	patient	prep_of	31	SENT_58	[p3l1242t3095r1556b3181],
34	:	:	O	:	_	0	SENT_58	[p3l1242t3095r1556b3181],
35	patients	NNS	O	patient	npadvmod	28	SENT_58	[p3l1621t3095r1915b3181],
36	with	IN	O	with	_	0	SENT_58	[p3l1976t3093r2144b3161],
37	ATD-induced	JJ	MISC	atd-induced	amod	38	SENT_58	[p3l6t3195r531b3263],
38	hepatitis	NN	O	hepatitis	prep_with	28	SENT_58	[p3l617t3195r937b3283],
39	and	CC	O	and	_	0	SENT_58	[p3l1026t3195r1163b3263],
40	patients	NNS	O	patient	prep_with	28	SENT_58	[p3l1249t3197r1544b3283],
41	without	IN	O	without	_	0	SENT_58	[p3l1630t3195r1927b3263],
42	any	DT	O	any	det	44	SENT_58	[p3l2014t3220r2147b3284],
43	adverse	JJ	O	adverse	amod	44	SENT_58	[p3l10t3296r285b3364],
44	reactions	NNS	O	reaction	prep_without	28	SENT_58	[p3l324t3298r661b3363],
45	to	TO	O	to	_	0	SENT_58	[p3l700t3309r773b3363],
46	ATD	NN	ORGANIZATION	atd	nn	48	SENT_58	[p3l811t3298r993b3362],
47	(	CD	NUMBER	(	num	48	SENT_58	[p3l1040t3296r1637b3377],
48	ATD	NN	O	atd	prep_to	28	SENT_58	[p3l1040t3296r1637b3377],
49	—	CD	NUMBER	—	num	48	SENT_58	[p3l1040t3296r1637b3377],
50	tolerant	JJ	O	tolerant	amod	51	SENT_58	[p3l1040t3296r1637b3377],
51	)	NN	O	)	prep_with	1	SENT_58	[p3l1040t3296r1637b3377],
52	.	.	O	.	_	0	SENT_58	[p3l1040t3296r1637b3377],

1	Clinical	JJ	O	clinical	amod	4	SENT_59	[p3l1681t3296r1967b3364],
2	and	CC	O	and	_	0	SENT_59	[p3l2007t3296r2144b3364],
3	treatment	NN	O	treatment	amod	4	SENT_59	[p4l8t30r376b85],
4	information	NN	O	information	nsubjpass	12	SENT_59	[p4l414t17r871b85],
5	of	IN	O	of	_	0	SENT_59	[p4l911t17r994b85],
6	the	DT	O	the	det	7	SENT_59	[p4l1020t17r1136b85],
7	case	NN	O	case	prep_of	4	SENT_59	[p4l1176t41r1323b85],
8	and	CC	O	and	_	0	SENT_59	[p4l1364t17r1501b85],
9	control	JJ	O	control	amod	10	SENT_59	[p4l1541t17r1812b85],
10	subjects	NNS	O	subject	conj_and	7	SENT_59	[p4l1851t17r2142b106],
11	were	VBD	O	be	auxpass	12	SENT_59	[p4l6t144r181b187],
12	recorded	VBN	O	record	_	0	SENT_59	[p4l219t119r549b187],
13	in	IN	O	in	_	0	SENT_59	[p4l586t121r659b186],
14	the	DT	O	the	det	21	SENT_59	[p4l695t119r811b187],
15	Adverse	JJ	O	adverse	amod	21	SENT_59	[p4l845t119r1143b187],
16	Drug	NN	O	drug	nn	21	SENT_59	[p4l1181t124r1374b208],
17	Reaction	NN	O	reaction	nn	21	SENT_59	[p4l1411t121r1740b187],
18	Pharmacogenomic	NNP	ORGANIZATION	Pharmacogenomic	nn	21	SENT_59	[p4l1777t119r2140b187, p4l10t223r380b311],
19	Research	NNP	ORGANIZATION	Research	nn	21	SENT_59	[p4l415t221r746b289],
20	Group	NNP	ORGANIZATION	Group	nn	21	SENT_59	[p4l784t225r1026b310],
21	database	NN	O	database	prep_in	12	SENT_59	[p4l1066t221r1385b289],
22	of	IN	O	of	_	0	SENT_59	[p4l1422t221r1504b289],
23	Korea	NNP	LOCATION	Korea	prep_of	21	SENT_59	[p4l1530t226r1771b300],
24	,	,	O	,	_	0	SENT_59	[p4l1530t226r1771b300],
25	in	IN	O	in	_	0	SENT_59	[p4l1810t223r1883b288],
26	which	WDT	O	which	rel	37	SENT_59	[p4l1917t221r2144b289],
27	cases	NNS	O	case	nsubjpass	37	SENT_59	[p4l10t348r190b392],
28	of	IN	O	of	_	0	SENT_59	[p4l221t324r303b392],
29	adverse	JJ	O	adverse	amod	30	SENT_59	[p4l321t324r597b392],
30	reactions	NNS	O	reaction	prep_of	27	SENT_59	[p4l625t326r962b392],
31	induced	VBN	O	induce	partmod	30	SENT_59	[p4l992t324r1293b392],
32	by	IN	O	by	_	0	SENT_59	[p4l1319t324r1412b413],
33	various	JJ	O	various	amod	34	SENT_59	[p4l1433t326r1709b392],
34	drugs	NNS	O	drug	agent	31	SENT_59	[p4l1739t324r1945b413],
35	have	VBP	O	have	aux	37	SENT_59	[p4l1973t324r2144b392],
36	been	VBN	O	be	auxpass	37	SENT_59	[p4l7t426r182b494],
37	collected	VBN	O	collect	rcmod	21	SENT_59	[p4l219t426r547b494],
38	from	IN	O	from	_	0	SENT_59	[p4l583t426r767b494],
39	seven	CD	NUMBER	seven	num	41	SENT_59	[p4l803t451r1004b494],
40	university	NN	O	university	nn	41	SENT_59	[p4l1040t428r1415b515],
41	hospitals	NNS	O	hospital	prep_from	37	SENT_59	[p4l1445t426r1777b514],
42	in	IN	O	in	_	0	SENT_59	[p4l1814t428r1887b493],
43	Korea	NNP	LOCATION	Korea	nn	47	SENT_59	[p4l1922t431r2144b494],
44	(	NNP	O	(	nn	47	SENT_59	[p4l14t528r394b610],
45	Dankook	NNP	ORGANIZATION	Dankook	nn	47	SENT_59	[p4l14t528r394b610],
46	University	NNP	ORGANIZATION	University	nn	47	SENT_59	[p4l431t530r823b617],
47	Hospital	NNP	ORGANIZATION	Hospital	prep_in	41	SENT_59	[p4l860t528r1200b616],
48	,	,	O	,	_	0	SENT_59	[p4l860t528r1200b616],
49	Eulji	NNP	ORGANIZATION	Eulji	nn	51	SENT_59	[p4l1243t528r1414b617],
50	University	NNP	ORGANIZATION	University	nn	51	SENT_59	[p4l1454t531r1846b617],
51	Hospital	NNP	ORGANIZATION	Hospital	conj_and	47	SENT_59	[p4l1883t531r2139b616, p4l8t630r119b708],
52	,	,	O	,	_	0	SENT_59	[p4l1883t531r2139b616, p4l8t630r119b708],
53	Hanyang	NNP	ORGANIZATION	Hanyang	nn	55	SENT_59	[p4l179t635r519b719],
54	University	NNP	ORGANIZATION	University	nn	55	SENT_59	[p4l575t632r967b719],
55	Hospital	NNP	ORGANIZATION	Hospital	conj_and	47	SENT_59	[p4l1021t630r1361b718],
56	,	,	O	,	_	0	SENT_59	[p4l1021t630r1361b718],
57	Hallym	NNP	ORGANIZATION	Hallym	nn	59	SENT_59	[p4l1422t630r1697b719],
58	University	NNP	ORGANIZATION	University	nn	59	SENT_59	[p4l1755t632r2147b719],
59	Hospital	NNP	ORGANIZATION	Hospital	conj_and	47	SENT_59	[p4l9t732r350b820],
60	,	,	O	,	_	0	SENT_59	[p4l9t732r350b820],
61	Seoul	NNP	ORGANIZATION	Seoul	nn	64	SENT_59	[p4l382t732r585b800],
62	National	NNP	ORGANIZATION	National	nn	64	SENT_59	[p4l613t732r942b800],
63	University	NNP	ORGANIZATION	University	nn	64	SENT_59	[p4l969t734r1361b821],
64	Hospital	NNP	ORGANIZATION	Hospital	conj_and	47	SENT_59	[p4l1387t732r1727b820],
65	,	,	O	,	_	0	SENT_59	[p4l1387t732r1727b820],
66	Ajou	NNP	ORGANIZATION	Ajou	nn	68	SENT_59	[p4l1756t734r1939b821],
67	University	NNP	ORGANIZATION	University	nn	68	SENT_59	[p4l1967t734r2140b800, p4l6t836r255b923],
68	Hospital	NNP	ORGANIZATION	Hospital	conj_and	47	SENT_59	[p4l295t834r635b922],
69	,	,	O	,	_	0	SENT_59	[p4l295t834r635b922],
70	and	CC	O	and	_	0	SENT_59	[p4l681t834r819b902],
71	Seoul	NNP	ORGANIZATION	Seoul	nn	76	SENT_59	[p4l862t834r1065b902],
72	National	NNP	ORGANIZATION	National	nn	76	SENT_59	[p4l1106t834r1433b902],
73	University	NNP	ORGANIZATION	University	nn	76	SENT_59	[p4l1475t836r1868b923],
74	Bundang	NNP	ORGANIZATION	Bundang	nn	76	SENT_59	[p4l1907t834r2139b902, p4l10t961r141b1025],
75	Hospital	NNP	ORGANIZATION	Hospital	nn	76	SENT_59	[p4l168t936r517b1024],
76	)	NN	O	)	conj_and	47	SENT_59	[p4l168t936r517b1024],
77	since	IN	O	since	_	0	SENT_59	[p4l552t938r735b1004],
78	2003	CD	DATE	2003	prep_since	37	SENT_59	[p4l763t943r958b1004],
79	.	.	O	.	_	0	SENT_59	[p4l763t943r958b1004],

1	The	DT	O	the	det	2	SENT_60	[p4l112t1037r254b1105],
2	enrolment	NN	O	enrolment	nsubj	6	SENT_60	[p4l296t1037r685b1105],
3	of	IN	O	of	_	0	SENT_60	[p4l727t1037r809b1105],
4	ATD	NN	O	atd	nn	5	SENT_60	[p4l836t1037r1362b1105],
5	—	NN	O	—	prep_of	2	SENT_60	[p4l836t1037r1362b1105],
6	induced	VBD	O	induce	dep	17	SENT_60	[p4l836t1037r1362b1105],
7	ADR	NN	O	adr	nn	8	SENT_60	[p4l1399t1041r1588b1105],
8	cases	NNS	O	case	dobj	6	SENT_60	[p4l1629t1062r1808b1105],
9	and	CC	O	and	_	0	SENT_60	[p4l1851t1037r1989b1105],
10	the	DT	O	the	det	11	SENT_60	[p4l2028t1037r2143b1105],
11	submission	NN	O	submission	conj_and	8	SENT_60	[p4l10t1139r433b1207],
12	of	IN	O	of	_	0	SENT_60	[p4l470t1139r552b1207],
13	clinical	JJ	O	clinical	amod	14	SENT_60	[p4l579t1139r843b1207],
14	information	NN	O	information	prep_of	11	SENT_60	[p4l880t1139r1336b1207],
15	have	VBP	O	have	aux	17	SENT_60	[p4l1372t1139r1542b1207],
16	been	VBN	O	be	auxpass	17	SENT_60	[p4l1577t1139r1752b1207],
17	described	VBN	O	describe	_	0	SENT_60	[p4l1790t1139r2143b1207],
18	elsewhere	RB	O	elsewhere	advmod	17	SENT_60	[p4l10t1242r366b1310],
19	(	RB	O	(	advmod	17	SENT_60	[p4l409t1242r579b1324],
20	20	CD	NUMBER	20	num	21	SENT_60	[p4l409t1242r579b1324],
21	)	NN	O	)	nsubjpass	17	SENT_60	[p4l409t1242r579b1324],
22	.	.	O	.	_	0	SENT_60	[p4l409t1242r579b1324],

1	The	DT	O	the	det	2	SENT_61	[p4l619t1242r761b1310],
2	patients	NNS	O	patient	nsubjpass	6	SENT_61	[p4l797t1244r1092b1330],
3	with	IN	O	with	_	0	SENT_61	[p4l1126t1242r1294b1310],
4	TB	NN	O	tb	prep_with	2	SENT_61	[p4l1330t1245r1436b1309],
5	were	VBD	O	be	auxpass	6	SENT_61	[p4l1472t1267r1646b1310],
6	treated	VBN	O	treat	_	0	SENT_61	[p4l1682t1242r1942b1310],
7	with	IN	O	with	_	0	SENT_61	[p4l1976t1242r2144b1310],
8	ﬁrst	NN	O	ﬁrst	nn	11	SENT_61	[p4l9t1344r327b1412],
9	—	CD	NUMBER	—	num	11	SENT_61	[p4l9t1344r327b1412],
10	line	NN	O	line	nn	11	SENT_61	[p4l9t1344r327b1412],
11	ATD	NN	ORGANIZATION	atd	prep_with	6	SENT_61	[p4l380t1347r562b1411],
12	according	VBG	O	accord	_	0	SENT_61	[p4l622t1344r991b1433],
13	to	TO	O	to	prepc_according_to	6	SENT_61	[p4l1044t1358r1116b1412],
14	the	DT	O	the	det	16	SENT_61	[p4l1173t1344r1288b1412],
15	treatment	NN	O	treatment	nn	16	SENT_61	[p4l1343t1357r1712b1412],
16	guidelines	NNS	O	guideline	pobj	6	SENT_61	[p4l1766t1344r2142b1433],
17	from	IN	O	from	_	0	SENT_61	[p4l9t1445r193b1514],
18	the	DT	O	the	det	23	SENT_61	[p4l223t1445r338b1514],
19	American	JJ	O	american	amod	23	SENT_61	[p4l367t1448r734b1514],
20	Thoracic	NNP	ORGANIZATION	Thoracic	nn	23	SENT_61	[p4l764t1445r1097b1514],
21	Society	NNP	ORGANIZATION	Society	nn	23	SENT_61	[p4l1128t1448r1396b1536],
22	(	CD	NUMBER	(	num	23	SENT_61	[p4l1428t1446r1601b1528],
23	NY	NNP	O	NY	prep_from	16	SENT_61	[p4l1428t1446r1601b1528],
24	,	,	O	,	_	0	SENT_61	[p4l1428t1446r1601b1528],
25	USA	NNP	LOCATION	USA	conj_and	23	SENT_61	[p4l1633t1446r1860b1528],
26	)	CD	NUMBER	)	num	25	SENT_61	[p4l1633t1446r1860b1528],
27	,	,	O	,	_	0	SENT_61	[p4l1633t1446r1860b1528],
28	Center	NNP	ORGANIZATION	Center	conj_and	23	SENT_61	[p4l1894t1449r2145b1514],
29	for	IN	ORGANIZATION	for	_	0	SENT_61	[p4l9t1548r117b1616],
30	Disease	NNP	ORGANIZATION	Disease	nn	31	SENT_61	[p4l150t1550r425b1616],
31	Control	NNP	ORGANIZATION	Control	prep_for	28	SENT_61	[p4l461t1548r754b1617],
32	and	CC	ORGANIZATION	and	_	0	SENT_61	[p4l788t1548r926b1616],
33	Prevention	NNP	ORGANIZATION	Prevention	nn	35	SENT_61	[p4l960t1550r1370b1616],
34	(	CD	NUMBER	(	num	35	SENT_61	[p4l1409t1548r1581b1631],
35	GA	NNP	O	GA	prep_for	28	SENT_61	[p4l1409t1548r1581b1631],
36	,	,	O	,	_	0	SENT_61	[p4l1409t1548r1581b1631],
37	USA	NNP	LOCATION	USA	appos	31	SENT_61	[p4l1617t1548r1817b1631],
38	)	CD	NUMBER	)	num	37	SENT_61	[p4l1617t1548r1817b1631],
39	and	CC	O	and	_	0	SENT_61	[p4l1858t1548r1996b1616],
40	the	DT	O	the	det	42	SENT_61	[p4l2028t1548r2143b1616],
41	Infectious	JJ	ORGANIZATION	infectious	amod	42	SENT_61	[p4l9t1651r381b1719],
42	Diseases	NNS	ORGANIZATION	disease	prep_from	16	SENT_61	[p4l422t1654r730b1719],
43	Society	NNP	ORGANIZATION	Society	dep	23	SENT_61	[p4l773t1653r1042b1740],
44	of	IN	ORGANIZATION	of	_	0	SENT_61	[p4l1079t1651r1162b1719],
45	America	NNP	ORGANIZATION	America	prep_of	43	SENT_61	[p4l1188t1654r1506b1719],
46	(	CD	NUMBER	(	num	45	SENT_61	[p4l1551t1651r1720b1733],
47	VA	NNP	ORGANIZATION	VA	dep	43	SENT_61	[p4l1551t1651r1720b1733],
48	,	,	O	,	_	0	SENT_61	[p4l1551t1651r1720b1733],
49	USA	NNP	LOCATION	USA	appos	23	SENT_61	[p4l1763t1651r1962b1733],
50	)	CD	NUMBER	)	num	49	SENT_61	[p4l1763t1651r1962b1733],
51	(	CD	NUMBER	(	number	52	SENT_61	[p4l2015t1651r2139b1733],
52	1	CD	NUMBER	1	num	53	SENT_61	[p4l2015t1651r2139b1733],
53	)	NN	O	)	dep	49	SENT_61	[p4l2015t1651r2139b1733],
54	.	.	O	.	_	0	SENT_61	[p4l2015t1651r2139b1733],

1	The	DT	O	the	det	2	SENT_62	[p4l8t1752r151b1820],
2	treatment	NN	O	treatment	nsubj	3	SENT_62	[p4l182t1766r550b1820],
3	consisted	VBD	O	consist	_	0	SENT_62	[p4l582t1752r927b1820],
4	of	IN	O	of	_	0	SENT_62	[p4l960t1752r1042b1820],
5	an	DT	O	a	det	7	SENT_62	[p4l1064t1777r1151b1820],
6	initial	JJ	O	initial	amod	7	SENT_62	[p4l1183t1752r1401b1820],
7	phase	NN	O	phase	prep_of	3	SENT_62	[p4l1431t1752r1642b1841],
8	of	IN	O	of	_	0	SENT_62	[p4l1674t1752r1757b1820],
9	2	CD	DURATION	2	num	10	SENT_62	[p4l1778t1759r1816b1819],
10	months	NNS	NUMBER	month	prep_of	7	SENT_62	[p4l1857t1752r2142b1820],
11	and	CC	O	and	_	0	SENT_62	[p4l10t1855r148b1923],
12	a	DT	O	a	det	15	SENT_62	[p4l204t1879r242b1923],
13	subsequent	JJ	O	subsequent	amod	15	SENT_62	[p4l299t1855r718b1943],
14	continuation	NN	O	continuation	nn	15	SENT_62	[p4l774t1857r1262b1923],
15	phase	NN	O	phase	conj_and	7	SENT_62	[p4l1317t1855r1528b1943],
16	of	IN	O	of	_	0	SENT_62	[p4l1586t1855r1668b1923],
17	4	CD	NUMBER	4	num	20	SENT_62	[p4l1713t1862r1754b1922],
18	or	CC	O	or	_	0	SENT_62	[p4l1813t1879r1892b1923],
19	more	JJR	O	more	num	20	SENT_62	[p4l1948t1879r2143b1923],
20	months	NNS	DURATION	month	prep_of	15	SENT_62	[p4l9t1957r314b2025],
21	.	.	O	.	_	0	SENT_62	[p4l9t1957r314b2025],

1	During	IN	O	during	_	0	SENT_63	[p4l383t1960r653b2046],
2	the	DT	O	the	det	4	SENT_63	[p4l716t1957r831b2025],
3	initial	JJ	O	initial	amod	4	SENT_63	[p4l897t1957r1114b2025],
4	phase	NN	O	phase	prep_during	9	SENT_63	[p4l1178t1957r1408b2045],
5	,	,	O	,	_	0	SENT_63	[p4l1178t1957r1408b2045],
6	four	CD	NUMBER	four	num	7	SENT_63	[p4l1476t1957r1635b2025],
7	drugs	NNS	O	drug	nsubjpass	9	SENT_63	[p4l1699t1957r1905b2046],
8	were	VBD	O	be	auxpass	9	SENT_63	[p4l1968t1982r2143b2025],
9	administered	VBN	O	administer	_	0	SENT_63	[p4l10t2058r521b2138],
10	,	,	O	,	_	0	SENT_63	[p4l10t2058r521b2138],
11	including	VBG	O	include	_	0	SENT_63	[p4l551t2058r907b2149],
12	isoniazid	NN	O	isoniazid	nn	13	SENT_63	[p4l934t2058r1268b2127],
13	(	NN	O	(	prep_including	9	SENT_63	[p4l1301t2059r1460b2141],
14	300	CD	NUMBER	300	num	15	SENT_63	[p4l1301t2059r1460b2141],
15	mg	NN	O	mg	dep	26	SENT_63	[p4l1501t2083r1618b2149],
16	daily	JJ	SET	daily	amod	17	SENT_63	[p4l1646t2058r1878b2149],
17	)	NN	O	)	dep	15	SENT_63	[p4l1646t2058r1878b2149],
18	,	,	O	,	_	0	SENT_63	[p4l1646t2058r1878b2149],
19	rifam	NN	O	rifam	nn	22	SENT_63	[p4l1908t2058r2139b2127],
20	—	NN	O	—	nn	22	SENT_63	[p4l1908t2058r2139b2127],
21	picin	NN	O	picin	nn	22	SENT_63	[p4l8t2164r196b2250],
22	(	NN	O	(	appos	17	SENT_63	[p4l269t2162r611b2244],
23	450	CD	NUMBER	450	num	24	SENT_63	[p4l269t2162r611b2244],
24	—	NN	O	—	dep	26	SENT_63	[p4l269t2162r611b2244],
25	600	CD	NUMBER	600	num	26	SENT_63	[p4l269t2162r611b2244],
26	mg	NN	O	mg	dep	33	SENT_63	[p4l651t2186r768b2251],
27	daily	JJ	SET	daily	amod	28	SENT_63	[p4l835t2162r1068b2251],
28	)	NN	O	)	dep	26	SENT_63	[p4l835t2162r1068b2251],
29	,	,	O	,	_	0	SENT_63	[p4l835t2162r1068b2251],
30	ethambutol	NN	O	ethambutol	nn	31	SENT_63	[p4l1139t2162r1573b2230],
31	(	NN	O	(	appos	28	SENT_63	[p4l1645t2162r1987b2244],
32	600	CD	NUMBER	600	num	33	SENT_63	[p4l1645t2162r1987b2244],
33	—	NN	O	—	dep	35	SENT_63	[p4l1645t2162r1987b2244],
34	800	CD	NUMBER	800	num	35	SENT_63	[p4l1645t2162r1987b2244],
35	mg	NN	O	mg	dep	37	SENT_63	[p4l2027t2186r2144b2251],
36	daily	JJ	SET	daily	amod	37	SENT_63	[p4l10t2264r216b2353],
37	)	NN	O	)	dep	42	SENT_63	[p4l10t2264r216b2353],
38	and	CC	O	and	_	0	SENT_63	[p4l267t2264r405b2332],
39	pyrazinamide	NN	O	pyrazinamide	conj_and	37	SENT_63	[p4l448t2264r960b2353],
40	(	CD	NUMBER	(	num	39	SENT_63	[p4l1010t2264r1442b2346],
41	1000-1500	CD	DATE	1000-1500	num	42	SENT_63	[p4l1010t2264r1442b2346],
42	mg	NN	O	mg	dep	44	SENT_63	[p4l1483t2289r1601b2353],
43	daily	JJ	SET	daily	amod	44	SENT_63	[p4l1645t2264r1876b2353],
44	)	NN	O	)	dep	13	SENT_63	[p4l1645t2264r1876b2353],
45	.	.	O	.	_	0	SENT_63	[p4l1645t2264r1876b2353],

1	Doses	NNS	O	dose	nsubjpass	6	SENT_64	[p4l1924t2269r2143b2332],
2	of	IN	O	of	_	0	SENT_64	[p4l10t2365r92b2434],
3	each	DT	O	each	det	4	SENT_64	[p4l114t2365r278b2434],
4	drug	NN	O	drug	prep_of	1	SENT_64	[p4l310t2365r485b2456],
5	were	VBD	O	be	auxpass	6	SENT_64	[p4l513t2390r687b2434],
6	adjusted	VBN	O	adjust	_	0	SENT_64	[p4l720t2365r1034b2455],
7	based	VBN	O	base	_	0	SENT_64	[p4l1062t2365r1273b2434],
8	on	IN	O	on	prepc_based_on	6	SENT_64	[p4l1304t2390r1399b2434],
9	the	DT	O	the	det	11	SENT_64	[p4l1429t2365r1544b2434],
10	body	NN	O	body	nn	11	SENT_64	[p4l1574t2365r1765b2456],
11	weight	NN	O	weight	pobj	6	SENT_64	[p4l1790t2365r2041b2456],
12	of	IN	O	of	_	0	SENT_64	[p4l2072t2365r2154b2434],
13	the	DT	O	the	det	14	SENT_64	[p4l8t2469r123b2536],
14	patient	NN	O	patient	prep_of	11	SENT_64	[p4l174t2471r456b2557],
15	.	.	O	.	_	0	SENT_64	[p4l174t2471r456b2557],

1	In	IN	O	in	_	0	SENT_65	[p4l512t2474r590b2536],
2	the	DT	O	the	det	4	SENT_65	[p4l641t2469r756b2536],
3	continuation	NN	O	continuation	nn	4	SENT_65	[p4l808t2471r1295b2537],
4	phase	NN	O	phase	prep_in	8	SENT_65	[p4l1347t2469r1577b2557],
5	,	,	O	,	_	0	SENT_65	[p4l1347t2469r1577b2557],
6	pyrazinamide	NN	O	pyrazinamide	nsubjpass	8	SENT_65	[p4l1631t2469r2144b2558],
7	was	VBD	O	be	auxpass	8	SENT_65	[p4l6t2596r142b2639],
8	discontinued	VBN	O	discontinue	_	0	SENT_65	[p4l188t2571r698b2650],
9	,	,	O	,	_	0	SENT_65	[p4l188t2571r698b2650],
10	whereas	IN	O	whereas	mark	16	SENT_65	[p4l741t2571r1040b2639],
11	the	DT	O	the	det	14	SENT_65	[p4l1085t2571r1200b2639],
12	other	JJ	O	other	amod	14	SENT_65	[p4l1245t2571r1443b2639],
13	three	CD	NUMBER	three	num	14	SENT_65	[p4l1486t2571r1674b2639],
14	drugs	NNS	O	drug	nsubjpass	16	SENT_65	[p4l1720t2571r1925b2660],
15	were	VBD	O	be	auxpass	16	SENT_65	[p4l1969t2596r2143b2639],
16	continued	VBN	O	continue	advcl	8	SENT_65	[p4l10t2672r409b2741],
17	.	.	O	.	_	0	SENT_65	[p4l10t2672r409b2741],

1	The	DT	O	the	det	2	SENT_66	[p4l440t2672r582b2740],
2	period	NN	O	period	_	0	SENT_66	[p4l609t2672r855b2761],
3	of	IN	O	of	_	0	SENT_66	[p4l883t2672r965b2740],
4	the	DT	O	the	det	6	SENT_66	[p4l981t2672r1096b2740],
5	continuation	NN	O	continuation	nn	6	SENT_66	[p4l1125t2675r1613b2740],
6	phase	NN	O	phase	prep_of	2	SENT_66	[p4l1639t2672r1850b2761],
7	in	IN	O	in	_	0	SENT_66	[p4l1878t2675r1950b2739],
8	each	DT	O	each	prep_in	2	SENT_66	[p4l1979t2672r2144b2740],

1	Kim	NNP	PERSON	Kim	_	0	SENT_67	[p4l1843t3035r1956b3091],
2	et	FW	O	et	nn	3	SENT_67	[p4l1982t3042r2045b3092],
3	a	FW	O	a	dep	1	SENT_67	[p4l2071t3034r2135b3091],
4	/	:	O	/	punct	3	SENT_67	[p4l2071t3034r2135b3091],
5	.	.	O	.	_	0	SENT_67	[p4l2071t3034r2135b3091],

1	patient	NN	O	patient	nsubjpass	3	SENT_68	[p4l7t3264r271b3350],
2	was	VBD	O	be	auxpass	3	SENT_68	[p4l311t3286r447b3329],
3	determined	VBN	O	determine	_	0	SENT_68	[p4l492t3262r923b3330],
4	by	IN	O	by	_	0	SENT_68	[p4l963t3262r1056b3351],
5	the	DT	O	the	det	6	SENT_68	[p4l1095t3262r1210b3329],
6	clinician	NN	O	clinician	agent	3	SENT_68	[p4l1255t3262r1591b3340],
7	,	,	O	,	_	0	SENT_68	[p4l1255t3262r1591b3340],
8	based	VBN	O	base	_	0	SENT_68	[p4l1635t3262r1845b3330],
9	on	IN	O	on	prepc_based_on	3	SENT_68	[p4l1890t3286r1984b3329],
10	the	DT	O	the	det	12	SENT_68	[p4l2027t3262r2143b3329],
11	clinical	JJ	O	clinical	amod	12	SENT_68	[p4l9t3364r274b3432],
12	features	NNS	O	feature	pobj	3	SENT_68	[p4l340t3364r630b3432],
13	and	CC	O	and	_	0	SENT_68	[p4l698t3364r836b3432],
14	treatment	NN	O	treatment	nn	15	SENT_68	[p4l900t3378r1269b3432],
15	response	NN	O	response	conj_and	12	SENT_68	[p4l1335t3388r1679b3452],
16	.	.	O	.	_	0	SENT_68	[p4l1335t3388r1679b3452],

1	Treatment	NN	O	treatment	nn	2	SENT_69	[p4l1749t3367r2144b3432],
2	response	NN	O	response	nsubjpass	12	SENT_69	[p4l9t3489r334b3554],
3	and	CC	O	and	_	0	SENT_69	[p4l379t3465r516b3533],
4	the	DT	O	the	det	5	SENT_69	[p4l558t3465r674b3533],
5	development	NN	O	development	nsubjpass	12	SENT_69	[p4l719t3465r1206b3554],
6	of	IN	O	of	_	0	SENT_69	[p4l1251t3465r1333b3533],
7	adverse	JJ	O	adverse	amod	8	SENT_69	[p4l1367t3465r1641b3534],
8	reactions	NNS	O	reaction	prep_of	5	SENT_69	[p4l1686t3468r2023b3533],
9	to	TO	O	to	_	0	SENT_69	[p4l2068t3479r2141b3533],
10	ATD	NN	ORGANIZATION	atd	prep_to	8	SENT_69	[p4l6t3570r188b3634],
11	were	VBD	O	be	auxpass	12	SENT_69	[p4l222t3591r397b3635],
12	evaluated	VBN	O	evaluate	_	0	SENT_69	[p4l432t3567r785b3635],
13	at	IN	O	at	_	0	SENT_69	[p4l820t3580r886b3635],
14	2	CD	NUMBER	2	prep_at	12	SENT_69	[p4l920t3574r981b3645],
15	,	,	O	,	_	0	SENT_69	[p4l920t3574r981b3645],
16	4	CD	NUMBER	4	nn	19	SENT_69	[p4l1016t3574r1057b3634],
17	and	CC	O	and	_	0	SENT_69	[p4l1092t3567r1230b3635],
18	8	CD	DURATION	8	nn	19	SENT_69	[p4l1266t3574r1302b3635],
19	weeks	NNS	NUMBER	week	appos	14	SENT_69	[p4l1341t3567r1560b3635],
20	after	IN	O	after	_	0	SENT_69	[p4l1596t3567r1763b3635],
21	the	DT	O	the	det	22	SENT_69	[p4l1795t3567r1911b3635],
22	onset	NN	O	onset	prep_after	19	SENT_69	[p4l1946t3580r2143b3635],
23	of	IN	O	of	_	0	SENT_69	[p5l9t19r92b87],
24	treatment	NN	O	treatment	prep_of	22	SENT_69	[p5l138t32r505b87],
25	and	CC	O	and	_	0	SENT_69	[p5l565t19r702b87],
26	bimonthly	JJ	SET	bimonthly	prep_of	22	SENT_69	[p5l758t19r1157b108],
27	thereafter	RB	O	thereafter	advmod	12	SENT_69	[p5l1210t19r1589b87],
28	.	.	O	.	_	0	SENT_69	[p5l1210t19r1589b87],

1	Unscheduled	JJ	O	unscheduled	amod	2	SENT_70	[p5l1651t19r2144b87],
2	visits	NNS	O	visit	nsubj	3	SENT_70	[p5l6t123r193b189],
3	occurred	VBD	O	occur	_	0	SENT_70	[p5l242t120r573b189],
4	if	IN	O	if	mark	8	SENT_70	[p5l621t120r681b188],
5	a	DT	O	a	det	7	SENT_70	[p5l717t145r754b189],
6	new	JJ	O	new	amod	7	SENT_70	[p5l800t145r953b189],
7	symptom	NN	O	symptom	nsubj	8	SENT_70	[p5l998t134r1352b211],
8	arose	VBD	O	arise	advcl	3	SENT_70	[p5l1399t145r1611b189],
9	.	.	O	.	_	0	SENT_70	[p5l1399t145r1611b189],

1	During	IN	O	during	_	0	SENT_71	[p5l1661t123r1932b211],
2	each	DT	O	each	det	3	SENT_71	[p5l1978t120r2143b189],
3	visit	NN	O	visit	prep_during	7	SENT_71	[p5l6t226r181b302],
4	,	,	O	,	_	0	SENT_71	[p5l6t226r181b302],
5	patients	NNS	O	patient	nsubjpass	9	SENT_71	[p5l220t226r514b312],
6	were	VBD	O	be	auxpass	7	SENT_71	[p5l550t248r724b291],
7	questioned	VBN	O	question	dep	28	SENT_71	[p5l762t224r1174b312],
8	and	CC	O	and	_	0	SENT_71	[p5l1211t224r1348b292],
9	examined	VBN	O	examine	conj_and	7	SENT_71	[p5l1385t224r1749b292],
10	regarding	VBG	O	regard	_	0	SENT_71	[p5l1785t224r2144b313],
11	adverse	JJ	O	adverse	amod	12	SENT_71	[p5l9t326r284b394],
12	reactions	NNS	O	reaction	prep_regarding	7	SENT_71	[p5l314t329r650b394],
13	to	TO	O	to	_	0	SENT_71	[p5l679t340r752b394],
14	ATD	NN	ORGANIZATION	atd	prep_to	12	SENT_71	[p5l780t329r962b393],
15	and	CC	O	and	_	0	SENT_71	[p5l994t326r1132b394],
16	were	VBD	O	be	auxpass	17	SENT_71	[p5l1158t351r1332b394],
17	assessed	VBN	O	assess	conj_and	7	SENT_71	[p5l1362t326r1660b394],
18	for	IN	O	for	_	0	SENT_71	[p5l1689t326r1796b394],
19	hepatitis	NN	O	hepatitis	prep_for	17	SENT_71	[p5l1822t326r2142b414],
20	by	IN	O	by	_	0	SENT_71	[p5l6t427r98b518],
21	measuring	VBG	O	measure	agent	17	SENT_71	[p5l129t430r522b518],
22	the	DT	O	the	det	24	SENT_71	[p5l555t427r669b496],
23	serum	NN	O	serum	nn	24	SENT_71	[p5l705t452r935b496],
24	levels	NNS	O	level	dobj	21	SENT_71	[p5l969t427r1168b496],
25	of	IN	O	of	_	0	SENT_71	[p5l1204t427r1286b496],
26	aspartate	NN	O	aspartate	nn	27	SENT_71	[p5l1311t441r1644b517],
27	aminotrans	NNS	O	aminotran	prep_of	24	SENT_71	[p5l1680t430r2139b496],
28	—	VBP	O	—	_	0	SENT_71	[p5l1680t430r2139b496],
29	aminase	NN	O	aminase	dobj	28	SENT_71	[p5l9t532r312b597],
30	(	CD	NUMBER	(	num	31	SENT_71	[p5l358t530r603b611],
31	AST	NNP	O	AST	nsubj	28	SENT_71	[p5l358t530r603b611],
32	)	CD	NUMBER	)	num	31	SENT_71	[p5l358t530r603b611],
33	,	,	O	,	_	0	SENT_71	[p5l358t530r603b611],
34	alanine	NN	O	alanine	nn	35	SENT_71	[p5l645t530r913b597],
35	aminotransaminase	NN	O	aminotransaminase	appos	31	SENT_71	[p5l953t532r1690b597],
36	(	CD	NUMBER	(	num	38	SENT_71	[p5l1736t530r1958b611],
37	ALT	NN	O	alt	nn	38	SENT_71	[p5l1736t530r1958b611],
38	)	NN	O	)	dep	35	SENT_71	[p5l1736t530r1958b611],
39	and	CC	O	and	_	0	SENT_71	[p5l2006t530r2143b597],
40	total	JJ	O	total	amod	41	SENT_71	[p5l7t631r177b699],
41	bilirubin	NN	O	bilirubin	dep	35	SENT_71	[p5l212t631r560b699],
42	.	.	O	.	_	0	SENT_71	[p5l212t631r560b699],

1	The	DT	O	the	det	3	SENT_72	[p5l600t631r743b699],
2	ATD	NN	O	atd	nn	3	SENT_72	[p5l777t631r1303b699],
3	—	NN	O	—	nsubj	4	SENT_72	[p5l777t631r1303b699],
4	induced	VBD	O	induce	_	0	SENT_72	[p5l777t631r1303b699],
5	hepatitis	NN	O	hepatitis	nsubjpass	7	SENT_72	[p5l1338t631r1657b720],
6	was	VBD	O	be	auxpass	7	SENT_72	[p5l1692t656r1828b699],
7	deﬁned	VBN	O	deﬁned	ccomp	4	SENT_72	[p5l1866t631r2144b700],
8	as	IN	O	as	_	0	SENT_72	[p5l9t757r78b800],
9	an	DT	O	a	det	10	SENT_72	[p5l121t757r208b800],
10	elevation	NN	O	elevation	prep_as	7	SENT_72	[p5l250t732r587b800],
11	in	IN	O	in	_	0	SENT_72	[p5l628t735r700b800],
12	the	DT	O	the	det	14	SENT_72	[p5l740t732r856b800],
13	serum	NN	O	serum	nn	14	SENT_72	[p5l898t757r1129b800],
14	level	NN	O	level	prep_in	10	SENT_72	[p5l1168t732r1336b800],
15	of	IN	O	of	_	0	SENT_72	[p5l1376t732r1459b800],
16	ALT	NNP	O	ALT	prep_of	14	SENT_72	[p5l1487t735r1653b800],
17	or	CC	O	or	_	0	SENT_72	[p5l1695t757r1775b800],
18	AST	NNP	O	AST	prep_of	14	SENT_72	[p5l1812t735r1973b801],
19	>	JJR	O	>	tmod	7	SENT_72	[p5l2013t745r2064b791],
20	3	CD	NUMBER	3	dep	19	SENT_72	[p5l2103t739r2139b800],

1	times	NNS	O	time	dep	12	SENT_73	[p5l7t838r216b904],
2	the	DT	O	the	det	4	SENT_73	[p5l297t836r415b904],
3	upper	JJ	O	upper	amod	4	SENT_73	[p5l496t860r726b925],
4	limit	NN	O	limit	dep	1	SENT_73	[p5l804t836r991b904],
5	of	IN	O	of	_	0	SENT_73	[p5l1072t836r1156b904],
6	normal	JJ	O	normal	amod	9	SENT_73	[p5l1226t836r1508b904],
7	(	NN	O	(	nn	9	SENT_73	[p5l1593t836r1843b918],
8	ULN	NN	O	uln	nn	9	SENT_73	[p5l1593t836r1843b918],
9	)	NN	O	)	prep_of	4	SENT_73	[p5l1593t836r1843b918],
10	range	NN	O	range	dep	12	SENT_73	[p5l1931t860r2143b926],
11	(	CD	NUMBER	(	num	10	SENT_73	[p5l14t939r35b1021],
12	3	CD	NUMBER	3	dep	16	SENT_73	[p5l67t946r124b1019],
13	40	CD	NUMBER	40	num	15	SENT_73	[p5l183t946r270b1007],
14	U/L	NN	O	u/l	nn	15	SENT_73	[p5l312t939r486b1021],
15	)	NN	O	)	dep	12	SENT_73	[p5l312t939r486b1021],
16	during	IN	O	during	_	0	SENT_73	[p5l524t939r776b1028],
17	treatment	NN	O	treatment	pobj	16	SENT_73	[p5l804t952r1192b1017],
18	,	,	O	,	_	0	SENT_73	[p5l804t952r1192b1017],
19	according	VBG	O	accord	_	0	SENT_73	[p5l1226t939r1595b1028],
20	to	TO	O	to	prepc_according_to	17	SENT_73	[p5l1624t952r1697b1007],
21	the	DT	O	the	det	25	SENT_73	[p5l1729t939r1844b1007],
22	American	JJ	ORGANIZATION	american	amod	25	SENT_73	[p5l1872t941r2139b1007, p5l9t1065r136b1109],
23	Thoracic	NNP	ORGANIZATION	Thoracic	nn	25	SENT_73	[p5l207t1041r539b1109],
24	Society	NNP	ORGANIZATION	Society	nn	25	SENT_73	[p5l611t1043r879b1130],
25	guidelines	NNS	O	guideline	pobj	17	SENT_73	[p5l947t1041r1323b1130],
26	(	CD	NUMBER	(	number	27	SENT_73	[p5l1400t1041r1525b1122],
27	3	CD	NUMBER	3	num	28	SENT_73	[p5l1400t1041r1525b1122],
28	)	NN	O	)	dep	25	SENT_73	[p5l1400t1041r1525b1122],
29	.	.	O	.	_	0	SENT_73	[p5l1400t1041r1525b1122],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_74	[p5l1602t1043r1897b1109],
2	were	VBD	O	be	auxpass	3	SENT_74	[p5l1968t1065r2143b1109],
3	excluded	VBN	O	exclude	_	0	SENT_74	[p5l9t1143r341b1211],
4	for	IN	O	for	_	0	SENT_74	[p5l394t1142r501b1211],
5	the	DT	O	the	det	7	SENT_74	[p5l552t1143r667b1211],
6	following	VBG	O	follow	amod	7	SENT_74	[p5l720t1142r1073b1233],
7	reasons	NNS	O	reason	prep_for	3	SENT_74	[p5l1124t1167r1420b1211],
8	:	:	O	:	_	0	SENT_74	[p5l1124t1167r1420b1211],
9	(	CD	NUMBER	(	number	10	SENT_74	[p5l1482t1143r1582b1225],
10	1	CD	NUMBER	1	num	11	SENT_74	[p5l1482t1143r1582b1225],
11	)	CD	NUMBER	)	nsubj	73	SENT_74	[p5l1482t1143r1582b1225],
12	an	DT	O	a	det	16	SENT_74	[p5l1641t1167r1729b1211],
13	abnormal	JJ	O	abnormal	amod	16	SENT_74	[p5l1782t1143r2144b1211],
14	liver	NN	O	liver	nn	16	SENT_74	[p5l7t1245r170b1313],
15	function	NN	O	function	nn	16	SENT_74	[p5l226t1245r545b1313],
16	test	NN	O	test	nsubj	17	SENT_74	[p5l599t1258r728b1313],
17	result	VBP	O	result	rcmod	11	SENT_74	[p5l783t1245r991b1313],
18	at	IN	O	at	_	0	SENT_74	[p5l1046t1258r1113b1313],
19	baseline	NN	O	baseline	prep_at	17	SENT_74	[p5l1165t1245r1464b1313],
20	(	CD	NUMBER	(	num	22	SENT_74	[p5l1525t1245r1857b1328],
21	elevated	JJ	O	elevated	amod	22	SENT_74	[p5l1525t1245r1857b1328],
22	serum	NN	O	serum	dobj	17	SENT_74	[p5l1913t1270r2143b1313],
23	AST	NNP	O	AST	nn	25	SENT_74	[p5l6t1350r187b1426],
24	,	,	O	,	_	0	SENT_74	[p5l6t1350r187b1426],
25	ALT	NNP	O	ALT	dep	22	SENT_74	[p5l225t1350r392b1415],
26	or	CC	O	or	_	0	SENT_74	[p5l430t1372r510b1415],
27	bilirubin	NN	O	bilirubin	conj_or	22	SENT_74	[p5l544t1348r875b1416],
28	above	IN	O	above	_	0	SENT_74	[p5l915t1348r1130b1416],
29	normal	JJ	O	normal	amod	31	SENT_74	[p5l1168t1348r1441b1415],
30	range	NN	O	range	nn	31	SENT_74	[p5l1479t1348r1739b1437],
31	)	NN	O	)	prep_above	27	SENT_74	[p5l1479t1348r1739b1437],
32	;	:	O	;	_	0	SENT_74	[p5l1479t1348r1739b1437],
33	(	NN	O	(	conj_or	22	SENT_74	[p5l1785t1348r1885b1429],
34	2	CD	NUMBER	2	num	33	SENT_74	[p5l1785t1348r1885b1429],
35	)	CD	NUMBER	)	number	36	SENT_74	[p5l1785t1348r1885b1429],
36	active	JJ	O	active	dep	33	SENT_74	[p5l1930t1350r2143b1416],
37	or	CC	O	or	_	0	SENT_74	[p5l9t1474r89b1518],
38	chronic	JJ	O	chronic	amod	39	SENT_74	[p5l127t1450r411b1518],
39	hepatitis	NN	O	hepatitis	conj_or	36	SENT_74	[p5l447t1450r788b1538],
40	,	,	O	,	_	0	SENT_74	[p5l447t1450r788b1538],
41	including	VBG	O	include	conj_or	22	SENT_74	[p5l829t1450r1185b1539],
42	alcoholic	JJ	O	alcoholic	amod	43	SENT_74	[p5l1224t1450r1559b1518],
43	hepatitis	NN	O	hepatitis	pobj	41	SENT_74	[p5l1596t1450r1936b1538],
44	,	,	O	,	_	0	SENT_74	[p5l1596t1450r1936b1538],
45	fatty	NN	O	fatty	nn	47	SENT_74	[p5l1977t1450r2147b1539],
46	liver	NN	O	liver	nn	47	SENT_74	[p5l7t1552r170b1620],
47	disease	NN	O	disease	appos	43	SENT_74	[p5l203t1552r459b1620],
48	and	CC	O	and	_	0	SENT_74	[p5l493t1552r630b1620],
49	cirrhosis	NN	O	cirrhosis	conj_and	47	SENT_74	[p5l662t1552r1002b1630],
50	;	:	O	;	_	0	SENT_74	[p5l662t1552r1002b1630],
51	(	CD	NUMBER	(	number	52	SENT_74	[p5l1042t1552r1142b1634],
52	3	CD	NUMBER	3	num	54	SENT_74	[p5l1042t1552r1142b1634],
53	)	NN	O	)	nn	54	SENT_74	[p5l1042t1552r1142b1634],
54	carriers	NNS	O	carrier	dep	47	SENT_74	[p5l1182t1554r1457b1620],
55	of	IN	O	of	_	0	SENT_74	[p5l1491t1552r1573b1620],
56	the	DT	O	the	det	58	SENT_74	[p5l1593t1552r1708b1620],
57	hepatitis	NN	O	hepatitis	nn	58	SENT_74	[p5l1740t1552r2060b1640],
58	B	NN	O	b	prep_of	54	SENT_74	[p5l2093t1557r2141b1619],
59	or	CC	O	or	_	0	SENT_74	[p5l9t1678r89b1722],
60	C	NN	O	c	nn	61	SENT_74	[p5l121t1657r177b1722],
61	virus	NN	O	virus	conj_or	58	SENT_74	[p5l207t1656r412b1732],
62	;	:	O	;	_	0	SENT_74	[p5l207t1656r412b1732],
63	(	CD	NUMBER	(	number	64	SENT_74	[p5l452t1654r552b1736],
64	4	CD	NUMBER	4	num	65	SENT_74	[p5l452t1654r552b1736],
65	)	NN	O	)	dep	47	SENT_74	[p5l452t1654r552b1736],
66	heavy	JJ	O	heavy	amod	68	SENT_74	[p5l590t1654r806b1743],
67	alcohol	NN	O	alcohol	nn	68	SENT_74	[p5l835t1654r1106b1721],
68	intake	NN	O	intake	dep	65	SENT_74	[p5l1138t1654r1386b1732],
69	;	:	O	;	_	0	SENT_74	[p5l1138t1654r1386b1732],
70	(	CD	NUMBER	(	number	71	SENT_74	[p5l1426t1654r1525b1735],
71	5	CD	NUMBER	5	dep	47	SENT_74	[p5l1426t1654r1525b1735],
72	)	NN	O	)	dep	71	SENT_74	[p5l1426t1654r1525b1735],
73	decreased	VBD	O	decrease	parataxis	3	SENT_74	[p5l1565t1654r1926b1722],
74	renal	JJ	O	renal	amod	75	SENT_74	[p5l1958t1654r2143b1721],
75	function	NN	O	function	dobj	73	SENT_74	[p5l8t1756r348b1834],
76	;	:	O	;	_	0	SENT_74	[p5l8t1756r348b1834],
77	(	CD	NUMBER	(	num	83	SENT_74	[p5l396t1756r496b1838],
78	6	CD	NUMBER	6	num	83	SENT_74	[p5l396t1756r496b1838],
79	)	NN	O	)	nn	83	SENT_74	[p5l396t1756r496b1838],
80	other	JJ	O	other	amod	83	SENT_74	[p5l545t1756r743b1824],
81	chronic	JJ	O	chronic	amod	83	SENT_74	[p5l783t1756r1068b1824],
82	medical	JJ	O	medical	amod	83	SENT_74	[p5l1108t1756r1401b1824],
83	conditions	NNS	O	condition	dep	75	SENT_74	[p5l1442t1756r1839b1824],
84	requiring	VBG	O	require	partmod	83	SENT_74	[p5l1881t1758r2139b1844, p5l8t1860r125b1947],
85	medication	NN	O	medication	nn	92	SENT_74	[p5l153t1858r576b1926],
86	and	CC	O	and	_	0	SENT_74	[p5l607t1858r744b1926],
87	(	NN	O	(	conj_and	85	SENT_74	[p5l778t1858r877b1940],
88	7	CD	NUMBER	7	num	92	SENT_74	[p5l778t1858r877b1940],
89	)	NN	O	)	nn	92	SENT_74	[p5l778t1858r877b1940],
90	non	JJ	O	non	amod	92	SENT_74	[p5l913t1858r1477b1926],
91	—	NN	O	—	nn	92	SENT_74	[p5l913t1858r1477b1926],
92	adherence	NN	O	adherence	dobj	84	SENT_74	[p5l913t1858r1477b1926],
93	to	TO	O	to	_	0	SENT_74	[p5l1506t1871r1579b1926],
94	the	DT	O	the	det	95	SENT_74	[p5l1609t1858r1724b1926],
95	treatment	NN	O	treatment	prep_to	84	SENT_74	[p5l1752t1871r2139b1926],
96	.	.	O	.	_	0	SENT_74	[p5l1752t1871r2139b1926],

1	We	PRP	O	we	nsubj	2	SENT_75	[p5l6t1965r133b2028],
2	selected	VBD	O	select	_	0	SENT_75	[p5l165t1960r454b2028],
3	control	JJ	O	control	amod	4	SENT_75	[p5l485t1960r756b2028],
4	subjects	NNS	O	subject	dobj	2	SENT_75	[p5l787t1960r1079b2050],
5	(	JJ	O	(	dep	9	SENT_75	[p5l1115t1960r1334b2042],
6	three	CD	NUMBER	three	num	7	SENT_75	[p5l1115t1960r1334b2042],
7	times	NNS	O	time	dep	9	SENT_75	[p5l1364t1962r1564b2028],
8	the	DT	O	the	det	9	SENT_75	[p5l1596t1960r1711b2028],
9	number	NN	O	number	advmod	2	SENT_75	[p5l1742t1960r2040b2028],
10	of	IN	O	of	_	0	SENT_75	[p5l2071t1960r2154b2028],
11	case	NN	O	case	nn	12	SENT_75	[p5l9t2087r157b2131],
12	subjects	NNS	O	subject	prep_of	9	SENT_75	[p5l193t2063r513b2152],
13	)	CD	NUMBER	)	dep	9	SENT_75	[p5l193t2063r513b2152],
14	from	IN	O	from	_	0	SENT_75	[p5l555t2063r738b2131],
15	patients	NNS	O	patient	prep_from	2	SENT_75	[p5l771t2065r1067b2151],
16	with	IN	O	with	_	0	SENT_75	[p5l1099t2063r1266b2131],
17	TB	NN	O	tb	prep_with	15	SENT_75	[p5l1300t2066r1407b2130],
18	who	WP	O	who	nsubj	21	SENT_75	[p5l1440t2063r1599b2131],
19	did	VBD	O	do	aux	21	SENT_75	[p5l1637t2063r1757b2131],
20	not	RB	O	not	neg	21	SENT_75	[p5l1791t2076r1918b2131],
21	show	VB	O	show	dep	2	SENT_75	[p5l1952t2063r2146b2131],
22	any	DT	O	any	det	24	SENT_75	[p5l9t2190r142b2254],
23	ATD	NN	O	atd	nn	24	SENT_75	[p5l167t2165r643b2233],
24	—	NN	O	—	iobj	21	SENT_75	[p5l167t2165r643b2233],
25	related	JJ	O	related	amod	27	SENT_75	[p5l167t2165r643b2233],
26	adverse	JJ	O	adverse	amod	27	SENT_75	[p5l674t2165r949b2233],
27	reactions	NNS	O	reaction	dobj	21	SENT_75	[p5l981t2167r1318b2233],
28	during	IN	O	during	_	0	SENT_75	[p5l1350t2165r1601b2254],
29	the	DT	O	the	det	31	SENT_75	[p5l1630t2165r1746b2233],
30	treatment	NN	O	treatment	nn	31	SENT_75	[p5l1776t2178r2144b2233],
31	period	NN	O	period	prep_during	21	SENT_75	[p5l7t2267r253b2355],
32	and	CC	O	and	_	0	SENT_75	[p5l292t2267r430b2335],
33	who	WP	O	who	nsubj	34	SENT_75	[p5l465t2267r624b2335],
34	consented	VBD	O	consent	dep	2	SENT_75	[p5l667t2267r1044b2335],
35	to	TO	O	to	aux	36	SENT_75	[p5l1080t2281r1154b2335],
36	participate	VB	O	participate	xcomp	34	SENT_75	[p5l1194t2269r1595b2355],
37	in	IN	O	in	_	0	SENT_75	[p5l1634t2270r1707b2334],
38	this	DT	O	this	det	39	SENT_75	[p5l1744t2267r1879b2335],
39	study	NN	O	study	prep_in	36	SENT_75	[p5l1920t2267r2139b2356],
40	.	.	O	.	_	0	SENT_75	[p5l1920t2267r2139b2356],

1	This	DT	O	this	det	2	SENT_76	[p5l8t2369r169b2437],
2	study	NN	O	study	nsubjpass	4	SENT_76	[p5l221t2369r426b2458],
3	was	VBD	O	be	auxpass	4	SENT_76	[p5l470t2393r606b2437],
4	approved	VBN	O	approve	_	0	SENT_76	[p5l658t2369r1010b2457],
5	by	IN	O	by	_	0	SENT_76	[p5l1057t2369r1149b2458],
6	the	DT	O	the	det	9	SENT_76	[p5l1195t2369r1310b2437],
7	Institutional	JJ	O	institutional	amod	9	SENT_76	[p5l1361t2369r1828b2437],
8	Review	NN	O	review	nn	9	SENT_76	[p5l1878t2371r2146b2437],
9	Boards	NNS	O	board	agent	4	SENT_76	[p5l9t2471r266b2539],
10	of	IN	O	of	_	0	SENT_76	[p5l296t2471r377b2539],
11	each	DT	O	each	det	13	SENT_76	[p5l395t2471r560b2539],
12	participating	VBG	O	participate	amod	13	SENT_76	[p5l587t2473r1070b2560],
13	hospital	NN	O	hospital	prep_of	9	SENT_76	[p5l1096t2471r1413b2559],
14	.	.	O	.	_	0	SENT_76	[p5l1096t2471r1413b2559],

1	Genotyping	NN	O	genotyping	_	0	SENT_77	[p5l9t2732r436b2815],
2	of	IN	O	of	_	0	SENT_77	[p5l460t2730r538b2795],
3	TNF-oz	NN	O	tnf-oz	prep_of	1	SENT_77	[p5l554t2733r798b2795],
4	—	CD	NUMBER	—	num	5	SENT_77	[p5l829t2734r1172b2798],
5	308G/A	NN	O	308g/a	dep	1	SENT_77	[p5l829t2734r1172b2798],

1	The	DT	O	the	det	2	SENT_78	[p5l8t2881r150b2949],
2	DNA	NN	MISC	dna	nsubjpass	4	SENT_78	[p5l191t2885r387b2949],
3	was	VBD	O	be	auxpass	4	SENT_78	[p5l423t2906r559b2949],
4	extracted	VBN	O	extract	_	0	SENT_78	[p5l601t2881r943b2949],
5	from	IN	O	from	_	0	SENT_78	[p5l983t2881r1166b2949],
6	whole	JJ	O	whole	amod	7	SENT_78	[p5l1204t2881r1428b2949],
7	blood	NN	O	blood	prep_from	4	SENT_78	[p5l1466t2881r1685b2949],
8	of	IN	O	of	_	0	SENT_78	[p5l1725t2881r1808b2949],
9	enrolled	VBN	O	enrol	amod	10	SENT_78	[p5l1838t2881r2144b2949],
10	subjects	NNS	O	subject	prep_of	7	SENT_78	[p5l9t2985r300b3075],
11	using	VBG	O	use	partmod	10	SENT_78	[p5l345t2987r545b3075],
12	the	DT	O	the	det	18	SENT_78	[p5l587t2985r702b3053],
13	Genomic	JJ	O	genomic	amod	18	SENT_78	[p5l747t2987r1089b3054],
14	PUREGENE	NN	O	puregene	nn	18	SENT_78	[p5l1133t2967r1653b3054],
15	®	NN	O	®	nn	18	SENT_78	[p5l1133t2967r1653b3054],
16	DNA	NN	O	dna	nn	18	SENT_78	[p5l1696t2989r1892b3053],
17	Isolation	NN	O	isolation	nn	18	SENT_78	[p5l1934t2985r2139b3053, p5l7t3090r159b3156],
18	Kit	NN	O	kit	dobj	11	SENT_78	[p5l189t3090r302b3156],
19	(	CD	NUMBER	(	num	21	SENT_78	[p5l335t3088r623b3170],
20	Gentra	NNP	ORGANIZATION	Gentra	nn	21	SENT_78	[p5l335t3088r623b3170],
21	Systems	NNPS	ORGANIZATION	Systems	dep	18	SENT_78	[p5l653t3092r968b3177],
22	,	,	ORGANIZATION	,	_	0	SENT_78	[p5l653t3092r968b3177],
23	Inc.	NNP	ORGANIZATION	Inc.	appos	21	SENT_78	[p5l1000t3093r1159b3166],
24	,	,	O	,	_	0	SENT_78	[p5l1000t3093r1159b3166],
25	Minneapolis	NNP	LOCATION	Minneapolis	appos	21	SENT_78	[p5l1191t3088r1681b3176],
26	,	,	O	,	_	0	SENT_78	[p5l1191t3088r1681b3176],
27	MN	NN	O	mn	appos	21	SENT_78	[p5l1712t3093r1883b3166],
28	,	,	O	,	_	0	SENT_78	[p5l1712t3093r1883b3166],
29	USA	NNP	LOCATION	USA	appos	21	SENT_78	[p5l1914t3088r2139b3170],
30	)	CD	NUMBER	)	num	29	SENT_78	[p5l1914t3088r2139b3170],
31	.	.	O	.	_	0	SENT_78	[p5l1914t3088r2139b3170],

1	Genotyping	NN	O	genotyping	nsubjpass	12	SENT_79	[p5l10t3192r452b3279],
2	of	IN	O	of	_	0	SENT_79	[p5l489t3190r571b3258],
3	the	DT	O	the	det	4	SENT_79	[p5l597t3190r712b3258],
4	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_79	[p5l748t3190r1339b3279],
5	in	IN	O	in	_	0	SENT_79	[p5l1379t3192r1451b3257],
6	TNF	NN	O	tnf	nn	7	SENT_79	[p5l1487t3193r1746b3258],
7	—	NN	O	—	prep_in	4	SENT_79	[p5l1487t3193r1746b3258],
8	oL	NN	O	ol	nn	10	SENT_79	[p5l1487t3193r1746b3258],
9	—	CD	NUMBER	—	num	10	SENT_79	[p5l1788t3194r2144b3261],
10	308G/A	NNP	O	308G/A	dep	7	SENT_79	[p5l1788t3194r2144b3261],
11	was	VBD	O	be	auxpass	12	SENT_79	[p5l6t3316r142b3359],
12	performed	VBN	O	perform	_	0	SENT_79	[p5l188t3291r586b3379],
13	with	IN	O	with	_	0	SENT_79	[p5l629t3291r796b3359],
14	the	DT	O	the	det	16	SENT_79	[p5l841t3291r957b3359],
15	high	JJ	O	high	amod	16	SENT_79	[p5l1002t3291r1168b3381],
16	throughput	NN	O	throughput	prep_with	12	SENT_79	[p5l1212t3291r1647b3381],
17	single	JJ	O	single	amod	20	SENT_79	[p5l1694t3291r1904b3381],
18	basepair	NN	O	basepair	nn	20	SENT_79	[p5l1949t3291r2138b3359, p5l7t3397r156b3483],
19	extension	NN	O	extension	nn	20	SENT_79	[p5l193t3397r549b3463],
20	method	NN	O	method	tmod	12	SENT_79	[p5l586t3395r877b3463],
21	(	CD	NUMBER	(	num	22	SENT_79	[p5l918t3377r1340b3477],
22	SNP	NN	O	snp	dep	20	SENT_79	[p5l918t3377r1340b3477],
23	.	.	O	.	_	0	SENT_79	[p5l918t3377r1340b3477],

1	—	NN	O	—	_	0	SENT_80	[p5l918t3377r1340b3477],
2	.	.	O	.	_	0	SENT_80	[p5l918t3377r1340b3477],

1	ITTM	NN	ORGANIZATION	ittm	nn	3	SENT_81	[p5l918t3377r1340b3477],
2	assay	NN	O	assay	nn	3	SENT_81	[p5l1378t3395r1593b3484],
3	)	NN	O	)	_	0	SENT_81	[p5l1378t3395r1593b3484],
4	using	VBG	O	use	partmod	3	SENT_81	[p5l1635t3397r1836b3484],
5	a	DT	O	a	det	9	SENT_81	[p5l1872t3419r1910b3463],
6	SNP	NN	O	snp	nn	9	SENT_81	[p5l1946t3399r2138b3463],
7	—	CD	NUMBER	—	num	9	SENT_81	[p5l1946t3399r2138b3463],
8	stream25K	NN	O	stream25k	nn	9	SENT_81	[p5l9t3502r412b3565],
9	system	NN	O	system	dobj	4	SENT_81	[p5l444t3510r693b3586],
10	that	WDT	O	that	nsubjpass	12	SENT_81	[p5l723t3497r871b3565],
11	was	VBD	O	be	auxpass	12	SENT_81	[p5l900t3522r1036b3565],
12	customized	VBN	O	customize	rcmod	9	SENT_81	[p5l1068t3497r1497b3565],
13	to	TO	O	to	aux	17	SENT_81	[p5l1526t3510r1600b3565],
14	automatically	RB	O	automatically	advmod	17	SENT_81	[p5l1634t3497r2146b3586],
15	genotype	NN	O	genotype	nn	17	SENT_81	[p5l9t3612r348b3688],
16	DNA	NN	O	dna	nn	17	SENT_81	[p5l378t3603r574b3667],
17	samples	NNS	O	sample	xcomp	12	SENT_81	[p5l604t3599r896b3687],
18	in	IN	O	in	_	0	SENT_81	[p5l928t3602r1001b3666],
19	384	CD	NUMBER	384	number	20	SENT_81	[p5l1032t3599r1347b3667],
20	—	CD	NUMBER	—	prep_in	17	SENT_81	[p5l1032t3599r1347b3667],
21	well	RB	O	well	advmod	20	SENT_81	[p5l1032t3599r1347b3667],
22	plates	NNS	O	plate	pobj	21	SENT_81	[p5l1376t3599r1588b3687],
23	and	CC	O	and	_	0	SENT_81	[p5l1621t3599r1758b3667],
24	provide	VB	O	provide	xcomp	12	SENT_81	[p5l1787t3599r2075b3687],
25	a	DT	O	a	det	27	SENT_81	[p5l2107t3624r2144b3667],
26	colorimetric	JJ	O	colorimetric	amod	27	SENT_81	[p5l9t3700r470b3768],
27	readout	NN	O	readout	iobj	24	SENT_81	[p5l532t3700r821b3768],
28	(	CD	NUMBER	(	num	30	SENT_81	[p5l887t3700r1183b3783],
29	Orchid	NNP	O	Orchid	nn	30	SENT_81	[p5l887t3700r1183b3783],
30	Biosciences	NNP	O	Biosciences	dobj	24	SENT_81	[p5l1244t3702r1689b3779],
31	,	,	O	,	_	0	SENT_81	[p5l1244t3702r1689b3779],
32	Princeton	NNP	LOCATION	Princeton	appos	30	SENT_81	[p5l1753t3702r2141b3779],
33	,	,	O	,	_	0	SENT_81	[p5l1753t3702r2141b3779],

1	NJ	NNP	O	NJ	nn	3	SENT_82	[p6l7t22r125b97],
2	,	,	O	,	_	0	SENT_82	[p6l7t22r125b97],
3	USA	NNP	LOCATION	USA	nsubj	7	SENT_82	[p6l155t17r355b99],
4	)	CD	NUMBER	)	num	3	SENT_82	[p6l155t17r355b99],
5	as	IN	O	as	prep	3	SENT_82	[p6l391t42r459b85],
6	previously	RB	DATE	previously	pcomp	5	SENT_82	[p6l487t17r879b106],
7	described	VBN	O	describe	_	0	SENT_82	[p6l904t17r1258b85],
8	(	NN	O	(	nn	10	SENT_82	[p6l1291t17r1461b99],
9	21	CD	NUMBER	21	num	10	SENT_82	[p6l1291t17r1461b99],
10	)	NN	O	)	dobj	7	SENT_82	[p6l1291t17r1461b99],
11	.	.	O	.	_	0	SENT_82	[p6l1291t17r1461b99],

1	Brieﬂy	NNP	O	Brieﬂy	nsubj	12	SENT_83	[p6l1494t17r1757b106],
2	,	,	O	,	_	0	SENT_83	[p6l1494t17r1757b106],
3	the	DT	O	the	det	6	SENT_83	[p6l1786t17r1902b85],
4	genomic	JJ	O	genomic	amod	6	SENT_83	[p6l1931t42r2139b106, p6l8t122r147b187],
5	DNA	NN	O	dna	nn	6	SENT_83	[p6l198t123r394b187],
6	region	NN	O	region	appos	1	SENT_83	[p6l446t121r684b208],
7	spanning	VBG	O	span	partmod	6	SENT_83	[p6l736t122r1078b208],
8	the	DT	O	the	det	10	SENT_83	[p6l1128t119r1243b187],
9	polymorphic	JJ	O	polymorphic	amod	10	SENT_83	[p6l1295t119r1782b208],
10	site	NN	O	site	dobj	7	SENT_83	[p6l1835t122r1957b187],
11	was	VBD	O	be	cop	12	SENT_83	[p6l2006t144r2143b187],
12	PCR	NN	O	pcr	_	0	SENT_83	[p6l9t225r180b289],
13	ampliﬁed	JJ	O	ampliﬁed	amod	12	SENT_83	[p6l214t221r569b309],
14	using	VBG	O	use	partmod	12	SENT_83	[p6l605t223r805b310],
15	one	CD	NUMBER	one	num	17	SENT_83	[p6l841t246r975b289],
16	phosphothiolated	JJ	O	phosphothiolated	amod	17	SENT_83	[p6l1011t221r1676b309],
17	primer	NN	O	primer	dobj	14	SENT_83	[p6l1711t223r1970b309],
18	and	CC	O	and	_	0	SENT_83	[p6l2006t221r2143b289],
19	one	CD	NUMBER	one	num	22	SENT_83	[p6l9t348r143b391],
20	regular	JJ	O	regular	amod	22	SENT_83	[p6l185t323r449b412],
21	PCR	NN	MISC	pcr	nn	22	SENT_83	[p6l489t327r660b391],
22	primer	NN	O	primer	conj_and	17	SENT_83	[p6l699t326r975b411],
23	.	.	O	.	_	0	SENT_83	[p6l699t326r975b411],

1	The	DT	O	the	det	4	SENT_84	[p6l1020t323r1162b391],
2	ampliﬁed	JJ	O	ampliﬁed	amod	4	SENT_84	[p6l1205t323r1559b411],
3	PCR	NN	O	pcr	nn	4	SENT_84	[p6l1600t327r1772b391],
4	products	NNS	O	product	nsubjpass	7	SENT_84	[p6l1810t323r2143b411],
5	were	VBD	O	be	auxpass	7	SENT_84	[p6l6t450r180b493],
6	then	RB	O	then	advmod	7	SENT_84	[p6l207t425r373b493],
7	digested	VBN	O	digest	_	0	SENT_84	[p6l402t425r707b514],
8	with	IN	O	with	_	0	SENT_84	[p6l731t425r898b493],
9	T7	NN	O	t7	nn	10	SENT_84	[p6l925t428r1022b493],
10	exonuclease	NN	O	exonuclease	prep_with	7	SENT_84	[p6l1052t425r1515b493],
11	.	.	O	.	_	0	SENT_84	[p6l1052t425r1515b493],

1	The	DT	O	the	det	4	SENT_85	[p6l1546t425r1688b493],
2	5	CD	NUMBER	5	num	4	SENT_85	[p6l1717t425r2139b513],
3	’	NN	O	’	nn	4	SENT_85	[p6l1717t425r2139b513],
4	phospho	NN	O	phospho	nsubj	26	SENT_85	[p6l1717t425r2139b513],
5	—	CD	NUMBER	—	num	6	SENT_85	[p6l1717t425r2139b513],
6	thiolates	NNS	O	thiolate	nsubj	7	SENT_85	[p6l7t527r323b595],
7	protected	VBD	O	protect	rcmod	4	SENT_85	[p6l355t527r713b615],
8	one	CD	NUMBER	one	num	9	SENT_85	[p6l745t552r879b595],
9	strand	NN	O	strand	dobj	7	SENT_85	[p6l911t527r1146b595],
10	of	IN	O	of	_	0	SENT_85	[p6l1178t527r1260b595],
11	the	DT	O	the	det	13	SENT_85	[p6l1280t527r1395b595],
12	PCR	NN	O	pcr	nn	13	SENT_85	[p6l1428t531r1599b595],
13	product	NN	O	product	prep_of	9	SENT_85	[p6l1627t527r1928b615],
14	from	IN	O	from	_	0	SENT_85	[p6l1959t527r2143b595],
15	T7exonuclease	NN	O	t7exonuclease	nn	16	SENT_85	[p6l8t629r555b697],
16	digestion	NN	O	digestion	prep_from	7	SENT_85	[p6l585t629r947b718],
17	,	,	O	,	_	0	SENT_85	[p6l585t629r947b718],
18	resulting	VBG	O	result	partmod	7	SENT_85	[p6l979t629r1305b718],
19	in	IN	O	in	_	0	SENT_85	[p6l1333t632r1406b696],
20	the	DT	O	the	det	21	SENT_85	[p6l1433t629r1549b697],
21	generation	NN	O	generation	prep_in	18	SENT_85	[p6l1578t632r1976b718],
22	of	IN	O	of	_	0	SENT_85	[p6l2006t629r2088b697],
23	a	DT	O	a	det	25	SENT_85	[p6l2107t654r2144b697],
24	single	JJ	O	single	amod	25	SENT_85	[p6l9t730r584b821],
25	—	NN	O	—	prep_of	21	SENT_85	[p6l9t730r584b821],
26	stranded	VBD	O	strand	_	0	SENT_85	[p6l9t730r584b821],
27	PCR	NN	O	pcr	nn	28	SENT_85	[p6l615t734r786b799],
28	template	NN	O	template	dobj	26	SENT_85	[p6l814t730r1159b820],
29	.	.	O	.	_	0	SENT_85	[p6l814t730r1159b820],

1	The	DT	O	the	det	3	SENT_86	[p6l1194t730r1336b799],
2	single	JJ	O	single	amod	3	SENT_86	[p6l1368t730r1943b821],
3	—	NN	O	—	nsubj	4	SENT_86	[p6l1368t730r1943b821],
4	stranded	VBD	O	strand	_	0	SENT_86	[p6l1368t730r1943b821],
5	PCR	NN	O	pcr	nn	6	SENT_86	[p6l1974t734r2145b799],
6	template	NN	O	template	nsubjpass	8	SENT_86	[p6l7t833r333b922],
7	was	VBD	O	be	auxpass	8	SENT_86	[p6l360t858r495b901],
8	overlaid	VBN	O	overlay	ccomp	4	SENT_86	[p6l526t833r828b902],
9	on	IN	O	on	_	0	SENT_86	[p6l856t858r951b901],
10	a	DT	O	a	det	14	SENT_86	[p6l980t858r1017b901],
11	384	CD	NUMBER	384	num	14	SENT_86	[p6l1047t833r1362b901],
12	—	RB	O	—	advmod	13	SENT_86	[p6l1047t833r1362b901],
13	well	RB	O	well	amod	14	SENT_86	[p6l1047t833r1362b901],
14	plate	NN	O	plate	prep_on	8	SENT_86	[p6l1389t833r1568b922],
15	that	WDT	O	that	nsubj	16	SENT_86	[p6l1596t833r1743b901],
16	contained	VBD	O	contain	rcmod	14	SENT_86	[p6l1772t833r2143b902],
17	a	DT	O	a	det	20	SENT_86	[p6l9t961r47b1004],
18	covalently	RB	O	covalently	advmod	19	SENT_86	[p6l87t936r468b1025],
19	attached	VBN	O	attach	amod	20	SENT_86	[p6l506t936r821b1004],
20	SNP	NN	O	snp	dobj	16	SENT_86	[p6l863t939r1148b1004],
21	.	.	O	.	_	0	SENT_86	[p6l863t939r1148b1004],

1	—	NN	O	—	_	0	SENT_87	[p6l863t939r1148b1004],
2	.	.	O	.	_	0	SENT_87	[p6l863t939r1148b1004],

1	IT	PRP	O	it	nsubj	5	SENT_88	[p6l863t939r1148b1004],
2	primer	NN	O	primer	nn	4	SENT_88	[p6l1188t939r1447b1024],
3	extension	NN	O	extension	nn	4	SENT_88	[p6l1488t939r1845b1004],
4	primer	NN	O	primer	dep	1	SENT_88	[p6l1885t938r2144b1024],
5	designed	VBN	O	design	_	0	SENT_88	[p6l9t1037r337b1128],
6	to	TO	O	to	aux	7	SENT_88	[p6l367t1051r440b1106],
7	hybridize	VB	O	hybridize	xcomp	5	SENT_88	[p6l472t1037r822b1128],
8	immediately	RB	O	immediately	advmod	9	SENT_88	[p6l855t1037r1325b1128],
9	adjacent	JJ	O	adjacent	acomp	7	SENT_88	[p6l1354t1037r1664b1128],
10	to	TO	O	to	_	0	SENT_88	[p6l1694t1051r1767b1106],
11	the	DT	O	the	det	13	SENT_88	[p6l1801t1037r1916b1106],
12	polymorphic	JJ	O	polymorphic	amod	13	SENT_88	[p6l1947t1037r2139b1128, p6l8t1141r331b1229],
13	site	NN	O	site	prep_to	9	SENT_88	[p6l377t1143r518b1209],
14	.	.	O	.	_	0	SENT_88	[p6l377t1143r518b1209],

1	The	DT	O	the	det	2	SENT_89	[p6l566t1141r709b1209],
2	SNP	NN	O	snp	_	0	SENT_89	[p6l756t1143r1041b1209],
3	.	.	O	.	_	0	SENT_89	[p6l756t1143r1041b1209],

1	—	NN	O	—	_	0	SENT_90	[p6l756t1143r1041b1209],
2	.	.	O	.	_	0	SENT_90	[p6l756t1143r1041b1209],

1	IT	PRP	O	it	nsubjpass	4	SENT_91	[p6l756t1143r1041b1209],
2	primer	NN	O	primer	nsubjpass	4	SENT_91	[p6l1086t1143r1345b1229],
3	was	VBD	O	be	auxpass	4	SENT_91	[p6l1387t1165r1523b1209],
4	extended	VBN	O	extend	_	0	SENT_91	[p6l1570t1141r1907b1209],
5	for	IN	O	for	_	0	SENT_91	[p6l1954t1141r2061b1209],
6	a	DT	O	a	det	8	SENT_91	[p6l2107t1165r2144b1209],
7	single	JJ	O	single	amod	8	SENT_91	[p6l9t1243r219b1332],
8	base	NN	O	base	prep_for	4	SENT_91	[p6l272t1243r432b1311],
9	with	IN	O	with	_	0	SENT_91	[p6l485t1243r651b1311],
10	DNA	NN	O	dna	nn	11	SENT_91	[p6l706t1247r902b1311],
11	polymerase	NN	O	polymerase	prep_with	8	SENT_91	[p6l954t1243r1381b1332],
12	and	CC	O	and	_	0	SENT_91	[p6l1436t1243r1574b1311],
13	a	DT	O	a	det	14	SENT_91	[p6l1628t1268r1665b1311],
14	mixture	NN	O	mixture	prep_for	4	SENT_91	[p6l1719t1246r2015b1311],
15	of	IN	O	of	_	0	SENT_91	[p6l2071t1243r2154b1311],
16	appropriate	JJ	O	appropriate	amod	17	SENT_91	[p6l9t1349r448b1436],
17	acycloterminators	NNS	O	acycloterminator	prep_of	14	SENT_91	[p6l510t1346r1183b1437],
18	complementary	JJ	O	complementary	amod	14	SENT_91	[p6l1245t1346r1837b1437],
19	to	TO	O	to	_	0	SENT_91	[p6l1893t1360r1965b1415],
20	the	DT	O	the	det	22	SENT_91	[p6l2027t1346r2143b1415],
21	polymorphic	JJ	O	polymorphic	amod	22	SENT_91	[p6l7t1450r495b1539],
22	nucleotide	NN	O	nucleotide	prep_to	18	SENT_91	[p6l540t1450r933b1517],
23	that	WDT	O	that	nsubjpass	25	SENT_91	[p6l978t1450r1126b1518],
24	were	VBD	O	be	auxpass	25	SENT_91	[p6l1168t1474r1343b1517],
25	labelled	VBN	O	label	rcmod	22	SENT_91	[p6l1388t1450r1674b1518],
26	with	IN	O	with	_	0	SENT_91	[p6l1716t1450r1884b1517],
27	either	CC	O	either	preconj	28	SENT_91	[p6l1930t1450r2144b1517],
28	FITC	NN	O	fitc	prep_with	25	SENT_91	[p6l9t1555r202b1620],
29	or	CC	O	or	_	0	SENT_91	[p6l232t1577r311b1620],
30	biotin	NN	O	biotin	conj_or	28	SENT_91	[p6l336t1552r581b1620],
31	.	.	O	.	_	0	SENT_91	[p6l336t1552r581b1620],

1	The	DT	O	the	det	2	SENT_92	[p6l612t1552r755b1620],
2	identity	NN	O	identity	nsubjpass	8	SENT_92	[p6l784t1552r1075b1641],
3	of	IN	O	of	_	0	SENT_92	[p6l1100t1552r1183b1620],
4	the	DT	O	the	det	6	SENT_92	[p6l1200t1552r1315b1620],
5	incorporated	JJ	O	incorporated	amod	6	SENT_92	[p6l1344t1552r1832b1640],
6	nucleotide	NN	O	nucleotide	prep_of	2	SENT_92	[p6l1860t1552r2139b1620, p6l7t1653r148b1722],
7	was	VBD	O	be	auxpass	8	SENT_92	[p6l204t1678r340b1722],
8	determined	VBN	O	determine	_	0	SENT_92	[p6l400t1653r831b1722],
9	by	IN	O	by	_	0	SENT_92	[p6l886t1653r979b1744],
10	serial	NN	O	serial	nn	12	SENT_92	[p6l1034t1653r1227b1722],
11	colorimetric	JJ	O	colorimetric	amod	12	SENT_92	[p6l1286t1653r1747b1722],
12	reactions	NNS	O	reaction	agent	8	SENT_92	[p6l1805t1656r2141b1722],

1	Liver	NN	O	liver	nn	3	SENT_93	[p6l1504t1915r1618b1961],
2	International	NNP	O	International	nn	3	SENT_93	[p6l1638t1914r1956b1961],
3	(	NNP	O	(	_	0	SENT_93	[p6l1978t1914r2143b1969],
4	2012	CD	DATE	2012	num	9	SENT_93	[p6l1978t1914r2143b1969],
5	)	CD	NUMBER	)	num	9	SENT_93	[p6l1978t1914r2143b1969],
6	©	CD	NUMBER	©	num	9	SENT_93	[p6l1360t1989r1405b2035],
7	2011	CD	DATE	2011	num	9	SENT_93	[p6l1423t1990r1543b2035],
8	John	NNP	PERSON	John	nn	9	SENT_93	[p6l1570t1988r1687b2035],
9	Wiley	NNP	PERSON	Wiley	dep	3	SENT_93	[p6l1707t1988r1849b2045],
10	&	CC	O	&	_	0	SENT_93	[p6l1866t1990r1903b2035],
11	Sons	NNP	O	Sons	dep	3	SENT_93	[p6l1923t1990r2040b2035],
12	A/S	NNP	O	A/S	dep	3	SENT_93	[p6l2058t1990r2142b2035],

1	Kim	NNP	PERSON	Kim	_	0	SENT_94	[p6l14t2216r127b2272],
2	et	FW	O	et	nn	3	SENT_94	[p6l153t2222r217b2273],
3	a	FW	O	a	dep	1	SENT_94	[p6l242t2215r307b2272],
4	/	:	O	/	punct	3	SENT_94	[p6l242t2215r307b2272],
5	.	.	O	.	_	0	SENT_94	[p6l242t2215r307b2272],

1	with	IN	O	with	_	0	SENT_95	[p6l7t2443r174b2511],
2	anti	JJ	O	anti	pobj	1	SENT_95	[p6l203t2445r725b2512],
3	.	.	O	.	_	0	SENT_95	[p6l203t2445r725b2512],

1	—	NN	O	—	_	0	SENT_96	[p6l203t2445r725b2512],
2	.	.	O	.	_	0	SENT_96	[p6l203t2445r725b2512],

1	FITC	NN	ORGANIZATION	fitc	_	0	SENT_97	[p6l203t2445r725b2512],
2	.	.	O	.	_	0	SENT_97	[p6l203t2445r725b2512],

1	—	NN	O	—	_	0	SENT_98	[p6l203t2445r725b2512],
2	.	.	O	.	_	0	SENT_98	[p6l203t2445r725b2512],

1	AP	NN	O	ap	_	0	SENT_99	[p6l203t2445r725b2512],
2	and	CC	O	and	_	0	SENT_99	[p6l757t2443r895b2511],
3	streptavidin-horseradish	JJ	O	streptavidin-horseradish	amod	4	SENT_99	[p6l924t2443r1848b2532],
4	peroxidase	NN	O	peroxidase	conj_and	1	SENT_99	[p6l1876t2445r2145b2532, p6l10t2546r169b2615],
5	respectively	RB	O	respectively	amod	1	SENT_99	[p6l216t2546r670b2636],
6	.	.	O	.	_	0	SENT_99	[p6l216t2546r670b2636],

1	Resultant	JJ	O	resultant	amod	3	SENT_100	[p6l720t2546r1074b2615],
2	yellow	JJ	O	yellow	amod	3	SENT_100	[p6l1117t2546r1361b2636],
3	and/or	NN	O	and/or	nsubjpass	19	SENT_100	[p6l1405t2546r1657b2618],
4	blue	JJ	O	blue	amod	6	SENT_100	[p6l1700t2546r1861b2615],
5	colour	NN	O	colour	nn	6	SENT_100	[p6l1908t2546r2151b2615],
6	development	NN	O	development	nsubjpass	8	SENT_100	[p6l10t2648r498b2738],
7	was	VBD	O	be	auxpass	8	SENT_100	[p6l538t2673r674b2717],
8	analysed	VBN	O	analyse	rcmod	3	SENT_100	[p6l719t2648r1037b2739],
9	using	VBG	O	use	xcomp	8	SENT_100	[p6l1080t2651r1281b2739],
10	an	DT	O	a	det	12	SENT_100	[p6l1324t2673r1412b2717],
11	ELISA	NN	MISC	elisa	nn	12	SENT_100	[p6l1454t2652r1692b2717],
12	reader	NN	O	reader	dobj	9	SENT_100	[p6l1734t2648r1969b2717],
13	and	CC	O	and	_	0	SENT_100	[p6l2012t2648r2150b2717],
14	the	DT	O	the	det	17	SENT_100	[p6l8t2752r124b2820],
15	ﬁnal	JJ	O	ﬁnal	amod	17	SENT_100	[p6l168t2751r333b2820],
16	genotype	NN	O	genotype	nn	17	SENT_100	[p6l376t2765r715b2842],
17	calls	NNS	O	call	dobj	9	SENT_100	[p6l761t2752r916b2820],
18	were	VBD	O	be	auxpass	19	SENT_100	[p6l958t2776r1133b2820],
19	made	VBN	O	make	_	0	SENT_100	[p6l1177t2752r1381b2820],
20	using	VBG	O	use	xcomp	19	SENT_100	[p6l1425t2754r1626b2842],
21	a	DT	O	a	det	27	SENT_100	[p6l1670t2776r1708b2820],
22	QCReview	NN	O	qcreview	nn	27	SENT_100	[p6l1752t2754r2153b2834],
23	programme	NN	O	programme	nn	27	SENT_100	[p6l8t2879r452b2945],
24	(	CD	NUMBER	(	num	27	SENT_100	[p6l485t2855r782b2938],
25	Orchid	NNP	O	Orchid	nn	27	SENT_100	[p6l485t2855r782b2938],
26	Biosciences	NNP	O	Biosciences	nn	27	SENT_100	[p6l810t2855r1290b2938],
27	)	NN	O	)	dobj	20	SENT_100	[p6l810t2855r1290b2938],
28	.	.	O	.	_	0	SENT_100	[p6l810t2855r1290b2938],

1	Statistical	JJ	O	statistical	amod	2	SENT_101	[p6l10t3115r359b3181],
2	analysis	NN	O	analysis	_	0	SENT_101	[p6l385t3115r665b3201],

1	Baseline	NN	O	baseline	nn	2	SENT_102	[p7l9t39r314b108],
2	characteristics	NNS	O	characteristic	nsubjpass	7	SENT_102	[p7l360t39r890b108],
3	of	IN	O	of	_	0	SENT_102	[p7l937t39r1020b108],
4	the	DT	O	the	det	5	SENT_102	[p7l1054t39r1169b108],
5	subjects	NNS	O	subject	prep_of	2	SENT_102	[p7l1215t39r1508b130],
6	were	VBD	O	be	auxpass	7	SENT_102	[p7l1551t64r1726b108],
7	compared	VBN	O	compare	_	0	SENT_102	[p7l1773t39r2150b129],
8	using	VBG	O	use	xcomp	7	SENT_102	[p7l9t145r210b233],
9	the	DT	O	the	det	13	SENT_102	[p7l243t143r358b211],
10	Chi	NNP	O	Chi	nn	13	SENT_102	[p7l393t143r807b232],
11	—	CD	NUMBER	—	num	13	SENT_102	[p7l393t143r807b232],
12	square	JJ	O	square	amod	13	SENT_102	[p7l393t143r807b232],
13	test	NN	O	test	dobj	8	SENT_102	[p7l841t156r970b211],
14	for	IN	O	for	_	0	SENT_102	[p7l1003t143r1111b211],
15	categorical	JJ	O	categorical	amod	16	SENT_102	[p7l1145t143r1547b233],
16	variables	NNS	O	variable	prep_for	13	SENT_102	[p7l1577t143r1906b211],
17	and	CC	O	and	_	0	SENT_102	[p7l1941t143r2078b211],
18	a	DT	O	a	det	19	SENT_102	[p7l2113t167r2151b211],
19	Student	NN	O	student	poss	23	SENT_102	[p7l10t246r357b315],
20	’s	POS	O	’s	_	0	SENT_102	[p7l10t246r357b315],
21	t	NN	O	t	nn	23	SENT_102	[p7l398t260r587b315],
22	—	CD	NUMBER	—	num	23	SENT_102	[p7l398t260r587b315],
23	test	NN	O	test	conj_and	13	SENT_102	[p7l398t260r587b315],
24	for	IN	O	for	_	0	SENT_102	[p7l624t246r731b315],
25	continuous	JJ	O	continuous	amod	26	SENT_102	[p7l768t249r1193b315],
26	variables	NNS	O	variable	prep_for	23	SENT_102	[p7l1229t246r1577b315],
27	.	.	O	.	_	0	SENT_102	[p7l1229t246r1577b315],

1	Genotype	NN	O	genotype	nn	2	SENT_103	[p7l1619t250r1980b336],
2	frequencies	NNS	O	frequency	nsubjpass	7	SENT_103	[p7l2018t246r2145b315, p7l10t351r331b438],
3	and	CC	O	and	_	0	SENT_103	[p7l369t348r507b417],
4	minor	JJ	O	minor	amod	5	SENT_103	[p7l543t351r778b417],
5	alleles	NNS	O	allele	conj_and	2	SENT_103	[p7l814t348r1032b417],
6	were	VBD	O	be	auxpass	7	SENT_103	[p7l1067t373r1242b417],
7	compared	VBN	O	compare	_	0	SENT_103	[p7l1279t348r1656b438],
8	between	IN	O	between	_	0	SENT_103	[p7l1690t348r1998b417],
9	the	DT	O	the	det	13	SENT_103	[p7l2034t348r2149b417],
10	case	NN	O	case	nn	13	SENT_103	[p7l10t476r158b520],
11	and	CC	O	and	_	0	SENT_103	[p7l226t452r364b520],
12	control	NN	O	control	conj_and	10	SENT_103	[p7l431t452r703b520],
13	groups	NNS	O	group	prep_between	7	SENT_103	[p7l769t476r1025b542],
14	using	VBG	O	use	xcomp	7	SENT_103	[p7l1093t454r1294b542],
15	multivariate	JJ	O	multivariate	amod	18	SENT_103	[p7l1360t452r1817b520],
16	logistic	JJ	O	logistic	amod	18	SENT_103	[p7l1883t452r2150b542],
17	regression	NN	O	regression	nn	18	SENT_103	[p7l9t557r389b645],
18	analysis	NN	O	analysis	dobj	14	SENT_103	[p7l424t555r710b645],
19	adjusted	VBN	O	adjust	partmod	18	SENT_103	[p7l747t555r1061b645],
20	for	IN	O	for	_	0	SENT_103	[p7l1095t555r1203b623],
21	age	NN	O	age	prep_for	19	SENT_103	[p7l1238t580r1357b645],
22	and	CC	O	and	_	0	SENT_103	[p7l1393t555r1531b623],
23	gender	NN	O	gender	conj_and	21	SENT_103	[p7l1566t555r1837b645],
24	.	.	O	.	_	0	SENT_103	[p7l1566t555r1837b645],

1	All	DT	O	all	det	3	SENT_104	[p7l1873t555r1981b622],
2	statistical	JJ	O	statistical	amod	3	SENT_104	[p7l2016t568r2145b623, p7l8t658r253b726],
3	analyses	NNS	O	analysis	nsubjpass	5	SENT_104	[p7l315t657r615b748],
4	were	VBD	O	be	auxpass	5	SENT_104	[p7l675t682r850b726],
5	performed	VBN	O	perform	_	0	SENT_104	[p7l911t657r1310b747],
6	using	VBG	O	use	xcomp	5	SENT_104	[p7l1372t660r1573b748],
7	SAS	NNP	O	SAS	dobj	6	SENT_104	[p7l1634t661r1779b726],
8	(	CD	NUMBER	(	num	7	SENT_104	[p7l1847t658r2150b740],
9	version	NN	O	version	dep	7	SENT_104	[p7l1847t658r2150b740],
10	9.13	CD	NUMBER	9.13	num	9	SENT_104	[p7l10t767r183b840],
11	;	:	O	;	_	0	SENT_104	[p7l10t767r183b840],
12	SAS	NNP	ORGANIZATION	SAS	nn	19	SENT_104	[p7l214t764r358b829],
13	Institute	NNP	ORGANIZATION	Institute	nn	19	SENT_104	[p7l388t763r723b840],
14	,	,	O	,	_	0	SENT_104	[p7l388t763r723b840],
15	Cary	NNP	PERSON	Cary	appos	19	SENT_104	[p7l755t764r950b851],
16	,	,	O	,	_	0	SENT_104	[p7l755t764r950b851],
17	NC	NNP	ORGANIZATION	NC	appos	19	SENT_104	[p7l977t764r1127b840],
18	,	,	O	,	_	0	SENT_104	[p7l977t764r1127b840],
19	USA	NNP	LOCATION	USA	dep	7	SENT_104	[p7l1155t761r1355b843],
20	)	CD	NUMBER	)	num	19	SENT_104	[p7l1155t761r1355b843],
21	and	CC	O	and	_	0	SENT_104	[p7l1390t761r1528b829],
22	P	NN	O	p	nn	24	SENT_104	[p7l1553t761r1868b829],
23	—	NN	O	—	nn	24	SENT_104	[p7l1553t761r1868b829],
24	values	NNS	O	value	conj_and	19	SENT_104	[p7l1553t761r1868b829],
25	<	JJR	O	<	tmod	6	SENT_104	[p7l1907t774r1957b819],
26	0.05	CD	NUMBER	0.05	nsubjpass	28	SENT_104	[p7l1996t767r2146b829],
27	were	VBD	O	be	auxpass	28	SENT_104	[p7l7t889r182b932],
28	regarded	VBN	O	regard	rcmod	25	SENT_104	[p7l210t864r539b954],
29	as	IN	O	as	_	0	SENT_104	[p7l566t889r636b932],
30	statistically	RB	O	statistically	advmod	31	SENT_104	[p7l665t864r1081b954],
31	signiﬁcant	JJ	O	signiﬁcant	prep_as	28	SENT_104	[p7l1106t864r1511b954],
32	.	.	O	.	_	0	SENT_104	[p7l1106t864r1511b954],

1	Results	NNS	O	result	_	0	SENT_105	[p7l13t1124r302b1193],

1	Characteristics	NNS	O	characteristic	_	0	SENT_106	[p7l10t1283r544b1348],
2	of	IN	O	of	_	0	SENT_106	[p7l572t1283r651b1348],
3	the	DT	O	the	det	4	SENT_106	[p7l666t1283r780b1348],
4	subjects	NNS	O	subject	prep_of	1	SENT_106	[p7l806t1283r1092b1368],

1	In	IN	O	in	_	0	SENT_107	[p7l10t1439r88b1501],
2	total	NN	O	total	prep_in	25	SENT_107	[p7l129t1434r318b1513],
3	,	,	O	,	_	0	SENT_107	[p7l129t1434r318b1513],
4	77	CD	NUMBER	77	num	5	SENT_107	[p7l365t1442r448b1503],
5	patients	NNS	O	patient	appos	2	SENT_107	[p7l491t1436r786b1523],
6	with	IN	O	with	_	0	SENT_107	[p7l827t1434r994b1503],
7	ATD-induced	JJ	O	atd-induced	amod	11	SENT_107	[p7l1034t1434r1560b1503],
8	hepatitis	NN	O	hepatitis	nn	11	SENT_107	[p7l1601t1434r1923b1523],
9	(	CD	NUMBER	(	num	11	SENT_107	[p7l1970t1434r2149b1517],
10	case	NN	O	case	nn	11	SENT_107	[p7l1970t1434r2149b1517],
11	subjects	NNS	O	subject	prep_with	5	SENT_107	[p7l10t1537r332b1627],
12	)	JJ	O	)	amod	22	SENT_107	[p7l10t1537r332b1627],
13	and	CC	O	and	_	0	SENT_107	[p7l374t1537r512b1606],
14	229	CD	NUMBER	229	num	15	SENT_107	[p7l546t1544r676b1606],
15	patients	NNS	O	patient	amod	22	SENT_107	[p7l712t1539r1008b1626],
16	with	IN	O	with	_	0	SENT_107	[p7l1041t1537r1208b1606],
17	ATD	NN	O	atd	nn	20	SENT_107	[p7l1240t1537r1807b1606],
18	—	CD	NUMBER	—	num	20	SENT_107	[p7l1240t1537r1807b1606],
19	tolerance	NN	O	tolerance	nn	20	SENT_107	[p7l1240t1537r1807b1606],
20	(	NN	O	(	prep_with	15	SENT_107	[p7l1848t1537r2150b1620],
21	control	NN	O	control	nn	22	SENT_107	[p7l1848t1537r2150b1620],
22	subjects	NNS	O	subject	nsubjpass	25	SENT_107	[p7l10t1640r332b1730],
23	)	JJ	O	)	amod	22	SENT_107	[p7l10t1640r332b1730],
24	were	VBD	O	be	auxpass	25	SENT_107	[p7l386t1664r561b1708],
25	enrolled	VBN	O	enrol	_	0	SENT_107	[p7l613t1640r937b1708],
26	.	.	O	.	_	0	SENT_107	[p7l613t1640r937b1708],

1	All	DT	O	all	det	2	SENT_108	[p7l988t1640r1096b1707],
2	case	NN	O	case	nsubj	8	SENT_108	[p7l1146t1664r1294b1708],
3	and	CC	O	and	_	0	SENT_108	[p7l1346t1640r1484b1708],
4	control	JJ	O	control	amod	5	SENT_108	[p7l1534t1640r1807b1708],
5	subjects	NNS	O	subject	conj_and	2	SENT_108	[p7l1857t1640r2149b1730],
6	were	VBD	O	be	cop	8	SENT_108	[p7l7t1768r182b1811],
7	ethnically	RB	O	ethnically	advmod	8	SENT_108	[p7l247t1743r611b1833],
8	Korean	JJ	MISC	korean	_	0	SENT_108	[p7l673t1748r964b1811],
9	.	.	O	.	_	0	SENT_108	[p7l673t1748r964b1811],

1	Of	IN	O	of	_	0	SENT_109	[p7l1034t1743r1138b1812],
2	77	CD	NUMBER	77	num	3	SENT_109	[p7l1194t1751r1277b1811],
3	patients	NNS	O	patient	prep_of	14	SENT_109	[p7l1341t1745r1638b1832],
4	with	IN	O	with	_	0	SENT_109	[p7l1700t1743r1868b1811],
5	ATDinduced	NN	O	atdinduced	nn	6	SENT_109	[p7l1929t1746r2146b1810, p7l9t1846r313b1915],
6	hepatitis	NN	O	hepatitis	prep_with	3	SENT_109	[p7l355t1846r697b1935],
7	,	,	O	,	_	0	SENT_109	[p7l355t1846r697b1935],
8	14	CD	PERCENT	14	number	9	SENT_109	[p7l752t1853r830b1913],
9	(	CD	PERCENT	(	nsubj	14	SENT_109	[p7l880t1846r1173b1929],
10	18.2	CD	PERCENT	18.2	num	11	SENT_109	[p7l880t1846r1173b1929],
11	%	NN	PERCENT	%	dep	9	SENT_109	[p7l880t1846r1173b1929],
12	)	CD	NUMBER	)	num	13	SENT_109	[p7l880t1846r1173b1929],
13	subjects	NNS	O	subject	dep	9	SENT_109	[p7l1226t1846r1517b1936],
14	showed	VBD	O	show	_	0	SENT_109	[p7l1564t1846r1846b1915],
15	one	CD	NUMBER	one	num	18	SENT_109	[p7l1891t1871r2025b1915],
16	or	CC	O	or	_	0	SENT_109	[p7l2071t1871r2151b1915],
17	more	JJR	O	more	num	18	SENT_109	[p7l9t1973r205b2017],
18	features	NNS	O	feature	iobj	14	SENT_109	[p7l248t1949r540b2017],
19	of	IN	O	of	_	0	SENT_109	[p7l583t1949r666b2017],
20	hypersensitivity	NN	O	hypersensitivity	nn	21	SENT_109	[p7l698t1949r1293b2039],
21	reactions	NNS	O	reaction	prep_of	18	SENT_109	[p7l1332t1951r1670b2017],
22	(	JJ	O	(	amod	23	SENT_109	[p7l1719t1948r1949b2031],
23	fever	NN	O	fever	dobj	14	SENT_109	[p7l1719t1948r1949b2031],
24	,	,	O	,	_	0	SENT_109	[p7l1719t1948r1949b2031],
25	rash	NN	O	rash	conj_and	23	SENT_109	[p7l1995t1949r2150b2017],
26	and	CC	O	and	_	0	SENT_109	[p7l10t2052r148b2120],
27	peripheral	JJ	O	peripheral	amod	30	SENT_109	[p7l180t2052r565b2141],
28	blood	NN	O	blood	nn	30	SENT_109	[p7l596t2052r814b2121],
29	eosinophilia	NN	O	eosinophilia	nn	30	SENT_109	[p7l848t2052r1360b2141],
30	)	NN	O	)	conj_and	23	SENT_109	[p7l848t2052r1360b2141],
31	.	.	O	.	_	0	SENT_109	[p7l848t2052r1360b2141],

1	Hyperbilirubinemia	NN	O	hyperbilirubinemia	nn	5	SENT_110	[p7l1398t2052r2150b2142],
2	(	NN	O	(	nn	5	SENT_110	[p7l15t2155r276b2238],
3	serum	NN	O	serum	nn	5	SENT_110	[p7l15t2155r276b2238],
4	bilirubin	NN	O	bilirubin	nn	5	SENT_110	[p7l305t2155r636b2224],
5	concentration	NN	O	concentration	nsubjpass	15	SENT_110	[p7l668t2157r1193b2224],
6	>	JJR	O	>	amod	10	SENT_110	[p7l1230t2168r1280b2213],
7	two	CD	NUMBER	two	num	8	SENT_110	[p7l1318t2169r1455b2224],
8	times	NNS	O	time	dep	6	SENT_110	[p7l1487t2157r1688b2224],
9	upper	JJ	O	upper	amod	10	SENT_110	[p7l1720t2179r1942b2244],
10	limit	NN	O	limit	dep	5	SENT_110	[p7l1971t2155r2150b2224],
11	of	IN	O	of	_	0	SENT_110	[p7l10t2258r92b2326],
12	normal	JJ	O	normal	amod	13	SENT_110	[p7l118t2258r419b2340],
13	)	NN	O	)	prep_of	5	SENT_110	[p7l118t2258r419b2340],
14	was	VBD	O	be	auxpass	15	SENT_110	[p7l462t2282r597b2326],
15	observed	VBN	O	observe	_	0	SENT_110	[p7l636t2258r968b2326],
16	in	IN	O	in	_	0	SENT_110	[p7l1005t2260r1077b2325],
17	16	CD	PERCENT	16	num	18	SENT_110	[p7l1122t2264r1199b2326],
18	(	CD	PERCENT	(	prep_in	15	SENT_110	[p7l1242t2258r1535b2341],
19	20.8	CD	PERCENT	20.8	num	20	SENT_110	[p7l1242t2258r1535b2341],
20	%	NN	PERCENT	%	tmod	15	SENT_110	[p7l1242t2258r1535b2341],
21	)	CD	NUMBER	)	num	22	SENT_110	[p7l1242t2258r1535b2341],
22	patients	NNS	O	patient	dep	20	SENT_110	[p7l1577t2260r1892b2347],
23	.	.	O	.	_	0	SENT_110	[p7l1577t2260r1892b2347],

1	There	EX	O	there	expl	2	SENT_111	[p7l1933t2258r2150b2326],
2	were	VBD	O	be	_	0	SENT_111	[p7l7t2386r182b2429],
3	no	DT	O	no	det	5	SENT_111	[p7l215t2386r309b2429],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_111	[p7l345t2361r733b2451],
5	differences	NNS	O	difference	nsubj	2	SENT_111	[p7l765t2361r1166b2429],
6	in	IN	O	in	_	0	SENT_111	[p7l1201t2363r1273b2428],
7	demographic	JJ	O	demographic	amod	8	SENT_111	[p7l1307t2361r1803b2451],
8	parameters	NNS	O	parameter	prep_in	5	SENT_111	[p7l1834t2385r2145b2450, p7l8t2477r162b2543],
9	,	,	O	,	_	0	SENT_111	[p7l1834t2385r2145b2450, p7l8t2477r162b2543],
10	such	JJ	O	such	mwe	11	SENT_111	[p7l207t2464r376b2533],
11	as	IN	O	as	conj_and	5	SENT_111	[p7l419t2489r487b2533],
12	age	NN	O	age	nn	22	SENT_111	[p7l530t2489r669b2554],
13	,	,	O	,	_	0	SENT_111	[p7l530t2489r669b2554],
14	gender	NN	O	gender	nn	22	SENT_111	[p7l715t2464r987b2554],
15	,	,	O	,	_	0	SENT_111	[p7l715t2464r987b2554],
16	height	NN	O	height	nn	22	SENT_111	[p7l1031t2464r1286b2554],
17	,	,	O	,	_	0	SENT_111	[p7l1031t2464r1286b2554],
18	weight	NN	O	weight	nn	22	SENT_111	[p7l1328t2464r1578b2554],
19	or	CC	O	or	_	0	SENT_111	[p7l1620t2489r1699b2533],
20	body	NN	O	body	nn	22	SENT_111	[p7l1738t2464r1930b2554],
21	mass	NN	O	mass	nn	22	SENT_111	[p7l1968t2489r2149b2533],
22	index	NN	O	index	pobj	11	SENT_111	[p7l9t2567r218b2635],
23	between	IN	O	between	_	0	SENT_111	[p7l241t2567r550b2635],
24	the	DT	O	the	det	25	SENT_111	[p7l577t2567r692b2635],
25	case	NN	O	case	prep_between	22	SENT_111	[p7l721t2592r869b2635],
26	and	CC	O	and	_	0	SENT_111	[p7l898t2567r1036b2635],
27	control	JJ	O	control	amod	28	SENT_111	[p7l1064t2567r1336b2635],
28	subjects	NNS	O	subject	conj_and	5	SENT_111	[p7l1364t2567r1655b2657],
29	(	JJ	O	(	amod	30	SENT_111	[p7l1690t2567r1925b2650],
30	Table	NNP	O	Table	dep	28	SENT_111	[p7l1690t2567r1925b2650],
31	1	CD	NUMBER	1	number	32	SENT_111	[p7l1972t2567r2059b2649],
32	)	CD	NUMBER	)	dep	30	SENT_111	[p7l1972t2567r2059b2649],
33	.	.	O	.	_	0	SENT_111	[p7l1972t2567r2059b2649],

1	Associations	NNS	O	association	_	0	SENT_112	[p7l7t2829r461b2892],
2	between	IN	O	between	_	0	SENT_112	[p7l485t2827r783b2892],
3	—	CD	NUMBER	—	num	4	SENT_112	[p7l815t2830r1158b2894],
4	308G/A	NN	O	308g/a	prep_between	1	SENT_112	[p7l815t2830r1158b2894],
5	and	CC	O	and	_	0	SENT_112	[p7l1183t2827r1317b2892],
6	ATD-induced	JJ	O	atd-induced	amod	7	SENT_112	[p7l1339t2827r1842b2892],
7	hepatitis	NN	O	hepatitis	prep_between	1	SENT_112	[p7l8t2929r318b3013],

1	The	DT	O	the	det	3	SENT_113	[p7l9t3081r151b3150],
2	genotype	NN	O	genotype	nn	3	SENT_113	[p7l181t3095r519b3171],
3	frequencies	NNS	O	frequency	nsubjpass	18	SENT_113	[p7l548t3081r972b3170],
4	in	IN	O	in	_	0	SENT_113	[p7l1002t3083r1075b3148],
5	the	DT	O	the	det	9	SENT_113	[p7l1102t3081r1217b3150],
6	case	NN	O	case	nn	9	SENT_113	[p7l1247t3106r1395b3150],
7	and	CC	O	and	_	0	SENT_113	[p7l1425t3081r1563b3150],
8	control	NN	O	control	nn	9	SENT_113	[p7l1592t3081r1865b3150],
9	groups	NNS	O	group	prep_in	3	SENT_113	[p7l1893t3105r2148b3171],
10	and	CC	O	and	_	0	SENT_113	[p7l10t3184r148b3253],
11	the	DT	O	the	det	12	SENT_113	[p7l182t3184r298b3253],
12	results	NNS	O	result	conj_and	3	SENT_113	[p7l333t3184r573b3253],
13	of	IN	O	of	_	0	SENT_113	[p7l610t3184r693b3253],
14	the	DT	O	the	det	16	SENT_113	[p7l716t3184r831b3253],
15	association	NN	O	association	nn	16	SENT_113	[p7l868t3187r1283b3253],
16	analysis	NN	O	analysis	prep_of	12	SENT_113	[p7l1318t3184r1604b3274],
17	are	VBP	O	be	auxpass	18	SENT_113	[p7l1641t3209r1751b3253],
18	presented	VBN	O	present	_	0	SENT_113	[p7l1786t3184r2149b3273],

1	Table	NNP	O	Table	_	0	SENT_114	[p7l7t3362r197b3420],
2	1	CD	NUMBER	1	dep	1	SENT_114	[p7l232t3365r284b3419],
3	.	.	O	.	_	0	SENT_114	[p7l232t3365r284b3419],

1	Clinical	JJ	O	clinical	amod	2	SENT_115	[p7l332t3362r552b3420],
2	characteristics	NNS	O	characteristic	_	0	SENT_115	[p7l579t3362r1021b3420],
3	of	IN	O	of	_	0	SENT_115	[p7l1044t3361r1107b3420],
4	study	NN	O	study	nn	5	SENT_115	[p7l1128t3362r1296b3435],
5	subjects	NNS	O	subject	prep_of	2	SENT_115	[p7l1318t3362r1568b3435],

1	ATD-induced	JJ	O	atd-induced	amod	2	SENT_116	[p7l771t3509r1182b3567],
2	ATD	NN	O	atd	_	0	SENT_116	[p7l1350t3509r1761b3567],
3	—	CD	NUMBER	—	number	5	SENT_116	[p7l1350t3509r1761b3567],
4	to	TO	O	to	dep	5	SENT_116	[p7l1350t3509r1761b3567],
5	|	CD	NUMBER	|	num	8	SENT_116	[p7l1350t3509r1761b3567],
6	erant	JJ	O	erant	amod	8	SENT_116	[p7l1350t3509r1761b3567],
7	hepatitis	NN	O	hepatitis	nn	8	SENT_116	[p7l776t3601r1039b3674],
8	control	NN	O	control	dep	2	SENT_116	[p7l1352t3601r1569b3659],
9	(	CD	NUMBER	(	num	10	SENT_116	[p7l773t3695r830b3762],
10	n	NN	O	n	dep	2	SENT_116	[p7l773t3695r830b3762],
11	=	JJ	O	=	quantmod	13	SENT_116	[p7l861t3719r901b3735],
12	77	CD	NUMBER	77	number	13	SENT_116	[p7l934t3695r1032b3762],
13	)	CD	NUMBER	)	num	19	SENT_116	[p7l934t3695r1032b3762],
14	(	NN	O	(	nn	19	SENT_116	[p7l1352t3695r1409b3762],
15	n	NN	O	n	nn	19	SENT_116	[p7l1352t3695r1409b3762],
16	=	JJ	O	=	amod	19	SENT_116	[p7l1440t3719r1480b3735],
17	229	CD	NUMBER	229	number	18	SENT_116	[p7l1513t3695r1653b3762],
18	)	CD	NUMBER	)	dep	16	SENT_116	[p7l1513t3695r1653b3762],
19	Pvalue	NN	O	pvalue	dep	10	SENT_116	[p7l1931t3695r2149b3753],

1	Males	NNS	O	male	dep	117	SENT_117	[p8l13t95r209b162],
2	,	,	O	,	_	0	SENT_117	[p8l13t95r209b162],
3	number	NN	O	number	dep	117	SENT_117	[p8l239t95r484b153],
4	(	CD	PERCENT	(	dep	117	SENT_117	[p8l505t95r617b163],
5	%	NN	PERCENT	%	dep	117	SENT_117	[p8l505t95r617b163],
6	)	CD	NUMBER	)	dep	117	SENT_117	[p8l505t95r617b163],
7	43	CD	NUMBER	43	dep	117	SENT_117	[p8l772t99r848b153],
8	(	NN	O	(	dep	117	SENT_117	[p8l875t95r1133b163],
9	55.8	CD	PERCENT	55.8	dep	117	SENT_117	[p8l875t95r1133b163],
10	%	NN	PERCENT	%	dep	117	SENT_117	[p8l875t95r1133b163],
11	)	CD	NUMBER	)	dep	117	SENT_117	[p8l875t95r1133b163],
12	155	CD	NUMBER	155	dep	117	SENT_117	[p8l1359t99r1470b153],
13	(	NN	O	(	dep	117	SENT_117	[p8l1495t95r1753b163],
14	67.7	CD	PERCENT	67.7	dep	117	SENT_117	[p8l1495t95r1753b163],
15	%	NN	PERCENT	%	dep	117	SENT_117	[p8l1495t95r1753b163],
16	)	CD	NUMBER	)	dep	117	SENT_117	[p8l1495t95r1753b163],
17	NS	NN	O	n	dep	117	SENT_117	[p8l1934t98r2012b153],
18	Age	NN	O	age	dep	117	SENT_117	[p8l8t193r133b262],
19	(	CD	NUMBER	(	dep	117	SENT_117	[p8l158t189r357b262],
20	years	NNS	NUMBER	year	dep	117	SENT_117	[p8l158t189r357b262],
21	)	VBP	O	)	dep	117	SENT_117	[p8l158t189r357b262],
22	44.9	CD	NUMBER	44.9	dep	117	SENT_117	[p8l813t192r954b247],
23	d	NN	O	d	dep	117	SENT_117	[p8l985t200r1025b241],
24	:	:	O	:	_	0	SENT_117	[p8l985t200r1025b241],
25	18.0	CD	NUMBER	18.0	dep	117	SENT_117	[p8l1062t192r1196b247],
26	43.1	CD	NUMBER	43.1	dep	117	SENT_117	[p8l1392t192r1521b247],
27	:1	CD	NUMBER	:1	dep	117	SENT_117	[p8l1564t200r1605b241],
28	:	:	O	:	_	0	SENT_117	[p8l1564t200r1605b241],
29	17.0	CD	NUMBER	17.0	dep	117	SENT_117	[p8l1641t192r1775b247],
30	NS	NN	O	n	dep	117	SENT_117	[p8l1934t192r2012b247],
31	Height	NN	O	height	dep	117	SENT_117	[p8l13t282r218b356],
32	(	CD	NUMBER	(	dep	117	SENT_117	[p8l241t282r374b350],
33	cm	NN	O	cm	dep	117	SENT_117	[p8l241t282r374b350],
34	)	NN	O	)	dep	117	SENT_117	[p8l241t282r374b350],
35	164.4	CD	NUMBER	164.4	dep	117	SENT_117	[p8l779t285r956b340],
36	:	:	O	:	_	0	SENT_117	[p8l985t294r1025b334],
37	|	CD	NUMBER	|	dep	117	SENT_117	[p8l985t294r1025b334],
38	:	:	O	:	_	0	SENT_117	[p8l985t294r1025b334],
39	9.6	CD	NUMBER	9.6	dep	117	SENT_117	[p8l1057t285r1154b340],
40	165.5	CD	NUMBER	165.5	dep	117	SENT_117	[p8l1358t285r1532b340],
41	:	:	O	:	_	0	SENT_117	[p8l1564t294r1605b334],
42	l	NN	O	l	dep	117	SENT_117	[p8l1564t294r1605b334],
43	:	:	O	:	_	0	SENT_117	[p8l1564t294r1605b334],
44	8.9	CD	NUMBER	8.9	dep	117	SENT_117	[p8l1635t285r1733b340],
45	NS	NN	O	n	dep	117	SENT_117	[p8l1934t285r2012b340],
46	Weight	NNP	O	Weight	dep	117	SENT_117	[p8l7t375r239b449],
47	(	CD	NUMBER	(	dep	117	SENT_117	[p8l261t375r377b449],
48	kg	NN	O	kg	dep	117	SENT_117	[p8l261t375r377b449],
49	)	NN	O	)	dep	117	SENT_117	[p8l261t375r377b449],
50	58.1	CD	NUMBER	58.1	dep	117	SENT_117	[p8l817t378r942b433],
51	A	NN	O	a	dep	117	SENT_117	[p8l985t387r1025b428],
52	:	:	O	:	_	0	SENT_117	[p8l985t387r1025b428],
53	10.1	CD	NUMBER	10.1	dep	117	SENT_117	[p8l1062t378r1184b433],
54	58.1	CD	NUMBER	58.1	dep	117	SENT_117	[p8l1397t378r1521b433],
55	:	:	O	:	_	0	SENT_117	[p8l1564t387r1605b427],
56	l	NN	O	l	dep	117	SENT_117	[p8l1564t387r1605b427],
57	:	:	O	:	_	0	SENT_117	[p8l1564t387r1605b427],
58	10.7	CD	NUMBER	10.7	dep	117	SENT_117	[p8l1642t378r1774b433],
59	NS	NN	O	n	dep	117	SENT_117	[p8l1934t378r2012b433],
60	Body	NN	O	body	dep	117	SENT_117	[p8l12t467r164b541],
61	mass	NN	O	mass	dep	117	SENT_117	[p8l189t485r340b525],
62	21.1	CD	NUMBER	21.1	dep	117	SENT_117	[p8l815t471r942b525],
63	3	CD	NUMBER	3	dep	117	SENT_117	[p8l985t479r1025b520],
64	:	:	O	:	_	0	SENT_117	[p8l985t479r1025b520],
65	3.8	CD	NUMBER	3.8	dep	117	SENT_117	[p8l1057t471r1155b525],
66	21.2	CD	NUMBER	21.2	dep	117	SENT_117	[p8l1394t471r1530b525],
67	3	CD	NUMBER	3	dep	117	SENT_117	[p8l1564t479r1604b520],
68	:	:	O	:	_	0	SENT_117	[p8l1564t479r1604b520],
69	3.2	CD	NUMBER	3.2	dep	117	SENT_117	[p8l1636t471r1731b525],
70	NS	NN	O	n	dep	117	SENT_117	[p8l1934t470r2012b525],
71	index	NN	O	index	dep	117	SENT_117	[p8l50t561r214b619],
72	(	CD	NUMBER	(	dep	117	SENT_117	[p8l237t549r467b635],
73	kg/m2	NN	O	kg/m2	dep	117	SENT_117	[p8l237t549r467b635],
74	)	CD	NUMBER	)	dep	117	SENT_117	[p8l237t549r467b635],
75	Basal	JJ	O	basal	dep	117	SENT_117	[p8l12t654r164b712],
76	AST	NNP	O	AST	dep	117	SENT_117	[p8l188t657r313b712],
77	(	CD	NUMBER	(	dep	117	SENT_117	[p8l335t654r476b722],
78	U/L	NN	O	u/l	dep	117	SENT_117	[p8l335t654r476b722],
79	)	CD	NUMBER	)	dep	117	SENT_117	[p8l335t654r476b722],
80	26.0	CD	NUMBER	26.0	dep	117	SENT_117	[p8l815t657r954b712],
81	A	DT	O	a	dep	117	SENT_117	[p8l985t666r1025b706],
82	:	:	O	:	_	0	SENT_117	[p8l985t666r1025b706],
83	15.4	CD	NUMBER	15.4	dep	117	SENT_117	[p8l1062t658r1198b712],
84	23.9	CD	NUMBER	23.9	dep	117	SENT_117	[p8l1394t657r1533b712],
85	:	:	O	:	_	0	SENT_117	[p8l1564t666r1605b706],
86	|	CD	NUMBER	|	dep	117	SENT_117	[p8l1564t666r1605b706],
87	:	:	O	:	_	0	SENT_117	[p8l1564t666r1605b706],
88	21.8	CD	NUMBER	21.8	dep	117	SENT_117	[p8l1636t657r1775b712],
89	NS	NN	O	n	dep	117	SENT_117	[p8l1934t657r2012b712],
90	Basal	JJ	O	basal	dep	117	SENT_117	[p8l12t746r164b804],
91	ALT	NN	O	alt	dep	117	SENT_117	[p8l188t750r309b804],
92	(	NN	O	(	dep	117	SENT_117	[p8l331t746r472b814],
93	U/L	NN	O	u/l	dep	117	SENT_117	[p8l331t746r472b814],
94	)	CD	NUMBER	)	dep	117	SENT_117	[p8l331t746r472b814],
95	23.4	CD	NUMBER	23.4	dep	117	SENT_117	[p8l815t750r956b804],
96	II	CD	NUMBER	ii	dep	117	SENT_117	[p8l985t758r1025b798],
97	:	:	O	:	_	0	SENT_117	[p8l985t758r1025b798],
98	13.5	CD	NUMBER	13.5	dep	117	SENT_117	[p8l1063t750r1195b804],
99	21.6	CD	NUMBER	21.6	dep	117	SENT_117	[p8l1394t750r1533b804],
100	:	:	O	:	_	0	SENT_117	[p8l1564t758r1605b798],
101	l	NN	O	l	dep	117	SENT_117	[p8l1564t758r1605b798],
102	:	:	O	:	_	0	SENT_117	[p8l1564t758r1605b798],
103	24.7	CD	NUMBER	24.7	dep	117	SENT_117	[p8l1636t750r1774b804],
104	NS	NN	O	n	dep	117	SENT_117	[p8l1934t749r2012b804],
105	Basal	JJ	O	basal	dep	117	SENT_117	[p8l12t840r164b898],
106	total	JJ	O	total	dep	117	SENT_117	[p8l188t840r328b898],
107	0.6	CD	NUMBER	0.6	dep	117	SENT_117	[p8l857t843r955b898],
108	i	FW	O	i	dep	117	SENT_117	[p8l985t851r1025b892],
109	0.3	CD	NUMBER	0.3	dep	117	SENT_117	[p8l1057t843r1152b898],
110	0.5	CD	NUMBER	0.5	dep	117	SENT_117	[p8l1436t843r1532b898],
111	i	FW	O	i	dep	117	SENT_117	[p8l1564t851r1605b892],
112	0.3	CD	NUMBER	0.3	dep	117	SENT_117	[p8l1636t843r1731b898],
113	NS	NN	O	n	dep	117	SENT_117	[p8l1934t843r2012b898],
114	bilirubin	NN	O	bilirubin	dep	117	SENT_117	[p8l49t933r296b991],
115	(	CD	NUMBER	(	dep	117	SENT_117	[p8l322t933r543b1007],
116	mg/dl	NN	O	mg/dl	dep	117	SENT_117	[p8l322t933r543b1007],
117	)	NN	O	)	_	0	SENT_117	[p8l322t933r543b1007],

1	Data	NNS	O	datum	nsubjpass	3	SENT_118	[p8l12t1146r143b1196],
2	are	VBP	O	be	auxpass	3	SENT_118	[p8l168t1158r258b1196],
3	expressed	VBN	O	express	_	0	SENT_118	[p8l280t1142r567b1210],
4	as	IN	O	as	_	0	SENT_118	[p8l592t1158r650b1196],
5	means	NNS	O	means	prep_as	3	SENT_118	[p8l675t1158r864b1196],
6	:1	CD	NUMBER	:1	num	5	SENT_118	[p8l892t1153r930b1191],
7	:	:	O	:	_	0	SENT_118	[p8l892t1153r930b1191],
8	SD	NN	O	sd	dep	5	SENT_118	[p8l959t1145r1052b1205],
9	,	,	O	,	_	0	SENT_118	[p8l959t1145r1052b1205],
10	except	IN	O	except	_	0	SENT_118	[p8l1078t1149r1271b1210],
11	for	IN	O	for	prepc_except_for	3	SENT_118	[p8l1291t1142r1376b1196],
12	gender	NN	O	gender	pobj	3	SENT_118	[p8l1397t1142r1619b1211],
13	.	.	O	.	_	0	SENT_118	[p8l1397t1142r1619b1211],

1	NS	NN	O	n	_	0	SENT_119	[p8l12t1238r103b1298],
2	,	,	O	,	_	0	SENT_119	[p8l12t1238r103b1298],
3	not	RB	O	not	neg	4	SENT_119	[p8l136t1242r232b1289],
4	significant	JJ	O	significant	appos	1	SENT_119	[p8l258t1234r575b1304],
5	;	:	O	;	_	0	SENT_119	[p8l258t1234r575b1304],
6	ALT	NNP	O	ALT	dep	1	SENT_119	[p8l604t1239r731b1298],
7	,	,	O	,	_	0	SENT_119	[p8l604t1239r731b1298],
8	alanine	NN	O	alanine	nn	9	SENT_119	[p8l762t1235r972b1289],
9	aminotransferase	NN	O	aminotransferase	appos	6	SENT_119	[p8l1000t1234r1528b1298],
10	;	:	O	;	_	0	SENT_119	[p8l1000t1234r1528b1298],
11	AST	NNP	ORGANIZATION	AST	dep	1	SENT_119	[p8l1557t1238r1688b1298],
12	,	,	O	,	_	0	SENT_119	[p8l1557t1238r1688b1298],
13	aspartate	NN	O	aspartate	nn	14	SENT_119	[p8l1719t1242r1993b1303],
14	aminotransferase	NN	O	aminotransferase	appos	11	SENT_119	[p8l2020t1236r2149b1289, p8l12t1304r427b1358],
15	.	.	O	.	_	0	SENT_119	[p8l2020t1236r2149b1289, p8l12t1304r427b1358],

1	Liver	NN	O	liver	nn	3	SENT_120	[p8l11t1529r125b1576],
2	International	NNP	O	International	nn	3	SENT_120	[p8l146t1528r465b1576],
3	(	NNP	O	(	_	0	SENT_120	[p8l487t1528r652b1584],
4	2012	CD	DATE	2012	num	9	SENT_120	[p8l487t1528r652b1584],
5	)	CD	NUMBER	)	num	9	SENT_120	[p8l487t1528r652b1584],
6	©	CD	NUMBER	©	num	9	SENT_120	[p8l7t1605r52b1651],
7	2011	CD	DATE	2011	num	9	SENT_120	[p8l69t1606r190b1651],
8	John	NNP	PERSON	John	nn	9	SENT_120	[p8l218t1604r334b1651],
9	Wiley	NNP	PERSON	Wiley	dep	3	SENT_120	[p8l354t1604r495b1662],
10	&	CC	O	&	_	0	SENT_120	[p8l514t1606r551b1651],
11	Sons	NNP	O	Sons	dep	3	SENT_120	[p8l571t1606r688b1651],
12	A/S	NNP	O	A/S	dep	3	SENT_120	[p8l706t1606r790b1651],

1	TNF-or	JJ	O	tnf-or	amod	2	SENT_121	[p8l479t1703r677b1757],
2	polymorphism	NN	O	polymorphism	_	0	SENT_121	[p8l702t1700r1192b1772],
3	and	CC	O	and	_	0	SENT_121	[p8l1219t1700r1344b1757],
4	ATD-induced	JJ	O	atd-induced	amod	5	SENT_121	[p8l1369t1700r1817b1757],
5	hepatitis	NN	O	hepatitis	conj_and	2	SENT_121	[p8l1847t1700r2144b1772],

1	Table	NNP	O	Table	_	0	SENT_122	[p8l6t1943r196b2001],
2	2	CD	NUMBER	2	dep	1	SENT_122	[p8l228t1945r282b2000],
3	.	.	O	.	_	0	SENT_122	[p8l228t1945r282b2000],

1	Genotype	NN	O	genotype	nn	2	SENT_123	[p8l332t1945r636b2016],
2	frequencies	NNS	O	frequency	_	0	SENT_123	[p8l666t1942r1028b2016],
3	of	IN	O	of	_	0	SENT_123	[p8l1058t1942r1121b2001],
4	TNF-OC	NN	O	tnf-oc	nn	5	SENT_123	[p8l1148t1946r1334b2000],
5	polymorphism	NN	O	polymorphism	prep_of	2	SENT_123	[p8l1366t1943r1807b2016],
6	—	NN	O	—	nn	7	SENT_123	[p8l1844t1945r2145b2001],
7	308G/A	NN	O	308g/a	dep	2	SENT_123	[p8l1844t1945r2145b2001],
8	in	IN	O	in	_	0	SENT_123	[p8l12t2037r59b2093],
9	patients	NNS	O	patient	conj_and	9	SENT_123	[p8l88t2037r334b2108],
10	with	IN	O	with	_	0	SENT_123	[p8l355t2035r491b2093],
11	ATD-induced	JJ	MISC	atd-induced	amod	12	SENT_123	[p8l516t2035r925b2093],
12	hepatitis	NN	O	hepatitis	prep_with	9	SENT_123	[p8l954t2035r1217b2109],
13	and	CC	O	and	_	0	SENT_123	[p8l1240t2035r1353b2093],
14	in	IN	O	in	_	0	SENT_123	[p8l1382t2037r1429b2093],
15	controls	NNS	O	control	prep_in	9	SENT_123	[p8l1455t2035r1704b2093],

1	ATD-induced	JJ	O	atd-induced	amod	3	SENT_124	[p8l400t2214r809b2272],
2	ATD	NN	O	atd	nn	3	SENT_124	[p8l896t2214r1305b2272],
3	—	NN	O	—	_	0	SENT_124	[p8l896t2214r1305b2272],
4	tolerant	JJ	O	tolerant	amod	5	SENT_124	[p8l896t2214r1305b2272],
5	hepatitis	NN	O	hepatitis	dep	3	SENT_124	[p8l404t2307r667b2379],
6	control	NN	O	control	nn	7	SENT_124	[p8l898t2307r1114b2364],
7	OR	NN	O	or	dep	3	SENT_124	[p8l1700t2310r1790b2364],

1	Genotype	NN	O	genotype	nn	3	SENT_125	[p8l11t2402r316b2473],
2	(	NN	O	(	nn	3	SENT_125	[p8l402t2399r458b2467],
3	n	NN	O	n	dep	22	SENT_125	[p8l402t2399r458b2467],
4	=	JJ	O	=	quantmod	6	SENT_125	[p8l489t2423r530b2439],
5	77	CD	NUMBER	77	number	6	SENT_125	[p8l563t2399r659b2467],
6	)	CD	NUMBER	)	num	8	SENT_125	[p8l563t2399r659b2467],
7	(	NN	O	(	nn	8	SENT_125	[p8l898t2399r954b2467],
8	n	NN	O	n	npadvmod	9	SENT_125	[p8l898t2399r954b2467],
9	=	JJ	O	=	amod	16	SENT_125	[p8l986t2423r1026b2439],
10	229	CD	NUMBER	229	number	11	SENT_125	[p8l1058t2399r1197b2467],
11	)	CD	NUMBER	)	num	16	SENT_125	[p8l1058t2399r1197b2467],
12	Pvalue	NNP	O	Pvalue	nn	16	SENT_125	[p8l1390t2399r1607b2457],
13	(	CD	PERCENT	(	num	16	SENT_125	[p8l1699t2399r1868b2467],
14	95	CD	PERCENT	95	number	15	SENT_125	[p8l1699t2399r1868b2467],
15	%	NN	PERCENT	%	amod	16	SENT_125	[p8l1699t2399r1868b2467],
16	CI	NN	O	ci	dep	3	SENT_125	[p8l1898t2399r1978b2467],
17	)	CD	NUMBER	)	num	18	SENT_125	[p8l1898t2399r1978b2467],
18	GG	NNS	O	gg	dep	16	SENT_125	[p8l11t2548r108b2603],
19	57	CD	PERCENT	57	dep	22	SENT_125	[p8l405t2549r477b2603],
20	(	CD	PERCENT	(	num	22	SENT_125	[p8l503t2545r760b2612],
21	74.0	CD	PERCENT	74.0	num	22	SENT_125	[p8l503t2545r760b2612],
22	%	NN	PERCENT	%	dep	30	SENT_125	[p8l503t2545r760b2612],
23	)	CD	NUMBER	)	num	25	SENT_125	[p8l503t2545r760b2612],
24	194	CD	NUMBER	194	num	25	SENT_125	[p8l904t2548r1018b2603],
25	(	NN	O	(	dep	22	SENT_125	[p8l1040t2545r1297b2612],
26	84.7	CD	PERCENT	84.7	num	27	SENT_125	[p8l1040t2545r1297b2612],
27	%	NN	PERCENT	%	dep	25	SENT_125	[p8l1040t2545r1297b2612],
28	)	CD	NUMBER	)	number	29	SENT_125	[p8l1040t2545r1297b2612],
29	0.034	CD	NUMBER	0.034	num	27	SENT_125	[p8l1391t2548r1610b2603],
30	*	NN	O	*	_	0	SENT_125	[p8l1391t2548r1610b2603],
31	1.94	CD	NUMBER	1.94	num	30	SENT_125	[p8l1705t2548r1840b2603],

1	AG	NNP	ORGANIZATION	AG	dep	10	SENT_126	[p8l7t2734r104b2789],
2	18	CD	PERCENT	18	num	1	SENT_126	[p8l408t2734r479b2789],
3	(	CD	PERCENT	(	number	4	SENT_126	[p8l503t2731r760b2799],
4	23.4	CD	PERCENT	23.4	num	5	SENT_126	[p8l503t2731r760b2799],
5	%	NN	PERCENT	%	dep	1	SENT_126	[p8l503t2731r760b2799],
6	)	CD	NUMBER	)	dep	5	SENT_126	[p8l503t2731r760b2799],
7	34	CD	NUMBER	34	num	8	SENT_126	[p8l940t2734r1018b2789],
8	(	NN	O	(	dep	10	SENT_126	[p8l1040t2731r1297b2799],
9	14.9	CD	PERCENT	14.9	num	10	SENT_126	[p8l1040t2731r1297b2799],
10	%	NN	PERCENT	%	dep	16	SENT_126	[p8l1040t2731r1297b2799],
11	)	CD	NUMBER	)	num	12	SENT_126	[p8l1040t2731r1297b2799],
12	AA	NN	ORGANIZATION	aa	dep	10	SENT_126	[p8l7t2828r106b2882],
13	2	CD	PERCENT	2	number	14	SENT_126	[p8l443t2828r476b2882],
14	(	CD	PERCENT	(	dep	12	SENT_126	[p8l503t2824r719b2892],
15	2.6	CD	PERCENT	2.6	num	16	SENT_126	[p8l503t2824r719b2892],
16	%	NN	PERCENT	%	dep	23	SENT_126	[p8l503t2824r719b2892],
17	)	CD	NUMBER	)	number	18	SENT_126	[p8l503t2824r719b2892],
18	1	CD	NUMBER	1	num	19	SENT_126	[p8l987t2828r1004b2882],
19	(	NN	O	(	dep	16	SENT_126	[p8l1040t2824r1256b2892],
20	0.4	CD	PERCENT	0.4	number	21	SENT_126	[p8l1040t2824r1256b2892],
21	%	NN	PERCENT	%	amod	19	SENT_126	[p8l1040t2824r1256b2892],
22	)	CD	NUMBER	)	num	23	SENT_126	[p8l1040t2824r1256b2892],
23	Aallele	NNP	O	Aallele	dep	27	SENT_126	[p8l7t2917r235b2975],
24	0.143	CD	NUMBER	0.143	num	23	SENT_126	[p8l443t2920r622b2975],
25	0.079	CD	NUMBER	0.079	dep	23	SENT_126	[p8l981t2920r1161b2975],
26	0.018	CD	NUMBER	0.018	num	27	SENT_126	[p8l1391t2920r1571b2975],
27	1.95	CD	NUMBER	1.95	_	0	SENT_126	[p8l1705t2920r1837b2975],

1	*	RB	O	*	advmod	13	SENT_127	[p8l13t3217r265b3284],
2	Logistic	JJ	O	logistic	amod	3	SENT_127	[p8l13t3217r265b3284],
3	analysis	NN	O	analysis	nsubj	13	SENT_127	[p8l309t3216r530b3284],
4	controlling	VBG	O	control	partmod	3	SENT_127	[p8l573t3216r886b3284],
5	for	IN	O	for	_	0	SENT_127	[p8l929t3215r1013b3270],
6	age	NN	O	age	prep_for	4	SENT_127	[p8l1055t3232r1159b3284],
7	and	CC	O	and	_	0	SENT_127	[p8l1203t3216r1309b3270],
8	gender	NN	O	gender	prep_for	4	SENT_127	[p8l1355t3216r1561b3284],
9	with	IN	O	with	_	0	SENT_127	[p8l1601t3216r1729b3270],
10	grouping	NN	O	grouping	prep_with	4	SENT_127	[p8l1775t3217r2040b3284],
11	of	IN	O	of	_	0	SENT_127	[p8l2085t3215r2144b3270],
12	genotypes	NNS	O	genotype	prep_of	10	SENT_127	[p8l9t3320r313b3382],
13	(	VBP	O	(	_	0	SENT_127	[p8l335t3313r448b3376],
14	G6	NN	O	g6	nsubj	16	SENT_127	[p8l335t3313r448b3376],
15	vs.	CC	O	vs.	_	0	SENT_127	[p8l472t3329r543b3367],
16	AG	NNP	O	AG	xcomp	13	SENT_127	[p8l568t3316r659b3367],
17	+	CC	O	+	_	0	SENT_127	[p8l692t3324r730b3362],
18	AA	NNP	O	AA	xcomp	13	SENT_127	[p8l757t3313r884b3376],
19	)	CD	NUMBER	)	num	18	SENT_127	[p8l757t3313r884b3376],
20	.	.	O	.	_	0	SENT_127	[p8l757t3313r884b3376],

1	in	IN	O	in	_	0	SENT_128	[p9l9t95r81b159],
2	Table	NNP	O	Table	pobj	1	SENT_128	[p9l114t92r320b160],
3	2	CD	NUMBER	2	num	2	SENT_128	[p9l359t99r418b160],
4	.	.	O	.	_	0	SENT_128	[p9l359t99r418b160],

1	There	EX	O	there	expl	2	SENT_129	[p9l455t92r671b160],
2	were	VBD	O	be	dep	12	SENT_129	[p9l702t117r877b160],
3	a	DT	O	a	det	6	SENT_129	[p9l911t117r949b160],
4	signiﬁcantly	RB	O	signiﬁcantly	advmod	5	SENT_129	[p9l983t92r1439b181],
5	higher	JJR	O	higher	amod	6	SENT_129	[p9l1467t92r1707b181],
6	number	NN	O	number	nsubj	2	SENT_129	[p9l1740t92r2038b160],
7	of	IN	O	of	_	0	SENT_129	[p9l2072t92r2154b160],
8	patients	NNS	O	patient	prep_of	6	SENT_129	[p9l8t196r303b282],
9	with	IN	O	with	_	0	SENT_129	[p9l353t194r521b262],
10	ATD	NN	ORGANIZATION	atd	nn	11	SENT_129	[p9l571t194r1096b262],
11	—	NN	O	—	prep_with	8	SENT_129	[p9l571t194r1096b262],
12	induced	VBD	O	induce	_	0	SENT_129	[p9l571t194r1096b262],
13	hepatitis	NN	O	hepatitis	dobj	12	SENT_129	[p9l1148t194r1468b282],
14	that	WDT	O	that	nsubj	15	SENT_129	[p9l1520t194r1668b262],
15	had	VBD	O	have	rcmod	13	SENT_129	[p9l1719t194r1858b262],
16	minor	JJ	O	minor	amod	18	SENT_129	[p9l1910t196r2145b262],
17	allele	NN	O	allele	nn	18	SENT_129	[p9l9t296r637b385],
18	—	NN	O	—	nsubj	19	SENT_129	[p9l9t296r637b385],
19	containing	VBG	O	contain	ccomp	15	SENT_129	[p9l9t296r637b385],
20	genotypes	NNS	O	genotype	dobj	19	SENT_129	[p9l670t309r1040b385],
21	(	CD	NUMBER	(	num	22	SENT_129	[p9l1081t296r1233b378],
22	AG	NNP	O	AG	tmod	15	SENT_129	[p9l1081t296r1233b378],
23	or	CC	O	or	_	0	SENT_129	[p9l1269t321r1348b364],
24	AA	NNP	O	AA	conj_or	22	SENT_129	[p9l1379t296r1527b378],
25	)	CD	NUMBER	)	num	24	SENT_129	[p9l1379t296r1527b378],
26	compared	VBN	O	compare	_	0	SENT_129	[p9l1569t296r1945b384],
27	with	IN	O	with	prepc_compared_with	12	SENT_129	[p9l1976t296r2143b364],
28	ATD	NN	O	atd	pobj	12	SENT_129	[p9l6t397r522b465],
29	—	CD	NUMBER	—	num	31	SENT_129	[p9l6t397r522b465],
30	tolerant	JJ	O	tolerant	amod	31	SENT_129	[p9l6t397r522b465],
31	controls	NNS	O	control	nsubj	32	SENT_129	[p9l584t397r886b465],
32	(	VBP	O	(	rcmod	28	SENT_129	[p9l953t397r1214b480],
33	26.0	CD	PERCENT	26.0	num	34	SENT_129	[p9l953t397r1214b480],
34	%	NN	PERCENT	%	dobj	32	SENT_129	[p9l953t397r1214b480],
35	vs.	CC	O	vs.	prep	34	SENT_129	[p9l1273t422r1368b465],
36	15.3	CD	PERCENT	15.3	num	37	SENT_129	[p9l1440t403r1686b477],
37	%	NN	PERCENT	%	dep	35	SENT_129	[p9l1440t403r1686b477],
38	,	,	O	,	_	0	SENT_129	[p9l1440t403r1686b477],
39	P	NN	O	p	appos	37	SENT_129	[p9l1745t403r1799b464],
40	=	JJ	O	=	amod	41	SENT_129	[p9l1833t423r1883b443],
41	0.034	CD	NUMBER	0.034	nsubj	12	SENT_129	[p9l1922t404r2141b477],
42	,	,	O	,	_	0	SENT_129	[p9l1922t404r2141b477],
43	OR	NN	O	or	appos	41	SENT_129	[p9l10t503r136b568],
44	=	JJ	O	=	amod	43	SENT_129	[p9l172t525r222b545],
45	1.94	CD	NUMBER	1.94	tmod	44	SENT_129	[p9l268t506r434b578],
46	,	,	O	,	_	0	SENT_129	[p9l268t506r434b578],
47	95	CD	PERCENT	95	number	48	SENT_129	[p9l498t505r660b570],
48	%	NN	PERCENT	%	amod	49	SENT_129	[p9l498t505r660b570],
49	CI	NN	O	ci	appos	43	SENT_129	[p9l724t503r831b578],
50	,	,	O	,	_	0	SENT_129	[p9l724t503r831b578],
51	1.04-3	CD	NUMBER	1.04-3	number	52	SENT_129	[p9l902t499r1307b582],
52	.63	CD	NUMBER	.63	num	53	SENT_129	[p9l902t499r1307b582],
53	)	NN	O	)	appos	43	SENT_129	[p9l902t499r1307b582],
54	.	.	O	.	_	0	SENT_129	[p9l902t499r1307b582],

1	In	IN	O	in	_	0	SENT_130	[p9l1372t504r1449b566],
2	addition	NN	O	addition	prep_in	7	SENT_130	[p9l1510t499r1847b578],
3	,	,	O	,	_	0	SENT_130	[p9l1510t499r1847b578],
4	minor	JJ	O	minor	amod	6	SENT_130	[p9l1910t501r2145b567],
5	allele	NN	O	allele	nn	6	SENT_130	[p9l9t602r194b670],
6	frequencies	NNS	O	frequency	nsubj	7	SENT_130	[p9l224t602r647b690],
7	showed	VBD	O	show	_	0	SENT_130	[p9l678t602r960b670],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_130	[p9l989t602r1377b691],
9	differences	NNS	O	difference	dobj	7	SENT_130	[p9l1407t602r1807b670],
10	between	IN	O	between	_	0	SENT_130	[p9l1835t602r2143b670],
11	the	DT	O	the	det	12	SENT_130	[p9l7t704r123b772],
12	case	NN	O	case	prep_between	9	SENT_130	[p9l152t729r299b772],
13	and	CC	O	and	_	0	SENT_130	[p9l329t704r466b772],
14	control	JJ	O	control	amod	15	SENT_130	[p9l495t704r766b772],
15	subjects	NNS	O	subject	dobj	7	SENT_130	[p9l794t704r1085b793],
16	(	JJ	O	(	amod	15	SENT_130	[p9l1119t704r1344b786],
17	0.143	CD	NUMBER	0.143	tmod	16	SENT_130	[p9l1119t704r1344b786],
18	vs.	CC	O	vs.	prep	15	SENT_130	[p9l1373t729r1467b772],
19	0.079	CD	NUMBER	0.079	dep	18	SENT_130	[p9l1500t711r1717b783],
20	,	,	O	,	_	0	SENT_130	[p9l1500t711r1717b783],
21	P	NN	O	p	appos	19	SENT_130	[p9l1745t709r1799b771],
22	=	JJ	O	=	amod	15	SENT_130	[p9l1833t730r1883b749],
23	0.018	CD	NUMBER	0.018	tmod	22	SENT_130	[p9l1922t711r2141b783],
24	,	,	O	,	_	0	SENT_130	[p9l1922t711r2141b783],
25	OR	NN	O	or	appos	15	SENT_130	[p9l10t810r136b874],
26	=	JJ	O	=	amod	25	SENT_130	[p9l172t832r222b851],
27	1.95	CD	NUMBER	1.95	tmod	26	SENT_130	[p9l268t813r434b885],
28	,	,	O	,	_	0	SENT_130	[p9l268t813r434b885],
29	95	CD	PERCENT	95	number	30	SENT_130	[p9l475t812r637b876],
30	%	NN	PERCENT	%	amod	31	SENT_130	[p9l475t812r637b876],
31	CI	NN	O	ci	appos	15	SENT_130	[p9l679t810r787b884],
32	,	,	O	,	_	0	SENT_130	[p9l679t810r787b884],
33	1.11-3	CD	NUMBER	1.11-3	number	34	SENT_130	[p9l836t806r1240b888],
34	.44	CD	NUMBER	.44	num	35	SENT_130	[p9l836t806r1240b888],
35	)	NN	O	)	appos	15	SENT_130	[p9l836t806r1240b888],
36	.	.	O	.	_	0	SENT_130	[p9l836t806r1240b888],

1	These	DT	O	these	det	2	SENT_131	[p9l1282t806r1497b874],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_131	[p9l1535t806r1836b895],
3	suggest	VBP	O	suggest	_	0	SENT_131	[p9l1875t819r2144b895],
4	that	IN	O	that	complm	14	SENT_131	[p9l7t908r155b976],
5	TNF-OL	NN	O	tnf-ol	nsubj	14	SENT_131	[p9l186t911r444b976],
6	—	CD	NUMBER	—	num	5	SENT_131	[p9l480t912r836b979],
7	308G/A	NNP	O	308G/A	nsubj	10	SENT_131	[p9l480t912r836b979],
8	is	VBZ	O	be	cop	10	SENT_131	[p9l867t911r921b976],
9	closely	RB	O	closely	advmod	10	SENT_131	[p9l954t908r1203b997],
10	related	JJ	O	related	rcmod	5	SENT_131	[p9l1231t908r1483b976],
11	to	TO	O	to	_	0	SENT_131	[p9l1513t921r1587b976],
12	ATD	NN	O	atd	nn	13	SENT_131	[p9l1618t908r2143b976],
13	—	NN	O	—	prep_to	10	SENT_131	[p9l1618t908r2143b976],
14	induced	VBD	O	induce	ccomp	3	SENT_131	[p9l1618t908r2143b976],
15	hepatitis	NN	O	hepatitis	dobj	14	SENT_131	[p9l8t1009r347b1098],
16	.	.	O	.	_	0	SENT_131	[p9l8t1009r347b1098],

1	Discussion	NN	O	discussion	_	0	SENT_132	[p9l13t1268r438b1335],

1	In	IN	O	in	_	0	SENT_133	[p9l9t1427r87b1489],
2	this	DT	O	this	det	5	SENT_133	[p9l148t1421r282b1490],
3	pharmacogenetic	JJ	O	pharmacogenetic	amod	5	SENT_133	[p9l344t1421r991b1512],
4	association	NN	O	association	nn	5	SENT_133	[p9l1053t1424r1466b1490],
5	study	NN	O	study	prep_in	13	SENT_133	[p9l1529t1421r1733b1512],
6	of	IN	O	of	_	0	SENT_133	[p9l1793t1421r1876b1490],
7	ATDinduced	JJ	O	atdinduced	amod	8	SENT_133	[p9l1924t1424r2140b1489, p9l9t1525r312b1593],
8	hepatitis	NN	O	hepatitis	prep_of	5	SENT_133	[p9l352t1525r672b1613],
9	in	IN	O	in	_	0	SENT_133	[p9l717t1527r789b1592],
10	Koreans	NNPS	LOCATION	Koreans	prep_in	8	SENT_133	[p9l832t1530r1157b1604],
11	,	,	O	,	_	0	SENT_133	[p9l832t1530r1157b1604],
12	we	PRP	O	we	nsubj	13	SENT_133	[p9l1201t1550r1302b1593],
13	found	VBD	O	find	_	0	SENT_133	[p9l1345t1525r1570b1593],
14	that	IN	O	that	complm	24	SENT_133	[p9l1612t1525r1759b1593],
15	a	DT	O	a	det	18	SENT_133	[p9l1803t1550r1841b1593],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_133	[p9l1883t1525r2139b1614, p9l9t1626r235b1717],
17	higher	JJR	O	higher	amod	18	SENT_133	[p9l284t1626r524b1717],
18	number	NN	O	number	nsubj	24	SENT_133	[p9l576t1626r874b1695],
19	of	IN	O	of	_	0	SENT_133	[p9l928t1626r1010b1695],
20	patients	NNS	O	patient	prep_of	18	SENT_133	[p9l1053t1629r1348b1716],
21	with	IN	O	with	_	0	SENT_133	[p9l1400t1626r1567b1695],
22	ATD	NN	O	atd	nn	23	SENT_133	[p9l1618t1626r2143b1695],
23	—	NN	O	—	prep_with	20	SENT_133	[p9l1618t1626r2143b1695],
24	induced	VBD	O	induce	ccomp	13	SENT_133	[p9l1618t1626r2143b1695],
25	hepatitis	NN	O	hepatitis	nsubj	26	SENT_133	[p9l8t1730r328b1819],
26	have	VBP	O	have	ccomp	24	SENT_133	[p9l367t1730r537b1798],
27	genetic	JJ	O	genetic	amod	28	SENT_133	[p9l577t1732r840b1820],
28	variants	NNS	O	variant	dobj	26	SENT_133	[p9l877t1732r1173b1798],
29	in	IN	O	in	_	0	SENT_133	[p9l1214t1732r1287b1797],
30	the	DT	O	the	det	32	SENT_133	[p9l1326t1730r1441b1798],
31	promoter	NN	O	promoter	nn	32	SENT_133	[p9l1480t1744r1840b1819],
32	area	NN	O	area	prep_in	28	SENT_133	[p9l1880t1754r2032b1798],
33	of	IN	O	of	_	0	SENT_133	[p9l2072t1730r2154b1798],
34	TNF-OL	NN	O	tnf-ol	prep_of	32	SENT_133	[p9l8t1836r274b1901],
35	at	IN	O	at	_	0	SENT_133	[p9l324t1847r393b1901],
36	position	NN	O	position	nn	38	SENT_133	[p9l441t1835r765b1921],
37	—	CD	NUMBER	—	num	38	SENT_133	[p9l820t1837r1207b1912],
38	308G/A	NNP	O	308G/A	prep_at	26	SENT_133	[p9l820t1837r1207b1912],
39	,	,	O	,	_	0	SENT_133	[p9l820t1837r1207b1912],
40	compared	VBN	O	compare	_	0	SENT_133	[p9l1261t1833r1650b1921],
41	with	IN	O	with	prepc_compared_with	38	SENT_133	[p9l1698t1833r1870b1901],
42	ATDtolerant	NN	O	atdtolerant	nn	43	SENT_133	[p9l1918t1836r2139b1900, p9l8t1934r303b2002],
43	patients	NNS	O	patient	pobj	38	SENT_133	[p9l358t1937r671b2023],
44	.	.	O	.	_	0	SENT_133	[p9l358t1937r671b2023],

1	These	DT	O	these	det	2	SENT_134	[p9l731t1934r947b2002],
2	results	NNS	O	result	nsubj	3	SENT_134	[p9l1004t1934r1242b2002],
3	demonstrate	VBP	O	demonstrate	_	0	SENT_134	[p9l1301t1934r1769b2002],
4	that	IN	O	that	complm	12	SENT_134	[p9l1825t1934r1972b2002],
5	the	DT	O	the	det	9	SENT_134	[p9l2027t1934r2143b2002],
6	TNF-OL	NN	O	tnf-ol	nn	9	SENT_134	[p9l8t2040r267b2105],
7	polymorphism	NN	O	polymorphism	nn	9	SENT_134	[p9l305t2037r863b2127],
8	—	NN	O	—	nn	9	SENT_134	[p9l908t2040r1265b2108],
9	308G/A	NN	O	308g/a	nsubjpass	12	SENT_134	[p9l908t2040r1265b2108],
10	is	VBZ	O	be	auxpass	12	SENT_134	[p9l1304t2039r1357b2105],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_134	[p9l1399t2036r1855b2127],
12	associated	VBN	O	associate	ccomp	3	SENT_134	[p9l1892t2039r2140b2105, p9l9t2140r165b2208],
13	with	IN	O	with	_	0	SENT_134	[p9l204t2140r371b2208],
14	ATD	NN	O	atd	nn	15	SENT_134	[p9l411t2140r936b2208],
15	—	NN	O	—	prep_with	12	SENT_134	[p9l411t2140r936b2208],
16	induced	VBD	O	induce	partmod	15	SENT_134	[p9l411t2140r936b2208],
17	hepatitis	NN	O	hepatitis	dobj	16	SENT_134	[p9l977t2140r1296b2228],
18	in	IN	O	in	_	0	SENT_134	[p9l1340t2143r1413b2207],
19	a	DT	O	a	det	21	SENT_134	[p9l1455t2165r1492b2208],
20	Korean	JJ	LOCATION	korean	amod	21	SENT_134	[p9l1534t2145r1807b2208],
21	population	NN	O	population	prep_in	16	SENT_134	[p9l1847t2140r2139b2228, p9l8t2244r178b2310],
22	.	.	O	.	_	0	SENT_134	[p9l1847t2140r2139b2228, p9l8t2244r178b2310],

1	To	TO	O	to	_	0	SENT_135	[p9l211t2244r311b2310],
2	the	DT	O	the	det	3	SENT_135	[p9l341t2241r457b2310],
3	best	JJS	O	best	prep_to	12	SENT_135	[p9l484t2241r633b2310],
4	of	IN	O	of	_	0	SENT_135	[p9l662t2241r745b2310],
5	our	PRP$	O	we	poss	6	SENT_135	[p9l764t2266r895b2310],
6	knowledge	NN	O	knowledge	prep_of	3	SENT_135	[p9l921t2241r1344b2332],
7	,	,	O	,	_	0	SENT_135	[p9l921t2241r1344b2332],
8	this	DT	O	this	nsubj	12	SENT_135	[p9l1375t2241r1509b2310],
9	is	VBZ	O	be	cop	12	SENT_135	[p9l1539t2244r1593b2310],
10	the	DT	O	the	det	12	SENT_135	[p9l1622t2241r1738b2310],
11	ﬁrst	NN	O	ﬁrst	nn	12	SENT_135	[p9l1767t2241r1912b2310],
12	study	NN	O	study	_	0	SENT_135	[p9l1942t2241r2147b2332],
13	to	TO	O	to	aux	14	SENT_135	[p9l8t2358r81b2413],
14	reveal	VB	O	reveal	infmod	12	SENT_135	[p9l120t2345r337b2413],
15	signiﬁcant	JJ	O	signiﬁcant	amod	17	SENT_135	[p9l374t2344r761b2435],
16	genetic	JJ	O	genetic	amod	17	SENT_135	[p9l797t2347r1060b2435],
17	association	NN	O	association	dobj	14	SENT_135	[p9l1097t2347r1509b2413],
18	of	IN	O	of	_	0	SENT_135	[p9l1547t2345r1629b2413],
19	TNF-OL	NN	O	tnf-ol	nn	20	SENT_135	[p9l1655t2347r1913b2413],
20	polymorphisms	NNS	O	polymorphism	prep_of	17	SENT_135	[p9l1948t2345r2139b2435, p9l8t2448r434b2536],
21	with	IN	O	with	_	0	SENT_135	[p9l460t2448r627b2516],
22	DILI	NNP	ORGANIZATION	DILI	prep_with	14	SENT_135	[p9l655t2453r851b2516],
23	.	.	O	.	_	0	SENT_135	[p9l655t2453r851b2516],

1	In	IN	O	in	_	0	SENT_136	[p9l112t2555r191b2617],
2	the	DT	O	the	det	4	SENT_136	[p9l241t2549r356b2618],
3	present	JJ	DATE	present	amod	4	SENT_136	[p9l407t2563r681b2639],
4	study	NN	O	study	prep_in	13	SENT_136	[p9l733t2549r954b2640],
5	,	,	O	,	_	0	SENT_136	[p9l733t2549r954b2640],
6	which	WDT	O	which	nsubj	7	SENT_136	[p9l1006t2549r1233b2618],
7	investigated	VBD	O	investigate	rcmod	4	SENT_136	[p9l1285t2549r1731b2640],
8	a	DT	O	a	det	10	SENT_136	[p9l1783t2574r1820b2618],
9	Korean	JJ	LOCATION	korean	amod	10	SENT_136	[p9l1871t2555r2143b2618],
10	population	NN	O	population	dobj	7	SENT_136	[p9l8t2653r444b2742],
11	,	,	O	,	_	0	SENT_136	[p9l8t2653r444b2742],
12	we	PRP	O	we	nsubj	13	SENT_136	[p9l489t2677r590b2721],
13	found	VBD	O	find	_	0	SENT_136	[p9l634t2653r859b2721],
14	that	IN	O	that	complm	30	SENT_136	[p9l902t2653r1049b2721],
15	TNF	NN	O	tnf	nn	17	SENT_136	[p9l1092t2656r1351b2721],
16	—	NN	O	—	nn	17	SENT_136	[p9l1092t2656r1351b2721],
17	ot	NN	O	ot	nsubj	30	SENT_136	[p9l1092t2656r1351b2721],
18	—	CD	NUMBER	—	num	19	SENT_136	[p9l1399t2656r1756b2724],
19	308G/A	NNP	O	308G/A	nsubjpass	22	SENT_136	[p9l1399t2656r1756b2724],
20	is	VBZ	O	be	auxpass	22	SENT_136	[p9l1798t2655r1852b2721],
21	closely	RB	O	closely	advmod	22	SENT_136	[p9l1898t2653r2147b2743],
22	associated	VBN	O	associate	rcmod	17	SENT_136	[p9l9t2756r386b2824],
23	with	IN	O	with	_	0	SENT_136	[p9l414t2756r581b2824],
24	an	DT	O	a	det	26	SENT_136	[p9l613t2780r700b2824],
25	increased	VBN	O	increase	amod	26	SENT_136	[p9l731t2756r1080b2824],
26	risk	NN	O	risk	prep_with	22	SENT_136	[p9l1111t2756r1249b2824],
27	of	IN	O	of	_	0	SENT_136	[p9l1277t2756r1360b2824],
28	ATD	NN	O	atd	nn	29	SENT_136	[p9l1377t2756r1903b2824],
29	—	NN	O	—	prep_of	26	SENT_136	[p9l1377t2756r1903b2824],
30	induced	VBD	O	induce	ccomp	13	SENT_136	[p9l1377t2756r1903b2824],
31	hepatitis	NN	O	hepatitis	dobj	30	SENT_136	[p9l1931t2756r2139b2844, p9l8t2860r147b2925],
32	in	IN	O	in	_	0	SENT_136	[p9l183t2860r255b2925],
33	contrast	NN	O	contrast	prep_in	30	SENT_136	[p9l291t2871r593b2925],
34	to	TO	O	to	_	0	SENT_136	[p9l627t2871r700b2925],
35	the	DT	O	the	det	36	SENT_136	[p9l737t2857r852b2925],
36	results	NNS	O	result	prep_to	30	SENT_136	[p9l887t2857r1127b2925],
37	of	IN	O	of	_	0	SENT_136	[p9l1164t2857r1246b2925],
38	previous	JJ	O	previous	amod	39	SENT_136	[p9l1269t2860r1590b2946],
39	studies	NNS	O	study	prep_of	36	SENT_136	[p9l1628t2857r1902b2925],
40	.	.	O	.	_	0	SENT_136	[p9l1628t2857r1902b2925],

1	In	IN	O	in	_	0	SENT_137	[p9l1942t2863r2020b2924],
2	an	DT	O	a	det	4	SENT_137	[p9l2055t2882r2144b2925],
3	early	JJ	O	early	amod	4	SENT_137	[p9l9t2960r188b3050],
4	study	NN	O	study	prep_in	17	SENT_137	[p9l222t2960r427b3050],
5	by	IN	O	by	_	0	SENT_137	[p9l456t2960r549b3050],
6	Bernal	NNP	PERSON	Bernal	prep_by	4	SENT_137	[p9l582t2960r822b3028],
7	et	FW	O	et	nsubjpass	17	SENT_137	[p9l858t2974r924b3028],
8	al.	FW	O	al.	nn	9	SENT_137	[p9l957t2960r1037b3028],
9	(	FW	O	(	dep	7	SENT_137	[p9l1085t2960r1257b3042],
10	18	CD	NUMBER	18	num	11	SENT_137	[p9l1085t2960r1257b3042],
11	)	NN	O	)	dep	7	SENT_137	[p9l1085t2960r1257b3042],
12	,	,	O	,	_	0	SENT_137	[p9l1085t2960r1257b3042],
13	no	DT	O	no	det	15	SENT_137	[p9l1295t2984r1389b3028],
14	signiﬁcant	JJ	O	signiﬁcant	amod	15	SENT_137	[p9l1428t2960r1814b3050],
15	association	NN	O	association	appos	11	SENT_137	[p9l1851t2962r2139b3028, p9l8t3065r159b3131],
16	was	VBD	O	be	auxpass	17	SENT_137	[p9l190t3087r326b3131],
17	identiﬁed	VBN	O	identiﬁed	_	0	SENT_137	[p9l361t3063r719b3131],
18	between	IN	O	between	_	0	SENT_137	[p9l749t3063r1057b3131],
19	TNF	NN	O	tnf	nn	22	SENT_137	[p9l1090t3066r1348b3131],
20	—	NN	O	—	nn	22	SENT_137	[p9l1090t3066r1348b3131],
21	oc	NN	O	oc	nn	22	SENT_137	[p9l1090t3066r1348b3131],
22	polymorphisms	NNS	O	polymorphism	prep_between	17	SENT_137	[p9l1380t3063r1971b3152],
23	and	CC	O	and	_	0	SENT_137	[p9l2006t3063r2144b3131],
24	acetaminophen	NN	O	acetaminophen	nn	25	SENT_137	[p9l9t3164r929b3254],
25	—	NN	O	—	nsubj	26	SENT_137	[p9l9t3164r929b3254],
26	induced	VBD	O	induce	conj_and	17	SENT_137	[p9l9t3164r929b3254],
27	hepatotoxicitiy	NN	O	hepatotoxicitiy	dobj	26	SENT_137	[p9l957t3164r1541b3255],
28	.	.	O	.	_	0	SENT_137	[p9l957t3164r1541b3255],

1	However	RB	O	however	advmod	5	SENT_138	[p9l1575t3170r1932b3244],
2	,	,	O	,	_	0	SENT_138	[p9l1575t3170r1932b3244],
3	acetaminophen	NN	O	acetaminophen	nn	4	SENT_138	[p9l1965t3178r2139b3233, p9l9t3268r779b3356],
4	—	NN	O	—	nsubj	5	SENT_138	[p9l1965t3178r2139b3233, p9l9t3268r779b3356],
5	induced	VBD	O	induce	_	0	SENT_138	[p9l1965t3178r2139b3233, p9l9t3268r779b3356],
6	hepatotoxicitiy	NN	O	hepatotoxicitiy	nsubj	8	SENT_138	[p9l814t3268r1383b3357],
7	usually	RB	O	usually	advmod	8	SENT_138	[p9l1415t3268r1679b3357],
8	exists	VBZ	O	exist	ccomp	5	SENT_138	[p9l1713t3270r1911b3335],
9	in	IN	O	in	mark	16	SENT_138	[p9l1948t3270r2020b3335],
10	an	DT	O	a	det	12	SENT_138	[p9l2056t3292r2144b3335],
11	overdose	NN	O	overdose	nn	12	SENT_138	[p9l9t3369r342b3437],
12	situation	NN	O	situation	nsubj	16	SENT_138	[p9l399t3371r730b3437],
13	via	IN	O	via	_	0	SENT_138	[p9l784t3371r893b3437],
14	toxic	JJ	O	toxic	amod	15	SENT_138	[p9l948t3371r1132b3437],
15	mechanisms	NNS	O	mechanism	prep_via	12	SENT_138	[p9l1188t3369r1651b3437],
16	(	VBP	O	(	advcl	8	SENT_138	[p9l1715t3369r1886b3452],
17	22	CD	NUMBER	22	num	18	SENT_138	[p9l1715t3369r1886b3452],
18	)	CD	NUMBER	)	dobj	16	SENT_138	[p9l1715t3369r1886b3452],
19	,	,	O	,	_	0	SENT_138	[p9l1715t3369r1886b3452],
20	while	IN	O	while	mark	23	SENT_138	[p9l1943t3369r2143b3437],
21	ATD	NN	O	atd	nn	22	SENT_138	[p9l6t3471r531b3540],
22	—	NN	O	—	nsubj	23	SENT_138	[p9l6t3471r531b3540],
23	induced	VBD	O	induce	advcl	16	SENT_138	[p9l6t3471r531b3540],
24	hepatitis	NN	O	hepatitis	nsubjpass	26	SENT_138	[p9l595t3471r915b3561],
25	is	VBZ	O	be	auxpass	26	SENT_138	[p9l980t3474r1034b3540],
26	mediated	VBN	O	mediate	ccomp	23	SENT_138	[p9l1099t3471r1448b3540],
27	by	IN	O	by	_	0	SENT_138	[p9l1509t3471r1601b3562],
28	idiosyncratic	JJ	O	idiosyncratic	amod	29	SENT_138	[p9l1662t3471r2144b3562],
29	reactions	NNS	O	reaction	agent	26	SENT_138	[p9l9t3577r365b3643],
30	.	.	O	.	_	0	SENT_138	[p9l9t3577r365b3643],

1	Thus	RB	O	thus	advmod	6	SENT_139	[p9l408t3575r616b3653],
2	,	,	O	,	_	0	SENT_139	[p9l408t3575r616b3653],
3	it	PRP	O	it	nsubjpass	6	SENT_139	[p9l658t3577r709b3642],
4	can	MD	O	can	aux	6	SENT_139	[p9l748t3599r874b3642],
5	be	VB	O	be	auxpass	6	SENT_139	[p9l911t3575r997b3642],
6	speculated	VBN	O	speculate	_	0	SENT_139	[p9l1037t3575r1428b3663],
7	that	IN	O	that	complm	12	SENT_139	[p9l1466t3575r1613b3642],
8	TNF	NN	O	tnf	nn	11	SENT_139	[p9l1651t3578r1910b3642],
9	—	NN	O	—	nn	11	SENT_139	[p9l1651t3578r1910b3642],
10	oL	NN	O	ol	nn	11	SENT_139	[p9l1651t3578r1910b3642],
11	polymorphisms	NNS	O	polymorphism	nsubj	12	SENT_139	[p9l1947t3575r2139b3664, p9l8t3677r434b3765],
12	have	VBP	O	have	ccomp	6	SENT_139	[p9l468t3677r639b3745],
13	more	RBR	O	more	advmod	14	SENT_139	[p9l673t3701r868b3745],
14	critical	JJ	O	critical	amod	15	SENT_139	[p9l904t3677r1157b3745],
15	roles	NNS	O	role	dobj	12	SENT_139	[p9l1191t3677r1366b3745],
16	in	IN	O	in	_	0	SENT_139	[p9l1401t3679r1473b3744],
17	the	DT	O	the	det	18	SENT_139	[p9l1506t3677r1621b3745],
18	development	NN	O	development	prep_in	15	SENT_139	[p9l1657t3677r2144b3765],
19	of	IN	O	of	_	0	SENT_139	[p10l9t14r92b82],
20	idiosyncratic	JJ	O	idiosyncratic	amod	21	SENT_139	[p10l144t14r625b103],
21	DILI	NNP	O	DILI	prep_of	18	SENT_139	[p10l688t19r863b81],
22	than	IN	O	than	prep	12	SENT_139	[p10l927t14r1095b82],
23	in	IN	O	in	pcomp	22	SENT_139	[p10l1158t16r1231b81],
24	toxic	JJ	O	toxic	amod	25	SENT_139	[p10l1292t16r1476b82],
25	DILI	NNP	O	DILI	pobj	23	SENT_139	[p10l1539t19r1735b82],
26	.	.	O	.	_	0	SENT_139	[p10l1539t19r1735b82],

1	Recently	RB	DATE	recently	advmod	9	SENT_140	[p10l1802t14r2141b103],
2	,	,	O	,	_	0	SENT_140	[p10l1802t14r2141b103],
3	Pachkoria	NNP	O	Pachkoria	nsubj	19	SENT_140	[p10l9t116r385b184],
4	et	FW	O	et	dep	3	SENT_140	[p10l439t130r504b184],
5	al.	FW	O	al.	nn	6	SENT_140	[p10l537t116r616b184],
6	(	FW	O	(	dep	3	SENT_140	[p10l682t116r827b198],
7	19	CD	NUMBER	19	number	8	SENT_140	[p10l682t116r827b198],
8	)	CD	NUMBER	)	dep	6	SENT_140	[p10l682t116r827b198],
9	studied	VBN	O	study	_	0	SENT_140	[p10l888t116r1162b184],
10	140	CD	NUMBER	140	num	11	SENT_140	[p10l1223t123r1344b184],
11	patients	NNS	O	patient	dobj	9	SENT_140	[p10l1398t118r1694b204],
12	with	IN	O	with	_	0	SENT_140	[p10l1745t116r1912b184],
13	DILI	NNP	ORGANIZATION	DILI	prep_with	11	SENT_140	[p10l1966t121r2142b183],
14	from	IN	O	from	_	0	SENT_140	[p10l9t218r193b286],
15	the	DT	O	the	det	17	SENT_140	[p10l223t218r338b286],
16	Spanish	JJ	MISC	spanish	amod	17	SENT_140	[p10l370t218r660b306],
17	Registry	NN	MISC	registry	prep_from	9	SENT_140	[p10l691t220r997b307],
18	and	CC	O	and	_	0	SENT_140	[p10l1024t218r1162b286],
19	reported	VBD	O	report	conj_and	9	SENT_140	[p10l1193t218r1514b306],
20	a	DT	O	a	det	21	SENT_140	[p10l1545t242r1583b286],
21	lack	NN	O	lack	dobj	19	SENT_140	[p10l1611t218r1761b286],
22	of	IN	O	of	_	0	SENT_140	[p10l1789t218r1872b286],
23	association	NN	O	association	prep_of	21	SENT_140	[p10l1892t220r2140b286, p10l9t322r201b388],
24	between	IN	O	between	_	0	SENT_140	[p10l227t320r535b388],
25	TNF	NN	O	tnf	nn	29	SENT_140	[p10l563t323r822b388],
26	—	NN	O	—	nn	29	SENT_140	[p10l563t323r822b388],
27	oc	NN	O	oc	nn	29	SENT_140	[p10l563t323r822b388],
28	—	NN	O	—	nn	29	SENT_140	[p10l855t324r1211b391],
29	308G/A	NN	O	308g/a	prep_between	23	SENT_140	[p10l855t324r1211b391],
30	and	CC	O	and	_	0	SENT_140	[p10l1239t320r1377b388],
31	DILI	NNP	ORGANIZATION	DILI	prep_between	23	SENT_140	[p10l1406t325r1601b388],
32	.	.	O	.	_	0	SENT_140	[p10l1406t325r1601b388],

1	In	IN	O	in	_	0	SENT_141	[p10l1634t325r1712b387],
2	the	DT	O	the	det	5	SENT_141	[p10l1739t320r1855b388],
3	Pachk	NN	O	pachk	nn	5	SENT_141	[p10l1884t320r2139b388],
4	—	NN	O	—	nn	5	SENT_141	[p10l1884t320r2139b388],
5	oria	NN	O	orium	pobj	1	SENT_141	[p10l9t424r155b490],
6	et	FW	O	et	dep	5	SENT_141	[p10l211t436r276b490],
7	all	DT	O	all	dep	6	SENT_141	[p10l309t421r389b490],
8	.	.	O	.	_	0	SENT_141	[p10l309t421r389b490],

1	study	NN	O	study	nsubj	8	SENT_142	[p10l452t422r673b512],
2	,	,	O	,	_	0	SENT_142	[p10l452t422r673b512],
3	patients	NNS	O	patient	appos	1	SENT_142	[p10l730t424r1025b511],
4	with	IN	O	with	_	0	SENT_142	[p10l1078t422r1245b490],
5	various	JJ	O	various	amod	7	SENT_142	[p10l1297t424r1573b490],
6	drug	NN	O	drug	nn	7	SENT_142	[p10l1630t422r2144b512],
7	—	NN	O	—	prep_with	3	SENT_142	[p10l1630t422r2144b512],
8	induced	VBD	O	induce	_	0	SENT_142	[p10l1630t422r2144b512],
9	hepatotoxicities	NNS	O	hepatotoxicity	nsubjpass	11	SENT_142	[p10l8t525r602b613],
10	were	VBD	O	be	auxpass	11	SENT_142	[p10l663t549r837b593],
11	enrolled	VBN	O	enrol	ccomp	8	SENT_142	[p10l900t525r1223b593],
12	.	.	O	.	_	0	SENT_142	[p10l900t525r1223b593],

1	Amoxicillin	NNP	O	Amoxicillin	dep	3	SENT_143	[p10l1286t525r2144b593],
2	—	CD	NUMBER	—	num	1	SENT_143	[p10l1286t525r2144b593],
3	clavulanic	JJ	O	clavulanic	_	0	SENT_143	[p10l1286t525r2144b593],

1	TNF	NN	O	tnf	nn	4	SENT_144	[p10l7t889r205b943],
2	—	NN	O	—	nn	4	SENT_144	[p10l7t889r205b943],
3	oc	NN	O	oc	nn	4	SENT_144	[p10l7t889r205b943],
4	polymorphism	NN	O	polymorphism	nsubj	14	SENT_144	[p10l230t886r719b958],
5	and	CC	O	and	_	0	SENT_144	[p10l747t886r872b943],
6	ATD-induced	JJ	O	atd-induced	amod	8	SENT_144	[p10l897t886r1345b943],
7	hepatitis	NN	O	hepatitis	nn	8	SENT_144	[p10l1374t886r1671b958],
8	acid	NN	O	acid	conj_and	4	SENT_144	[p10l10t1129r161b1197],
9	was	VBD	O	be	cop	14	SENT_144	[p10l192t1153r327b1197],
10	the	DT	O	the	det	14	SENT_144	[p10l360t1129r475b1197],
11	most	RBS	O	most	advmod	12	SENT_144	[p10l508t1143r694b1197],
12	common	JJ	O	common	amod	14	SENT_144	[p10l727t1153r1066b1197],
13	cause	NN	O	cause	nn	14	SENT_144	[p10l1099t1153r1298b1197],
14	(	NN	O	(	_	0	SENT_144	[p10l1337t1129r1450b1211],
15	29	CD	NUMBER	29	nsubj	32	SENT_144	[p10l1337t1129r1450b1211],
16	of	IN	O	of	_	0	SENT_144	[p10l1487t1129r1569b1197],
17	140	CD	NUMBER	140	num	18	SENT_144	[p10l1599t1136r1721b1197],
18	cases	NNS	O	case	prep_of	15	SENT_144	[p10l1756t1129r1965b1211],
19	)	CD	NUMBER	)	dep	18	SENT_144	[p10l1756t1129r1965b1211],
20	and	CC	O	and	_	0	SENT_144	[p10l2007t1129r2144b1197],
21	the	DT	O	the	det	22	SENT_144	[p10l8t1232r119b1300],
22	types	NNS	O	type	conj_and	18	SENT_144	[p10l148t1245r331b1321],
23	of	IN	O	of	_	0	SENT_144	[p10l363t1232r444b1300],
24	DILI	NNP	O	DILI	prep_of	22	SENT_144	[p10l463t1237r633b1299],
25	observed	VBN	O	observe	partmod	15	SENT_144	[p10l665t1232r985b1300],
26	were	VBD	O	be	cop	32	SENT_144	[p10l1012t1257r1181b1300],
27	not	RB	O	not	neg	32	SENT_144	[p10l1211t1245r1334b1300],
28	homogenous	JJ	O	homogenous	amod	32	SENT_144	[p10l1362t1232r1833b1321],
29	(	NN	O	(	nn	32	SENT_144	[p10l1870t1232r2140b1320],
30	hepato	NN	O	hepato	nn	32	SENT_144	[p10l1870t1232r2140b1320],
31	cellular	JJ	O	cellular	amod	32	SENT_144	[p10l10t1333r281b1402],
32	type	NN	O	type	rcmod	14	SENT_144	[p10l319t1347r497b1424],
33	,	,	O	,	_	0	SENT_144	[p10l319t1347r497b1424],
34	48	CD	PERCENT	48	num	35	SENT_144	[p10l538t1334r758b1416],
35	%	NN	PERCENT	%	attr	32	SENT_144	[p10l538t1334r758b1416],
36	)	CD	NUMBER	)	dep	35	SENT_144	[p10l538t1334r758b1416],
37	.	.	O	.	_	0	SENT_144	[p10l538t1334r758b1416],

1	Therefore	RB	O	therefore	advmod	12	SENT_145	[p10l801t1333r1187b1413],
2	,	,	O	,	_	0	SENT_145	[p10l801t1333r1187b1413],
3	the	DT	O	the	det	4	SENT_145	[p10l1227t1333r1343b1402],
4	lack	NN	O	lack	nsubjpass	12	SENT_145	[p10l1381t1333r1531b1402],
5	of	IN	O	of	_	0	SENT_145	[p10l1569t1333r1651b1402],
6	a	DT	O	a	det	8	SENT_145	[p10l1681t1358r1718b1402],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_145	[p10l1757t1333r2144b1424],
8	association	NN	O	association	prep_of	4	SENT_145	[p10l10t1439r423b1505],
9	might	MD	O	might	aux	12	SENT_145	[p10l451t1437r672b1526],
10	be	VB	O	be	auxpass	12	SENT_145	[p10l697t1437r783b1505],
11	partly	RB	O	partly	advmod	12	SENT_145	[p10l810t1437r1031b1526],
12	explained	VBN	O	explain	_	0	SENT_145	[p10l1056t1437r1415b1525],
13	by	IN	O	by	_	0	SENT_145	[p10l1441t1437r1533b1526],
14	the	DT	O	the	det	15	SENT_145	[p10l1556t1437r1671b1504],
15	heterogeneity	NN	O	heterogeneity	agent	12	SENT_145	[p10l1699t1437r2139b1526, p10l9t1542r106b1628],
16	of	IN	O	of	_	0	SENT_145	[p10l139t1539r221b1607],
17	the	DT	O	the	det	19	SENT_145	[p10l246t1539r361b1607],
18	causative	JJ	O	causative	amod	19	SENT_145	[p10l399t1542r736b1607],
19	drugs	NNS	O	drug	prep_of	15	SENT_145	[p10l774t1539r979b1628],
20	and	CC	O	and	_	0	SENT_145	[p10l1018t1539r1155b1607],
21	types	NNS	O	type	conj_and	19	SENT_145	[p10l1190t1553r1380b1628],
22	of	IN	O	of	_	0	SENT_145	[p10l1418t1539r1500b1607],
23	hepatotoxicities	NNS	O	hepatotoxicity	prep_of	19	SENT_145	[p10l1525t1539r2140b1627],
24	.	.	O	.	_	0	SENT_145	[p10l1525t1539r2140b1627],

1	Various	JJ	O	various	amod	2	SENT_146	[p10l6t1643r300b1708],
2	mechanisms	NNS	O	mechanism	nsubjpass	4	SENT_146	[p10l331t1640r794b1708],
3	are	VBP	O	be	auxpass	4	SENT_146	[p10l824t1665r933b1708],
4	involved	VBN	O	involve	_	0	SENT_146	[p10l962t1640r1283b1709],
5	in	IN	O	in	_	0	SENT_146	[p10l1312t1643r1384b1707],
6	the	DT	O	the	det	7	SENT_146	[p10l1411t1640r1526b1708],
7	development	NN	O	development	prep_in	4	SENT_146	[p10l1556t1640r2043b1729],
8	of	IN	O	of	_	0	SENT_146	[p10l2072t1640r2154b1708],
9	DILI	NNP	O	DILI	prep_of	7	SENT_146	[p10l9t1748r185b1810],
10	and	CC	O	and	_	0	SENT_146	[p10l221t1743r358b1811],
11	the	DT	O	the	det	12	SENT_146	[p10l391t1743r506b1811],
12	mechanisms	NNS	O	mechanism	nsubj	14	SENT_146	[p10l540t1743r1003b1811],
13	could	MD	O	could	aux	14	SENT_146	[p10l1038t1743r1247b1811],
14	vary	VB	O	vary	conj_and	4	SENT_146	[p10l1277t1767r1440b1832],
15	depending	VBG	O	depend	_	0	SENT_146	[p10l1471t1743r1866b1832],
16	on	IN	O	on	prepc_depending_on	14	SENT_146	[p10l1900t1767r1995b1811],
17	the	DT	O	the	det	19	SENT_146	[p10l2028t1743r2143b1810],
18	culprit	NN	O	culprit	nn	19	SENT_146	[p10l10t1845r258b1933],
19	drugs	NNS	O	drug	pobj	14	SENT_146	[p10l289t1845r495b1934],
20	and	CC	O	and	_	0	SENT_146	[p10l527t1845r664b1913],
21	patterns	NNS	O	pattern	pobj	14	SENT_146	[p10l694t1859r998b1933],
22	of	IN	O	of	_	0	SENT_146	[p10l1029t1845r1112b1913],
23	DILI	NNP	O	DILI	prep_of	19	SENT_146	[p10l1131t1850r1328b1913],
24	.	.	O	.	_	0	SENT_146	[p10l1131t1850r1328b1913],

1	Experiences	NNS	O	experience	nsubj	10	SENT_147	[p10l1362t1848r1803b1933],
2	in	IN	O	in	_	0	SENT_147	[p10l1835t1847r1907b1912],
3	pharmacogenetic	JJ	O	pharmacogenetic	amod	5	SENT_147	[p10l1937t1845r2140b1933, p10l9t1949r479b2037],
4	association	NN	O	association	nn	5	SENT_147	[p10l513t1949r926b2015],
5	studies	NNS	O	study	prep_in	1	SENT_147	[p10l961t1946r1218b2015],
6	on	IN	O	on	_	0	SENT_147	[p10l1254t1971r1349b2015],
7	ADR	NN	O	adr	prep_on	5	SENT_147	[p10l1380t1951r1569b2015],
8	and	CC	O	and	_	0	SENT_147	[p10l1603t1946r1740b2015],
9	DILI	NNP	ORGANIZATION	DILI	prep_on	5	SENT_147	[p10l1774t1952r1950b2014],
10	suggest	VBP	O	suggest	_	0	SENT_147	[p10l1986t1971r2140b2037, p10l9t2064r151b2140],
11	that	IN	O	that	complm	19	SENT_147	[p10l188t2050r335b2118],
12	most	JJS	O	most	amod	13	SENT_147	[p10l372t2064r558b2118],
13	associations	NNS	O	association	nsubj	19	SENT_147	[p10l597t2052r1043b2118],
14	were	VBD	O	be	cop	19	SENT_147	[p10l1079t2074r1253b2118],
15	not	RB	O	not	neg	16	SENT_147	[p10l1293t2063r1419b2118],
16	only	RB	O	only	preconj	19	SENT_147	[p10l1457t2050r1621b2140],
17	drug	NN	O	drug	nn	19	SENT_147	[p10l1657t2049r2144b2140],
18	—	NN	O	—	nn	19	SENT_147	[p10l1657t2049r2144b2140],
19	speciﬁc	NN	O	speciﬁc	ccomp	10	SENT_147	[p10l1657t2049r2144b2140],
20	but	CC	O	but	_	0	SENT_147	[p10l7t2153r134b2221],
21	also	RB	O	also	_	0	SENT_147	[p10l184t2153r323b2221],
22	phenotype	NN	O	phenotype	nn	24	SENT_147	[p10l374t2153r1084b2242],
23	—	NN	O	—	nn	24	SENT_147	[p10l374t2153r1084b2242],
24	speciﬁc	NN	O	speciﬁc	ccomp	10	SENT_147	[p10l374t2153r1084b2242],
25	(	CD	NUMBER	(	number	26	SENT_147	[p10l1138t2153r1274b2235],
26	23	CD	NUMBER	23	dep	24	SENT_147	[p10l1138t2153r1274b2235],
27	,	,	O	,	_	0	SENT_147	[p10l1138t2153r1274b2235],
28	24	CD	NUMBER	24	num	29	SENT_147	[p10l1326t2153r1466b2235],
29	)	NN	O	)	appos	24	SENT_147	[p10l1326t2153r1466b2235],
30	.	.	O	.	_	0	SENT_147	[p10l1326t2153r1466b2235],

1	As	IN	O	as	mark	18	SENT_148	[p10l1516t2157r1608b2221],
2	the	DT	O	the	det	5	SENT_148	[p10l1657t2153r1773b2221],
3	previous	JJ	O	previous	amod	5	SENT_148	[p10l1821t2156r2142b2241],
4	Spanish	JJ	MISC	spanish	amod	5	SENT_148	[p10l10t2254r301b2344],
5	study	NN	O	study	nsubj	18	SENT_148	[p10l340t2254r546b2345],
6	of	IN	O	of	_	0	SENT_148	[p10l581t2254r663b2323],
7	association	NN	O	association	prep_of	5	SENT_148	[p10l692t2257r1104b2323],
8	between	IN	O	between	_	0	SENT_148	[p10l1141t2254r1449b2323],
9	TNF-Ot	JJ	O	tnf-ot	amod	11	SENT_148	[p10l1487t2257r1745b2323],
10	—	NN	O	—	nn	11	SENT_148	[p10l1788t2258r2144b2326],
11	308G/A	NN	O	308g/a	prep_between	7	SENT_148	[p10l1788t2258r2144b2326],
12	and	CC	O	and	_	0	SENT_148	[p10l10t2358r148b2426],
13	various	JJ	O	various	amod	14	SENT_148	[p10l182t2360r458b2426],
14	drug	NN	O	drug	prep_of	5	SENT_148	[p10l498t2358r963b2447],
15	—	RB	O	—	advmod	16	SENT_148	[p10l498t2358r963b2447],
16	related	JJ	O	related	amod	17	SENT_148	[p10l498t2358r963b2447],
17	DILI	NNP	ORGANIZATION	DILI	dep	14	SENT_148	[p10l1001t2363r1176b2425],
18	showed	VBD	O	show	advcl	23	SENT_148	[p10l1217t2358r1497b2426],
19	negative	JJ	O	negative	amod	20	SENT_148	[p10l1535t2360r1843b2447],
20	results	NNS	O	result	dobj	18	SENT_148	[p10l1881t2358r2142b2436],
21	,	,	O	,	_	0	SENT_148	[p10l1881t2358r2142b2436],
22	we	PRP	O	we	nsubj	23	SENT_148	[p10l6t2484r108b2528],
23	focused	VBD	O	focus	_	0	SENT_148	[p10l150t2460r435b2528],
24	only	RB	O	only	advmod	23	SENT_148	[p10l477t2460r641b2549],
25	on	IN	O	on	_	0	SENT_148	[p10l680t2484r775b2528],
26	ATD-induced	JJ	O	atd-induced	amod	27	SENT_148	[p10l814t2460r1340b2528],
27	hepatitis	NN	O	hepatitis	prep_on	23	SENT_148	[p10l1380t2460r1720b2548],
28	,	,	O	,	_	0	SENT_148	[p10l1380t2460r1720b2548],
29	instead	RB	O	instead	_	0	SENT_148	[p10l1765t2460r2030b2528],
30	of	IN	O	of	_	0	SENT_148	[p10l2072t2460r2154b2528],
31	various	JJ	O	various	amod	33	SENT_148	[p10l6t2564r282b2630],
32	drug	NN	O	drug	nn	33	SENT_148	[p10l326t2561r840b2652],
33	—	NN	O	—	prep_instead_of	23	SENT_148	[p10l326t2561r840b2652],
34	induced	VBD	O	induce	partmod	33	SENT_148	[p10l326t2561r840b2652],
35	liver	NN	O	liver	nn	36	SENT_148	[p10l882t2561r1045b2630],
36	injuries	NNS	O	injury	dobj	34	SENT_148	[p10l1088t2564r1387b2652],
37	,	,	O	,	_	0	SENT_148	[p10l1088t2564r1387b2652],
38	and	CC	O	and	_	0	SENT_148	[p10l1434t2561r1572b2630],
39	the	DT	O	the	det	41	SENT_148	[p10l1614t2561r1729b2630],
40	DILI	NNP	O	DILI	nn	41	SENT_148	[p10l1772t2567r1948b2629],
41	patterns	NNS	O	pattern	nsubj	43	SENT_148	[p10l1992t2575r2139b2651, p10l8t2678r191b2733],
42	were	VBD	O	be	cop	43	SENT_148	[p10l217t2689r393b2733],
43	hepatocellular	JJ	O	hepatocellular	conj_and	23	SENT_148	[p10l420t2665r952b2753],
44	in	IN	O	in	_	0	SENT_148	[p10l980t2667r1052b2732],
45	all	DT	O	all	det	46	SENT_148	[p10l1081t2665r1165b2733],
46	cases	NNS	O	case	prep_in	43	SENT_148	[p10l1193t2689r1393b2733],
47	.	.	O	.	_	0	SENT_148	[p10l1193t2689r1393b2733],

1	The	DT	O	the	det	2	SENT_149	[p10l1425t2665r1568b2733],
2	data	NNS	O	datum	nsubj	3	SENT_149	[p10l1597t2665r1755b2733],
3	presented	VBD	O	present	_	0	SENT_149	[p10l1781t2665r2143b2753],
4	provide	VBP	O	provide	ccomp	3	SENT_149	[p10l8t2767r295b2855],
5	evidence	NN	O	evidence	dobj	4	SENT_149	[p10l347t2767r667b2835],
6	that	IN	O	that	complm	9	SENT_149	[p10l717t2767r864b2835],
7	—	NN	O	—	nn	8	SENT_149	[p10l918t2771r1275b2838],
8	308G/A	NN	O	308g/a	nsubj	9	SENT_149	[p10l918t2771r1275b2838],
9	increased	VBD	O	increase	ccomp	4	SENT_149	[p10l1324t2767r1673b2835],
10	the	DT	O	the	det	11	SENT_149	[p10l1721t2767r1836b2835],
11	risk	NN	O	risk	dobj	9	SENT_149	[p10l1887t2767r2025b2835],
12	of	IN	O	of	_	0	SENT_149	[p10l2072t2767r2154b2835],
13	ATD-induced	JJ	O	atd-induced	amod	14	SENT_149	[p10l6t2868r531b2936],
14	hepatitis	NN	O	hepatitis	prep_of	11	SENT_149	[p10l558t2868r898b2957],
15	.	.	O	.	_	0	SENT_149	[p10l558t2868r898b2957],

1	Among	IN	O	among	_	0	SENT_150	[p10l109t2975r391b3060],
2	various	JJ	O	various	amod	3	SENT_150	[p10l417t2973r692b3039],
3	cytokines	NNS	O	cytokine	prep_among	20	SENT_150	[p10l723t2971r1072b3060],
4	that	WDT	O	that	nsubjpass	7	SENT_150	[p10l1103t2971r1250b3038],
5	have	VBP	O	have	aux	7	SENT_150	[p10l1278t2971r1448b3039],
6	been	VBN	O	be	auxpass	7	SENT_150	[p10l1476t2971r1652b3039],
7	suggested	VBN	O	suggest	rcmod	3	SENT_150	[p10l1682t2971r2040b3060],
8	to	TO	O	to	aux	9	SENT_150	[p10l2068t2984r2141b3038],
9	play	VB	O	play	xcomp	7	SENT_150	[p10l8t3073r166b3162],
10	a	DT	O	a	det	11	SENT_150	[p10l206t3097r244b3141],
11	role	NN	O	role	dobj	9	SENT_150	[p10l287t3073r428b3141],
12	in	IN	O	in	_	0	SENT_150	[p10l472t3075r545b3140],
13	the	DT	O	the	det	14	SENT_150	[p10l587t3073r702b3141],
14	pathogenesis	NN	O	pathogenesis	prep_in	9	SENT_150	[p10l745t3073r1226b3162],
15	of	IN	O	of	_	0	SENT_150	[p10l1271t3073r1353b3141],
16	DILI	NNP	LOCATION	DILI	prep_of	14	SENT_150	[p10l1387t3078r1584b3151],
17	,	,	O	,	_	0	SENT_150	[p10l1387t3078r1584b3151],
18	TNF-oc	NN	O	tnf-oc	nsubj	20	SENT_150	[p10l1630t3076r1887b3141],
19	is	VBZ	O	be	cop	20	SENT_150	[p10l1931t3075r1984b3141],
20	the	DT	O	the	_	0	SENT_150	[p10l2028t3073r2143b3141],
21	most	RBS	O	most	advmod	20	SENT_150	[p10l9t3188r194b3243],
22	extensively	RB	O	extensively	advmod	23	SENT_150	[p10l234t3174r642b3265],
23	investigated	VBN	O	investigate	partmod	20	SENT_150	[p10l678t3174r1124b3265],
24	protein	NN	O	protein	dobj	23	SENT_150	[p10l1161t3177r1437b3264],
25	to	TO	O	to	_	0	SENT_150	[p10l1475t3188r1548b3243],
26	date	NN	O	date	prep_to	23	SENT_150	[p10l1590t3174r1744b3243],
27	(	CD	NUMBER	(	num	26	SENT_150	[p10l1788t3174r1958b3257],
28	25	CD	NUMBER	25	num	29	SENT_150	[p10l1788t3174r1958b3257],
29	)	NN	O	)	dep	26	SENT_150	[p10l1788t3174r1958b3257],
30	.	.	O	.	_	0	SENT_150	[p10l1788t3174r1958b3257],

1	The	DT	O	the	det	4	SENT_151	[p10l2001t3175r2143b3243],
2	TNF	NN	MISC	tnf	nn	4	SENT_151	[p10l8t3280r267b3346],
3	—	NN	O	—	nn	4	SENT_151	[p10l8t3280r267b3346],
4	oc	NN	O	oc	nsubj	5	SENT_151	[p10l8t3280r267b3346],
5	augments	VBZ	O	augment	_	0	SENT_151	[p10l304t3292r664b3368],
6	the	DT	O	the	det	8	SENT_151	[p10l702t3278r817b3346],
7	inﬂammatory	JJ	O	inﬂammatory	amod	8	SENT_151	[p10l855t3278r1374b3368],
8	process	NN	O	process	dobj	5	SENT_151	[p10l1407t3302r1682b3367],
9	in	IN	O	in	_	0	SENT_151	[p10l1720t3280r1792b3345],
10	the	DT	O	the	det	11	SENT_151	[p10l1829t3278r1944b3346],
11	liver	NN	O	liver	prep_in	8	SENT_151	[p10l1981t3278r2144b3346],
12	by	IN	O	by	_	0	SENT_151	[p10l7t3381r99b3470],
13	inducing	VBG	O	induce	prepc_by	5	SENT_151	[p10l141t3381r474b3470],
14	proinﬂammatory	JJ	O	proinﬂammatory	amod	15	SENT_151	[p10l517t3381r1172b3470],
15	cytokines	NNS	O	cytokine	dobj	13	SENT_151	[p10l1215t3381r1585b3470],
16	,	,	O	,	_	0	SENT_151	[p10l1215t3381r1585b3470],
17	such	JJ	O	such	_	0	SENT_151	[p10l1634t3381r1802b3449],
18	as	IN	O	as	_	0	SENT_151	[p10l1849t3405r1918b3449],
19	IL-1	NN	O	il-1	prep_such_as	15	SENT_151	[p10l1965t3386r2141b3459],
20	,	,	O	,	_	0	SENT_151	[p10l1965t3386r2141b3459],
21	IL-8	NN	O	il-8	prep_such_as	15	SENT_151	[p10l9t3488r162b3550],
22	and	CC	O	and	_	0	SENT_151	[p10l203t3482r341b3550],
23	IFN	NN	O	ifn	prep_such_as	15	SENT_151	[p10l377t3488r622b3569],
24	—	CD	NUMBER	—	num	25	SENT_151	[p10l377t3488r622b3569],
25	y.	NN	O	y.	tmod	13	SENT_151	[p10l377t3488r622b3569],
26	In	IN	O	in	_	0	SENT_151	[p10l663t3488r741b3549],
27	addition	NN	O	addition	prep_in	30	SENT_151	[p10l778t3482r1114b3561],
28	,	,	O	,	_	0	SENT_151	[p10l778t3482r1114b3561],
29	TNF	NN	O	tnf	nsubj	30	SENT_151	[p10l1153t3485r1323b3550],
30	binds	VBZ	O	bind	rcmod	25	SENT_151	[p10l1358t3482r1564b3550],
31	to	TO	O	to	_	0	SENT_151	[p10l1600t3496r1673b3550],
32	its	PRP$	O	its	poss	36	SENT_151	[p10l1712t3485r1795b3550],
33	receptor	NN	O	receptor	nn	36	SENT_151	[p10l1833t3496r2145b3571],
34	(	CD	NUMBER	(	num	36	SENT_151	[p10l14t3585r382b3667],
35	TNFR	NN	O	tnfr	nn	36	SENT_151	[p10l14t3585r382b3667],
36	—	NN	O	—	prep_to	30	SENT_151	[p10l14t3585r382b3667],
37	1	CD	NUMBER	1	num	38	SENT_151	[p10l14t3585r382b3667],
38	)	NN	O	)	dep	36	SENT_151	[p10l14t3585r382b3667],
39	on	IN	O	on	_	0	SENT_151	[p10l430t3609r526b3653],
40	hepatocytes	NNS	O	hepatocyte	prep_on	30	SENT_151	[p10l566t3585r1004b3674],
41	leading	VBG	O	lead	partmod	40	SENT_151	[p10l1046t3585r1318b3674],
42	to	TO	O	to	_	0	SENT_151	[p10l1357t3598r1430b3653],
43	hepatocyte	NN	O	hepatocyte	nn	44	SENT_151	[p10l1473t3585r1878b3674],
44	injury	NN	O	injury	prep_to	41	SENT_151	[p10l1920t3587r2147b3674],
45	(	CD	NUMBER	(	num	47	SENT_151	[p10l14t3687r184b3769],
46	26	CD	NUMBER	26	num	47	SENT_151	[p10l14t3687r184b3769],
47	)	NN	O	)	dep	25	SENT_151	[p10l14t3687r184b3769],
48	.	.	O	.	_	0	SENT_151	[p10l14t3687r184b3769],

1	Experiments	NNS	O	experiment	nsubj	8	SENT_152	[p10l216t3689r686b3775],
2	using	VBG	O	use	partmod	1	SENT_152	[p10l716t3689r917b3776],
3	animal	NN	O	animal	nn	4	SENT_152	[p10l945t3687r1201b3755],
4	models	NNS	O	model	dobj	2	SENT_152	[p10l1228t3687r1497b3755],
5	of	IN	O	of	_	0	SENT_152	[p10l1527t3687r1609b3755],
6	CC14	NN	O	cc14	nn	7	SENT_152	[p10l1628t3687r2144b3769],
7	—	NN	O	—	prep_of	4	SENT_152	[p10l1628t3687r2144b3769],
8	induced	VBD	O	induce	_	0	SENT_152	[p10l1628t3687r2144b3769],
9	liver	NN	O	liver	nn	10	SENT_152	[p11l8t13r171b81],
10	injury	NN	O	injury	nsubj	20	SENT_152	[p11l212t15r439b102],
11	(	CD	NUMBER	(	number	12	SENT_152	[p11l481t13r625b95],
12	27	CD	NUMBER	27	num	13	SENT_152	[p11l481t13r625b95],
13	)	NN	O	)	dep	10	SENT_152	[p11l481t13r625b95],
14	and	CC	O	and	_	0	SENT_152	[p11l674t13r812b81],
15	halothane-induced	JJ	O	halothane-induced	amod	16	SENT_152	[p11l852t13r1564b81],
16	hepatotoxicity	NN	O	hepatotoxicity	conj_and	10	SENT_152	[p11l1604t13r2147b102],
17	(	CD	NUMBER	(	number	18	SENT_152	[p11l14t115r159b197],
18	13	CD	NUMBER	13	num	19	SENT_152	[p11l14t115r159b197],
19	)	NN	O	)	dep	16	SENT_152	[p11l14t115r159b197],
20	showed	VBD	O	show	ccomp	8	SENT_152	[p11l198t115r479b183],
21	a	DT	O	a	det	23	SENT_152	[p11l512t139r548b183],
22	protoxicant	JJ	O	protoxicant	amod	23	SENT_152	[p11l578t117r1018b203],
23	role	NN	O	role	dobj	20	SENT_152	[p11l1050t115r1191b183],
24	of	IN	O	of	_	0	SENT_152	[p11l1224t115r1306b183],
25	TNF	NN	O	tnf	nn	27	SENT_152	[p11l1326t117r1585b182],
26	—	NN	O	—	nn	27	SENT_152	[p11l1326t117r1585b182],
27	oL	NN	O	ol	prep_of	23	SENT_152	[p11l1326t117r1585b182],
28	in	IN	O	in	_	0	SENT_152	[p11l1616t117r1688b182],
29	DILI	NNP	LOCATION	DILI	prep_in	20	SENT_152	[p11l1720t120r1915b183],
30	.	.	O	.	_	0	SENT_152	[p11l1720t120r1915b183],

1	Contrary	JJ	O	contrary	_	0	SENT_153	[p11l1952t118r2139b183, p11l8t230r190b306],
2	to	TO	O	to	_	0	SENT_153	[p11l237t230r310b285],
3	these	DT	O	these	det	4	SENT_153	[p11l363t217r551b285],
4	publications	NNS	O	publication	prep_contrary_to	9	SENT_153	[p11l602t217r1086b305],
5	,	,	O	,	_	0	SENT_153	[p11l602t217r1086b305],
6	further	JJ	O	further	amod	7	SENT_153	[p11l1141t217r1404b285],
7	studies	NNS	O	study	nsubj	9	SENT_153	[p11l1456t217r1711b285],
8	have	VBP	O	have	aux	9	SENT_153	[p11l1763t217r1933b285],
9	suggested	VBN	O	suggest	_	0	SENT_153	[p11l1986t241r2140b306, p11l9t319r239b408],
10	that	IN	O	that	complm	12	SENT_153	[p11l293t319r441b387],
11	TNF-OL	NN	O	tnf-ol	nsubj	12	SENT_153	[p11l494t322r752b387],
12	has	VBZ	O	have	ccomp	9	SENT_153	[p11l805t319r925b387],
13	a	DT	O	a	det	15	SENT_153	[p11l982t344r1019b387],
14	protective	JJ	O	protective	amod	15	SENT_153	[p11l1072t321r1447b407],
15	role	NN	O	role	dobj	12	SENT_153	[p11l1502t319r1643b387],
16	in	IN	O	in	_	0	SENT_153	[p11l1699t321r1771b386],
17	DILI	NNP	ORGANIZATION	DILI	prep_in	12	SENT_153	[p11l1826t324r2001b386],
18	by	IN	O	by	_	0	SENT_153	[p11l2055t319r2147b408],
19	promoting	VBG	O	promote	prepc_by	12	SENT_153	[p11l8t423r415b510],
20	tissue	NN	O	tissue	nn	21	SENT_153	[p11l447t423r656b489],
21	repair	NN	O	repair	dobj	19	SENT_153	[p11l691t423r912b509],
22	and	CC	O	and	_	0	SENT_153	[p11l946t421r1084b489],
23	liver	NN	O	liver	nn	24	SENT_153	[p11l1116t421r1280b488],
24	regeneration	NN	O	regeneration	conj_and	21	SENT_153	[p11l1314t423r1786b510],
25	(	CD	NUMBER	(	number	26	SENT_153	[p11l1826t421r1962b503],
26	28	CD	NUMBER	28	dep	21	SENT_153	[p11l1826t421r1962b503],
27	,	,	O	,	_	0	SENT_153	[p11l1826t421r1962b503],
28	29	CD	NUMBER	29	num	29	SENT_153	[p11l2000t421r2139b503],
29	)	NN	O	)	appos	21	SENT_153	[p11l2000t421r2139b503],
30	.	.	O	.	_	0	SENT_153	[p11l2000t421r2139b503],

1	While	IN	O	while	mark	8	SENT_154	[p11l6t523r232b591],
2	the	DT	O	the	det	3	SENT_154	[p11l267t523r382b591],
3	roles	NNS	O	role	nsubj	8	SENT_154	[p11l418t523r592b591],
4	of	IN	O	of	_	0	SENT_154	[p11l630t523r712b591],
5	TNF	NN	O	tnf	nn	7	SENT_154	[p11l737t526r994b591],
6	—	NN	O	—	nn	7	SENT_154	[p11l737t526r994b591],
7	oc	NN	O	oc	prep_of	3	SENT_154	[p11l737t526r994b591],
8	seem	VBP	O	seem	advcl	26	SENT_154	[p11l1030t547r1214b591],
9	to	TO	O	to	aux	11	SENT_154	[p11l1249t536r1322b591],
10	be	VB	O	be	cop	11	SENT_154	[p11l1358t523r1443b591],
11	different	JJ	O	different	xcomp	8	SENT_154	[p11l1479t523r1799b591],
12	depending	VBG	O	depend	_	0	SENT_154	[p11l1835t523r2140b611, p11l9t627r126b714],
13	on	IN	O	on	prepc_depending_on	11	SENT_154	[p11l163t650r258b693],
14	the	DT	O	the	det	15	SENT_154	[p11l294t625r409b693],
15	situation	NN	O	situation	pobj	11	SENT_154	[p11l447t627r778b693],
16	and	CC	O	and	_	0	SENT_154	[p11l815t625r954b693],
17	phases	NNS	O	phase	conj_and	15	SENT_154	[p11l989t625r1233b713],
18	of	IN	O	of	_	0	SENT_154	[p11l1271t625r1353b693],
19	inﬂammation	NN	O	inﬂammation	prep_of	15	SENT_154	[p11l1380t625r1916b703],
20	,	,	O	,	_	0	SENT_154	[p11l1380t625r1916b703],
21	these	DT	O	these	det	22	SENT_154	[p11l1955t625r2143b693],
22	studies	NNS	O	study	nsubj	26	SENT_154	[p11l10t727r265b795],
23	when	WRB	O	when	advmod	24	SENT_154	[p11l312t727r514b794],
24	considered	VBN	O	consider	dep	22	SENT_154	[p11l564t727r970b795],
25	together	RB	O	together	advmod	24	SENT_154	[p11l1017t727r1329b816],
26	suggest	VBP	O	suggest	_	0	SENT_154	[p11l1377t740r1645b816],
27	that	IN	O	that	complm	31	SENT_154	[p11l1692t727r1839b795],
28	TNF	NN	MISC	tnf	nn	30	SENT_154	[p11l1886t729r2145b794],
29	—	NN	O	—	nn	30	SENT_154	[p11l1886t729r2145b794],
30	oL	NN	O	ol	nsubj	31	SENT_154	[p11l1886t729r2145b794],
31	plays	VBZ	O	play	ccomp	26	SENT_154	[p11l8t829r194b918],
32	an	DT	O	a	det	34	SENT_154	[p11l244t853r331b897],
33	important	JJ	O	important	amod	34	SENT_154	[p11l379t831r763b917],
34	role	NN	O	role	dobj	31	SENT_154	[p11l811t829r952b897],
35	in	IN	O	in	_	0	SENT_154	[p11l1001t831r1073b896],
36	DILI	NNP	ORGANIZATION	DILI	prep_in	34	SENT_154	[p11l1122t834r1318b897],
37	.	.	O	.	_	0	SENT_154	[p11l1122t834r1318b897],

1	The	DT	O	the	det	2	SENT_155	[p11l1369t829r1511b897],
2	mechanisms	NNS	O	mechanism	nsubj	14	SENT_155	[p11l1560t829r2022b897],
3	of	IN	O	of	_	0	SENT_155	[p11l2072t829r2154b897],
4	how	WRB	O	how	advmod	9	SENT_155	[p11l8t931r171b999],
5	the	DT	O	the	det	8	SENT_155	[p11l211t931r326b999],
6	—	NN	O	—	nn	8	SENT_155	[p11l375t935r732b1002],
7	308G/A	NN	O	308g/a	nn	8	SENT_155	[p11l375t935r732b1002],
8	polymorphism	NN	O	polymorphism	nsubj	9	SENT_155	[p11l773t931r1331b1020],
9	affects	VBZ	O	affect	prepc_of	2	SENT_155	[p11l1376t931r1607b999],
10	susceptibility	NN	O	susceptibility	dobj	9	SENT_155	[p11l1654t931r2147b1020],
11	to	TO	O	to	_	0	SENT_155	[p11l8t1047r81b1101],
12	ATD	NN	O	atd	nn	13	SENT_155	[p11l113t1033r639b1101],
13	—	NN	O	—	prep_to	9	SENT_155	[p11l113t1033r639b1101],
14	induced	VBD	O	induce	_	0	SENT_155	[p11l113t1033r639b1101],
15	hepatitis	NN	O	hepatitis	nsubjpass	19	SENT_155	[p11l671t1033r991b1121],
16	have	VBP	O	have	aux	19	SENT_155	[p11l1023t1033r1193b1101],
17	not	RB	O	not	neg	19	SENT_155	[p11l1227t1046r1353b1101],
18	been	VBN	O	be	auxpass	19	SENT_155	[p11l1383t1033r1559b1101],
19	assessed	VBN	O	assess	ccomp	14	SENT_155	[p11l1592t1033r1890b1101],
20	in	IN	O	in	_	0	SENT_155	[p11l1924t1036r1996b1100],
21	the	DT	O	the	det	23	SENT_155	[p11l2028t1033r2143b1101],
22	current	JJ	DATE	current	amod	23	SENT_155	[p11l10t1148r285b1203],
23	study	NN	O	study	prep_in	19	SENT_155	[p11l330t1135r549b1224],
24	.	.	O	.	_	0	SENT_155	[p11l330t1135r549b1224],

1	Variations	NNS	O	variation	nsubj	7	SENT_156	[p11l597t1137r987b1203],
2	in	IN	O	in	_	0	SENT_156	[p11l1035t1137r1107b1202],
3	this	DT	O	this	det	5	SENT_156	[p11l1151t1135r1286b1203],
4	promoter	NN	O	promoter	nn	5	SENT_156	[p11l1332t1148r1691b1223],
5	area	NN	O	area	prep_in	1	SENT_156	[p11l1738t1159r1889b1203],
6	could	MD	O	could	aux	7	SENT_156	[p11l1936t1135r2144b1203],
7	affect	VB	O	affect	_	0	SENT_156	[p11l10t1237r209b1305],
8	transcription	NN	O	transcription	nn	10	SENT_156	[p11l240t1239r730b1325],
9	factor	NN	O	factor	nn	10	SENT_156	[p11l762t1237r980b1305],
10	binding	NN	O	binding	nsubj	24	SENT_156	[p11l1009t1237r1302b1326],
11	to	TO	O	to	_	0	SENT_156	[p11l1332t1250r1406b1305],
12	the	DT	O	the	det	13	SENT_156	[p11l1439t1237r1554b1305],
13	region	NN	O	region	prep_to	10	SENT_156	[p11l1587t1239r1825b1326],
14	encompassing	VBG	O	encompass	partmod	13	SENT_156	[p11l1858t1262r2140b1305, p11l8t1341r283b1428],
15	—	NN	O	—	dobj	14	SENT_156	[p11l316t1346r535b1418],
16	308	CD	NUMBER	308	num	15	SENT_156	[p11l316t1346r535b1418],
17	,	,	O	,	_	0	SENT_156	[p11l316t1346r535b1418],
18	leading	VBG	O	lead	appos	15	SENT_156	[p11l564t1339r835b1428],
19	to	TO	O	to	_	0	SENT_156	[p11l861t1353r934b1407],
20	alteration	NN	O	alteration	prep_to	18	SENT_156	[p11l966t1339r1325b1407],
21	of	IN	O	of	_	0	SENT_156	[p11l1354t1339r1436b1407],
22	TNF-oc	NN	O	tnf-oc	nn	23	SENT_156	[p11l1453t1342r1711b1407],
23	levels	NNS	O	level	prep_of	18	SENT_156	[p11l1737t1339r1936b1407],
24	(	VBP	O	(	ccomp	7	SENT_156	[p11l1969t1339r2139b1421],
25	30	CD	NUMBER	30	num	26	SENT_156	[p11l1969t1339r2139b1421],
26	)	CD	NUMBER	)	dobj	24	SENT_156	[p11l1969t1339r2139b1421],
27	.	.	O	.	_	0	SENT_156	[p11l1969t1339r2139b1421],

1	The	DT	O	the	det	2	SENT_157	[p11l8t1441r151b1509],
2	variant	NN	O	variant	nsubj	7	SENT_157	[p11l181t1443r447b1509],
3	A	DT	O	a	det	5	SENT_157	[p11l477t1445r538b1508],
4	allele	NN	O	allele	nn	5	SENT_157	[p11l571t1441r756b1509],
5	(	NN	O	(	dep	2	SENT_157	[p11l795t1441r966b1523],
6	also	RB	O	also	advmod	7	SENT_157	[p11l795t1441r966b1523],
7	called	VBD	O	call	_	0	SENT_157	[p11l1003t1441r1215b1509],
8	TNF2	NN	O	tnf2	nn	9	SENT_157	[p11l1247t1441r1492b1523],
9	)	NN	O	)	nsubjpass	12	SENT_157	[p11l1247t1441r1492b1523],
10	is	VBZ	O	be	auxpass	12	SENT_157	[p11l1532t1443r1586b1509],
11	strongly	RB	O	strongly	advmod	12	SENT_157	[p11l1622t1441r1926b1530],
12	associated	VBN	O	associate	ccomp	7	SENT_157	[p11l1957t1466r2140b1509, p11l10t1543r229b1611],
13	with	IN	O	with	_	0	SENT_157	[p11l267t1543r434b1611],
14	elevated	JJ	O	elevated	amod	16	SENT_157	[p11l476t1543r776b1611],
15	TNF-OL	NN	O	tnf-ol	nn	16	SENT_157	[p11l815t1546r1073b1611],
16	levels	NNS	O	level	prep_with	12	SENT_157	[p11l1111t1543r1329b1611],
17	.	.	O	.	_	0	SENT_157	[p11l1111t1543r1329b1611],

1	Therefore	RB	O	therefore	advmod	6	SENT_158	[p11l1373t1543r1759b1622],
2	,	,	O	,	_	0	SENT_158	[p11l1373t1543r1759b1622],
3	it	PRP	O	it	nsubjpass	6	SENT_158	[p11l1802t1546r1853b1611],
4	can	MD	O	can	aux	6	SENT_158	[p11l1894t1568r2020b1611],
5	be	VB	O	be	auxpass	6	SENT_158	[p11l2058t1543r2144b1611],
6	speculated	VBN	O	speculate	_	0	SENT_158	[p11l10t1645r401b1733],
7	that	IN	O	that	complm	11	SENT_158	[p11l439t1645r587b1713],
8	the	DT	O	the	det	10	SENT_158	[p11l623t1645r738b1713],
9	TNF2	NN	O	tnf2	nn	10	SENT_158	[p11l778t1648r991b1713],
10	allele	NN	O	allele	nsubj	11	SENT_158	[p11l1033t1645r1218b1713],
11	leads	VBZ	O	lead	ccomp	6	SENT_158	[p11l1255t1645r1439b1713],
12	to	TO	O	to	_	0	SENT_158	[p11l1478t1659r1551b1713],
13	increased	VBN	O	increase	amod	14	SENT_158	[p11l1592t1645r1942b1713],
14	production	NN	O	production	prep_to	11	SENT_158	[p11l1978t1669r2140b1733, p11l10t1747r300b1815],
15	of	IN	O	of	_	0	SENT_158	[p11l334t1747r417b1815],
16	TNF-oz	NN	O	tnf-oz	prep_of	14	SENT_158	[p11l439t1750r717b1826],
17	,	,	O	,	_	0	SENT_158	[p11l439t1750r717b1826],
18	inﬂuencing	VBG	O	inﬂuencing	xcomp	6	SENT_158	[p11l753t1747r1178b1836],
19	the	DT	O	the	det	21	SENT_158	[p11l1210t1747r1325b1815],
20	immune	JJ	O	immune	amod	21	SENT_158	[p11l1359t1749r1676b1815],
21	response	NN	O	response	dobj	18	SENT_158	[p11l1711t1771r2035b1835],
22	to	TO	O	to	_	0	SENT_158	[p11l2068t1760r2141b1815],
23	ATD	NN	ORGANIZATION	atd	prep_to	18	SENT_158	[p11l6t1852r188b1916],
24	or	CC	O	or	_	0	SENT_158	[p11l238t1874r317b1917],
25	their	PRP$	O	they	poss	27	SENT_158	[p11l361t1849r537b1917],
26	reactive	JJ	O	reactive	amod	27	SENT_158	[p11l583t1852r869b1917],
27	metabolites	NNS	O	metabolite	prep_to	18	SENT_158	[p11l915t1849r1365b1917],
28	.	.	O	.	_	0	SENT_158	[p11l915t1849r1365b1917],

1	However	RB	O	however	advmod	6	SENT_159	[p11l1415t1854r1772b1928],
2	,	,	O	,	_	0	SENT_159	[p11l1415t1854r1772b1928],
3	it	PRP	O	it	nsubj	6	SENT_159	[p11l1821t1852r1872b1917],
4	is	VBZ	O	be	cop	6	SENT_159	[p11l1918t1852r1972b1917],
5	not	RB	O	not	neg	6	SENT_159	[p11l2018t1863r2144b1917],
6	clear	JJ	O	clear	_	0	SENT_159	[p11l10t1950r183b2018],
7	at	IN	O	at	_	0	SENT_159	[p11l219t1964r285b2018],
8	present	JJ	DATE	present	prep_at	6	SENT_159	[p11l319t1964r593b2039],
9	whether	IN	O	whether	complm	19	SENT_159	[p11l626t1950r931b2018],
10	the	DT	O	the	det	11	SENT_159	[p11l964t1950r1080b2018],
11	effects	NNS	O	effect	nsubj	19	SENT_159	[p11l1117t1950r1345b2018],
12	of	IN	O	of	_	0	SENT_159	[p11l1383t1950r1466b2018],
13	TNF	NN	MISC	tnf	nn	14	SENT_159	[p11l1490t1953r1748b2018],
14	—	NN	O	—	prep_of	11	SENT_159	[p11l1490t1953r1748b2018],
15	oL	NN	O	ol	nn	17	SENT_159	[p11l1490t1953r1748b2018],
16	—	CD	NUMBER	—	num	17	SENT_159	[p11l1788t1954r2144b2021],
17	308G/A	NNP	O	308G/A	dep	14	SENT_159	[p11l1788t1954r2144b2021],
18	are	VBP	O	be	cop	19	SENT_159	[p11l10t2078r119b2121],
19	speciﬁc	JJ	O	speciﬁc	ccomp	6	SENT_159	[p11l165t2053r438b2141],
20	to	TO	O	to	_	0	SENT_159	[p11l481t2066r555b2121],
21	ATD	NN	ORGANIZATION	atd	prep_to	19	SENT_159	[p11l599t2056r781b2120],
22	or	CC	O	or	_	0	SENT_159	[p11l829t2078r908b2121],
23	whether	IN	O	whether	complm	25	SENT_159	[p11l950t2053r1254b2121],
24	it	PRP	O	it	nsubj	25	SENT_159	[p11l1298t2055r1350b2121],
25	affects	VBZ	O	affect	ccomp	6	SENT_159	[p11l1394t2053r1626b2121],
26	other	JJ	O	other	amod	27	SENT_159	[p11l1672t2053r1870b2121],
27	drugs	NNS	O	drug	dobj	25	SENT_159	[p11l1914t2053r2139b2142],
28	.	.	O	.	_	0	SENT_159	[p11l1914t2053r2139b2142],

1	Given	VBN	O	give	prep	25	SENT_160	[p11l10t2158r229b2223],
2	the	DT	O	the	det	4	SENT_160	[p11l259t2155r374b2223],
3	reported	VBN	O	report	amod	4	SENT_160	[p11l406t2155r727b2243],
4	roles	NNS	O	role	dep	1	SENT_160	[p11l758t2155r932b2223],
5	of	IN	O	of	_	0	SENT_160	[p11l965t2155r1047b2223],
6	TNF-OL	NN	O	tnf-ol	prep_of	4	SENT_160	[p11l1066t2158r1325b2223],
7	in	IN	O	in	_	0	SENT_160	[p11l1355t2158r1427b2222],
8	inﬂammation	NN	O	inﬂammation	nn	11	SENT_160	[p11l1458t2155r1975b2223],
9	and	CC	O	and	_	0	SENT_160	[p11l2007t2155r2144b2223],
10	DILI	NN	ORGANIZATION	dili	nn	11	SENT_160	[p11l9t2262r185b2324],
11	pathogenesis	NN	O	pathogenesis	prep_in	6	SENT_160	[p11l232t2256r733b2347],
12	,	,	O	,	_	0	SENT_160	[p11l232t2256r733b2347],
13	TNF	NN	O	tnf	nn	15	SENT_160	[p11l782t2259r1041b2325],
14	—	NN	O	—	nn	15	SENT_160	[p11l782t2259r1041b2325],
15	oL	NN	O	ol	nsubj	25	SENT_160	[p11l782t2259r1041b2325],
16	—	CD	NUMBER	—	num	17	SENT_160	[p11l1091t2260r1448b2328],
17	308G/A	NN	O	308g/a	nsubjpass	20	SENT_160	[p11l1091t2260r1448b2328],
18	might	MD	O	might	aux	20	SENT_160	[p11l1494t2256r1715b2347],
19	be	VB	O	be	auxpass	20	SENT_160	[p11l1759t2256r1844b2325],
20	associated	VBN	O	associate	rcmod	15	SENT_160	[p11l1892t2259r2140b2325, p11l10t2360r165b2428],
21	with	IN	O	with	_	0	SENT_160	[p11l190t2360r357b2427],
22	other	JJ	O	other	amod	24	SENT_160	[p11l385t2360r583b2427],
23	drug	NN	O	drug	nn	24	SENT_160	[p11l611t2360r1125b2449],
24	—	NN	O	—	prep_with	20	SENT_160	[p11l611t2360r1125b2449],
25	induced	VBD	O	induce	_	0	SENT_160	[p11l611t2360r1125b2449],
26	hepatitis	NN	O	hepatitis	dobj	25	SENT_160	[p11l1151t2360r1490b2448],
27	.	.	O	.	_	0	SENT_160	[p11l1151t2360r1490b2448],

1	It	PRP	O	it	nsubjpass	3	SENT_161	[p11l112t2467r169b2530],
2	is	VBZ	O	be	auxpass	3	SENT_161	[p11l197t2465r251b2530],
3	acknowledged	VBN	O	acknowledge	_	0	SENT_161	[p11l280t2462r811b2551],
4	that	IN	O	that	complm	13	SENT_161	[p11l838t2462r985b2530],
5	various	JJ	O	various	amod	6	SENT_161	[p11l1010t2465r1285b2530],
6	phenotypes	NNS	O	phenotype	nsubj	13	SENT_161	[p11l1313t2462r1743b2551],
7	or	CC	O	or	_	0	SENT_161	[p11l1772t2487r1852b2530],
8	clinical	JJ	O	clinical	amod	9	SENT_161	[p11l1880t2462r2144b2530],
9	patterns	NNS	O	pattern	nsubj	13	SENT_161	[p11l8t2577r312b2653],
10	of	IN	O	of	_	0	SENT_161	[p11l347t2563r429b2632],
11	DILI	NNP	O	DILI	prep_of	9	SENT_161	[p11l451t2569r626b2631],
12	are	VBP	O	be	cop	13	SENT_161	[p11l661t2588r771b2632],
13	present	JJ	DATE	present	ccomp	3	SENT_161	[p11l804t2577r1096b2653],
14	,	,	O	,	_	0	SENT_161	[p11l804t2577r1096b2653],
15	and	CC	O	and	_	0	SENT_161	[p11l1133t2563r1270b2632],
16	immunoallergic	JJ	O	immunoallergic	amod	17	SENT_161	[p11l1303t2563r1901b2654],
17	hepatitis	NN	O	hepatitis	nsubj	19	SENT_161	[p11l1932t2563r2140b2653, p11l8t2669r147b2735],
18	is	VBZ	O	be	cop	19	SENT_161	[p11l177t2669r230b2735],
19	one	CD	NUMBER	one	conj_and	3	SENT_161	[p11l260t2691r394b2735],
20	of	IN	O	of	_	0	SENT_161	[p11l424t2666r506b2735],
21	distinct	JJ	O	distinct	amod	22	SENT_161	[p11l524t2667r803b2735],
22	phenotypes	NNS	O	phenotype	prep_of	19	SENT_161	[p11l830t2667r1260b2757],
23	(	VBP	O	(	rcmod	19	SENT_161	[p11l1294t2667r1464b2749],
24	31	CD	NUMBER	31	num	25	SENT_161	[p11l1294t2667r1464b2749],
25	)	CD	NUMBER	)	dobj	23	SENT_161	[p11l1294t2667r1464b2749],
26	.	.	O	.	_	0	SENT_161	[p11l1294t2667r1464b2749],

1	While	IN	O	while	mark	3	SENT_162	[p11l1494t2667r1719b2735],
2	there	EX	O	there	expl	3	SENT_162	[p11l1747t2667r1936b2735],
3	is	VBZ	O	be	advcl	13	SENT_162	[p11l1965t2669r2018b2735],
4	no	DT	O	no	det	6	SENT_162	[p11l2047t2691r2141b2735],
5	standardized	JJ	O	standardized	amod	6	SENT_162	[p11l9t2770r489b2838],
6	deﬁnition	NN	O	deﬁnition	nsubj	3	SENT_162	[p11l517t2770r885b2838],
7	of	IN	O	of	_	0	SENT_162	[p11l915t2770r997b2838],
8	immunoallergic	JJ	O	immunoallergic	amod	9	SENT_162	[p11l1014t2770r1611b2859],
9	hepatitis	NN	O	hepatitis	prep_of	6	SENT_162	[p11l1638t2770r1979b2858],
10	,	,	O	,	_	0	SENT_162	[p11l1638t2770r1979b2858],
11	it	PRP	O	it	nsubjpass	13	SENT_162	[p11l2010t2773r2061b2838],
12	is	VBZ	O	be	auxpass	13	SENT_162	[p11l2089t2773r2143b2838],
13	characterized	VBN	O	characterize	_	0	SENT_162	[p11l10t2871r506b2940],
14	by	IN	O	by	_	0	SENT_162	[p11l549t2871r641b2962],
15	the	DT	O	the	det	16	SENT_162	[p11l681t2871r796b2940],
16	presence	NN	O	presence	agent	13	SENT_162	[p11l840t2896r1163b2961],
17	of	IN	O	of	_	0	SENT_162	[p11l1209t2871r1291b2940],
18	hypersensitivity	NN	O	hypersensitivity	nn	19	SENT_162	[p11l1324t2871r1918b2962],
19	reactions	NNS	O	reaction	prep_of	16	SENT_162	[p11l1959t2896r2139b2940, p11l8t2977r192b3043],
20	(	JJ	O	(	amod	26	SENT_162	[p11l229t2975r458b3057],
21	fever	NN	O	fever	nn	26	SENT_162	[p11l229t2975r458b3057],
22	,	,	O	,	_	0	SENT_162	[p11l229t2975r458b3057],
23	rash	NN	O	rash	nn	26	SENT_162	[p11l491t2975r645b3043],
24	and	CC	O	and	_	0	SENT_162	[p11l677t2975r814b3043],
25	eosinophilia	NN	O	eosinophilia	nn	26	SENT_162	[p11l845t2975r1331b3063],
26	)	NN	O	)	tmod	13	SENT_162	[p11l845t2975r1331b3063],
27	and	CC	O	and	_	0	SENT_162	[p11l1369t2975r1507b3043],
28	DILI	NNP	ORGANIZATION	DILI	tmod	13	SENT_162	[p11l1537t2980r1732b3043],
29	.	.	O	.	_	0	SENT_162	[p11l1537t2980r1732b3043],

1	As	IN	O	as	mark	6	SENT_163	[p11l1764t2979r1855b3043],
2	TNF	NN	O	tnf	nn	4	SENT_163	[p11l1886t2977r2145b3043],
3	—	NN	O	—	nn	4	SENT_163	[p11l1886t2977r2145b3043],
4	oc	NN	O	oc	nsubjpass	6	SENT_163	[p11l1886t2977r2145b3043],
5	is	VBZ	O	be	auxpass	6	SENT_163	[p11l9t3080r63b3145],
6	involved	VBN	O	involve	advcl	16	SENT_163	[p11l109t3077r429b3145],
7	in	IN	O	in	_	0	SENT_163	[p11l475t3080r547b3144],
8	immune	JJ	O	immune	amod	11	SENT_163	[p11l592t3080r909b3145],
9	and	CC	O	and	_	0	SENT_163	[p11l955t3077r1093b3145],
10	inﬂammatory	JJ	O	inﬂammatory	amod	11	SENT_163	[p11l1138t3077r1657b3166],
11	response	NN	O	response	prep_in	6	SENT_163	[p11l1700t3101r2045b3165],
12	,	,	O	,	_	0	SENT_163	[p11l1700t3101r2045b3165],
13	it	PRP	O	it	nsubjpass	16	SENT_163	[p11l2093t3079r2144b3145],
14	can	MD	O	can	aux	16	SENT_163	[p11l10t3203r136b3247],
15	be	VB	O	be	auxpass	16	SENT_163	[p11l169t3178r254b3247],
16	speculated	VBN	O	speculate	_	0	SENT_163	[p11l290t3178r681b3268],
17	that	IN	O	that	complm	21	SENT_163	[p11l714t3178r862b3247],
18	TNF-OL	NN	O	tnf-ol	nsubjpass	21	SENT_163	[p11l895t3181r1153b3247],
19	is	VBZ	O	be	auxpass	21	SENT_163	[p11l1187t3181r1241b3247],
20	speciﬁcally	RB	O	speciﬁcally	advmod	21	SENT_163	[p11l1278t3178r1685b3268],
21	involved	VBN	O	involve	ccomp	16	SENT_163	[p11l1716t3178r2036b3247],
22	in	IN	O	in	prep	21	SENT_163	[p11l2071t3181r2144b3246],

1	Kim	NNP	PERSON	Kim	_	0	SENT_164	[p11l1843t3543r1956b3599],
2	et	FW	O	et	nn	3	SENT_164	[p11l1982t3550r2045b3600],
3	al.	FW	O	al.	dep	1	SENT_164	[p11l2071t3542r2135b3599],
4	.	.	O	.	_	0	SENT_164	[p11l2071t3542r2135b3599],

1	immunoallergic	JJ	O	immunoallergic	amod	2	SENT_165	[p12l9t92r605b181],
2	hepatitis	NN	O	hepatitis	_	0	SENT_165	[p12l674t92r1013b180],
3	.	.	O	.	_	0	SENT_165	[p12l674t92r1013b180],

1	In	IN	O	in	_	0	SENT_166	[p12l1088t97r1166b159],
2	the	DT	O	the	det	4	SENT_166	[p12l1235t92r1350b159],
3	present	JJ	DATE	present	amod	4	SENT_166	[p12l1419t105r1693b180],
4	study	NN	O	study	prep_in	11	SENT_166	[p12l1763t92r1984b181],
5	,	,	O	,	_	0	SENT_166	[p12l1763t92r1984b181],
6	14	CD	NUMBER	14	num	7	SENT_166	[p12l2064t99r2142b159],
7	patients	NNS	O	patient	nsubj	11	SENT_166	[p12l7t197r303b282],
8	of	IN	O	of	_	0	SENT_166	[p12l344t194r427b262],
9	77	CD	NUMBER	77	num	10	SENT_166	[p12l458t202r541b262],
10	cases	NNS	O	case	prep_of	7	SENT_166	[p12l584t219r763b262],
11	presented	VBD	O	present	_	0	SENT_166	[p12l804t194r1166b282],
12	one	CD	NUMBER	one	dobj	11	SENT_166	[p12l1208t219r1342b262],
13	or	CC	O	or	_	0	SENT_166	[p12l1383t219r1462b262],
14	more	JJR	O	more	conj_or	12	SENT_166	[p12l1501t219r1697b262],
15	of	IN	O	of	_	0	SENT_166	[p12l1738t194r1821b262],
16	the	DT	O	the	det	17	SENT_166	[p12l1849t194r1964b262],
17	features	NNS	O	feature	prep_of	12	SENT_166	[p12l2005t194r2139b262, p12l7t309r190b364],
18	of	IN	O	of	_	0	SENT_166	[p12l272t295r355b364],
19	hypersensitivity	NN	O	hypersensitivity	nn	20	SENT_166	[p12l422t295r1016b386],
20	reactions	NNS	O	reaction	prep_of	17	SENT_166	[p12l1092t298r1429b364],
21	and	CC	O	and	_	0	SENT_166	[p12l1511t295r1648b364],
22	4	CD	NUMBER	4	num	23	SENT_166	[p12l1727t303r1767b363],
23	patients	NNS	O	patient	prep_of	12	SENT_166	[p12l1847t298r2142b385],
24	(	IN	O	(	quantmod	25	SENT_166	[p12l14t399r306b481],
25	28.6	CD	PERCENT	28.6	num	26	SENT_166	[p12l14t399r306b481],
26	%	NN	PERCENT	%	dep	23	SENT_166	[p12l14t399r306b481],
27	)	CD	NUMBER	)	nsubj	28	SENT_166	[p12l14t399r306b481],
28	had	VBD	O	have	rcmod	12	SENT_166	[p12l345t399r484b467],
29	AA	NN	O	aa	dobj	28	SENT_166	[p12l514t403r637b466],
30	or	CC	O	or	_	0	SENT_166	[p12l669t423r749b467],
31	AG	NNP	O	AG	nn	32	SENT_166	[p12l779t403r904b468],
32	genotype	NN	O	genotype	dobj	28	SENT_166	[p12l938t412r1296b489],
33	.	.	O	.	_	0	SENT_166	[p12l938t412r1296b489],

1	While	IN	O	while	mark	12	SENT_167	[p12l1331t399r1557b467],
2	the	DT	O	the	det	3	SENT_167	[p12l1590t399r1705b467],
3	number	NN	O	number	nsubj	12	SENT_167	[p12l1740t399r2038b467],
4	of	IN	O	of	_	0	SENT_167	[p12l2071t398r2154b467],
5	the	DT	O	the	det	6	SENT_167	[p12l7t502r123b570],
6	patients	NNS	O	patient	prep_of	3	SENT_167	[p12l153t505r449b590],
7	with	IN	O	with	_	0	SENT_167	[p12l478t502r646b570],
8	immunoallergic	JJ	O	immunoallergic	amod	9	SENT_167	[p12l677t502r1274b591],
9	features	NNS	O	feature	prep_with	6	SENT_167	[p12l1305t502r1596b570],
10	was	VBD	O	be	cop	12	SENT_167	[p12l1625t527r1761b570],
11	too	RB	O	too	advmod	12	SENT_167	[p12l1792t516r1914b570],
12	small	JJ	O	small	advcl	29	SENT_167	[p12l1949t502r2144b570],
13	for	IN	O	for	_	0	SENT_167	[p12l9t603r116b672],
14	statistical	JJ	O	statistical	amod	15	SENT_167	[p12l165t603r512b672],
15	analysis	NN	O	analysis	prep_for	12	SENT_167	[p12l562t603r869b694],
16	,	,	O	,	_	0	SENT_167	[p12l562t603r869b694],
17	the	DT	O	the	det	20	SENT_167	[p12l919t603r1035b672],
18	genotype	NN	O	genotype	nn	20	SENT_167	[p12l1085t617r1423b694],
19	(	CD	NUMBER	(	num	20	SENT_167	[p12l1478t604r1628b686],
20	AA	NN	O	aa	nsubj	29	SENT_167	[p12l1478t604r1628b686],
21	or	CC	O	or	_	0	SENT_167	[p12l1676t628r1756b672],
22	AG	NNP	O	AG	nn	24	SENT_167	[p12l1802t604r1955b686],
23	)	CD	NUMBER	)	num	24	SENT_167	[p12l1802t604r1955b686],
24	frequencies	NNS	O	frequency	conj_or	20	SENT_167	[p12l2012t603r2139b672, p12l9t709r329b795],
25	in	IN	O	in	_	0	SENT_167	[p12l365t709r437b774],
26	overall	JJ	O	overall	amod	28	SENT_167	[p12l473t707r722b775],
27	ATD	NN	O	atd	nn	28	SENT_167	[p12l753t707r1279b775],
28	—	NN	O	—	prep_in	24	SENT_167	[p12l753t707r1279b775],
29	induced	VBD	O	induce	_	0	SENT_167	[p12l753t707r1279b775],
30	hepatitis	NN	O	hepatitis	dobj	29	SENT_167	[p12l1312t707r1632b795],
31	(	CD	PERCENT	(	number	32	SENT_167	[p12l1672t707r1964b789],
32	26.0	CD	PERCENT	26.0	num	33	SENT_167	[p12l1672t707r1964b789],
33	%	NN	PERCENT	%	nsubj	43	SENT_167	[p12l1672t707r1964b789],
34	)	CD	NUMBER	)	dep	33	SENT_167	[p12l1672t707r1964b789],
35	and	CC	O	and	_	0	SENT_167	[p12l2006t707r2143b775],
36	immunoallergic	JJ	O	immunoallergic	amod	37	SENT_167	[p12l9t809r605b898],
37	hepatitis	NN	O	hepatitis	nsubj	43	SENT_167	[p12l637t809r956b897],
38	(	CD	PERCENT	(	number	39	SENT_167	[p12l995t809r1287b891],
39	28.6	CD	PERCENT	28.6	num	40	SENT_167	[p12l995t809r1287b891],
40	%	NN	PERCENT	%	dep	37	SENT_167	[p12l995t809r1287b891],
41	)	CD	NUMBER	)	dep	37	SENT_167	[p12l995t809r1287b891],
42	appear	VBP	O	appear	cop	43	SENT_167	[p12l1327t833r1579b897],
43	similar	JJ	O	similar	rcmod	30	SENT_167	[p12l1612t809r1886b877],
44	.	.	O	.	_	0	SENT_167	[p12l1612t809r1886b877],

1	Given	VBN	O	give	prep	8	SENT_168	[p12l1924t812r2143b877],
2	these	DT	O	these	det	3	SENT_168	[p12l7t910r195b978],
3	result	NN	O	result	dep	1	SENT_168	[p12l249t910r475b989],
4	,	,	O	,	_	0	SENT_168	[p12l249t910r475b989],
5	it	PRP	O	it	nsubj	21	SENT_168	[p12l532t913r583b978],
6	can	MD	O	can	aux	8	SENT_168	[p12l637t935r763b978],
7	be	VB	O	be	aux	8	SENT_168	[p12l815t910r900b978],
8	speculated	VBN	O	speculate	_	0	SENT_168	[p12l954t910r1346b999],
9	that	IN	O	that	complm	14	SENT_168	[p12l1399t910r1546b978],
10	TNF-OL	NN	O	tnf-ol	nsubjpass	14	SENT_168	[p12l1598t913r1857b978],
11	is	VBZ	O	be	auxpass	14	SENT_168	[p12l1909t913r1963b978],
12	not	RB	O	not	neg	14	SENT_168	[p12l2018t924r2143b978],
13	directly	RB	O	directly	advmod	14	SENT_168	[p12l9t1013r291b1102],
14	involved	VBN	O	involve	ccomp	8	SENT_168	[p12l321t1013r641b1081],
15	in	IN	O	in	_	0	SENT_168	[p12l674t1015r746b1080],
16	hypersensitivity	NN	O	hypersensitivity	nn	17	SENT_168	[p12l778t1013r1371b1102],
17	reaction	NN	O	reaction	prep_in	14	SENT_168	[p12l1401t1015r1726b1091],
18	,	,	O	,	_	0	SENT_168	[p12l1401t1015r1726b1091],
19	but	CC	O	but	_	0	SENT_168	[p12l1759t1013r1886b1081],
20	rather	RB	O	rather	_	0	SENT_168	[p12l1919t1013r2144b1081],
21	associated	VBN	O	associate	conj_negcc	8	SENT_168	[p12l9t1114r386b1183],
22	with	IN	O	with	_	0	SENT_168	[p12l419t1114r586b1183],
23	immune	JJ	O	immune	amod	24	SENT_168	[p12l622t1117r939b1183],
24	response	NN	O	response	prep_with	21	SENT_168	[p12l975t1139r1300b1204],
25	other	JJ	O	other	amod	24	SENT_168	[p12l1337t1114r1535b1183],
26	than	IN	O	than	_	0	SENT_168	[p12l1569t1114r1738b1183],
27	hypersensitivity	NN	O	hypersensitivity	nn	28	SENT_168	[p12l1772t1114r2139b1205, p12l9t1220r262b1307],
28	reactions	NNS	O	reaction	prep_than	8	SENT_168	[p12l286t1220r642b1285],
29	.	.	O	.	_	0	SENT_168	[p12l286t1220r642b1285],

1	Our	PRP$	O	we	poss	2	SENT_169	[p12l113t1324r265b1389],
2	results	NNS	O	result	nsubj	3	SENT_169	[p12l302t1320r541b1388],
3	add	VBP	O	add	_	0	SENT_169	[p12l582t1320r718b1388],
4	to	TO	O	to	_	0	SENT_169	[p12l755t1333r829b1388],
5	a	DT	O	a	det	7	SENT_169	[p12l870t1344r907b1388],
6	growing	VBG	O	grow	amod	7	SENT_169	[p12l945t1322r1252b1410],
7	body	NN	O	body	prep_to	3	SENT_169	[p12l1287t1320r1478b1410],
8	of	IN	O	of	_	0	SENT_169	[p12l1514t1320r1596b1388],
9	evidence	NN	O	evidence	prep_of	7	SENT_169	[p12l1625t1320r1946b1388],
10	suggesting	VBG	O	suggest	partmod	9	SENT_169	[p12l1986t1344r2139b1410, p12l9t1425r271b1512],
11	the	DT	O	the	det	12	SENT_169	[p12l298t1423r414b1491],
12	role	NN	O	role	dobj	10	SENT_169	[p12l445t1423r586b1491],
13	of	IN	O	of	_	0	SENT_169	[p12l617t1423r699b1491],
14	cytokine	NN	O	cytokine	nn	16	SENT_169	[p12l720t1423r1035b1512],
15	gene	NN	O	gene	nn	16	SENT_169	[p12l1067t1447r1234b1512],
16	polymorphisms	NNS	O	polymorphism	prep_of	12	SENT_169	[p12l1264t1423r1855b1512],
17	in	IN	O	in	_	0	SENT_169	[p12l1887t1425r1959b1490],
18	predisposing	VBG	O	predispose	prepc_in	10	SENT_169	[p12l1988t1446r2139b1511, p12l9t1525r366b1614],
19	patients	NNS	O	patient	dobj	18	SENT_169	[p12l427t1527r722b1613],
20	to	TO	O	to	_	0	SENT_169	[p12l785t1538r858b1593],
21	DILI	NNP	ORGANIZATION	DILI	prep_to	18	SENT_169	[p12l924t1530r1120b1593],
22	.	.	O	.	_	0	SENT_169	[p12l924t1530r1120b1593],

1	To	TO	O	to	_	0	SENT_170	[p12l1186t1528r1286b1592],
2	date	NN	O	date	prep_to	9	SENT_170	[p12l1352t1525r1527b1603],
3	,	,	O	,	_	0	SENT_170	[p12l1352t1525r1527b1603],
4	the	DT	O	the	det	6	SENT_170	[p12l1592t1525r1707b1593],
5	prevailing	VBG	O	prevail	amod	6	SENT_170	[p12l1770t1525r2143b1614],
6	theory	NN	O	theory	nsubj	9	SENT_170	[p12l7t1627r252b1717],
7	of	IN	O	of	_	0	SENT_170	[p12l277t1626r359b1695],
8	DILI	NNP	ORGANIZATION	DILI	prep_of	6	SENT_170	[p12l376t1632r552b1694],
9	holds	VBZ	O	hold	_	0	SENT_170	[p12l580t1627r782b1695],
10	that	IN	O	that	complm	20	SENT_170	[p12l809t1627r957b1695],
11	reactive	JJ	O	reactive	amod	12	SENT_170	[p12l985t1629r1270b1695],
12	metabolites	NNS	O	metabolite	nsubj	20	SENT_170	[p12l1298t1627r1750b1706],
13	,	,	O	,	_	0	SENT_170	[p12l1298t1627r1750b1706],
14	generated	VBN	O	generate	partmod	12	SENT_170	[p12l1781t1627r2143b1717],
15	by	IN	O	by	_	0	SENT_170	[p12l6t1730r98b1819],
16	drug	NN	O	drug	nn	18	SENT_170	[p12l128t1730r303b1819],
17	metabolizing	VBG	O	metabolize	amod	18	SENT_170	[p12l335t1730r823b1819],
18	enzymes	NNS	O	enzyme	agent	14	SENT_170	[p12l856t1753r1192b1819],
19	,	,	O	,	_	0	SENT_170	[p12l856t1753r1192b1819],
20	lead	VBP	O	lead	ccomp	9	SENT_170	[p12l1227t1730r1378b1798],
21	to	TO	O	to	aux	22	SENT_170	[p12l1410t1743r1483b1798],
22	direct	VB	O	direct	xcomp	20	SENT_170	[p12l1519t1730r1732b1798],
23	toxic	JJ	O	toxic	amod	25	SENT_170	[p12l1763t1732r1949b1798],
24	liver	NN	O	liver	nn	25	SENT_170	[p12l1980t1730r2144b1798],
25	injury	NN	O	injury	dobj	22	SENT_170	[p12l9t1834r236b1921],
26	or	CC	O	or	_	0	SENT_170	[p12l262t1856r341b1899],
27	immune	JJ	O	immune	amod	28	SENT_170	[p12l369t1832r1073b1900],
28	—	NN	O	—	conj_or	25	SENT_170	[p12l369t1832r1073b1900],
29	mediated	VBN	O	mediate	partmod	25	SENT_170	[p12l369t1832r1073b1900],
30	reactions	NNS	O	reaction	dobj	29	SENT_170	[p12l1103t1834r1440b1900],
31	to	TO	O	to	aux	32	SENT_170	[p12l1468t1845r1542b1900],
32	hapten	VB	O	hapten	infmod	30	SENT_170	[p12l1572t1832r2142b1920],
33	—	NN	O	—	nn	35	SENT_170	[p12l1572t1832r2142b1920],
34	protein	NN	O	protein	nn	35	SENT_170	[p12l1572t1832r2142b1920],
35	conjugates	NNS	O	conjugate	dobj	32	SENT_170	[p12l9t1936r424b2023],
36	,	,	O	,	_	0	SENT_170	[p12l9t1936r424b2023],
37	culminating	VBG	O	culminate	partmod	29	SENT_170	[p12l472t1934r926b2023],
38	in	IN	O	in	_	0	SENT_170	[p12l970t1936r1043b2001],
39	hepatic	JJ	O	hepatic	amod	43	SENT_170	[p12l1086t1934r1358b2022],
40	inﬂammation	NN	O	inﬂammation	nn	43	SENT_170	[p12l1402t1934r1919b2002],
41	(	NN	O	(	nn	43	SENT_170	[p12l1969t1934r2139b2016],
42	32	CD	NUMBER	32	num	43	SENT_170	[p12l1969t1934r2139b2016],
43	)	NN	O	)	prep_in	37	SENT_170	[p12l1969t1934r2139b2016],
44	.	.	O	.	_	0	SENT_170	[p12l1969t1934r2139b2016],

1	Based	VBN	O	base	_	0	SENT_171	[p12l9t2036r223b2104],
2	on	IN	O	on	prepc_based_on	11	SENT_171	[p12l262t2060r357b2104],
3	these	DT	O	these	det	4	SENT_171	[p12l394t2036r581b2104],
4	hypotheses	NNS	O	hypothesis	pobj	11	SENT_171	[p12l619t2036r1052b2125],
5	,	,	O	,	_	0	SENT_171	[p12l619t2036r1052b2125],
6	pharmacogenetic	JJ	O	pharmacogenetic	amod	7	SENT_171	[p12l1091t2036r1737b2125],
7	studies	NNS	O	study	nsubj	11	SENT_171	[p12l1776t2036r2031b2104],
8	of	IN	O	of	_	0	SENT_171	[p12l2071t2036r2154b2104],
9	DILI	NNP	ORGANIZATION	DILI	prep_of	7	SENT_171	[p12l8t2143r184b2205],
10	have	VBP	O	have	aux	11	SENT_171	[p12l222t2138r392b2206],
11	focused	VBN	O	focus	_	0	SENT_171	[p12l430t2138r716b2207],
12	on	IN	O	on	_	0	SENT_171	[p12l753t2162r848b2206],
13	genes	NNS	O	gene	prep_on	11	SENT_171	[p12l886t2162r1087b2228],
14	related	VBN	O	relate	partmod	13	SENT_171	[p12l1125t2138r1378b2207],
15	with	IN	O	with	_	0	SENT_171	[p12l1412t2138r1579b2206],
16	drug	NN	O	drug	prep_with	14	SENT_171	[p12l1617t2138r1792b2228],
17	metabolizing	VBG	O	metabolize	partmod	16	SENT_171	[p12l1828t2138r2139b2206, p12l7t2241r212b2330],
18	enzymes	NNS	O	enzyme	dobj	17	SENT_171	[p12l265t2264r579b2330],
19	to	TO	O	to	aux	20	SENT_171	[p12l633t2254r707b2309],
20	identify	VB	O	identify	xcomp	17	SENT_171	[p12l762t2241r1052b2330],
21	genetic	JJ	O	genetic	amod	22	SENT_171	[p12l1101t2243r1364b2330],
22	variants	NNS	O	variant	dobj	20	SENT_171	[p12l1415t2243r1712b2309],
23	associated	VBN	O	associate	partmod	22	SENT_171	[p12l1766t2241r2143b2309],
24	with	IN	O	with	_	0	SENT_171	[p12l6t2343r173b2411],
25	the	DT	O	the	det	27	SENT_171	[p12l211t2343r326b2411],
26	increased	VBN	O	increase	amod	27	SENT_171	[p12l366t2343r716b2411],
27	risk	NN	O	risk	prep_with	23	SENT_171	[p12l755t2343r892b2411],
28	of	IN	O	of	_	0	SENT_171	[p12l930t2343r1012b2411],
29	DILI	NNP	O	DILI	prep_of	27	SENT_171	[p12l1041t2348r1217b2410],
30	(	CD	NUMBER	(	num	29	SENT_171	[p12l1263t2343r1433b2425],
31	33	CD	NUMBER	33	num	32	SENT_171	[p12l1263t2343r1433b2425],
32	)	NN	O	)	dep	29	SENT_171	[p12l1263t2343r1433b2425],
33	.	.	O	.	_	0	SENT_171	[p12l1263t2343r1433b2425],

1	Contrary	JJ	O	contrary	_	0	SENT_172	[p12l1477t2347r1819b2432],
2	to	TO	O	to	_	0	SENT_172	[p12l1853t2356r1927b2411],
3	drug	NN	O	drug	prep_contrary_to	4	SENT_172	[p12l1969t2343r2144b2432],
4	metabolizing	VBG	O	metabolize	dep	13	SENT_172	[p12l8t2445r496b2535],
5	enzyme	NN	O	enzyme	nn	6	SENT_172	[p12l552t2469r833b2535],
6	genes	NNS	O	gene	dobj	4	SENT_172	[p12l890t2469r1111b2535],
7	,	,	O	,	_	0	SENT_172	[p12l890t2469r1111b2535],
8	only	RB	O	only	advmod	11	SENT_172	[p12l1170t2445r1334b2535],
9	a	DT	O	a	det	11	SENT_172	[p12l1387t2469r1424b2513],
10	few	JJ	O	few	amod	11	SENT_172	[p12l1479t2445r1608b2513],
11	studies	NNS	O	study	nsubj	13	SENT_172	[p12l1661t2445r1917b2513],
12	have	VBP	O	have	aux	13	SENT_172	[p12l1973t2445r2143b2513],
13	analysed	VBN	O	analyse	_	0	SENT_172	[p12l9t2548r327b2637],
14	cytokine	NN	O	cytokine	nn	15	SENT_172	[p12l366t2548r682b2637],
15	genes	NNS	O	gene	dobj	13	SENT_172	[p12l722t2572r923b2637],
16	for	IN	O	for	_	0	SENT_172	[p12l963t2548r1071b2616],
17	their	PRP$	O	they	poss	18	SENT_172	[p12l1108t2548r1284b2616],
18	inﬂuence	NN	O	inﬂuence	prep_for	15	SENT_172	[p12l1323t2548r1666b2616],
19	on	IN	O	on	_	0	SENT_172	[p12l1707t2572r1802b2616],
20	the	DT	O	the	det	21	SENT_172	[p12l1840t2548r1955b2616],
21	susceptibility	NN	O	susceptibility	prep_on	13	SENT_172	[p12l1995t2572r2139b2616, p12l9t2650r386b2739],
22	to	TO	O	to	_	0	SENT_172	[p12l424t2663r497b2718],
23	DILI	NNP	ORGANIZATION	DILI	prep_to	13	SENT_172	[p12l542t2655r738b2718],
24	.	.	O	.	_	0	SENT_172	[p12l542t2655r738b2718],

1	A	DT	O	a	det	3	SENT_173	[p12l782t2654r844b2717],
2	signiﬁcant	JJ	O	signiﬁcant	amod	3	SENT_173	[p12l886t2650r1274b2739],
3	contribution	NN	O	contribution	nsubj	10	SENT_173	[p12l1316t2650r1793b2718],
4	of	IN	O	of	_	0	SENT_173	[p12l1838t2650r1920b2718],
5	cytokine	NN	O	cytokine	nn	6	SENT_173	[p12l1954t2663r2138b2739, p12l7t2752r166b2820],
6	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_173	[p12l193t2752r784b2841],
7	to	TO	O	to	_	0	SENT_173	[p12l812t2766r885b2820],
8	DILI	NNP	ORGANIZATION	DILI	prep_to	6	SENT_173	[p12l916t2757r1091b2819],
9	was	VBD	O	be	cop	10	SENT_173	[p12l1118t2777r1253b2820],
10	ﬁrst	JJ	O	ﬁrst	_	0	SENT_173	[p12l1282t2752r1428b2820],
11	identiﬁed	VBN	O	identiﬁed	csubj	20	SENT_173	[p12l1456t2752r1814b2820],
12	in	IN	O	in	_	0	SENT_173	[p12l1841t2754r1913b2819],
13	IL-10	NN	O	il-10	nn	16	SENT_173	[p12l1942t2757r2141b2820],
14	and	CC	O	and	_	0	SENT_173	[p12l9t2854r147b2922],
15	IL-4	NN	O	il-4	nn	16	SENT_173	[p12l180t2859r335b2921],
16	polymorphisms	NNS	O	polymorphism	prep_in	11	SENT_173	[p12l368t2854r959b2943],
17	in	IN	O	in	_	0	SENT_173	[p12l994t2856r1066b2921],
18	diclofenac	NN	O	diclofenac	nn	19	SENT_173	[p12l1100t2854r1821b2922],
19	—	NN	O	—	prep_in	16	SENT_173	[p12l1100t2854r1821b2922],
20	induced	VBD	O	induce	ccomp	10	SENT_173	[p12l1100t2854r1821b2922],
21	hepato	NN	O	hepato	nn	23	SENT_173	[p12l1853t2854r2139b2942],
22	—	NN	O	—	nn	23	SENT_173	[p12l1853t2854r2139b2942],
23	toxicity	NN	O	toxicity	dobj	20	SENT_173	[p12l7t2958r307b3045],
24	.	.	O	.	_	0	SENT_173	[p12l7t2958r307b3045],

1	These	DT	O	these	det	2	SENT_174	[p12l354t2956r570b3024],
2	results	NNS	O	result	nsubj	3	SENT_174	[p12l614t2956r852b3024],
3	suggested	VBD	O	suggest	_	0	SENT_174	[p12l899t2956r1256b3045],
4	the	DT	O	the	det	6	SENT_174	[p12l1298t2956r1413b3024],
5	important	JJ	O	important	amod	6	SENT_174	[p12l1458t2958r1842b3044],
6	role	NN	O	role	dobj	3	SENT_174	[p12l1885t2956r2026b3024],
7	of	IN	O	of	_	0	SENT_174	[p12l2071t2956r2154b3024],
8	an	DT	O	a	det	11	SENT_174	[p12l9t3083r97b3126],
9	adaptive	JJ	O	adaptive	amod	11	SENT_174	[p12l134t3058r449b3146],
10	immune	JJ	O	immune	amod	11	SENT_174	[p12l485t3060r801b3126],
11	response	NN	O	response	prep_of	6	SENT_174	[p12l839t3082r1164b3146],
12	in	IN	O	in	_	0	SENT_174	[p12l1200t3061r1273b3125],
13	DILI	NNP	LOCATION	DILI	prep_in	3	SENT_174	[p12l1310t3063r1485b3125],
14	(	CD	NUMBER	(	num	13	SENT_174	[p12l1528t3058r1698b3140],
15	34	CD	NUMBER	34	num	16	SENT_174	[p12l1528t3058r1698b3140],
16	)	NN	O	)	dep	13	SENT_174	[p12l1528t3058r1698b3140],
17	.	.	O	.	_	0	SENT_174	[p12l1528t3058r1698b3140],

1	In	IN	O	in	_	0	SENT_175	[p12l1738t3063r1817b3125],
2	tacrine	NN	O	tacrine	nn	3	SENT_175	[p12l1852t3060r2138b3126],
3	—	NN	O	—	prep_in	10	SENT_175	[p12l1852t3060r2138b3126],
4	induced	VBD	O	induce	partmod	3	SENT_175	[p12l9t3160r311b3228],
5	hepatotoxicity	NN	O	hepatotoxicity	dobj	4	SENT_175	[p12l397t3160r957b3249],
6	,	,	O	,	_	0	SENT_175	[p12l397t3160r957b3249],
7	IL-6	NN	O	il-6	nn	8	SENT_175	[p12l1048t3165r1202b3228],
8	polymorphisms	NNS	O	polymorphism	nsubjpass	10	SENT_175	[p12l1290t3160r1881b3249],
9	were	VBD	O	be	auxpass	10	SENT_175	[p12l1968t3184r2143b3228],
10	found	VBN	O	find	_	0	SENT_175	[p12l8t3262r233b3330],
11	to	TO	O	to	aux	12	SENT_175	[p12l268t3275r341b3330],
12	increase	VB	O	increase	xcomp	10	SENT_175	[p12l381t3264r678b3330],
13	the	DT	O	the	det	14	SENT_175	[p12l715t3262r830b3330],
14	risk	NN	O	risk	dobj	12	SENT_175	[p12l867t3262r1006b3330],
15	by	IN	O	by	_	0	SENT_175	[p12l1037t3262r1129b3351],
16	inﬂuencing	VBG	O	inﬂuencing	prepc_by	12	SENT_175	[p12l1162t3262r1587b3351],
17	the	DT	O	the	det	18	SENT_175	[p12l1622t3262r1737b3330],
18	transcription	NN	O	transcription	dobj	16	SENT_175	[p12l1773t3264r2139b3350, p12l7t3366r159b3432],
19	of	IN	O	of	_	0	SENT_175	[p12l215t3364r297b3432],
20	IL-6	NN	O	il-6	prep_of	18	SENT_175	[p12l342t3369r496b3432],
21	(	CD	NUMBER	(	num	20	SENT_175	[p12l558t3364r728b3446],
22	35	CD	NUMBER	35	num	23	SENT_175	[p12l558t3364r728b3446],
23	)	NN	O	)	dep	20	SENT_175	[p12l558t3364r728b3446],
24	.	.	O	.	_	0	SENT_175	[p12l558t3364r728b3446],

1	Regarding	VBG	O	regard	_	0	SENT_176	[p12l787t3364r1170b3453],
2	ATD	NN	O	atd	nn	3	SENT_176	[p12l1221t3364r1747b3432],
3	—	NN	O	—	prep_regarding	4	SENT_176	[p12l1221t3364r1747b3432],
4	induced	VBD	O	induce	_	0	SENT_176	[p12l1221t3364r1747b3432],
5	hepatitis	NN	O	hepatitis	nsubj	4	SENT_176	[p12l1800t3364r2140b3452],
6	,	,	O	,	_	0	SENT_176	[p12l1800t3364r2140b3452],
7	some	DT	O	some	det	9	SENT_176	[p12l9t3490r203b3534],
8	genetic	JJ	O	genetic	amod	9	SENT_176	[p12l241t3468r504b3555],
9	polymorphisms	NNS	O	polymorphism	appos	5	SENT_176	[p12l540t3466r1131b3555],
10	have	VBP	O	have	aux	12	SENT_176	[p12l1169t3466r1339b3534],
11	been	VBN	O	be	auxpass	12	SENT_176	[p12l1375t3466r1551b3534],
12	reported	VBN	O	report	rcmod	9	SENT_176	[p12l1589t3466r1911b3554],
13	to	TO	O	to	aux	15	SENT_176	[p12l1947t3479r2020b3534],
14	be	VB	O	be	auxpass	15	SENT_176	[p12l2058t3466r2143b3534],
15	associated	VBN	O	associate	xcomp	12	SENT_176	[p12l9t3568r386b3636],
16	with	IN	O	with	_	0	SENT_176	[p12l451t3568r619b3636],
17	various	JJ	O	various	amod	18	SENT_176	[p12l684t3570r959b3636],
18	drug	NN	O	drug	prep_with	15	SENT_176	[p12l1029t3568r1204b3657],
19	metabolizing	VBG	O	metabolize	partmod	18	SENT_176	[p12l1271t3568r1759b3657],
20	enzymes	NNS	O	enzyme	nn	21	SENT_176	[p12l1827t3592r2143b3657],
21	genes	NNS	O	gene	dobj	19	SENT_176	[p12l9t3695r228b3759],
22	:	:	O	:	_	0	SENT_176	[p12l9t3695r228b3759],
23	NAT2	NN	O	nat2	dep	18	SENT_176	[p12l275t3673r502b3738],
24	(	CD	NUMBER	(	number	25	SENT_176	[p12l554t3670r645b3752],
25	5	CD	NUMBER	5	dep	23	SENT_176	[p12l554t3670r645b3752],
26	,	,	O	,	_	0	SENT_176	[p12l554t3670r645b3752],
27	6	CD	NUMBER	6	num	28	SENT_176	[p12l692t3670r787b3752],
28	)	NN	O	)	appos	18	SENT_176	[p12l692t3670r787b3752],
29	,	,	O	,	_	0	SENT_176	[p12l692t3670r787b3752],
30	CYP2E1	NN	O	cyp2e1	nn	31	SENT_176	[p12l834t3674r1135b3738],
31	(	NN	O	(	appos	18	SENT_176	[p12l1191t3670r1317b3752],
32	7	CD	NUMBER	7	num	33	SENT_176	[p12l1191t3670r1317b3752],
33	)	NN	O	)	dep	31	SENT_176	[p12l1191t3670r1317b3752],
34	,	,	O	,	_	0	SENT_176	[p12l1191t3670r1317b3752],
35	GSTM1	NN	O	gstm1	appos	18	SENT_176	[p12l1364t3673r1648b3738],
36	(	CD	NUMBER	(	number	37	SENT_176	[p12l1705t3670r1831b3752],
37	8	CD	NUMBER	8	num	38	SENT_176	[p12l1705t3670r1831b3752],
38	)	NN	O	)	dep	35	SENT_176	[p12l1705t3670r1831b3752],
39	,	,	O	,	_	0	SENT_176	[p12l1705t3670r1831b3752],
40	GSTT1	NN	O	gstt1	appos	9	SENT_176	[p12l1879t3673r2135b3738],

1	(	NN	O	(	_	0	SENT_177	[p13l14t13r113b95],
2	9	CD	NUMBER	9	num	1	SENT_177	[p13l14t13r113b95],
3	)	NN	O	)	dep	1	SENT_177	[p13l14t13r113b95],
4	and	CC	O	and	_	0	SENT_177	[p13l166t12r304b81],
5	MnSOD	NN	O	mnsod	dep	1	SENT_177	[p13l349t16r662b81],
6	(	CD	NUMBER	(	number	7	SENT_177	[p13l715t12r886b95],
7	10	CD	NUMBER	10	num	8	SENT_177	[p13l715t12r886b95],
8	)	NN	O	)	dep	3	SENT_177	[p13l715t12r886b95],
9	.	.	O	.	_	0	SENT_177	[p13l715t12r886b95],

1	However	RB	O	however	advmod	15	SENT_178	[p13l936t18r1293b92],
2	,	,	O	,	_	0	SENT_178	[p13l936t18r1293b92],
3	most	JJS	O	most	nsubjpass	15	SENT_178	[p13l1340t26r1526b81],
4	of	IN	O	of	_	0	SENT_178	[p13l1573t12r1655b81],
5	the	DT	O	the	det	6	SENT_178	[p13l1688t12r1803b81],
6	associations	NNS	O	association	prep_of	3	SENT_178	[p13l1851t15r2139b81, p13l7t118r192b184],
7	of	IN	O	of	_	0	SENT_178	[p13l222t116r305b184],
8	the	DT	O	the	det	11	SENT_178	[p13l322t116r437b184],
9	reported	VBN	O	report	amod	11	SENT_178	[p13l468t116r788b204],
10	genetic	JJ	O	genetic	amod	11	SENT_178	[p13l818t118r1080b205],
11	variants	NNS	O	variant	prep_of	6	SENT_178	[p13l1106t118r1404b184],
12	have	VBP	O	have	aux	15	SENT_178	[p13l1432t116r1603b184],
13	not	RB	O	not	neg	15	SENT_178	[p13l1632t129r1758b184],
14	been	VBN	O	be	auxpass	15	SENT_178	[p13l1784t116r1960b184],
15	replicated	VBN	O	replicate	_	0	SENT_178	[p13l1990t140r2139b204, p13l7t218r253b286],
16	in	IN	O	in	_	0	SENT_178	[p13l283t221r356b285],
17	the	DT	O	the	det	19	SENT_178	[p13l385t218r500b286],
18	various	JJ	O	various	amod	19	SENT_178	[p13l528t220r804b286],
19	populations	NNS	O	population	prep_in	15	SENT_178	[p13l834t218r1304b306],
20	,	,	O	,	_	0	SENT_178	[p13l834t218r1304b306],
21	with	IN	O	with	_	0	SENT_178	[p13l1334t218r1501b286],
22	the	DT	O	the	det	23	SENT_178	[p13l1531t218r1646b286],
23	exception	NN	O	exception	prep_with	15	SENT_178	[p13l1678t220r2040b306],
24	of	IN	O	of	_	0	SENT_178	[p13l2071t218r2154b286],
25	NAT2	NN	O	nat2	nn	26	SENT_178	[p13l7t322r234b387],
26	polymorphisms	NNS	O	polymorphism	prep_of	23	SENT_178	[p13l283t319r893b410],
27	.	.	O	.	_	0	SENT_178	[p13l283t319r893b410],

1	We	PRP	O	we	nsubj	2	SENT_179	[p13l941t325r1068b388],
2	revealed	VBD	O	reveal	_	0	SENT_179	[p13l1116t319r1421b388],
3	for	IN	O	for	_	0	SENT_179	[p13l1469t319r1576b388],
4	the	DT	O	the	det	6	SENT_179	[p13l1621t319r1736b388],
5	ﬁrst	JJ	O	ﬁrst	amod	6	SENT_179	[p13l1784t319r1929b388],
6	time	NN	O	time	prep_for	2	SENT_179	[p13l1974t322r2143b388],
7	that	WDT	O	that	dobj	20	SENT_179	[p13l7t423r155b491],
8	TNF	NN	O	tnf	nn	11	SENT_179	[p13l215t426r473b491],
9	—	NN	O	—	nn	11	SENT_179	[p13l215t426r473b491],
10	oc	NN	O	oc	nn	11	SENT_179	[p13l215t426r473b491],
11	—	NN	O	—	nsubj	20	SENT_179	[p13l539t427r896b494],
12	308G/A	CD	NUMBER	308g/a	num	13	SENT_179	[p13l539t427r896b494],
13	polymorphism	NN	O	polymorphism	nsubjpass	16	SENT_179	[p13l954t423r1513b512],
14	is	VBZ	O	be	auxpass	16	SENT_179	[p13l1574t425r1628b491],
15	signiﬁcantly	RB	O	signiﬁcantly	advmod	16	SENT_179	[p13l1691t423r2147b512],
16	associated	VBN	O	associate	rcmod	11	SENT_179	[p13l9t525r386b593],
17	with	IN	O	with	_	0	SENT_179	[p13l438t525r605b593],
18	ATD	NN	O	atd	nn	19	SENT_179	[p13l657t525r1183b593],
19	—	NN	O	—	prep_with	16	SENT_179	[p13l657t525r1183b593],
20	induced	VBD	O	induce	ccomp	2	SENT_179	[p13l657t525r1183b593],
21	hepatitis	NN	O	hepatitis	dobj	20	SENT_179	[p13l1236t525r1576b613],
22	.	.	O	.	_	0	SENT_179	[p13l1236t525r1576b613],

1	Our	PRP$	O	we	poss	2	SENT_180	[p13l1636t529r1788b593],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_180	[p13l1841t525r2143b614],
3	suggest	VBP	O	suggest	dep	17	SENT_180	[p13l9t640r278b717],
4	an	DT	O	a	det	6	SENT_180	[p13l327t651r414b695],
5	important	JJ	O	important	amod	6	SENT_180	[p13l463t629r847b716],
6	role	NN	O	role	dobj	3	SENT_180	[p13l895t626r1036b695],
7	for	IN	O	for	_	0	SENT_180	[p13l1086t626r1193b695],
8	the	DT	O	the	det	10	SENT_180	[p13l1240t626r1355b695],
9	immune	JJ	O	immune	amod	10	SENT_180	[p13l1405t629r1722b695],
10	system	NN	O	system	prep_for	6	SENT_180	[p13l1771t640r2022b717],
11	in	IN	O	in	_	0	SENT_180	[p13l2071t629r2143b694],
12	determining	VBG	O	determine	prepc_in	3	SENT_180	[p13l9t730r471b819],
13	susceptibility	NN	O	susceptibility	dobj	12	SENT_180	[p13l532t730r1026b819],
14	of	IN	O	of	_	0	SENT_180	[p13l1084t730r1167b798],
15	ATD	NN	O	atd	nn	16	SENT_180	[p13l1214t730r1740b798],
16	—	NN	O	—	prep_of	13	SENT_180	[p13l1214t730r1740b798],
17	induced	VBD	O	induce	_	0	SENT_180	[p13l1214t730r1740b798],
18	hepatitis	NN	O	hepatitis	nsubj	17	SENT_180	[p13l1800t730r2140b818],
19	,	,	O	,	_	0	SENT_180	[p13l1800t730r2140b818],
20	separate	JJ	O	separate	appos	18	SENT_180	[p13l9t846r312b920],
21	from	IN	O	from	_	0	SENT_180	[p13l340t832r524b900],
22	drug	NN	O	drug	nn	23	SENT_180	[p13l553t832r727b921],
23	metabolism	NN	O	metabolism	prep_from	20	SENT_180	[p13l754t832r1212b900],
24	.	.	O	.	_	0	SENT_180	[p13l754t832r1212b900],

1	The	DT	O	the	det	2	SENT_181	[p13l111t933r253b1002],
2	HLA	NN	O	hlum	nsubjpass	5	SENT_181	[p13l287t938r467b1001],
3	has	VBZ	O	have	aux	5	SENT_181	[p13l497t933r617b1002],
4	been	VBN	O	be	auxpass	5	SENT_181	[p13l649t933r824b1002],
5	suggested	VBN	O	suggest	_	0	SENT_181	[p13l858t933r1215b1024],
6	to	TO	O	to	aux	7	SENT_181	[p13l1247t947r1320b1002],
7	play	VB	O	play	xcomp	5	SENT_181	[p13l1354t933r1511b1024],
8	a	DT	O	a	det	10	SENT_181	[p13l1540t958r1578b1002],
9	critical	JJ	O	critical	amod	10	SENT_181	[p13l1611t933r1863b1002],
10	role	NN	O	role	dobj	7	SENT_181	[p13l1896t933r2038b1002],
11	in	IN	O	in	_	0	SENT_181	[p13l2071t936r2143b1001],
12	the	DT	O	the	det	13	SENT_181	[p13l7t1037r121b1105],
13	development	NN	O	development	prep_in	7	SENT_181	[p13l150t1037r628b1125],
14	of	IN	O	of	_	0	SENT_181	[p13l655t1037r737b1105],
15	drug	NN	O	drug	nn	16	SENT_181	[p13l755t1037r927b1126],
16	hypersensitivity	NN	O	hypersensitivity	prep_of	13	SENT_181	[p13l952t1037r1533b1126],
17	(	CD	NUMBER	(	number	18	SENT_181	[p13l1561t1037r1728b1119],
18	36	CD	NUMBER	36	num	19	SENT_181	[p13l1561t1037r1728b1119],
19	)	NN	O	)	dep	16	SENT_181	[p13l1561t1037r1728b1119],
20	.	.	O	.	_	0	SENT_181	[p13l1561t1037r1728b1119],

1	Moreover	RB	O	moreover	advmod	10	SENT_182	[p13l1759t1042r2141b1116],
2	,	,	O	,	_	0	SENT_182	[p13l1759t1042r2141b1116],
3	application	NN	O	application	nsubj	10	SENT_182	[p13l9t1139r430b1227],
4	of	IN	O	of	_	0	SENT_182	[p13l458t1139r540b1207],
5	genome	NN	O	genome	npadvmod	7	SENT_182	[p13l556t1139r1063b1228],
6	—	CD	NUMBER	—	num	5	SENT_182	[p13l556t1139r1063b1228],
7	wide	JJ	O	wide	amod	9	SENT_182	[p13l556t1139r1063b1228],
8	association	NN	O	association	nn	9	SENT_182	[p13l1091t1142r1504b1207],
9	studies	NNS	O	study	prep_of	3	SENT_182	[p13l1532t1139r1787b1207],
10	(	VBP	O	(	_	0	SENT_182	[p13l1821t1139r2136b1221],
11	GWAS	NN	O	gwa	nn	12	SENT_182	[p13l1821t1139r2136b1221],
12	)	NN	O	)	nsubj	17	SENT_182	[p13l1821t1139r2136b1221],
13	in	IN	O	in	_	0	SENT_182	[p13l8t1243r81b1308],
14	DILI	NNP	LOCATION	DILI	prep_in	12	SENT_182	[p13l125t1246r302b1308],
15	has	VBZ	O	have	aux	17	SENT_182	[p13l346t1240r467b1309],
16	been	VBN	O	be	cop	17	SENT_182	[p13l509t1240r685b1309],
17	successful	JJ	O	successful	ccomp	10	SENT_182	[p13l730t1240r1097b1309],
18	in	IN	O	in	_	0	SENT_182	[p13l1141t1243r1214b1308],
19	identifying	VBG	O	identify	prepc_in	17	SENT_182	[p13l1257t1240r1664b1331],
20	very	RB	O	very	advmod	21	SENT_182	[p13l1705t1265r1866b1331],
21	strong	JJ	O	strong	amod	22	SENT_182	[p13l1908t1254r2144b1331],
22	associations	NNS	O	association	dobj	19	SENT_182	[p13l9t1346r454b1412],
23	between	IN	O	between	_	0	SENT_182	[p13l515t1344r822b1412],
24	speciﬁc	JJ	O	speciﬁc	amod	26	SENT_182	[p13l885t1343r1160b1432],
25	HLA	NN	O	hlum	nn	26	SENT_182	[p13l1221t1348r1402b1411],
26	alleles	NNS	O	allele	prep_between	22	SENT_182	[p13l1463t1344r1680b1412],
27	and	CC	O	and	_	0	SENT_182	[p13l1744t1344r1882b1412],
28	DILI	NNP	O	DILI	conj_and	22	SENT_182	[p13l1943t1349r2139b1412],
29	:	:	O	:	_	0	SENT_182	[p13l1943t1349r2139b1412],
30	HLA	NN	O	hlum	dep	28	SENT_182	[p13l9t1447r578b1514],
31	.	.	O	.	_	0	SENT_182	[p13l9t1447r578b1514],

1	—	NN	O	—	_	0	SENT_183	[p13l9t1447r578b1514],
2	.	.	O	.	_	0	SENT_183	[p13l9t1447r578b1514],

1	DRB1	NN	O	drb1	nsubj	11	SENT_184	[p13l9t1447r578b1514],
2	*	CD	NUMBER	*	number	3	SENT_184	[p13l9t1447r578b1514],
3	07	CD	NUMBER	07	dep	1	SENT_184	[p13l9t1447r578b1514],
4	and	CC	O	and	_	0	SENT_184	[p13l612t1446r748b1514],
5	DQA1	NN	O	dqa1	nn	7	SENT_184	[p13l781t1447r1151b1528],
6	*	CD	NUMBER	*	num	7	SENT_184	[p13l781t1447r1151b1528],
7	02	NN	NUMBER	02	conj_and	1	SENT_184	[p13l781t1447r1151b1528],
8	with	IN	O	with	_	0	SENT_184	[p13l1184t1446r1350b1514],
9	Ximelagatran	JJ	O	ximelagatran	amod	10	SENT_184	[p13l1380t1446r2143b1535],
10	—	NN	O	—	prep_with	7	SENT_184	[p13l1380t1446r2143b1535],
11	related	JJ	O	related	_	0	SENT_184	[p13l1380t1446r2143b1535],
12	DILI	NNP	O	DILI	dobj	11	SENT_184	[p13l8t1553r184b1615],
13	(	CD	NUMBER	(	number	14	SENT_184	[p13l236t1547r381b1630],
14	37	CD	NUMBER	37	num	15	SENT_184	[p13l236t1547r381b1630],
15	)	NN	O	)	dep	12	SENT_184	[p13l236t1547r381b1630],
16	and	CC	O	and	_	0	SENT_184	[p13l434t1547r571b1616],
17	HLA	NN	O	hlum	conj_and	12	SENT_184	[p13l616t1549r1105b1615],
18	.	.	O	.	_	0	SENT_184	[p13l616t1549r1105b1615],

1	—	NN	O	—	_	0	SENT_185	[p13l616t1549r1105b1615],
2	.	.	O	.	_	0	SENT_185	[p13l616t1549r1105b1615],

1	B	NN	O	b	_	0	SENT_186	[p13l616t1549r1105b1615],
2	*	CD	NUMBER	*	number	3	SENT_186	[p13l616t1549r1105b1615],
3	5701	CD	NUMBER	5701	dep	1	SENT_186	[p13l616t1549r1105b1615],
4	with	IN	O	with	_	0	SENT_186	[p13l1155t1547r1322b1615],
5	ﬂucloXacillin	NN	O	ﬂucloxacillin	prep_with	3	SENT_186	[p13l1367t1547r2143b1615],
6	—	CD	NUMBER	—	num	5	SENT_186	[p13l1367t1547r2143b1615],
7	related	JJ	O	related	amod	8	SENT_186	[p13l1367t1547r2143b1615],
8	DILI	NNP	O	DILI	dep	1	SENT_186	[p13l8t1655r184b1717],
9	(	CD	NUMBER	(	number	10	SENT_186	[p13l225t1649r395b1732],
10	38	CD	NUMBER	38	num	11	SENT_186	[p13l225t1649r395b1732],
11	)	NN	O	)	dep	8	SENT_186	[p13l225t1649r395b1732],
12	.	.	O	.	_	0	SENT_186	[p13l225t1649r395b1732],

1	Previously	RB	DATE	previously	dep	4	SENT_187	[p13l434t1649r844b1740],
2	,	,	O	,	_	0	SENT_187	[p13l434t1649r844b1740],
3	the	DT	O	the	det	4	SENT_187	[p13l879t1649r994b1718],
4	absence	NN	O	absence	_	0	SENT_187	[p13l1030t1649r1315b1718],
5	of	IN	O	of	_	0	SENT_187	[p13l1350t1649r1433b1718],
6	HLA	NN	O	hlum	prep_of	4	SENT_187	[p13l1457t1651r2141b1732],
7	.	.	O	.	_	0	SENT_187	[p13l1457t1651r2141b1732],

1	—	NN	O	—	_	0	SENT_188	[p13l1457t1651r2141b1732],
2	.	.	O	.	_	0	SENT_188	[p13l1457t1651r2141b1732],

1	DQA1	NN	O	dqa1	_	0	SENT_189	[p13l1457t1651r2141b1732],
2	*	CD	NUMBER	*	num	3	SENT_189	[p13l1457t1651r2141b1732],
3	0102	CD	DATE	0102	dep	1	SENT_189	[p13l1457t1651r2141b1732],
4	and	CC	O	and	_	0	SENT_189	[p13l9t1753r147b1821],
5	the	DT	O	the	det	6	SENT_189	[p13l194t1753r309b1821],
6	presence	NN	O	presence	dep	1	SENT_189	[p13l356t1777r678b1841],
7	of	IN	O	of	_	0	SENT_189	[p13l727t1753r810b1821],
8	HLA	NN	O	hlum	prep_of	1	SENT_189	[p13l848t1755r1520b1835],
9	.	.	O	.	_	0	SENT_189	[p13l848t1755r1520b1835],

1	—	NN	O	—	_	0	SENT_190	[p13l848t1755r1520b1835],
2	.	.	O	.	_	0	SENT_190	[p13l848t1755r1520b1835],

1	DQB1	NN	O	dqb1	nsubj	14	SENT_191	[p13l848t1755r1520b1835],
2	*	CD	NUMBER	*	number	3	SENT_191	[p13l848t1755r1520b1835],
3	0201	CD	DATE	0201	nsubjpass	5	SENT_191	[p13l848t1755r1520b1835],
4	were	VBD	O	be	auxpass	5	SENT_191	[p13l1573t1778r1748b1821],
5	found	VBN	O	find	rcmod	1	SENT_191	[p13l1796t1753r2021b1821],
6	to	TO	O	to	aux	7	SENT_191	[p13l2067t1767r2141b1821],
7	impose	VB	O	impose	xcomp	5	SENT_191	[p13l9t1857r278b1943],
8	an	DT	O	a	det	10	SENT_191	[p13l318t1879r406b1922],
9	increased	VBN	O	increase	amod	10	SENT_191	[p13l444t1854r794b1923],
10	risk	NN	O	risk	dobj	7	SENT_191	[p13l832t1854r970b1922],
11	for	IN	O	for	_	0	SENT_191	[p13l1005t1854r1113b1922],
12	ATD	NN	O	atd	nn	13	SENT_191	[p13l1148t1854r1674b1922],
13	—	NN	O	—	prep_for	10	SENT_191	[p13l1148t1854r1674b1922],
14	induced	VBD	O	induce	_	0	SENT_191	[p13l1148t1854r1674b1922],
15	hepatitis	NN	O	hepatitis	dobj	14	SENT_191	[p13l1711t1854r2031b1943],
16	in	IN	O	in	_	0	SENT_191	[p13l2071t1857r2143b1921],
17	an	DT	O	a	det	19	SENT_191	[p13l9t1981r97b2025],
18	Indian	JJ	MISC	indian	amod	19	SENT_191	[p13l136t1957r381b2025],
19	population	NN	O	population	prep_in	14	SENT_191	[p13l420t1957r836b2045],
20	(	CD	NUMBER	(	number	21	SENT_191	[p13l881t1957r1052b2039],
21	12	CD	NUMBER	12	num	22	SENT_191	[p13l881t1957r1052b2039],
22	)	NN	O	)	dep	14	SENT_191	[p13l881t1957r1052b2039],
23	;	:	O	;	_	0	SENT_191	[p13l881t1957r1052b2039],
24	however	RB	O	however	advmod	31	SENT_191	[p13l1093t1957r1429b2035],
25	,	,	O	,	_	0	SENT_191	[p13l1093t1957r1429b2035],
26	these	DT	O	these	det	27	SENT_191	[p13l1469t1957r1657b2025],
27	associations	NNS	O	association	nsubjpass	31	SENT_191	[p13l1697t1959r2143b2025],
28	have	VBP	O	have	aux	31	SENT_191	[p13l7t2059r177b2127],
29	not	RB	O	not	neg	31	SENT_191	[p13l210t2073r336b2127],
30	been	VBN	O	be	auxpass	31	SENT_191	[p13l365t2059r540b2127],
31	replicated	VBN	O	replicate	parataxis	14	SENT_191	[p13l573t2059r940b2147],
32	in	IN	O	in	_	0	SENT_191	[p13l972t2062r1044b2126],
33	other	JJ	O	other	amod	34	SENT_191	[p13l1077t2059r1275b2127],
34	studies	NNS	O	study	prep_in	31	SENT_191	[p13l1306t2059r1582b2127],
35	.	.	O	.	_	0	SENT_191	[p13l1306t2059r1582b2127],

1	As	IN	O	as	mark	6	SENT_192	[p13l1615t2063r1707b2127],
2	the	DT	O	the	det	4	SENT_192	[p13l1739t2059r1854b2127],
3	TNF-OL	NN	O	tnf-ol	nn	4	SENT_192	[p13l1886t2062r2144b2127],
4	gene	NN	O	gene	nsubj	6	SENT_192	[p13l9t2185r176b2251],
5	is	VBZ	O	be	cop	6	SENT_192	[p13l212t2163r265b2229],
6	located	JJ	O	located	_	0	SENT_192	[p13l299t2160r568b2229],
7	on	IN	O	on	_	0	SENT_192	[p13l604t2185r699b2229],
8	chromosome	NN	O	chromosome	prep_on	6	SENT_192	[p13l735t2160r1227b2229],
9	6	CD	NUMBER	6	num	8	SENT_192	[p13l1263t2167r1302b2229],
10	within	IN	O	within	_	0	SENT_192	[p13l1335t2160r1579b2229],
11	the	DT	O	the	det	13	SENT_192	[p13l1613t2160r1728b2229],
12	HLA	NN	O	hlum	nn	13	SENT_192	[p13l1763t2164r1944b2228],
13	class	NN	O	class	prep_within	8	SENT_192	[p13l1977t2161r2142b2229],

1	Liver	NN	O	liver	nn	3	SENT_193	[p13l1504t2422r1618b2468],
2	International	NNP	O	International	nn	3	SENT_193	[p13l1638t2421r1956b2468],
3	(	NNP	O	(	_	0	SENT_193	[p13l1978t2421r2143b2476],
4	2012	CD	DATE	2012	num	9	SENT_193	[p13l1978t2421r2143b2476],
5	)	CD	NUMBER	)	num	9	SENT_193	[p13l1978t2421r2143b2476],
6	©	CD	NUMBER	©	num	9	SENT_193	[p13l1360t2496r1405b2542],
7	2011	CD	DATE	2011	num	9	SENT_193	[p13l1423t2497r1543b2542],
8	John	NNP	PERSON	John	nn	9	SENT_193	[p13l1570t2495r1687b2542],
9	Wiley	NNP	PERSON	Wiley	dep	3	SENT_193	[p13l1707t2495r1849b2552],
10	&	CC	O	&	_	0	SENT_193	[p13l1866t2497r1903b2542],
11	Sons	NNP	O	Sons	dep	3	SENT_193	[p13l1923t2497r2040b2542],
12	A/S	NNP	O	A/S	dep	3	SENT_193	[p13l2057t2497r2142b2542],

1	Kim	NNP	PERSON	Kim	_	0	SENT_194	[p13l13t2723r126b2779],
2	et	FW	O	et	nn	3	SENT_194	[p13l152t2730r215b2780],
3	al.	FW	O	al.	dep	1	SENT_194	[p13l240t2722r305b2779],
4	.	.	O	.	_	0	SENT_194	[p13l240t2722r305b2779],

1	III	NNP	O	III	nn	2	SENT_195	[p13l9t2955r97b3017],
2	region	NN	O	region	nsubj	7	SENT_195	[p13l142t2952r380b3039],
3	and	CC	O	and	_	0	SENT_195	[p13l424t2950r562b3018],
4	the	DT	O	the	det	6	SENT_195	[p13l603t2950r718b3017],
5	TNF-OL	NN	O	tnf-ol	nn	6	SENT_195	[p13l762t2952r1020b3017],
6	polymorphism	NN	O	polymorphism	conj_and	2	SENT_195	[p13l1061t2950r1620b3039],
7	is	VBZ	O	be	ccomp	28	SENT_195	[p13l1664t2952r1717b3017],
8	in	IN	O	in	_	0	SENT_195	[p13l1761t2952r1834b3017],
9	linkage	NN	O	linkage	nn	10	SENT_195	[p13l1875t2950r2142b3039],
10	disequilibrium	NN	O	disequilibrium	prep_in	7	SENT_195	[p13l9t3052r562b3140],
11	with	IN	O	with	_	0	SENT_195	[p13l591t3052r759b3120],
12	the	DT	O	the	det	17	SENT_195	[p13l789t3052r905b3120],
13	HLA	NN	O	hlum	nn	17	SENT_195	[p13l936t3056r1118b3119],
14	locus	NN	O	locus	nn	17	SENT_195	[p13l1146t3052r1339b3120],
15	(	NN	O	(	nn	17	SENT_195	[p13l1377t3052r1548b3135],
16	39	CD	NUMBER	39	num	17	SENT_195	[p13l1377t3052r1548b3135],
17	)	NN	O	)	prep_with	10	SENT_195	[p13l1377t3052r1548b3135],
18	,	,	O	,	_	0	SENT_195	[p13l1377t3052r1548b3135],
19	the	DT	O	the	det	20	SENT_195	[p13l1581t3052r1697b3120],
20	association	NN	O	association	nsubj	28	SENT_195	[p13l1729t3055r2142b3120],
21	between	IN	O	between	_	0	SENT_195	[p13l6t3153r313b3221],
22	TNF-OL	NN	O	tnf-ol	nn	24	SENT_195	[p13l359t3156r618b3221],
23	—	CD	NUMBER	—	num	24	SENT_195	[p13l668t3157r1025b3224],
24	308G/A	NNP	O	308G/A	prep_between	20	SENT_195	[p13l668t3157r1025b3224],
25	and	CC	O	and	_	0	SENT_195	[p13l1071t3153r1208b3221],
26	ATD	NN	O	atd	nn	27	SENT_195	[p13l1252t3153r1777b3221],
27	—	NN	O	—	prep_between	20	SENT_195	[p13l1252t3153r1777b3221],
28	induced	VBD	O	induce	_	0	SENT_195	[p13l1252t3153r1777b3221],
29	hepatitis	NN	O	hepatitis	nsubjpass	32	SENT_195	[p13l1822t3153r2142b3242],
30	may	MD	O	may	aux	32	SENT_195	[p13l8t3280r168b3346],
31	be	VB	O	be	auxpass	32	SENT_195	[p13l190t3256r276b3324],
32	related	VBN	O	relate	ccomp	28	SENT_195	[p13l303t3256r556b3324],
33	to	TO	O	to	_	0	SENT_195	[p13l582t3269r656b3324],
34	a	DT	O	a	det	37	SENT_195	[p13l686t3280r724b3324],
35	speciﬁc	JJ	O	speciﬁc	amod	37	SENT_195	[p13l751t3255r1025b3345],
36	HLA	NN	O	hlum	nn	37	SENT_195	[p13l1053t3260r1233b3323],
37	allele	NN	O	allele	prep_to	32	SENT_195	[p13l1260t3256r1464b3324],
38	.	.	O	.	_	0	SENT_195	[p13l1260t3256r1464b3324],

1	Results	NNS	O	result	nsubjpass	11	SENT_196	[p13l112t3359r374b3427],
2	of	IN	O	of	_	0	SENT_196	[p13l434t3359r516b3427],
3	pharmacogenetic	JJ	O	pharmacogenetic	amod	5	SENT_196	[p13l560t3359r1207b3448],
4	association	NN	O	association	nn	5	SENT_196	[p13l1263t3362r1676b3427],
5	studies	NNS	O	study	prep_of	1	SENT_196	[p13l1733t3359r1990b3427],
6	on	IN	O	on	_	0	SENT_196	[p13l2048t3384r2143b3427],
7	ADR	NN	O	adr	prep_on	5	SENT_196	[p13l6t3465r194b3529],
8	are	VBP	O	be	aux	11	SENT_196	[p13l258t3485r367b3529],
9	now	RB	DATE	now	advmod	11	SENT_196	[p13l432t3485r596b3529],
10	being	VBG	O	be	auxpass	11	SENT_196	[p13l654t3460r861b3551],
11	translated	VBN	O	translate	_	0	SENT_196	[p13l924t3460r1293b3529],
12	to	TO	O	to	_	0	SENT_196	[p13l1357t3474r1430b3529],
13	clinical	JJ	O	clinical	amod	14	SENT_196	[p13l1497t3460r1762b3529],
14	practice	NN	O	practice	prep_to	11	SENT_196	[p13l1825t3463r2139b3550],
15	.	.	O	.	_	0	SENT_196	[p13l1825t3463r2139b3550],

1	Genetic	JJ	O	genetic	amod	3	SENT_197	[p13l9t3566r294b3633],
2	marker	NN	O	marker	nn	3	SENT_197	[p13l327t3564r597b3632],
3	testing	NN	O	testing	nsubj	5	SENT_197	[p13l629t3566r878b3654],
4	has	VBZ	O	have	aux	5	SENT_197	[p13l910t3564r1030b3632],
5	shown	VBN	O	show	_	0	SENT_197	[p13l1066t3564r1309b3632],
6	efﬁcacy	NN	O	efﬁcacy	dobj	5	SENT_197	[p13l1344t3563r1622b3654],
7	in	IN	O	in	_	0	SENT_197	[p13l1653t3566r1725b3631],
8	predicting	VBG	O	predict	prepc_in	5	SENT_197	[p13l1758t3564r2143b3654],
9	and	CC	O	and	_	0	SENT_197	[p13l9t3667r147b3735],
10	avoiding	VBG	O	avoid	conj_and	8	SENT_197	[p13l196t3667r520b3756],
11	ADR	NNP	O	ADR	dobj	8	SENT_197	[p13l566t3671r755b3735],
12	prior	RB	O	prior	_	0	SENT_197	[p13l800t3670r991b3755],
13	to	TO	O	to	_	0	SENT_197	[p13l1038t3681r1112b3735],
14	medication	NN	O	medication	prep_prior_to	11	SENT_197	[p13l1163t3667r1605b3735],
15	.	.	O	.	_	0	SENT_197	[p13l1163t3667r1605b3735],

1	Screening	NN	O	screening	_	0	SENT_198	[p13l1659t3670r2023b3756],
2	of	IN	O	of	prep	1	SENT_198	[p13l2071t3667r2153b3735],

1	HLA	NN	O	hlum	_	0	SENT_199	[p14l8t15r497b82],
2	.	.	O	.	_	0	SENT_199	[p14l8t15r497b82],

1	—	NN	O	—	_	0	SENT_200	[p14l8t15r497b82],
2	.	.	O	.	_	0	SENT_200	[p14l8t15r497b82],

1	B	NN	O	b	nsubj	4	SENT_201	[p14l8t15r497b82],
2	*	CD	NUMBER	*	num	3	SENT_201	[p14l8t15r497b82],
3	5701	CD	NUMBER	5701	dep	1	SENT_201	[p14l8t15r497b82],
4	reduced	VBD	O	reduce	_	0	SENT_201	[p14l534t13r832b82],
5	the	DT	O	the	det	6	SENT_201	[p14l861t13r976b82],
6	risk	NN	O	risk	dobj	4	SENT_201	[p14l1007t13r1144b82],
7	of	IN	O	of	_	0	SENT_201	[p14l1172t13r1254b82],
8	a	DT	O	a	det	10	SENT_201	[p14l1274t38r1311b82],
9	hypersensitivity	NN	O	hypersensitivity	nn	10	SENT_201	[p14l1339t13r1932b104],
10	reaction	NN	O	reaction	prep_of	6	SENT_201	[p14l1959t38r2138b82, p14l7t119r159b185],
11	to	TO	O	to	_	0	SENT_201	[p14l233t130r306b185],
12	avacavir	NN	O	avacavir	prep_to	4	SENT_201	[p14l384t119r707b195],
13	,	,	O	,	_	0	SENT_201	[p14l384t119r707b195],
14	a	DT	O	a	det	20	SENT_201	[p14l786t141r823b185],
15	nucleoside	JJ	O	nucleoside	amod	20	SENT_201	[p14l896t117r1293b185],
16	reverse	JJ	O	reverse	amod	20	SENT_201	[p14l1369t119r2142b205],
17	—	NN	O	—	nn	20	SENT_201	[p14l1369t119r2142b205],
18	transcriptase	NN	O	transcriptase	nn	20	SENT_201	[p14l1369t119r2142b205],
19	inhibitor	NN	O	inhibitor	nn	20	SENT_201	[p14l8t219r343b287],
20	(	NN	O	(	appos	12	SENT_201	[p14l379t219r549b302],
21	40	CD	NUMBER	40	num	22	SENT_201	[p14l379t219r549b302],
22	)	NN	O	)	dep	20	SENT_201	[p14l379t219r549b302],
23	.	.	O	.	_	0	SENT_201	[p14l379t219r549b302],

1	In	IN	O	in	dep	4	SENT_202	[p14l586t224r665b286],
2	addition	NN	O	addition	pobj	1	SENT_202	[p14l697t219r1034b298],
3	,	,	O	,	_	0	SENT_202	[p14l697t219r1034b298],
4	avoidance	NN	O	avoidance	_	0	SENT_202	[p14l1070t219r1444b287],
5	of	IN	O	of	_	0	SENT_202	[p14l1477t219r1560b287],
6	carbamazepine	NN	O	carbamazepine	prep_of	4	SENT_202	[p14l1582t219r2142b307],
7	in	IN	O	in	_	0	SENT_202	[p14l8t323r81b388],
8	subjects	NNS	O	subject	prep_in	4	SENT_202	[p14l120t320r410b410],
9	with	IN	O	with	_	0	SENT_202	[p14l447t320r614b389],
10	HLA	NN	O	hlum	prep_with	8	SENT_202	[p14l652t322r1146b389],
11	.	.	O	.	_	0	SENT_202	[p14l652t322r1146b389],

1	—	NN	O	—	_	0	SENT_203	[p14l652t322r1146b389],
2	.	.	O	.	_	0	SENT_203	[p14l652t322r1146b389],

1	B	NN	O	b	nsubj	4	SENT_204	[p14l652t322r1146b389],
2	*	CD	NUMBER	*	num	3	SENT_204	[p14l652t322r1146b389],
3	1502	CD	DATE	1502	dep	1	SENT_204	[p14l652t322r1146b389],
4	reduced	VBD	O	reduce	_	0	SENT_204	[p14l1187t320r1486b389],
5	the	DT	O	the	det	6	SENT_204	[p14l1523t320r1638b389],
6	incidence	NN	O	incidence	nsubj	10	SENT_204	[p14l1676t320r2032b389],
7	of	IN	O	of	_	0	SENT_204	[p14l2071t320r2153b389],
8	carbamazepine	NN	O	carbamazepine	nn	9	SENT_204	[p14l9t424r910b512],
9	—	NN	O	—	prep_of	6	SENT_204	[p14l9t424r910b512],
10	induced	VBD	O	induce	ccomp	4	SENT_204	[p14l9t424r910b512],
11	Stevens	NNP	PERSON	Stevens	dobj	10	SENT_204	[p14l939t424r1577b503],
12	—	CD	NUMBER	—	number	13	SENT_204	[p14l939t424r1577b503],
13	]	CD	NUMBER	]	num	15	SENT_204	[p14l939t424r1577b503],
14	ohnson	NN	O	ohnson	nn	15	SENT_204	[p14l939t424r1577b503],
15	syndrome	NN	O	syndrome	dep	11	SENT_204	[p14l1605t424r1976b513],
16	and	CC	O	and	_	0	SENT_204	[p14l2006t424r2143b492],
17	toxic	JJ	O	toxic	amod	19	SENT_204	[p14l7t528r191b594],
18	epidermal	JJ	O	epidermal	amod	19	SENT_204	[p14l222t526r598b614],
19	necrolysis	NN	O	necrolysis	dobj	10	SENT_204	[p14l627t526r992b615],
20	(	CD	NUMBER	(	number	21	SENT_204	[p14l1028t526r1198b608],
21	41	CD	NUMBER	41	num	22	SENT_204	[p14l1028t526r1198b608],
22	)	NN	O	)	dep	19	SENT_204	[p14l1028t526r1198b608],
23	.	.	O	.	_	0	SENT_204	[p14l1028t526r1198b608],

1	However	RB	O	however	advmod	8	SENT_205	[p14l1232t531r1589b604],
2	,	,	O	,	_	0	SENT_205	[p14l1232t531r1589b604],
3	genetic	JJ	O	genetic	amod	4	SENT_205	[p14l1622t528r1884b615],
4	markers	NNS	O	marker	nsubjpass	8	SENT_205	[p14l1913t526r2139b594, p14l9t652r110b695],
5	have	VBP	O	have	aux	8	SENT_205	[p14l140t627r311b695],
6	not	RB	O	not	neg	8	SENT_205	[p14l341t641r467b695],
7	been	VBN	O	be	auxpass	8	SENT_205	[p14l495t627r670b695],
8	identiﬁed	VBN	O	identiﬁed	_	0	SENT_205	[p14l701t627r1059b695],
9	that	WDT	O	that	nsubj	11	SENT_205	[p14l1088t627r1235b695],
10	are	VBP	O	be	cop	11	SENT_205	[p14l1266t652r1376b695],
11	effective	JJ	O	effective	ccomp	8	SENT_205	[p14l1407t627r1711b695],
12	in	IN	O	in	_	0	SENT_205	[p14l1742t630r1815b694],
13	predicting	VBG	O	predict	prepc_in	11	SENT_205	[p14l1844t627r2139b716, p14l8t732r125b819],
14	and	CC	O	and	_	0	SENT_205	[p14l188t730r325b798],
15	avoiding	VBG	O	avoid	prepc_in	11	SENT_205	[p14l388t730r712b819],
16	ATD	NN	O	atd	nn	17	SENT_205	[p14l772t730r1297b798],
17	—	NN	O	—	dobj	13	SENT_205	[p14l772t730r1297b798],
18	induced	VBD	O	induce	rcmod	17	SENT_205	[p14l772t730r1297b798],
19	hepatitis	NN	O	hepatitis	dobj	18	SENT_205	[p14l1359t730r1679b818],
20	in	IN	O	in	_	0	SENT_205	[p14l1743t732r1815b797],
21	clinical	JJ	O	clinical	amod	22	SENT_205	[p14l1879t730r2143b797],
22	practice	NN	O	practice	prep_in	18	SENT_205	[p14l7t834r321b920],
23	.	.	O	.	_	0	SENT_205	[p14l7t834r321b920],

1	In	IN	O	in	_	0	SENT_206	[p14l354t837r433b899],
2	the	DT	O	the	det	4	SENT_206	[p14l461t832r576b900],
3	present	JJ	DATE	present	amod	4	SENT_206	[p14l604t845r878b920],
4	study	NN	O	study	prep_in	8	SENT_206	[p14l908t832r1128b921],
5	,	,	O	,	_	0	SENT_206	[p14l908t832r1128b921],
6	we	PRP	O	we	nsubj	8	SENT_206	[p14l1158t856r1260b900],
7	have	VBP	O	have	aux	8	SENT_206	[p14l1288t832r1458b900],
8	identiﬁed	VBN	O	identiﬁed	_	0	SENT_206	[p14l1488t832r1846b900],
9	a	DT	O	a	det	11	SENT_206	[p14l1875t856r1913b900],
10	novel	JJ	O	novel	amod	11	SENT_206	[p14l1941t832r2143b900],
11	association	NN	O	association	dobj	8	SENT_206	[p14l9t936r422b1001],
12	between	IN	O	between	_	0	SENT_206	[p14l447t933r754b1001],
13	TNF	NN	O	tnf	nn	14	SENT_206	[p14l782t936r1040b1001],
14	—	NN	O	—	prep_between	11	SENT_206	[p14l782t936r1040b1001],
15	oL	NN	O	ol	nn	17	SENT_206	[p14l782t936r1040b1001],
16	—	CD	NUMBER	—	num	17	SENT_206	[p14l1072t937r1429b1004],
17	308G/A	NNP	O	308G/A	nsubj	21	SENT_206	[p14l1072t937r1429b1004],
18	and	CC	O	and	_	0	SENT_206	[p14l1456t933r1594b1001],
19	ATD	NN	O	atd	nn	20	SENT_206	[p14l1617t933r2144b1002],
20	—	NN	O	—	conj_and	17	SENT_206	[p14l1617t933r2144b1002],
21	induced	VBD	O	induce	rcmod	11	SENT_206	[p14l1617t933r2144b1002],
22	hepatitis	NN	O	hepatitis	dobj	21	SENT_206	[p14l7t1036r347b1125],
23	.	.	O	.	_	0	SENT_206	[p14l7t1036r347b1125],

1	With	IN	O	with	_	0	SENT_207	[p14l394t1036r587b1104],
2	accumulating	VBG	O	accumulate	prepc_with	18	SENT_207	[p14l634t1036r1144b1126],
3	knowledge	NN	O	knowledge	nsubj	12	SENT_207	[p14l1187t1036r1590b1126],
4	of	IN	O	of	_	0	SENT_207	[p14l1638t1036r1720b1104],
5	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_207	[p14l1756t1036r2144b1126],
6	genetic	JJ	O	genetic	amod	8	SENT_207	[p14l9t1141r272b1228],
7	risk	NN	O	risk	nn	8	SENT_207	[p14l312t1139r449b1207],
8	factors	NNS	O	factor	prep_of	3	SENT_207	[p14l487t1139r737b1207],
9	for	IN	O	for	_	0	SENT_207	[p14l778t1139r885b1207],
10	ATD	NN	O	atd	nn	11	SENT_207	[p14l922t1139r1448b1207],
11	—	NN	O	—	prep_for	8	SENT_207	[p14l922t1139r1448b1207],
12	induced	VBD	O	induce	ccomp	2	SENT_207	[p14l922t1139r1448b1207],
13	hepatitis	NN	O	hepatitis	dobj	12	SENT_207	[p14l1487t1139r1827b1227],
14	,	,	O	,	_	0	SENT_207	[p14l1487t1139r1827b1227],
15	we	PRP	O	we	nsubj	18	SENT_207	[p14l1869t1163r1970b1207],
16	will	MD	O	will	aux	18	SENT_207	[p14l2008t1139r2143b1206],
17	be	VB	O	be	cop	18	SENT_207	[p14l6t1240r91b1309],
18	able	JJ	O	able	_	0	SENT_207	[p14l143t1240r290b1309],
19	to	TO	O	to	aux	20	SENT_207	[p14l341t1254r414b1309],
20	enhance	VB	O	enhance	xcomp	18	SENT_207	[p14l468t1240r773b1309],
21	our	PRP$	O	we	poss	22	SENT_207	[p14l826t1265r956b1309],
22	understanding	NN	O	understanding	dobj	20	SENT_207	[p14l1006t1240r1553b1331],
23	of	IN	O	of	_	0	SENT_207	[p14l1604t1240r1687b1309],
24	the	DT	O	the	det	25	SENT_207	[p14l1726t1240r1842b1309],
25	pathomechanisms	NNS	O	pathomechanism	prep_of	22	SENT_207	[p14l1892t1240r2138b1330, p14l8t1344r471b1411],
26	and	CC	O	and	_	0	SENT_207	[p14l500t1344r638b1412],
27	develop	VB	O	develop	conj_and	20	SENT_207	[p14l666t1344r953b1432],
28	genetic	JJ	O	genetic	amod	29	SENT_207	[p14l983t1346r1245b1433],
29	tests	NNS	O	test	dobj	27	SENT_207	[p14l1271t1357r1432b1412],
30	to	TO	O	to	aux	31	SENT_207	[p14l1460t1357r1533b1412],
31	predict	VB	O	predict	xcomp	27	SENT_207	[p14l1562t1344r1827b1432],
32	hepato	NN	O	hepato	nn	34	SENT_207	[p14l1853t1344r2138b1432],
33	—	NN	O	—	nn	34	SENT_207	[p14l1853t1344r2138b1432],
34	toxicity	NN	O	toxicity	dobj	31	SENT_207	[p14l7t1448r291b1535],
35	prior	RB	O	prior	_	0	SENT_207	[p14l315t1448r506b1534],
36	to	TO	O	to	_	0	SENT_207	[p14l531t1459r605b1514],
37	the	DT	O	the	det	38	SENT_207	[p14l634t1446r749b1514],
38	use	NN	O	use	prep_prior_to	31	SENT_207	[p14l777t1470r896b1514],
39	of	IN	O	of	_	0	SENT_207	[p14l925t1446r1007b1514],
40	ATD	NN	ORGANIZATION	atd	prep_of	38	SENT_207	[p14l1021t1449r1204b1513],
41	in	IN	O	in	_	0	SENT_207	[p14l1234t1448r1306b1513],
42	near	JJ	DATE	near	amod	43	SENT_207	[p14l1333t1470r1496b1514],
43	future	NN	DATE	future	prep_in	40	SENT_207	[p14l1523t1446r1770b1514],
44	.	.	O	.	_	0	SENT_207	[p14l1523t1446r1770b1514],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_208	[p14l7t1705r835b1792],

1	This	DT	O	this	det	2	SENT_209	[p14l8t1859r169b1927],
2	study	NN	O	study	nsubjpass	4	SENT_209	[p14l217t1859r422b1948],
3	was	VBD	O	be	auxpass	4	SENT_209	[p14l462t1884r597b1927],
4	supported	VBN	O	support	_	0	SENT_209	[p14l645t1859r1027b1947],
5	by	IN	O	by	_	0	SENT_209	[p14l1071t1859r1163b1948],
6	a	DT	O	a	det	7	SENT_209	[p14l1206t1884r1243b1927],
7	grant	NN	O	grant	agent	4	SENT_209	[p14l1289t1872r1485b1948],
8	from	IN	O	from	_	0	SENT_209	[p14l1530t1859r1715b1927],
9	the	DT	O	the	det	14	SENT_209	[p14l1759t1859r1875b1927],
10	Korea	NNP	ORGANIZATION	Korea	nn	14	SENT_209	[p14l1922t1864r2144b1927],
11	Health	NNP	ORGANIZATION	Health	nn	14	SENT_209	[p14l8t1961r260b2029],
12	21	CD	NUMBER	21	num	14	SENT_209	[p14l301t1968r380b2028],
13	R&D	NN	O	r&d	nn	14	SENT_209	[p14l428t1966r614b2030],
14	project	NN	O	project	prep_from	4	SENT_209	[p14l656t1964r937b2050],
15	,	,	O	,	_	0	SENT_209	[p14l656t1964r937b2050],
16	Ministry	NNP	ORGANIZATION	Ministry	appos	14	SENT_209	[p14l979t1964r1305b2050],
17	for	IN	ORGANIZATION	for	_	0	SENT_209	[p14l1342t1961r1450b2029],
18	Health	NNP	ORGANIZATION	Health	prep_for	16	SENT_209	[p14l1490t1961r1741b2029],
19	and	CC	ORGANIZATION	and	_	0	SENT_209	[p14l1783t1961r1920b2029],
20	Welfare	NNP	ORGANIZATION	Welfare	prep_for	16	SENT_209	[p14l1957t1961r2139b2029, p14l8t2063r166b2141],
21	,	,	O	,	_	0	SENT_209	[p14l1957t1961r2139b2029, p14l8t2063r166b2141],
22	Republic	NNP	O	Republic	appos	14	SENT_209	[p14l253t2063r584b2151],
23	of	IN	O	of	_	0	SENT_209	[p14l668t2063r751b2131],
24	Korea	NNP	LOCATION	Korea	nn	26	SENT_209	[p14l824t2068r1045b2131],
25	(	CD	NUMBER	(	num	26	SENT_209	[p14l1134t2063r1912b2145],
26	A111218	NN	O	a111218	prep_of	22	SENT_209	[p14l1134t2063r1912b2145],
27	.	.	O	.	_	0	SENT_209	[p14l1134t2063r1912b2145],

1	—	NN	O	—	_	0	SENT_210	[p14l1134t2063r1912b2145],
2	.	.	O	.	_	0	SENT_210	[p14l1134t2063r1912b2145],

1	11	CD	NUMBER	11	_	0	SENT_211	[p14l1134t2063r1912b2145],
2	.	.	O	.	_	0	SENT_211	[p14l1134t2063r1912b2145],

1	—	NN	O	—	_	0	SENT_212	[p14l1134t2063r1912b2145],
2	.	.	O	.	_	0	SENT_212	[p14l1134t2063r1912b2145],

1	PG01	NN	O	pg01	_	0	SENT_213	[p14l1134t2063r1912b2145],
2	)	NN	O	)	dep	1	SENT_213	[p14l1134t2063r1912b2145],
3	.	.	O	.	_	0	SENT_213	[p14l1134t2063r1912b2145],

1	The	DT	O	the	det	2	SENT_214	[p14l2000t2063r2143b2131],
2	authors	NNS	O	author	nsubj	3	SENT_214	[p14l9t2164r291b2232],
3	thank	VBP	O	thank	_	0	SENT_214	[p14l322t2164r539b2232],
4	Eun	NNP	PERSON	Eun	dobj	3	SENT_214	[p14l567t2168r945b2232],
5	.	.	O	.	_	0	SENT_214	[p14l567t2168r945b2232],

1	—	NN	O	—	_	0	SENT_215	[p14l567t2168r945b2232],
2	.	.	O	.	_	0	SENT_215	[p14l567t2168r945b2232],

1	Soon	RB	O	soon	advmod	4	SENT_216	[p14l567t2168r945b2232],
2	Shin	NNP	O	Shin	nn	4	SENT_216	[p14l977t2164r1163b2242],
3	,	,	O	,	_	0	SENT_216	[p14l977t2164r1163b2242],
4	PhD	NNP	O	PhD	_	0	SENT_216	[p14l1197t2164r1362b2231],
5	for	IN	O	for	_	0	SENT_216	[p14l1395t2164r1502b2232],
6	assistance	NN	O	assistance	prep_for	4	SENT_216	[p14l1533t2166r1894b2232],
7	in	IN	O	in	_	0	SENT_216	[p14l1925t2166r1997b2231],
8	the	DT	O	the	det	10	SENT_216	[p14l2027t2164r2143b2232],
9	statistical	JJ	O	statistical	amod	10	SENT_216	[p14l9t2267r356b2335],
10	analyses	NNS	O	analysis	prep_in	6	SENT_216	[p14l384t2267r702b2356],
11	.	.	O	.	_	0	SENT_216	[p14l384t2267r702b2356],

1	Conflicts	NNS	O	conflict	nsubj	10	SENT_217	[p14l115t2369r428b2458],
2	of	IN	O	of	_	0	SENT_217	[p14l477t2369r556b2458],
3	interest	NN	O	interest	nn	4	SENT_217	[p14l589t2371r857b2437],
4	statement	NN	O	statement	prep_of	1	SENT_217	[p14l898t2383r1269b2437],
5	:	:	O	:	_	0	SENT_217	[p14l898t2383r1269b2437],
6	None	NN	O	none	dep	4	SENT_217	[p14l1321t2374r1526b2437],
7	of	IN	O	of	_	0	SENT_217	[p14l1576t2369r1658b2437],
8	the	DT	O	the	det	9	SENT_217	[p14l1694t2369r1810b2437],
9	authors	NNS	O	author	prep_of	6	SENT_217	[p14l1860t2369r2141b2437],
10	have	VBP	O	have	_	0	SENT_217	[p14l7t2471r177b2539],
11	any	DT	O	any	det	12	SENT_217	[p14l223t2496r356b2560],
12	conﬂicts	NNS	O	conﬂicts	dobj	10	SENT_217	[p14l397t2471r710b2539],
13	of	IN	O	of	_	0	SENT_217	[p14l756t2471r838b2539],
14	interest	NN	O	interest	prep_of	12	SENT_217	[p14l872t2473r1150b2539],
15	to	TO	O	to	aux	16	SENT_217	[p14l1192t2484r1265b2539],
16	declare	VB	O	declare	xcomp	10	SENT_217	[p14l1313t2471r1575b2539],
17	in	IN	O	in	_	0	SENT_217	[p14l1619t2473r1691b2538],
18	relation	NN	O	relation	prep_in	16	SENT_217	[p14l1735t2471r2024b2539],
19	to	TO	O	to	_	0	SENT_217	[p14l2067t2484r2140b2539],
20	this	DT	O	this	det	21	SENT_217	[p14l7t2572r141b2640],
21	work	NN	O	work	prep_to	16	SENT_217	[p14l168t2572r377b2640],
22	.	.	O	.	_	0	SENT_217	[p14l168t2572r377b2640],

1	References	NNS	O	reference	_	0	SENT_218	[p14l11t2810r510b2879],

1	1	LS	NUMBER	1	_	0	SENT_219	[p14l59t2972r106b3026],
2	.	.	O	.	_	0	SENT_219	[p14l59t2972r106b3026],

1	Blumberg	NNP	ORGANIZATION	Blumberg	nn	2	SENT_220	[p14l151t2965r482b3045],
2	HM	NNS	ORGANIZATION	hm	_	0	SENT_220	[p14l507t2970r663b3036],
3	,	,	O	,	_	0	SENT_220	[p14l507t2970r663b3036],
4	Burman	NNP	PERSON	Burman	nn	6	SENT_220	[p14l692t2970r966b3026],
5	W	NNP	O	W	nn	6	SENT_220	[p14l991t2970r1116b3037],
6	]	NN	O	]	appos	2	SENT_220	[p14l991t2970r1116b3037],
7	,	,	O	,	_	0	SENT_220	[p14l991t2970r1116b3037],
8	Chaisson	NNP	PERSON	Chaisson	nn	9	SENT_220	[p14l1146t2965r1451b3026],
9	RE	NNP	O	RE	appos	2	SENT_220	[p14l1479t2970r1592b3036],
10	,	,	O	,	_	0	SENT_220	[p14l1479t2970r1592b3036],
11	et	FW	O	et	appos	2	SENT_220	[p14l1622t2978r1681b3026],
12	all	DT	O	all	dep	11	SENT_220	[p14l1711t2965r1782b3026],
13	.	.	O	.	_	0	SENT_220	[p14l1711t2965r1782b3026],

1	American	JJ	MISC	american	amod	3	SENT_221	[p14l1813t2967r2143b3026],
2	thoracic	JJ	O	thoracic	amod	3	SENT_221	[p14l150t3056r424b3117],
3	society/centers	NNS	O	society/centers	_	0	SENT_221	[p14l470t3058r961b3136],
4	for	IN	O	for	_	0	SENT_221	[p14l1008t3056r1105b3117],
5	disease	NN	O	disease	nn	6	SENT_221	[p14l1150t3056r1381b3117],
6	control	NN	O	control	prep_for	3	SENT_221	[p14l1427t3056r1671b3117],
7	and	CC	O	and	_	0	SENT_221	[p14l1716t3056r1840b3118],
8	prevention/infectious	JJ	O	prevention/infectious	amod	10	SENT_221	[p14l1884t3077r2140b3136, p14l149t3148r645b3212],
9	diseases	NNS	O	disease	nn	10	SENT_221	[p14l688t3148r948b3210],
10	society	NN	O	society	conj_and	6	SENT_221	[p14l990t3151r1221b3229],
11	of	IN	O	of	_	0	SENT_221	[p14l1260t3148r1333b3210],
12	America	NNP	LOCATION	America	prep_of	6	SENT_221	[p14l1362t3151r1663b3210],
13	:	:	O	:	_	0	SENT_221	[p14l1362t3151r1663b3210],
14	treatment	NN	O	treatment	dep	3	SENT_221	[p14l1707t3160r2037b3210],
15	of	IN	O	of	_	0	SENT_221	[p14l2078t3148r2152b3210],
16	tuberculosis	NN	O	tuberculosis	prep_of	14	SENT_221	[p14l150t3242r574b3303],
17	.	.	O	.	_	0	SENT_221	[p14l150t3242r574b3303],

1	Am	VBP	O	be	_	0	SENT_222	[p14l596t3245r716b3303],
2	I	PRP	O	I	nsubj	3	SENT_222	[p14l736t3246r772b3313],
3	Respir	VB	O	respir	ccomp	1	SENT_222	[p14l787t3244r993b3322],
4	Crit	NNP	O	Crit	nn	5	SENT_222	[p14l1017t3244r1148b3303],
5	Care	NNP	O	Care	nsubj	6	SENT_222	[p14l1170t3245r1323b3303],
6	Med	VBD	O	med	ccomp	3	SENT_222	[p14l1341t3242r1492b3303],
7	2003	CD	DATE	2003	dobj	6	SENT_222	[p14l1514t3248r1691b3312],
8	;	:	O	;	_	0	SENT_222	[p14l1514t3248r1691b3312],
9	167	CD	NUMBER	167	num	11	SENT_222	[p14l1722t3247r1854b3303],
10	:	:	O	:	_	0	SENT_222	[p14l1722t3247r1854b3303],
11	603-62	CD	NUMBER	603-62	dep	7	SENT_222	[p14l1882t3247r2139b3303],
12	.	.	O	.	_	0	SENT_222	[p14l1882t3247r2139b3303],

1	2	LS	NUMBER	2	_	0	SENT_223	[p14l52t3339r106b3394],
2	.	.	O	.	_	0	SENT_223	[p14l52t3339r106b3394],

1	Tostmann	NNP	PERSON	Tostmann	nn	2	SENT_224	[p14l150t3336r496b3394],
2	A	NNP	O	A	_	0	SENT_224	[p14l529t3337r600b3404],
3	,	,	O	,	_	0	SENT_224	[p14l529t3337r600b3404],
4	Boeree	NNP	O	Boeree	nn	6	SENT_224	[p14l636t3338r862b3394],
5	M	NNP	O	M	nn	6	SENT_224	[p14l897t3338r1016b3405],
6	]	NN	O	]	appos	2	SENT_224	[p14l897t3338r1016b3405],
7	,	,	O	,	_	0	SENT_224	[p14l897t3338r1016b3405],
8	Aarnoutse	NNP	O	Aarnoutse	nn	9	SENT_224	[p14l1049t3337r1398b3394],
9	RE	NNP	O	RE	appos	2	SENT_224	[p14l1433t3338r1546b3404],
10	,	,	O	,	_	0	SENT_224	[p14l1433t3338r1546b3404],
11	et	FW	O	et	nn	12	SENT_224	[p14l1584t3346r1643b3394],
12	al.	FW	O	al.	appos	2	SENT_224	[p14l1672t3333r1744b3394],
13	.	.	O	.	_	0	SENT_224	[p14l1672t3333r1744b3394],

1	Antituber	NNP	O	Antituber	nsubj	6	SENT_225	[p14l1782t3333r2139b3394],
2	—	CD	NUMBER	—	num	1	SENT_225	[p14l1782t3333r2139b3394],
3	culosis	NN	O	culosis	nn	5	SENT_225	[p14l152t3426r375b3487],
4	drug	NN	O	drug	nn	5	SENT_225	[p14l425t3425r886b3506],
5	—	NN	O	—	dep	1	SENT_225	[p14l425t3425r886b3506],
6	induced	VBD	O	induce	_	0	SENT_225	[p14l425t3425r886b3506],
7	hepatotoxicityz	NN	O	hepatotoxicityz	nn	8	SENT_225	[p14l934t3426r1435b3506],
8	concise	NN	O	concise	dobj	6	SENT_225	[p14l1488t3428r1732b3487],
9	up	IN	O	up	prep	8	SENT_225	[p14l1780t3426r2143b3505],
10	—	CD	NUMBER	—	num	11	SENT_225	[p14l1780t3426r2143b3505],
11	to-date	NN	O	to-date	dep	9	SENT_225	[p14l1780t3426r2143b3505],
12	review	NN	O	review	dep	11	SENT_225	[p14l151t3521r384b3580],
13	.	.	O	.	_	0	SENT_225	[p14l151t3521r384b3580],
14	]	SYM	O	]	dep	8	SENT_225	[p14l406t3523r442b3590],

1	Gastroenterol	NNP	O	Gastroenterol	nn	2	SENT_226	[p14l463t3519r900b3580],
2	Hepatol	NNP	O	Hepatol	_	0	SENT_226	[p14l921t3519r1184b3599],
3	2008	CD	DATE	2008	num	2	SENT_226	[p14l1206t3525r1382b3589],
4	;	:	O	;	_	0	SENT_226	[p14l1206t3525r1382b3589],
5	23	CD	NUMBER	23	num	7	SENT_226	[p14l1409t3525r1506b3580],
6	:	:	O	:	_	0	SENT_226	[p14l1409t3525r1506b3580],
7	192-202	CD	NUMBER	192-202	dep	2	SENT_226	[p14l1541t3525r1833b3580],
8	.	.	O	.	_	0	SENT_226	[p14l1541t3525r1833b3580],

1	3	LS	NUMBER	3	_	0	SENT_227	[p14l54t3616r106b3671],
2	.	.	O	.	_	0	SENT_227	[p14l54t3616r106b3671],

1	Saukkonen	NNP	O	Saukkonen	nn	2	SENT_228	[p14l152t3610r524b3672],
2	II	NNP	O	II	_	0	SENT_228	[p14l548t3615r620b3682],
3	,	,	O	,	_	0	SENT_228	[p14l548t3615r620b3682],
4	Cohn	NNP	PERSON	Cohn	nn	5	SENT_228	[p14l649t3610r835b3672],
5	DL	NNP	O	DL	appos	2	SENT_228	[p14l860t3615r981b3681],
6	,	,	O	,	_	0	SENT_228	[p14l860t3615r981b3681],
7	Iasmer	NNP	O	Iasmer	nn	8	SENT_228	[p14l1007t3615r1236b3682],
8	RM	NN	O	rm	appos	2	SENT_228	[p14l1262t3615r1404b3681],
9	,	,	O	,	_	0	SENT_228	[p14l1262t3615r1404b3681],
10	et	FW	O	et	nn	11	SENT_228	[p14l1433t3623r1491b3671],
11	al.	FW	O	al.	appos	2	SENT_228	[p14l1521t3610r1593b3671],
12	.	.	O	.	_	0	SENT_228	[p14l1521t3610r1593b3671],

1	An	DT	O	a	det	4	SENT_229	[p14l1622t3614r1722b3671],
2	ofﬁcial	JJ	O	ofﬁcial	amod	4	SENT_229	[p14l1747t3610r1975b3671],
3	ATS	NN	O	at	nn	4	SENT_229	[p14l1998t3613r2141b3672],
4	statement	NN	O	statement	_	0	SENT_229	[p14l151t3714r496b3764],
5	:	:	O	:	_	0	SENT_229	[p14l151t3714r496b3764],
6	hepatotoxicity	NN	O	hepatotoxicity	dep	4	SENT_229	[p14l531t3703r1020b3783],
7	of	IN	O	of	_	0	SENT_229	[p14l1050t3702r1124b3764],
8	antituberculosis	NN	O	antituberculosis	nn	9	SENT_229	[p14l1149t3702r1686b3764],
9	therapy	NN	O	therapy	prep_of	6	SENT_229	[p14l1719t3702r1990b3783],
10	.	.	O	.	_	0	SENT_229	[p14l1719t3702r1990b3783],

1	Am	VBP	O	be	_	0	SENT_230	[p14l2021t3706r2142b3764],

1	I	PRP	O	I	nsubj	2	SENT_231	[p15l145t17r181b84],
2	Respir	VBP	O	respir	_	0	SENT_231	[p15l197t15r403b93],
3	Crit	NNP	O	Crit	nn	4	SENT_231	[p15l428t15r559b74],
4	Care	NNP	O	Care	nsubj	5	SENT_231	[p15l582t16r734b74],
5	Med	VBD	O	med	ccomp	2	SENT_231	[p15l754t12r905b74],
6	2006	CD	DATE	2006	dobj	5	SENT_231	[p15l927t18r1104b83],
7	;	:	O	;	_	0	SENT_231	[p15l927t18r1104b83],
8	174	CD	NUMBER	174	num	10	SENT_231	[p15l1135t19r1268b74],
9	:	:	O	:	_	0	SENT_231	[p15l1135t19r1268b74],
10	935-52	CD	NUMBER	935-52	dep	6	SENT_231	[p15l1297t19r1554b74],
11	.	.	O	.	_	0	SENT_231	[p15l1297t19r1554b74],

1	Yew	NNP	O	Yew	nn	2	SENT_232	[p15l148t110r293b167],
2	WW	NNP	O	WW	_	0	SENT_232	[p15l317t110r495b176],
3	,	,	O	,	_	0	SENT_232	[p15l317t110r495b176],
4	Leung	NNP	PERSON	Leung	nn	5	SENT_232	[p15l528t110r736b186],
5	CC	NN	O	cc	appos	2	SENT_232	[p15l767t109r890b167],
6	.	.	O	.	_	0	SENT_232	[p15l767t109r890b167],

1	Antituberculosis	NN	O	antituberculosis	_	0	SENT_233	[p15l921t106r1479b167],
2	drugs	NNS	O	drug	dep	1	SENT_233	[p15l1512t106r1697b186],
3	and	CC	O	and	_	0	SENT_233	[p15l1729t106r1853b167],
4	hepato	JJ	O	hepato	amod	6	SENT_233	[p15l1882t106r2139b185],
5	—	NN	O	—	nn	6	SENT_233	[p15l1882t106r2139b185],
6	toxicity	NN	O	toxicity	dep	1	SENT_233	[p15l149t200r419b278],
7	.	.	O	.	_	0	SENT_233	[p15l149t200r419b278],

1	Respirology	NNP	O	Respirology	_	0	SENT_234	[p15l445t198r820b278],
2	2006	CD	DATE	2006	num	1	SENT_234	[p15l841t203r1018b268],
3	;	:	O	;	_	0	SENT_234	[p15l841t203r1018b268],
4	11	CD	NUMBER	11	num	6	SENT_234	[p15l1049t204r1140b258],
5	:	:	O	:	_	0	SENT_234	[p15l1049t204r1140b258],
6	699-707	CD	NUMBER	699-707	dep	1	SENT_234	[p15l1169t203r1467b259],
7	.	.	O	.	_	0	SENT_234	[p15l1169t203r1467b259],

1	Huang	NNP	PERSON	Huang	nn	2	SENT_235	[p15l151t294r381b370],
2	YS	NNP	O	YS	_	0	SENT_235	[p15l405t293r513b360],
3	,	,	O	,	_	0	SENT_235	[p15l405t293r513b360],
4	Chern	NNP	O	Chern	nn	5	SENT_235	[p15l545t290r752b351],
5	HD	NNP	O	HD	appos	2	SENT_235	[p15l781t294r922b360],
6	,	,	O	,	_	0	SENT_235	[p15l781t294r922b360],
7	Su	NNP	O	Su	nn	9	SENT_235	[p15l954t293r1036b351],
8	W	NNP	O	W	nn	9	SENT_235	[p15l1062t294r1187b361],
9	]	NN	O	]	appos	2	SENT_235	[p15l1062t294r1187b361],
10	,	,	O	,	_	0	SENT_235	[p15l1062t294r1187b361],
11	et	FW	O	et	nn	12	SENT_235	[p15l1219t302r1278b351],
12	al.	FW	O	al.	appos	2	SENT_235	[p15l1307t290r1379b351],
13	.	.	O	.	_	0	SENT_235	[p15l1307t290r1379b351],

1	Polymorphism	NN	O	polymorphism	nsubj	18	SENT_236	[p15l1415t289r1918b370],
2	of	IN	O	of	_	0	SENT_236	[p15l1947t289r2021b351],
3	the	DT	O	the	det	8	SENT_236	[p15l2038t289r2143b351],
4	N	NN	O	n	nn	8	SENT_236	[p15l150t383r795b463],
5	—	NN	O	—	nn	8	SENT_236	[p15l150t383r795b463],
6	acetyltransferase	NN	O	acetyltransferase	nn	8	SENT_236	[p15l150t383r795b463],
7	2	CD	NUMBER	2	num	8	SENT_236	[p15l822t389r857b443],
8	gene	NN	O	gene	prep_of	1	SENT_236	[p15l886t404r1037b463],
9	as	IN	O	as	_	0	SENT_236	[p15l1063t404r1125b444],
10	a	DT	O	a	det	13	SENT_236	[p15l1153t405r1187b444],
11	susceptibility	NN	O	susceptibility	nn	13	SENT_236	[p15l1212t383r1656b463],
12	risk	NN	O	risk	nn	13	SENT_236	[p15l1679t383r1803b444],
13	factor	NN	O	factor	prep_as	1	SENT_236	[p15l1826t383r2022b444],
14	for	IN	O	for	_	0	SENT_236	[p15l2047t383r2144b444],
15	antituberculosis	JJ	O	antituberculosis	amod	17	SENT_236	[p15l151t476r688b537],
16	drug	NN	O	drug	nn	17	SENT_236	[p15l725t476r1186b556],
17	—	NN	O	—	prep_for	13	SENT_236	[p15l725t476r1186b556],
18	induced	VBD	O	induce	_	0	SENT_236	[p15l725t476r1186b556],
19	hepatitis	NN	O	hepatitis	dobj	18	SENT_236	[p15l1219t476r1524b555],
20	.	.	O	.	_	0	SENT_236	[p15l1219t476r1524b555],

1	Hepatology	NNP	O	Hepatology	_	0	SENT_237	[p15l1561t476r1933b556],
2	2002	CD	DATE	2002	num	1	SENT_237	[p15l1965t482r2141b546],
3	;	:	O	;	_	0	SENT_237	[p15l1965t482r2141b546],
4	35	CD	NUMBER	35	num	6	SENT_237	[p15l151t574r246b629],
5	:	:	O	:	_	0	SENT_237	[p15l151t574r246b629],
6	883-9	CD	NUMBER	883-9	dep	1	SENT_237	[p15l276t574r492b629],
7	.	.	O	.	_	0	SENT_237	[p15l276t574r492b629],

1	.	.	O	.	_	0	SENT_238	[p15l95t711r106b722],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_239	[p15l151t663r295b721],
2	SH	NNP	O	SH	_	0	SENT_239	[p15l311t664r430b731],
3	,	,	O	,	_	0	SENT_239	[p15l311t664r430b731],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_239	[p15l447t663r592b721],
5	SH	NNP	O	SH	appos	2	SENT_239	[p15l608t664r727b731],
6	,	,	O	,	_	0	SENT_239	[p15l608t664r727b731],
7	Bahn	NNP	PERSON	Bahn	nn	8	SENT_239	[p15l745t661r918b722],
8	IW	NNP	O	IW	appos	2	SENT_239	[p15l932t665r1055b732],
9	,	,	O	,	_	0	SENT_239	[p15l932t665r1055b732],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_239	[p15l1073t663r1217b721],
11	YK	NNP	O	YK	appos	2	SENT_239	[p15l1230t665r1353b731],
12	,	,	O	,	_	0	SENT_239	[p15l1230t665r1353b731],
13	et	FW	O	et	nn	14	SENT_239	[p15l1371t673r1430b722],
14	al.	FW	O	al.	appos	2	SENT_239	[p15l1459t661r1531b722],
15	.	.	O	.	_	0	SENT_239	[p15l1459t661r1531b722],

1	Genetic	JJ	O	genetic	amod	2	SENT_240	[p15l1553t663r1808b722],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_240	[p15l1822t661r2139b741, p15l150t754r389b833],
3	of	IN	O	of	_	0	SENT_240	[p15l424t754r497b815],
4	drug	NN	O	drug	prep_of	2	SENT_240	[p15l523t754r1151b834],
5	—	CD	NUMBER	—	num	4	SENT_240	[p15l523t754r1151b834],
6	metabolizing	VBG	O	metabolize	partmod	2	SENT_240	[p15l523t754r1151b834],
7	enzymes	NNS	O	enzyme	dobj	6	SENT_240	[p15l1186t775r1469b834],
8	and	CC	O	and	_	0	SENT_240	[p15l1504t754r1628b815],
9	anti	JJ	O	anti	dobj	6	SENT_240	[p15l1663t756r1920b815],
10	.	.	O	.	_	0	SENT_240	[p15l1663t756r1920b815],

1	—	NN	O	—	_	0	SENT_241	[p15l1663t756r1920b815],
2	.	.	O	.	_	0	SENT_241	[p15l1663t756r1920b815],

1	TB	NN	O	tb	nsubj	2	SENT_242	[p15l1663t756r1920b815],
2	druginduced	VBD	O	druginduce	_	0	SENT_242	[p15l1956t754r2139b834, p15l151t846r422b907],
3	hepatitis	NN	O	hepatitis	dobj	2	SENT_242	[p15l435t846r740b925],
4	.	.	O	.	_	0	SENT_242	[p15l435t846r740b925],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_243	[p15l756t845r1387b926],
2	2009	CD	DATE	2009	num	1	SENT_243	[p15l1401t852r1577b916],
3	;	:	O	;	_	0	SENT_243	[p15l1401t852r1577b916],
4	10	CD	NUMBER	10	num	6	SENT_243	[p15l1599t852r1690b907],
5	:	:	O	:	_	0	SENT_243	[p15l1599t852r1690b907],
6	1767-79	CD	NUMBER	1767-79	dep	1	SENT_243	[p15l1715t851r2007b907],
7	.	.	O	.	_	0	SENT_243	[p15l1715t851r2007b907],

1	.	.	O	.	_	0	SENT_244	[p15l95t989r106b1000],

1	Huang	NNP	PERSON	Huang	nn	2	SENT_245	[p15l151t943r380b1019],
2	YS	NNP	O	YS	_	0	SENT_245	[p15l420t942r528b1009],
3	,	,	O	,	_	0	SENT_245	[p15l420t942r528b1009],
4	Chern	NNP	O	Chern	nn	5	SENT_245	[p15l574t939r781b1000],
5	HD	NNP	O	HD	appos	2	SENT_245	[p15l824t943r966b1009],
6	,	,	O	,	_	0	SENT_245	[p15l824t943r966b1009],
7	Su	NNP	O	Su	nn	9	SENT_245	[p15l1011t942r1094b1000],
8	W	NNP	O	W	nn	9	SENT_245	[p15l1133t943r1259b1010],
9	]	NN	O	]	appos	2	SENT_245	[p15l1133t943r1259b1010],
10	,	,	O	,	_	0	SENT_245	[p15l1133t943r1259b1010],
11	et	FW	O	et	nn	12	SENT_245	[p15l1305t951r1364b1000],
12	al.	FW	O	al.	appos	2	SENT_245	[p15l1393t939r1465b1000],
13	.	.	O	.	_	0	SENT_245	[p15l1393t939r1465b1000],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_246	[p15l1516t939r1934b1019],
2	P450	NN	O	p450	nn	4	SENT_246	[p15l1978t943r2142b1000],
3	2E1	NN	O	2e1	nn	4	SENT_246	[p15l151t1036r269b1092],
4	genotype	NN	O	genotype	nsubj	12	SENT_246	[p15l323t1044r627b1112],
5	and	CC	O	and	_	0	SENT_246	[p15l676t1032r800b1093],
6	the	DT	O	the	det	7	SENT_246	[p15l847t1032r951b1093],
7	susceptibility	NN	O	susceptibility	conj_and	4	SENT_246	[p15l1000t1032r1443b1112],
8	to	TO	O	to	_	0	SENT_246	[p15l1488t1044r1554b1093],
9	antituberculosis	JJ	O	antituberculosis	amod	11	SENT_246	[p15l1605t1032r2142b1093],
10	drug	NN	O	drug	nn	11	SENT_246	[p15l152t1125r613b1205],
11	—	NN	O	—	prep_to	7	SENT_246	[p15l152t1125r613b1205],
12	induced	VBD	O	induce	_	0	SENT_246	[p15l152t1125r613b1205],
13	hepatitis	NN	O	hepatitis	dobj	12	SENT_246	[p15l636t1125r941b1204],
14	.	.	O	.	_	0	SENT_246	[p15l636t1125r941b1204],

1	Hepatology	NNP	O	Hepatology	_	0	SENT_247	[p15l967t1125r1340b1205],
2	2003	CD	DATE	2003	num	1	SENT_247	[p15l1361t1131r1538b1195],
3	;	:	O	;	_	0	SENT_247	[p15l1361t1131r1538b1195],
4	37	CD	NUMBER	37	num	6	SENT_247	[p15l1565t1131r1661b1186],
5	:	:	O	:	_	0	SENT_247	[p15l1565t1131r1661b1186],
6	924-30	CD	NUMBER	924-30	dep	1	SENT_247	[p15l1690t1131r1947b1186],
7	.	.	O	.	_	0	SENT_247	[p15l1690t1131r1947b1186],

1	Liver	NN	O	liver	nn	3	SENT_248	[p15l10t1376r124b1422],
2	International	NNP	O	International	nn	3	SENT_248	[p15l144t1375r463b1422],
3	(	NNP	O	(	_	0	SENT_248	[p15l484t1375r649b1430],
4	2012	CD	DATE	2012	num	9	SENT_248	[p15l484t1375r649b1430],
5	)	CD	NUMBER	)	num	9	SENT_248	[p15l484t1375r649b1430],
6	©	CD	NUMBER	©	num	9	SENT_248	[p15l6t1451r51b1497],
7	2011	CD	DATE	2011	num	9	SENT_248	[p15l68t1452r188b1497],
8	John	NNP	ORGANIZATION	John	nn	9	SENT_248	[p15l216t1450r332b1497],
9	Wiley	NNP	ORGANIZATION	Wiley	dep	3	SENT_248	[p15l352t1450r493b1508],
10	&	CC	ORGANIZATION	&	_	0	SENT_248	[p15l512t1452r549b1497],
11	Sons	NNP	ORGANIZATION	Sons	dep	3	SENT_248	[p15l568t1452r685b1497],
12	NS	NN	ORGANIZATION	n	dep	3	SENT_248	[p15l703t1452r787b1497],

1	TNF-OL	NN	O	tnf-ol	nn	2	SENT_249	[p15l478t1549r676b1603],
2	polymorphism	NN	O	polymorphism	nsubj	6	SENT_249	[p15l701t1546r1192b1619],
3	and	CC	O	and	_	0	SENT_249	[p15l1219t1546r1344b1604],
4	ATD	NN	O	atd	nn	5	SENT_249	[p15l1369t1546r1817b1604],
5	—	NN	O	—	nsubj	6	SENT_249	[p15l1369t1546r1817b1604],
6	induced	VBD	O	induce	_	0	SENT_249	[p15l1369t1546r1817b1604],
7	hepatitis	NN	O	hepatitis	dobj	6	SENT_249	[p15l1848t1546r2145b1619],

1	Roy	NNP	PERSON	Roy	nn	2	SENT_250	[p15l150t1794r284b1869],
2	B	NNP	PERSON	B	_	0	SENT_250	[p15l320t1794r384b1860],
3	,	,	O	,	_	0	SENT_250	[p15l320t1794r384b1860],
4	Chowdhury	NNP	PERSON	Chowdhury	nn	5	SENT_250	[p15l427t1789r833b1869],
5	A	NNP	O	A	appos	2	SENT_250	[p15l866t1793r938b1860],
6	,	,	O	,	_	0	SENT_250	[p15l866t1793r938b1860],
7	Kundu	NNP	PERSON	Kundu	nn	8	SENT_250	[p15l980t1789r1214b1850],
8	S	NNP	PERSON	S	appos	2	SENT_250	[p15l1255t1792r1310b1860],
9	,	,	O	,	_	0	SENT_250	[p15l1255t1792r1310b1860],
10	et	FW	O	et	nn	11	SENT_250	[p15l1352t1802r1411b1850],
11	al.	FW	O	al.	appos	2	SENT_250	[p15l1441t1789r1513b1850],
12	.	.	O	.	_	0	SENT_250	[p15l1441t1789r1513b1850],

1	Increased	VBN	O	increase	amod	2	SENT_251	[p15l1559t1789r1878b1850],
2	risk	NN	O	risk	nsubj	7	SENT_251	[p15l1918t1789r2042b1850],
3	of	IN	O	of	_	0	SENT_251	[p15l2080t1789r2154b1850],
4	antituberculosis	JJ	O	antituberculosis	amod	6	SENT_251	[p15l150t1882r688b1943],
5	drug	NN	O	drug	nn	6	SENT_251	[p15l721t1882r1183b1962],
6	—	NN	O	—	prep_of	2	SENT_251	[p15l721t1882r1183b1962],
7	induced	VBD	O	induce	_	0	SENT_251	[p15l721t1882r1183b1962],
8	hepatotoxicity	NN	O	hepatotoxicity	dobj	7	SENT_251	[p15l1214t1882r1703b1962],
9	in	IN	O	in	_	0	SENT_251	[p15l1731t1884r1797b1942],
10	individuals	NNS	O	individual	prep_in	8	SENT_251	[p15l1828t1882r2141b1943, p15l150t1976r233b2038],
11	with	IN	O	with	_	0	SENT_251	[p15l286t1976r436b2038],
12	glutathione	NN	O	glutathione	nn	13	SENT_251	[p15l491t1976r875b2057],
13	S	NN	O	s	prep_with	10	SENT_251	[p15l931t1976r1361b2038],
14	—	CD	NUMBER	—	num	16	SENT_251	[p15l931t1976r1361b2038],
15	transferase	NN	O	transferase	nn	16	SENT_251	[p15l931t1976r1361b2038],
16	M1	NN	O	m1	tmod	7	SENT_251	[p15l1415t1981r1522b2037],
17	‘	CD	NUMBER	‘	num	20	SENT_251	[p15l1584t1975r1752b2038],
18	null	JJ	O	null	amod	20	SENT_251	[p15l1584t1975r1752b2038],
19	’	NN	O	’	nn	20	SENT_251	[p15l1584t1975r1752b2038],
20	mutation	NN	O	mutation	dep	16	SENT_251	[p15l1809t1978r2141b2038],
21	.	.	O	.	_	0	SENT_251	[p15l1809t1978r2141b2038],

1	I	PRP	O	I	_	0	SENT_252	[p15l144t2074r180b2140],
2	Gastroenterol	NNP	O	Gastroenterol	nn	3	SENT_252	[p15l201t2069r639b2130],
3	Hepatol	NNP	O	Hepatol	dep	1	SENT_252	[p15l660t2069r922b2149],
4	2001	CD	DATE	2001	num	3	SENT_252	[p15l945t2075r1121b2140],
5	;	:	O	;	_	0	SENT_252	[p15l945t2075r1121b2140],
6	16	CD	NUMBER	16	num	8	SENT_252	[p15l1154t2075r1245b2130],
7	:	:	O	:	_	0	SENT_252	[p15l1154t2075r1245b2130],
8	1033-7	CD	NUMBER	1033-7	dep	1	SENT_252	[p15l1280t2075r1531b2130],
9	.	.	O	.	_	0	SENT_252	[p15l1280t2075r1531b2130],

1	.	.	O	.	_	0	SENT_253	[p15l94t2212r105b2223],

1	Leiro	NNP	O	Leiro	nn	2	SENT_254	[p15l150t2164r322b2223],
2	V	NNP	O	V	_	0	SENT_254	[p15l357t2166r430b2232],
3	,	,	O	,	_	0	SENT_254	[p15l357t2166r430b2232],
4	Fernandez	NNP	PERSON	Fernandez	appos	2	SENT_254	[p15l468t2162r1038b2223],
5	.	.	O	.	_	0	SENT_254	[p15l468t2162r1038b2223],

1	—	NN	O	—	_	0	SENT_255	[p15l468t2162r1038b2223],
2	.	.	O	.	_	0	SENT_255	[p15l468t2162r1038b2223],

1	Villar	NNP	PERSON	Villar	nn	2	SENT_256	[p15l468t2162r1038b2223],
2	A	NNP	O	A	_	0	SENT_256	[p15l1071t2165r1143b2232],
3	,	,	O	,	_	0	SENT_256	[p15l1071t2165r1143b2232],
4	Valverde	NNP	PERSON	Valverde	nn	5	SENT_256	[p15l1178t2162r1476b2223],
5	D	NNP	O	D	appos	2	SENT_256	[p15l1513t2166r1589b2232],
6	,	,	O	,	_	0	SENT_256	[p15l1513t2166r1589b2232],
7	et	FW	O	et	nn	8	SENT_256	[p15l1628t2175r1687b2223],
8	al.	FW	O	al.	appos	5	SENT_256	[p15l1716t2162r1788b2223],
9	.	.	O	.	_	0	SENT_256	[p15l1716t2162r1788b2223],

1	Inﬂuence	NN	O	inﬂuence	nsubj	20	SENT_257	[p15l1830t2162r2144b2223],
2	of	IN	O	of	_	0	SENT_257	[p15l150t2255r224b2316],
3	glutathione	NN	O	glutathione	nn	4	SENT_257	[p15l247t2255r632b2335],
4	S	NN	O	s	prep_of	1	SENT_257	[p15l665t2255r1095b2316],
5	—	CD	NUMBER	—	num	7	SENT_257	[p15l665t2255r1095b2316],
6	transferase	NN	O	transferase	nn	7	SENT_257	[p15l665t2255r1095b2316],
7	M1	NN	O	m1	dep	4	SENT_257	[p15l1128t2259r1235b2315],
8	and	CC	O	and	_	0	SENT_257	[p15l1274t2255r1398b2316],
9	T1	NN	O	t1	conj_and	4	SENT_257	[p15l1431t2257r1512b2315],
10	homozygous	JJ	O	homozygous	amod	12	SENT_257	[p15l1550t2255r1981b2335],
11	null	JJ	O	null	amod	12	SENT_257	[p15l2014t2255r2146b2316],
12	mutations	NNS	O	mutation	dep	9	SENT_257	[p15l149t2350r493b2409],
13	on	IN	O	on	_	0	SENT_257	[p15l540t2370r626b2409],
14	the	DT	O	the	det	15	SENT_257	[p15l670t2348r774b2409],
15	risk	NN	O	risk	prep_on	12	SENT_257	[p15l820t2348r943b2409],
16	of	IN	O	of	_	0	SENT_257	[p15l987t2348r1061b2409],
17	antituberculosis	JJ	O	antituberculosis	amod	19	SENT_257	[p15l1097t2348r1635b2409],
18	drug	NN	O	drug	nn	19	SENT_257	[p15l1682t2348r2144b2428],
19	—	NN	O	—	prep_of	15	SENT_257	[p15l1682t2348r2144b2428],
20	induced	VBD	O	induce	_	0	SENT_257	[p15l1682t2348r2144b2428],
21	hepatotoxicity	NN	O	hepatotoxicity	dobj	20	SENT_257	[p15l149t2441r638b2523],
22	in	IN	O	in	_	0	SENT_257	[p15l668t2443r734b2502],
23	a	DT	O	a	det	25	SENT_257	[p15l768t2464r802b2503],
24	Caucasian	JJ	LOCATION	caucasian	amod	25	SENT_257	[p15l836t2443r1178b2503],
25	population	NN	O	population	prep_in	20	SENT_257	[p15l1211t2441r1602b2522],
26	.	.	O	.	_	0	SENT_257	[p15l1211t2441r1602b2522],

1	Liver	NN	O	liver	nn	2	SENT_258	[p15l1638t2443r1807b2503],
2	Int	NN	O	int	_	0	SENT_258	[p15l1835t2446r1937b2503],
3	2008	CD	DATE	2008	dep	2	SENT_258	[p15l1966t2448r2143b2513],
4	;	:	O	;	_	0	SENT_258	[p15l1966t2448r2143b2513],
5	28	CD	NUMBER	28	num	7	SENT_258	[p15l149t2541r245b2597],
6	:	:	O	:	_	0	SENT_258	[p15l149t2541r245b2597],
7	835-9	CD	NUMBER	835-9	dep	2	SENT_258	[p15l275t2541r491b2597],
8	.	.	O	.	_	0	SENT_258	[p15l275t2541r491b2597],

1	Huang	NNP	PERSON	Huang	nn	2	SENT_259	[p15l145t2634r376b2709],
2	YS	NNP	O	YS	_	0	SENT_259	[p15l415t2632r523b2700],
3	,	,	O	,	_	0	SENT_259	[p15l415t2632r523b2700],
4	Su	NNP	PERSON	Su	nn	5	SENT_259	[p15l570t2632r652b2690],
5	WI	NNP	PERSON	WI	appos	2	SENT_259	[p15l693t2634r819b2701],
6	,	,	O	,	_	0	SENT_259	[p15l693t2634r819b2701],
7	Huang	NNP	PERSON	Huang	nn	8	SENT_259	[p15l865t2634r1095b2709],
8	YH	NNP	O	YH	appos	2	SENT_259	[p15l1135t2634r1267b2700],
9	,	,	O	,	_	0	SENT_259	[p15l1135t2634r1267b2700],
10	et	FW	O	et	nn	11	SENT_259	[p15l1314t2642r1373b2690],
11	al.	FW	O	al.	appos	2	SENT_259	[p15l1402t2629r1475b2690],
12	.	.	O	.	_	0	SENT_259	[p15l1402t2629r1475b2690],

1	Genetic	JJ	O	genetic	amod	2	SENT_260	[p15l1526t2631r1781b2690],
2	polymorphisms	NNS	O	polymorphism	nsubj	31	SENT_260	[p15l1823t2629r2141b2709, p15l144t2722r384b2803],
3	of	IN	O	of	_	0	SENT_260	[p15l430t2722r504b2784],
4	manganese	NN	O	manganese	nn	6	SENT_260	[p15l539t2745r910b2804],
5	superoxide	NN	O	superoxide	nn	6	SENT_260	[p15l955t2722r1324b2803],
6	dismutase	NN	O	dismutase	prep_of	2	SENT_260	[p15l1370t2722r1726b2794],
7	,	,	O	,	_	0	SENT_260	[p15l1370t2722r1726b2794],
8	NAD	NNP	O	NAD	nsubj	31	SENT_260	[p15l1772t2723r2141b2797],
9	(	CD	NUMBER	(	num	8	SENT_260	[p15l1772t2723r2141b2797],
10	P	NN	O	p	nn	12	SENT_260	[p15l1772t2723r2141b2797],
11	)	NN	O	)	nn	12	SENT_260	[p15l1772t2723r2141b2797],
12	H	NN	O	h	dep	8	SENT_260	[p15l1772t2723r2141b2797],
13	:	:	O	:	_	0	SENT_260	[p15l1772t2723r2141b2797],
14	quinone	NN	O	quinone	nn	15	SENT_260	[p15l146t2818r424b2897],
15	oxidoreductase	NN	O	oxidoreductase	dep	8	SENT_260	[p15l452t2816r982b2888],
16	,	,	O	,	_	0	SENT_260	[p15l452t2816r982b2888],
17	glutathione	NN	O	glutathione	nn	18	SENT_260	[p15l1012t2816r1397b2898],
18	S	NN	O	s	dep	8	SENT_260	[p15l1424t2816r1854b2878],
19	—	CD	NUMBER	—	num	21	SENT_260	[p15l1424t2816r1854b2878],
20	transferase	NN	O	transferase	nn	21	SENT_260	[p15l1424t2816r1854b2878],
21	M1	NN	O	m1	dep	18	SENT_260	[p15l1880t2821r1987b2877],
22	and	CC	O	and	_	0	SENT_260	[p15l2021t2816r2145b2878],
23	T1	NN	O	t1	dep	8	SENT_260	[p15l145t2913r252b2981],
24	,	,	O	,	_	0	SENT_260	[p15l145t2913r252b2981],
25	and	CC	O	and	_	0	SENT_260	[p15l301t2910r425b2971],
26	the	DT	O	the	det	27	SENT_260	[p15l470t2910r574b2971],
27	susceptibility	NN	O	susceptibility	conj_and	2	SENT_260	[p15l621t2910r1066b2990],
28	to	TO	O	to	_	0	SENT_260	[p15l1108t2922r1174b2971],
29	drug	NN	O	drug	nn	30	SENT_260	[p15l1222t2910r1685b2990],
30	—	NN	O	—	prep_to	27	SENT_260	[p15l1222t2910r1685b2990],
31	induced	VBD	O	induce	_	0	SENT_260	[p15l1222t2910r1685b2990],
32	liver	NN	O	liver	nn	33	SENT_260	[p15l1730t2910r1878b2971],
33	injury	NN	O	injury	dobj	31	SENT_260	[p15l1924t2912r2141b2990],
34	.	.	O	.	_	0	SENT_260	[p15l1924t2912r2141b2990],

1	I	PRP	O	I	nsubj	2	SENT_261	[p15l140t3008r176b3074],
2	Hepatol	VBP	O	hepatol	_	0	SENT_261	[p15l192t3003r454b3083],
3	2007	CD	DATE	2007	dobj	2	SENT_261	[p15l477t3009r654b3074],
4	;	:	O	;	_	0	SENT_261	[p15l477t3009r654b3074],
5	47	CD	NUMBER	47	num	7	SENT_261	[p15l680t3010r777b3064],
6	:	:	O	:	_	0	SENT_261	[p15l680t3010r777b3064],
7	128-34	CD	NUMBER	128-34	dep	3	SENT_261	[p15l813t3009r1064b3064],
8	.	.	O	.	_	0	SENT_261	[p15l813t3009r1064b3064],

1	Metushi	NNP	O	Metushi	nn	2	SENT_262	[p15l145t3096r423b3158],
2	IG	NNP	O	IG	_	0	SENT_262	[p15l472t3100r573b3168],
3	,	,	O	,	_	0	SENT_262	[p15l472t3100r573b3168],
4	Cai	NNP	PERSON	Cai	nn	5	SENT_262	[p15l625t3099r736b3159],
5	P	NN	PERSON	p	appos	2	SENT_262	[p15l784t3101r846b3168],
6	,	,	O	,	_	0	SENT_262	[p15l784t3101r846b3168],
7	Zhu	NNP	PERSON	Zhu	nn	8	SENT_262	[p15l896t3096r1035b3158],
8	X	NNP	O	X	appos	2	SENT_262	[p15l1080t3101r1152b3168],
9	,	,	O	,	_	0	SENT_262	[p15l1080t3101r1152b3168],
10	Nakagawa	NNP	PERSON	Nakagawa	nn	11	SENT_262	[p15l1201t3097r1548b3178],
11	T	NN	O	t	appos	2	SENT_262	[p15l1595t3099r1661b3168],
12	,	,	O	,	_	0	SENT_262	[p15l1595t3099r1661b3168],
13	Uetrecht	NNP	O	Uetrecht	nn	14	SENT_262	[p15l1711t3097r2005b3159],
14	IP	NNP	O	IP	appos	2	SENT_262	[p15l2052t3101r2141b3169],
15	.	.	O	.	_	0	SENT_262	[p15l2052t3101r2141b3169],

1	A	DT	O	a	det	3	SENT_263	[p15l143t3194r198b3250],
2	fresh	JJ	O	fresh	amod	3	SENT_263	[p15l225t3190r387b3251],
3	look	NN	O	look	_	0	SENT_263	[p15l414t3190r565b3251],
4	at	IN	O	at	_	0	SENT_263	[p15l591t3202r651b3251],
5	the	DT	O	the	det	6	SENT_263	[p15l678t3190r782b3251],
6	mechanism	NN	O	mechanism	prep_at	3	SENT_263	[p15l810t3190r1197b3251],
7	of	IN	O	of	_	0	SENT_263	[p15l1227t3190r1301b3251],
8	isoniazid-induced	JJ	O	isoniazid-induced	amod	9	SENT_263	[p15l1319t3190r1927b3251],
9	hepatotoxicity	NN	O	hepatotoxicity	prep_of	3	SENT_263	[p15l1954t3190r2141b3270, p15l144t3285r484b3364],
10	.	.	O	.	_	0	SENT_263	[p15l1954t3190r2141b3270, p15l144t3285r484b3364],

1	Clin	NNP	O	Clin	nn	3	SENT_264	[p15l516t3283r651b3345],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_264	[p15l675t3283r1032b3345],
3	Ther	NNP	O	Ther	_	0	SENT_264	[p15l1060t3283r1211b3345],
4	2011	CD	DATE	2011	num	3	SENT_264	[p15l1232t3290r1409b3355],
5	;	:	O	;	_	0	SENT_264	[p15l1232t3290r1409b3355],
6	89	CD	NUMBER	89	num	8	SENT_264	[p15l1436t3290r1532b3345],
7	:	:	O	:	_	0	SENT_264	[p15l1436t3290r1532b3345],
8	911-4	CD	NUMBER	911-4	dep	3	SENT_264	[p15l1561t3290r1778b3345],
9	.	.	O	.	_	0	SENT_264	[p15l1561t3290r1778b3345],

1	Sharma	FW	PERSON	sharma	nn	2	SENT_265	[p15l146t3377r403b3439],
2	SK	FW	O	sk	dep	5	SENT_265	[p15l430t3381r540b3449],
3	,	,	O	,	_	0	SENT_265	[p15l430t3381r540b3449],
4	Balamurugan	NNP	O	Balamurugan	nn	5	SENT_265	[p15l569t3377r1024b3459],
5	A	NNP	O	A	_	0	SENT_265	[p15l1049t3381r1120b3449],
6	,	,	O	,	_	0	SENT_265	[p15l1049t3381r1120b3449],
7	Saha	NNP	O	Saha	nn	8	SENT_265	[p15l1151t3377r1306b3439],
8	PK	NNP	O	PK	appos	5	SENT_265	[p15l1333t3382r1450b3449],
9	,	,	O	,	_	0	SENT_265	[p15l1333t3382r1450b3449],
10	Pandey	NNP	PERSON	Pandey	nn	11	SENT_265	[p15l1479t3377r1728b3459],
11	RM	NN	O	rm	appos	5	SENT_265	[p15l1752t3382r1895b3449],
12	,	,	O	,	_	0	SENT_265	[p15l1752t3382r1895b3449],
13	Mehra	NNP	ORGANIZATION	Mehra	nn	14	SENT_265	[p15l1924t3377r2146b3439],
14	NK	NN	ORGANIZATION	nk	appos	5	SENT_265	[p15l144t3476r277b3533],
15	.	.	O	.	_	0	SENT_265	[p15l144t3476r277b3533],

1	Evaluation	NN	O	evaluation	_	0	SENT_266	[p15l307t3472r670b3533],
2	of	IN	O	of	_	0	SENT_266	[p15l699t3471r773b3533],
3	clinical	JJ	O	clinical	amod	7	SENT_266	[p15l791t3471r1030b3533],
4	and	CC	O	and	_	0	SENT_266	[p15l1057t3472r1181b3534],
5	immunogenetic	JJ	O	immunogenetic	amod	7	SENT_266	[p15l1209t3474r1743b3553],
6	risk	NN	O	risk	nn	7	SENT_266	[p15l1771t3471r1894b3533],
7	factors	NNS	O	factor	prep_of	1	SENT_266	[p15l1919t3471r2144b3533],
8	for	IN	O	for	_	0	SENT_266	[p15l145t3565r242b3627],
9	the	DT	O	the	det	10	SENT_266	[p15l268t3565r371b3627],
10	development	NN	O	development	prep_for	7	SENT_266	[p15l399t3565r838b3646],
11	of	IN	O	of	_	0	SENT_266	[p15l865t3565r940b3627],
12	hepatotoxicity	NN	O	hepatotoxicity	prep_of	10	SENT_266	[p15l956t3565r1445b3647],
13	during	IN	O	during	_	0	SENT_266	[p15l1470t3565r1696b3647],
14	antituberculosis	NN	O	antituberculosis	nn	15	SENT_266	[p15l1723t3565r2141b3627, p15l144t3658r289b3719],
15	treatment	NN	O	treatment	prep_during	1	SENT_266	[p15l314t3670r661b3719],
16	.	.	O	.	_	0	SENT_266	[p15l314t3670r661b3719],

1	Am	VBP	O	be	_	0	SENT_267	[p15l685t3662r805b3719],
2	I	PRP	O	I	nsubj	3	SENT_267	[p15l827t3663r863b3729],
3	Respir	VB	O	respir	ccomp	1	SENT_267	[p15l880t3660r1086b3738],
4	Crit	NNP	O	Crit	nn	5	SENT_267	[p15l1111t3660r1243b3720],
5	Care	NNP	O	Care	nsubj	6	SENT_267	[p15l1266t3662r1419b3720],
6	Med	VBD	O	med	ccomp	3	SENT_267	[p15l1440t3658r1590b3719],
7	2002	CD	DATE	2002	dobj	6	SENT_267	[p15l1613t3664r1790b3729],
8	;	:	O	;	_	0	SENT_267	[p15l1613t3664r1790b3729],
9	166	CD	NUMBER	166	num	11	SENT_267	[p15l1823t3664r1955b3719],
10	:	:	O	:	_	0	SENT_267	[p15l1823t3664r1955b3719],
11	9169	CD	DATE	9169	dep	7	SENT_267	[p15l1985t3664r2147b3720, p15l146t3758r199b3814],
12	.	.	O	.	_	0	SENT_267	[p15l1985t3664r2147b3720, p15l146t3758r199b3814],

1	You	PRP	O	you	advmod	25	SENT_268	[p16l143t33r283b90],
2	Q	NNP	O	Q	nsubj	25	SENT_268	[p16l321t32r397b102],
3	,	,	O	,	_	0	SENT_268	[p16l321t32r397b102],
4	Cheng	NNP	PERSON	Cheng	nn	5	SENT_268	[p16l439t29r656b109],
5	L	NNP	PERSON	L	appos	2	SENT_268	[p16l693t33r752b99],
6	,	,	O	,	_	0	SENT_268	[p16l693t33r752b99],
7	Reilly	NNP	PERSON	Reilly	nn	8	SENT_268	[p16l792t29r983b109],
8	TP	NNP	O	TP	appos	2	SENT_268	[p16l1017t31r1131b99],
9	,	,	O	,	_	0	SENT_268	[p16l1017t31r1131b99],
10	Wegmann	NNP	PERSON	Wegmann	nn	11	SENT_268	[p16l1168t33r1519b109],
11	D	NNP	O	D	appos	2	SENT_268	[p16l1558t33r1634b99],
12	,	,	O	,	_	0	SENT_268	[p16l1558t33r1634b99],
13	Ju	NNP	PERSON	Ju	nn	15	SENT_268	[p16l1673t33r1745b100],
14	C.	NNP	PERSON	C.	nn	15	SENT_268	[p16l1783t32r1851b90],
15	Role	NN	PERSON	role	appos	2	SENT_268	[p16l1892t29r2042b90],
16	of	IN	O	of	_	0	SENT_268	[p16l2080t29r2154b90],
17	neutrophils	NNS	O	neutrophil	prep_of	15	SENT_268	[p16l145t121r533b201],
18	in	IN	O	in	_	0	SENT_268	[p16l567t123r632b182],
19	a	DT	O	a	det	21	SENT_268	[p16l666t143r699b182],
20	mouse	NN	O	mouse	nn	21	SENT_268	[p16l730t143r952b182],
21	model	NN	O	model	prep_in	17	SENT_268	[p16l984t121r1197b182],
22	of	IN	O	of	_	0	SENT_268	[p16l1230t121r1304b182],
23	halothane	NN	O	halothane	nn	24	SENT_268	[p16l1326t121r1966b182],
24	—	NN	O	—	prep_of	21	SENT_268	[p16l1326t121r1966b182],
25	induced	VBD	O	induce	_	0	SENT_268	[p16l1326t121r1966b182],
26	liver	NN	O	liver	nn	27	SENT_268	[p16l1998t121r2145b182],
27	hnury	NN	O	hnury	dobj	25	SENT_268	[p16l145t215r1411b297],
28	.	.	O	.	_	0	SENT_268	[p16l145t215r1411b297],

1	Eh4nu0hgy/2006	NN	O	eh4nu0hgy/2006	_	0	SENT_269	[p16l145t215r1411b297],
2	;	:	O	;	_	0	SENT_269	[p16l145t215r1411b297],
3	44:1421	CD	NUMBER	44:1421	number	4	SENT_269	[p16l145t215r1411b297],
4	-31	CD	NUMBER	-31	dep	1	SENT_269	[p16l145t215r1411b297],
5	.	.	O	.	_	0	SENT_269	[p16l145t215r1411b297],

1	Shaw	NNP	PERSON	Shaw	nn	3	SENT_270	[p16l146t309r325b370],
2	P	NN	O	p	nn	3	SENT_270	[p16l361t313r451b380],
3	]	NN	O	]	_	0	SENT_270	[p16l361t313r451b380],
4	,	,	O	,	_	0	SENT_270	[p16l361t313r451b380],
5	Hopfensperger	NN	O	hopfensperger	nn	7	SENT_270	[p16l492t309r995b389],
6	M	NN	O	m	nn	7	SENT_270	[p16l1033t313r1152b380],
7	]	NN	O	]	appos	3	SENT_270	[p16l1033t313r1152b380],
8	,	,	O	,	_	0	SENT_270	[p16l1033t313r1152b380],
9	Ganey	NNP	PERSON	Ganey	nn	10	SENT_270	[p16l1194t312r1408b389],
10	PE	NNP	O	PE	appos	3	SENT_270	[p16l1444t313r1552b379],
11	,	,	O	,	_	0	SENT_270	[p16l1444t313r1552b379],
12	Roth	NNP	PERSON	Roth	nn	13	SENT_270	[p16l1594t309r1759b370],
13	RA	NN	O	ra	appos	3	SENT_270	[p16l1797t312r1918b370],
14	.	.	O	.	_	0	SENT_270	[p16l1797t312r1918b370],

1	Lipopolysaccharide	NN	PERSON	lipopolysaccharide	nn	4	SENT_271	[p16l1961t311r2141b388, p16l144t402r643b482],
2	and	CC	O	and	_	0	SENT_271	[p16l709t402r833b463],
3	trovaﬂoxacin	NN	O	trovaﬂoxacin	conj_and	1	SENT_271	[p16l897t402r1343b463],
4	coexposure	NN	O	coexposure	nsubj	7	SENT_271	[p16l1409t423r1789b481],
5	in	IN	O	in	_	0	SENT_271	[p16l1855t404r1920b462],
6	mice	NNS	O	mouse	prep_in	4	SENT_271	[p16l1985t404r2144b463],
7	causes	VBZ	O	cause	_	0	SENT_271	[p16l146t518r354b557],
8	idiosyncrasy	NN	O	idiosyncrasy	nsubj	13	SENT_271	[p16l392t495r959b577],
9	—	CD	NUMBER	—	num	8	SENT_271	[p16l392t495r959b577],
10	like	IN	O	like	_	0	SENT_271	[p16l392t495r959b577],
11	liver	NN	O	liver	nn	12	SENT_271	[p16l995t495r1143b557],
12	injury	NN	O	injury	prep_like	8	SENT_271	[p16l1179t498r1383b577],
13	dependent	JJ	O	dependent	xcomp	7	SENT_271	[p16l1417t496r1772b576],
14	on	IN	O	on	_	0	SENT_271	[p16l1809t518r1895b557],
15	tumor	NN	O	tumor	nn	17	SENT_271	[p16l1930t508r2145b557],
16	necrosis	NN	O	necrosis	nn	17	SENT_271	[p16l145t591r415b650],
17	factor-alpha	NN	O	factor-alpha	prep_on	13	SENT_271	[p16l441t588r869b668],
18	.	.	O	.	_	0	SENT_271	[p16l441t588r869b668],

1	Toxicol	NNP	O	Toxicol	nn	2	SENT_272	[p16l901t588r1136b650],
2	Sci	NNP	O	Sci	_	0	SENT_272	[p16l1160t591r1250b650],
3	2007	CD	DATE	2007	num	2	SENT_272	[p16l1274t595r1451b659],
4	;	:	O	;	_	0	SENT_272	[p16l1274t595r1451b659],
5	100	CD	NUMBER	100	num	7	SENT_272	[p16l1483t595r1616b650],
6	:	:	O	:	_	0	SENT_272	[p16l1483t595r1616b650],
7	259-66	CD	NUMBER	259-66	dep	2	SENT_272	[p16l1644t594r1903b650],
8	.	.	O	.	_	0	SENT_272	[p16l1644t594r1903b650],

1	Tukov	NNP	O	Tukov	nn	2	SENT_273	[p16l145t682r366b743],
2	FF	NNP	O	FF	_	0	SENT_273	[p16l396t686r496b752],
3	,	,	O	,	_	0	SENT_273	[p16l396t686r496b752],
4	Luyendyk	NNP	PERSON	Luyendyk	nn	5	SENT_273	[p16l531t682r863b762],
5	IP	NNP	O	IP	appos	2	SENT_273	[p16l893t686r984b753],
6	,	,	O	,	_	0	SENT_273	[p16l893t686r984b753],
7	Ganey	NNP	PERSON	Ganey	nn	8	SENT_273	[p16l1019t685r1234b762],
8	PE	NNP	O	PE	appos	2	SENT_273	[p16l1263t686r1371b752],
9	,	,	O	,	_	0	SENT_273	[p16l1263t686r1371b752],
10	Roth	NNP	PERSON	Roth	nn	11	SENT_273	[p16l1406t682r1570b743],
11	RA	NN	O	ra	appos	2	SENT_273	[p16l1603t685r1723b743],
12	.	.	O	.	_	0	SENT_273	[p16l1603t685r1723b743],

1	The	DT	O	the	det	2	SENT_274	[p16l1759t682r1887b743],
2	role	NN	O	role	_	0	SENT_274	[p16l1919t682r2047b743],
3	of	IN	O	of	_	0	SENT_274	[p16l2080t682r2154b743],
4	tumor	NN	O	tumor	nn	6	SENT_274	[p16l144t788r360b837],
5	necrosis	NN	O	necrosis	nn	6	SENT_274	[p16l398t778r668b837],
6	factor	NN	O	factor	prep_of	2	SENT_274	[p16l708t775r904b837],
7	alpha	NN	O	alpha	amod	2	SENT_274	[p16l943t775r1125b856],
8	in	IN	O	in	_	0	SENT_274	[p16l1164t778r1229b837],
9	lipopolysaccharide/raniti	NNS	O	lipopolysaccharide/raniti	prep_in	7	SENT_274	[p16l1268t775r2141b857],
10	—	CD	NUMBER	—	num	14	SENT_274	[p16l1268t775r2141b857],
11	dine-induced	JJ	O	dine-induced	amod	14	SENT_274	[p16l146t870r597b932],
12	inﬂammatory	JJ	O	inﬂammatory	amod	14	SENT_274	[p16l632t869r1100b951],
13	liver	NN	O	liver	nn	14	SENT_274	[p16l1130t869r1278b931],
14	injury	NN	O	injury	dep	9	SENT_274	[p16l1312t872r1530b951],
15	.	.	O	.	_	0	SENT_274	[p16l1312t872r1530b951],

1	Toxicol	NNP	O	Toxicol	nn	2	SENT_275	[p16l1572t869r1807b931],
2	Sci	NNP	O	Sci	_	0	SENT_275	[p16l1841t872r1932b932],
3	2007	CD	DATE	2007	num	2	SENT_275	[p16l1966t876r2143b941],
4	;	:	O	;	_	0	SENT_275	[p16l1966t876r2143b941],
5	100	CD	NUMBER	100	num	7	SENT_275	[p16l151t969r283b1025],
6	:	:	O	:	_	0	SENT_275	[p16l151t969r283b1025],
7	267-80	CD	NUMBER	267-80	dep	2	SENT_275	[p16l311t969r570b1025],
8	.	.	O	.	_	0	SENT_275	[p16l311t969r570b1025],

1	Elahi	NNP	PERSON	Elahi	nn	2	SENT_276	[p16l145t1057r315b1118],
2	MM	NN	O	mm	_	0	SENT_276	[p16l360t1061r527b1127],
3	,	,	O	,	_	0	SENT_276	[p16l360t1061r527b1127],
4	Asotra	NNP	PERSON	Asotra	nn	5	SENT_276	[p16l573t1060r795b1118],
5	K	NNP	PERSON	K	appos	2	SENT_276	[p16l841t1061r911b1127],
6	,	,	O	,	_	0	SENT_276	[p16l841t1061r911b1127],
7	Matata	NNP	ORGANIZATION	Matata	nn	8	SENT_276	[p16l959t1061r1197b1118],
8	BM	NN	ORGANIZATION	bm	appos	2	SENT_276	[p16l1243t1061r1382b1127],
9	,	,	O	,	_	0	SENT_276	[p16l1243t1061r1382b1127],
10	Mastana	NNP	O	Mastana	nn	11	SENT_276	[p16l1430t1061r1717b1118],
11	SS	NNP	O	SS	appos	2	SENT_276	[p16l1764t1060r1857b1118],
12	.	.	O	.	_	0	SENT_276	[p16l1764t1060r1857b1118],

1	Tumor	NN	O	tumor	nn	7	SENT_277	[p16l1907t1059r2146b1118],
2	necrosis	NN	O	necrosis	nn	7	SENT_277	[p16l145t1153r415b1212],
3	factor	NN	O	factor	nn	7	SENT_277	[p16l449t1150r645b1212],
4	alpha	NN	O	alpha	nn	7	SENT_277	[p16l679t1150r861b1231],
5	-308	CD	NUMBER	-308	num	7	SENT_277	[p16l896t1157r1040b1212],
6	gene	NN	O	gene	nn	7	SENT_277	[p16l1077t1173r1228b1232],
7	locus	NN	O	locus	_	0	SENT_277	[p16l1260t1150r1433b1212],
8	promoter	NN	O	promoter	nn	9	SENT_277	[p16l1467t1163r1791b1231],
9	polymorphism	NN	O	polymorphism	dep	7	SENT_277	[p16l1823t1150r2141b1232, p16l144t1244r371b1323],
10	:	:	O	:	_	0	SENT_277	[p16l1823t1150r2141b1232, p16l144t1244r371b1323],
11	an	DT	O	a	det	12	SENT_277	[p16l408t1265r487b1305],
12	analysis	NN	O	analysis	dep	7	SENT_277	[p16l520t1244r777b1324],
13	of	IN	O	of	_	0	SENT_277	[p16l812t1244r886b1305],
14	association	NN	O	association	prep_of	12	SENT_277	[p16l910t1246r1281b1305],
15	with	IN	O	with	_	0	SENT_277	[p16l1312t1244r1463b1305],
16	health	NN	O	health	prep_with	14	SENT_277	[p16l1495t1244r1703b1305],
17	and	CC	O	and	_	0	SENT_277	[p16l1736t1244r1860b1305],
18	disease	NN	O	disease	conj_and	16	SENT_277	[p16l1893t1244r2141b1305],
19	.	.	O	.	_	0	SENT_277	[p16l1893t1244r2141b1305],

1	Biochim	NNP	O	Biochim	nn	3	SENT_278	[p16l143t1337r412b1398],
2	Biophys	NNP	O	Biophys	nn	3	SENT_278	[p16l436t1337r691b1417],
3	Actu	NNP	O	Actu	_	0	SENT_278	[p16l710t1340r862b1398],
4	2009	CD	DATE	2009	num	3	SENT_278	[p16l887t1343r1064b1407],
5	;	:	DATE	;	_	0	SENT_278	[p16l887t1343r1064b1407],
6	1792	CD	DATE	1792	num	8	SENT_278	[p16l1095t1343r1270b1398],
7	:	:	O	:	_	0	SENT_278	[p16l1095t1343r1270b1398],
8	163-72	CD	NUMBER	163-72	dep	3	SENT_278	[p16l1306t1342r1557b1398],
9	.	.	O	.	_	0	SENT_278	[p16l1306t1342r1557b1398],

1	Pirmohamed	NNP	O	Pirmohamed	nn	2	SENT_279	[p16l146t1430r589b1491],
2	M	NNP	O	M	_	0	SENT_279	[p16l619t1434r711b1500],
3	,	,	O	,	_	0	SENT_279	[p16l619t1434r711b1500],
4	Lin	NNP	PERSON	Lin	nn	5	SENT_279	[p16l745t1432r855b1490],
5	K	NNP	PERSON	K	appos	2	SENT_279	[p16l887t1434r957b1500],
6	,	,	O	,	_	0	SENT_279	[p16l887t1434r957b1500],
7	Chadwick	NNP	PERSON	Chadwick	nn	8	SENT_279	[p16l991t1430r1329b1491],
8	D	NNP	O	D	appos	2	SENT_279	[p16l1358t1434r1434b1500],
9	,	,	O	,	_	0	SENT_279	[p16l1358t1434r1434b1500],
10	Park	NNP	O	Park	nn	11	SENT_279	[p16l1468t1430r1624b1491],
11	BK	NNP	O	BK	appos	2	SENT_279	[p16l1653t1434r1771b1491],
12	.	.	O	.	_	0	SENT_279	[p16l1653t1434r1771b1491],

1	TNFalpha	NN	O	tnfalpha	nn	3	SENT_280	[p16l1806t1430r2145b1509],
2	promoter	NN	O	promoter	nn	3	SENT_280	[p16l144t1535r469b1602],
3	region	NN	O	region	_	0	SENT_280	[p16l504t1525r718b1603],
4	gene	NN	O	gene	nn	5	SENT_280	[p16l754t1544r905b1603],
5	polymorphisms	NNS	O	polymorphism	dep	3	SENT_280	[p16l939t1523r1471b1603],
6	in	IN	O	in	_	0	SENT_280	[p16l1508t1525r1573b1583],
7	carbamazepine	NN	O	carbamazepine	npadvmod	9	SENT_280	[p16l1609t1523r2141b1602],
8	—	CD	NUMBER	—	num	7	SENT_280	[p16l1609t1523r2141b1602],
9	hypersensitive	JJ	O	hypersensitive	amod	10	SENT_280	[p16l144t1616r623b1696],
10	patients	NNS	O	patient	prep_in	5	SENT_280	[p16l647t1618r930b1695],
11	.	.	O	.	_	0	SENT_280	[p16l647t1618r930b1695],

1	Neurology	NNP	O	Neurology	_	0	SENT_281	[p16l956t1616r1295b1696],
2	2001	CD	DATE	2001	num	1	SENT_281	[p16l1317t1622r1493b1686],
3	;	:	O	;	_	0	SENT_281	[p16l1317t1622r1493b1686],
4	56	CD	NUMBER	56	num	6	SENT_281	[p16l1521t1621r1617b1677],
5	:	:	O	:	_	0	SENT_281	[p16l1521t1621r1617b1677],
6	890-6	CD	NUMBER	890-6	dep	1	SENT_281	[p16l1646t1621r1863b1677],
7	.	.	O	.	_	0	SENT_281	[p16l1646t1621r1863b1677],

1	Bernal	NNP	PERSON	Bernal	nn	2	SENT_282	[p16l146t1710r362b1772],
2	W	NNP	PERSON	W	_	0	SENT_282	[p16l389t1715r486b1781],
3	,	,	O	,	_	0	SENT_282	[p16l389t1715r486b1781],
4	Donaldson	NNP	ORGANIZATION	Donaldson	nn	5	SENT_282	[p16l519t1710r890b1772],
5	P	NN	ORGANIZATION	p	appos	2	SENT_282	[p16l920t1715r982b1781],
6	,	,	O	,	_	0	SENT_282	[p16l920t1715r982b1781],
7	Underhill	NNP	PERSON	Underhill	nn	8	SENT_282	[p16l1014t1710r1340b1772],
8	I	NNP	O	I	appos	2	SENT_282	[p16l1370t1715r1413b1782],
9	,	,	O	,	_	0	SENT_282	[p16l1370t1715r1413b1782],
10	Wendon	NNP	O	Wendon	nn	14	SENT_282	[p16l1442t1710r1738b1772],
11	I	PRP	O	I	dep	14	SENT_282	[p16l1768t1715r1811b1782],
12	,	,	O	,	_	0	SENT_282	[p16l1768t1715r1811b1782],
13	Williams	NNP	PERSON	Williams	dep	14	SENT_282	[p16l1840t1710r2144b1772],
14	R.	NNP	O	R.	appos	2	SENT_282	[p16l146t1807r212b1864],
15	Tumor	NN	O	tumor	nn	17	SENT_282	[p16l239t1805r478b1864],
16	necrosis	NN	O	necrosis	nn	17	SENT_282	[p16l501t1805r771b1864],
17	factor	NN	O	factor	dep	14	SENT_282	[p16l796t1803r991b1864],
18	genomic	JJ	O	genomic	amod	19	SENT_282	[p16l1015t1805r1303b1883],
19	polymorphism	NN	O	polymorphism	dep	2	SENT_282	[p16l1326t1803r1829b1883],
20	and	CC	O	and	_	0	SENT_282	[p16l1853t1803r1977b1864],
21	outcome	NN	O	outcome	conj_and	19	SENT_282	[p16l2002t1815r2141b1864, p16l146t1917r326b1957],
22	of	IN	O	of	_	0	SENT_282	[p16l352t1896r426b1957],
23	acetaminophen	NN	O	acetaminophen	prep_of	19	SENT_282	[p16l442t1896r963b1975],
24	(	CD	NUMBER	(	dep	2	SENT_282	[p16l992t1896r1772b1975],
25	paracetamol	NNP	O	paracetamol	nn	26	SENT_282	[p16l992t1896r1772b1975],
26	)	NNP	O	)	dep	24	SENT_282	[p16l992t1896r1772b1975],
27	.	.	O	.	_	0	SENT_282	[p16l992t1896r1772b1975],

1	—	NN	O	—	_	0	SENT_283	[p16l992t1896r1772b1975],
2	.	.	O	.	_	0	SENT_283	[p16l992t1896r1772b1975],

1	induced	VBN	O	induce	_	0	SENT_284	[p16l992t1896r1772b1975],
2	acute	JJ	O	acute	amod	4	SENT_284	[p16l1798t1908r1974b1957],
3	liver	NN	O	liver	nn	4	SENT_284	[p16l1997t1896r2145b1957],
4	faﬂure	NN	O	faﬂure	dobj	1	SENT_284	[p16l145t1989r1242b2069],
5	,	,	O	,	_	0	SENT_284	[p16l145t1989r1242b2069],
6	IIﬂqnuol1998	NN	O	iiﬂqnuol1998	appos	4	SENT_284	[p16l145t1989r1242b2069],
7	;	:	O	;	_	0	SENT_284	[p16l145t1989r1242b2069],
8	29:53	CD	NUMBER	29:53	num	9	SENT_284	[p16l145t1989r1242b2069],
9	-9	CD	NUMBER	-9	dep	4	SENT_284	[p16l145t1989r1242b2069],
10	.	.	O	.	_	0	SENT_284	[p16l145t1989r1242b2069],

1	Pachkoria	NN	LOCATION	pachkorium	nn	2	SENT_285	[p16l146t2082r484b2143],
2	K	NN	LOCATION	k	_	0	SENT_285	[p16l518t2087r588b2153],
3	,	,	O	,	_	0	SENT_285	[p16l518t2087r588b2153],
4	Lucena	NNP	ORGANIZATION	Lucena	nn	5	SENT_285	[p16l626t2087r867b2143],
5	MI	NNP	ORGANIZATION	MI	appos	2	SENT_285	[p16l901t2087r1021b2153],
6	,	,	O	,	_	0	SENT_285	[p16l901t2087r1021b2153],
7	Crespo	NNP	PERSON	Crespo	nn	8	SENT_285	[p16l1059t2085r1293b2162],
8	E	NNP	O	E	appos	2	SENT_285	[p16l1330t2087r1392b2153],
9	,	,	O	,	_	0	SENT_285	[p16l1330t2087r1392b2153],
10	et	FW	O	et	nn	11	SENT_285	[p16l1430t2095r1489b2143],
11	al.	FW	O	al.	appos	2	SENT_285	[p16l1519t2082r1591b2143],
12	.	.	O	.	_	0	SENT_285	[p16l1519t2082r1591b2143],

1	Analysis	NN	O	analysis	nsubj	14	SENT_286	[p16l1629t2082r1907b2162],
2	of	IN	O	of	_	0	SENT_286	[p16l1944t2082r2018b2143],
3	IL10	NN	O	il10	nn	10	SENT_286	[p16l2044t2087r2141b2142, p16l152t2181r241b2245],
4	,	,	O	,	_	0	SENT_286	[p16l2044t2087r2141b2142, p16l152t2181r241b2245],
5	IL-4	NN	O	il-4	nn	10	SENT_286	[p16l278t2179r418b2235],
6	and	CC	O	and	_	0	SENT_286	[p16l454t2175r577b2236],
7	TNF	NN	O	tnf	nn	10	SENT_286	[p16l611t2175r982b2254],
8	—	NN	O	—	nn	10	SENT_286	[p16l611t2175r982b2254],
9	alpha	NN	O	alpha	nn	10	SENT_286	[p16l611t2175r982b2254],
10	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_286	[p16l1015t2175r1546b2255],
11	in	IN	O	in	_	0	SENT_286	[p16l1582t2177r1647b2235],
12	drug	NN	O	drug	nn	13	SENT_286	[p16l1682t2175r2144b2255],
13	—	NN	O	—	prep_in	1	SENT_286	[p16l1682t2175r2144b2255],
14	induced	VBD	O	induce	_	0	SENT_286	[p16l1682t2175r2144b2255],
15	liver	NN	O	liver	nn	16	SENT_286	[p16l144t2268r292b2329],
16	injury	NN	O	injury	iobj	14	SENT_286	[p16l330t2270r534b2348],
17	(	CD	NUMBER	(	num	18	SENT_286	[p16l575t2268r787b2342],
18	DILI	NNP	LOCATION	DILI	dobj	14	SENT_286	[p16l575t2268r787b2342],
19	)	CD	NUMBER	)	num	18	SENT_286	[p16l575t2268r787b2342],
20	and	CC	O	and	_	0	SENT_286	[p16l833t2268r957b2329],
21	its	PRP$	O	its	poss	22	SENT_286	[p16l995t2270r1070b2329],
22	outcome	NN	O	outcome	conj_and	18	SENT_286	[p16l1111t2280r1424b2329],
23	.	.	O	.	_	0	SENT_286	[p16l1111t2280r1424b2329],

1	I	PRP	O	I	nsubj	2	SENT_287	[p16l1461t2272r1497b2339],
2	Heputol	VBP	O	heputol	_	0	SENT_287	[p16l1527t2268r1790b2348],
3	2008	CD	DATE	2008	dobj	2	SENT_287	[p16l1827t2274r2004b2338],
4	;	:	O	;	_	0	SENT_287	[p16l1827t2274r2004b2338],
5	49	CD	NUMBER	49	num	7	SENT_287	[p16l2044t2274r2141b2329],
6	:	:	O	:	_	0	SENT_287	[p16l2044t2274r2141b2329],
7	107-14	CD	NUMBER	107-14	dep	3	SENT_287	[p16l152t2367r404b2423],
8	.	.	O	.	_	0	SENT_287	[p16l152t2367r404b2423],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_288	[p16l145t2458r290b2517],
2	SH	NNP	O	SH	_	0	SENT_288	[p16l326t2459r445b2528],
3	,	,	O	,	_	0	SENT_288	[p16l326t2459r445b2528],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_288	[p16l483t2458r627b2517],
5	SH	NNP	O	SH	appos	2	SENT_288	[p16l662t2460r782b2528],
6	,	,	O	,	_	0	SENT_288	[p16l662t2460r782b2528],
7	Yoon	NNP	PERSON	Yoon	nn	9	SENT_288	[p16l816t2461r1000b2518],
8	H	NNP	O	H	nn	9	SENT_288	[p16l1034t2461r1142b2529],
9	]	NN	O	]	appos	2	SENT_288	[p16l1034t2461r1142b2529],
10	,	,	O	,	_	0	SENT_288	[p16l1034t2461r1142b2529],
11	Shin	NNP	PERSON	Shin	nn	12	SENT_288	[p16l1180t2456r1330b2518],
12	DH	NNP	PERSON	DH	appos	2	SENT_288	[p16l1365t2461r1507b2528],
13	,	,	O	,	_	0	SENT_288	[p16l1365t2461r1507b2528],
14	et	FW	O	et	nn	15	SENT_288	[p16l1545t2469r1603b2518],
15	al.	FW	O	al.	appos	2	SENT_288	[p16l1634t2456r1705b2518],
16	.	.	O	.	_	0	SENT_288	[p16l1634t2456r1705b2518],

1	GSTT1	NN	O	gstt1	nsubj	9	SENT_289	[p16l1748t2459r1979b2518],
2	and	CC	O	and	_	0	SENT_289	[p16l2021t2456r2145b2518],
3	GSTM1	NN	O	gstm1	nn	5	SENT_289	[p16l146t2551r403b2610],
4	null	JJ	O	null	amod	5	SENT_289	[p16l442t2549r573b2610],
5	mutations	NNS	O	mutation	nsubj	9	SENT_289	[p16l607t2551r950b2610],
6	and	CC	O	and	_	0	SENT_289	[p16l985t2549r1109b2610],
7	adverse	JJ	O	adverse	amod	8	SENT_289	[p16l1143t2549r1390b2610],
8	reactions	NNS	O	reaction	conj_and	1	SENT_289	[p16l1425t2551r1728b2610],
9	induced	VBN	O	induce	_	0	SENT_289	[p16l1763t2549r2034b2610],
10	by	IN	O	by	_	0	SENT_289	[p16l2065t2549r2148b2629],
11	antituberculosis	NN	O	antituberculosis	nn	12	SENT_289	[p16l146t2642r684b2703],
12	drugs	NNS	O	drug	prep_by	9	SENT_289	[p16l736t2642r922b2722],
13	in	IN	O	in	_	0	SENT_289	[p16l973t2644r1038b2702],
14	Koreans	NNPS	LOCATION	Koreans	prep_in	12	SENT_289	[p16l1088t2647r1380b2703],
15	.	.	O	.	_	0	SENT_289	[p16l1088t2647r1380b2703],

1	Tuberculosis	NN	O	tuberculosis	nn	3	SENT_290	[p16l1439t2642r1840b2703],
2	(	CD	NUMBER	(	num	3	SENT_290	[p16l1895t2642r2141b2716],
3	Edinb	NNP	O	Edinb	_	0	SENT_290	[p16l1895t2642r2141b2716],
4	)	CD	NUMBER	)	num	5	SENT_290	[p16l1895t2642r2141b2716],
5	2010	CD	DATE	2010	dep	3	SENT_290	[p16l145t2741r691b2807],
6	;	:	O	;	_	0	SENT_290	[p16l145t2741r691b2807],
7	90:39	CD	NUMBER	90:39	num	8	SENT_290	[p16l145t2741r691b2807],
8	-43	CD	NUMBER	-43	dep	3	SENT_290	[p16l145t2741r691b2807],
9	.	.	O	.	_	0	SENT_290	[p16l145t2741r691b2807],

1	Han	NNP	MISC	Han	nn	2	SENT_291	[p16l145t2833r290b2890],
2	W	NNP	O	W	_	0	SENT_291	[p16l330t2833r427b2900],
3	,	,	O	,	_	0	SENT_291	[p16l330t2833r427b2900],
4	Kang	NNP	PERSON	Kang	nn	5	SENT_291	[p16l473t2833r647b2910],
5	D	NNP	PERSON	D	appos	2	SENT_291	[p16l688t2833r765b2900],
6	,	,	O	,	_	0	SENT_291	[p16l688t2833r765b2900],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_291	[p16l810t2833r921b2890],
8	IE	NN	O	ie	appos	2	SENT_291	[p16l964t2833r1054b2901],
9	,	,	O	,	_	0	SENT_291	[p16l964t2833r1054b2901],
10	et	FW	O	et	nn	11	SENT_291	[p16l1099t2841r1158b2890],
11	ul	FW	O	ul	appos	2	SENT_291	[p16l1188t2828r1260b2890],
12	.	.	O	.	_	0	SENT_291	[p16l1188t2828r1260b2890],

1	A	DT	O	a	det	3	SENT_292	[p16l1306t2832r1361b2889],
2	haplotype	NN	O	haplotype	nn	3	SENT_292	[p16l1401t2828r1735b2910],
3	analysis	NN	O	analysis	_	0	SENT_292	[p16l1779t2828r2036b2909],
4	of	IN	O	of	_	0	SENT_292	[p16l2080t2828r2154b2890],
5	HER	NN	O	her	nn	9	SENT_292	[p16l145t2926r376b2983],
6	—	NN	O	—	nn	9	SENT_292	[p16l145t2926r376b2983],
7	2	CD	NUMBER	2	num	9	SENT_292	[p16l145t2926r376b2983],
8	gene	NN	O	gene	nn	9	SENT_292	[p16l447t2944r599b3002],
9	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_292	[p16l666t2922r1215b3002],
10	:	:	O	:	_	0	SENT_292	[p16l666t2922r1215b3002],
11	association	NN	O	association	conj_and	3	SENT_292	[p16l1288t2924r1660b2983],
12	with	IN	O	with	_	0	SENT_292	[p16l1726t2922r1876b2983],
13	breast	NN	O	breast	nn	15	SENT_292	[p16l1943t2922r2145b2983],
14	cancer	NN	O	cancer	nn	15	SENT_292	[p16l146t3037r362b3076],
15	risk	NN	O	risk	prep_with	11	SENT_292	[p16l397t3015r536b3086],
16	,	,	O	,	_	0	SENT_292	[p16l397t3015r536b3086],
17	HER	NN	O	her	nn	18	SENT_292	[p16l574t3020r804b3076],
18	—	NN	O	—	appos	15	SENT_292	[p16l574t3020r804b3076],
19	2	CD	NUMBER	2	num	21	SENT_292	[p16l574t3020r804b3076],
20	protein	NN	O	protein	nn	21	SENT_292	[p16l840t3017r1088b3095],
21	expression	NN	O	expression	dep	18	SENT_292	[p16l1123t3017r1478b3095],
22	in	IN	O	in	_	0	SENT_292	[p16l1513t3017r1578b3075],
23	the	DT	O	the	det	24	SENT_292	[p16l1612t3015r1716b3076],
24	tumor	NN	O	tumor	prep_in	11	SENT_292	[p16l1750t3027r1983b3086],
25	,	,	O	,	_	0	SENT_292	[p16l1750t3027r1983b3086],
26	and	CC	O	and	_	0	SENT_292	[p16l2021t3015r2145b3076],
27	disease	NN	O	disease	nn	28	SENT_292	[p16l146t3107r377b3168],
28	recurrence	NN	O	recurrence	conj_and	3	SENT_292	[p16l424t3129r780b3168],
29	in	IN	O	in	_	0	SENT_292	[p16l827t3109r893b3168],
30	Korea	NNP	LOCATION	Korea	prep_in	28	SENT_292	[p16l939t3112r1154b3168],
31	.	.	O	.	_	0	SENT_292	[p16l939t3112r1154b3168],

1	Clin	NNP	O	Clin	nn	3	SENT_293	[p16l1208t3107r1343b3169],
2	Cancer	NNP	O	Cancer	nn	3	SENT_293	[p16l1393t3111r1623b3169],
3	Res	NNP	O	Res	_	0	SENT_293	[p16l1664t3112r1774b3168],
4	2005	CD	DATE	2005	num	3	SENT_293	[p16l1820t3113r1996b3178],
5	;	:	O	;	_	0	SENT_293	[p16l1820t3113r1996b3178],
6	11	CD	NUMBER	11	dep	3	SENT_293	[p16l2050t3113r2141b3168],
7	:	:	O	:	_	0	SENT_293	[p16l2050t3113r2141b3168],

1	Chun	NNP	PERSON	Chun	nn	3	SENT_294	[p16l146t3295r334b3356],
2	L	NNP	O	L	nn	3	SENT_294	[p16l359t3300r446b3367],
3	]	NN	O	]	_	0	SENT_294	[p16l359t3300r446b3367],
4	,	,	O	,	_	0	SENT_294	[p16l359t3300r446b3367],
5	Tong	NNP	O	Tong	nn	7	SENT_294	[p16l473t3298r651b3375],
6	M	NNP	O	M	nn	7	SENT_294	[p16l674t3300r793b3367],
7	]	NN	O	]	appos	3	SENT_294	[p16l674t3300r793b3367],
8	,	,	O	,	_	0	SENT_294	[p16l674t3300r793b3367],
9	Busuttil	NNP	PERSON	Busuttil	nn	10	SENT_294	[p16l821t3295r1085b3356],
10	RW	NNP	O	RW	appos	3	SENT_294	[p16l1110t3300r1257b3366],
11	,	,	O	,	_	0	SENT_294	[p16l1110t3300r1257b3366],
12	Hiatt	NNP	PERSON	Hiatt	nn	13	SENT_294	[p16l1284t3297r1459b3356],
13	IR	NNP	O	IR	appos	3	SENT_294	[p16l1483t3300r1577b3367],
14	.	.	O	.	_	0	SENT_294	[p16l1483t3300r1577b3367],

1	Acetaminophen	NN	O	acetaminophen	_	0	SENT_295	[p16l1603t3295r2144b3375],
2	hepatotoxicity	NN	O	hepatotoxicity	nn	6	SENT_295	[p16l144t3388r634b3469],
3	and	CC	O	and	_	0	SENT_295	[p16l664t3388r788b3450],
4	acute	JJ	O	acute	nn	6	SENT_295	[p16l821t3401r997b3450],
5	liver	NN	O	liver	nn	6	SENT_295	[p16l1029t3388r1176b3450],
6	failure	NN	O	failure	dep	1	SENT_295	[p16l1208t3388r1439b3450],
7	.	.	O	.	_	0	SENT_295	[p16l1208t3388r1439b3450],

1	I	PRP	O	I	nsubj	2	SENT_296	[p16l1471t3393r1507b3460],
2	Clin	VBP	O	clin	_	0	SENT_296	[p16l1536t3388r1671b3450],
3	Gustroenterol	JJ	O	gustroenterol	amod	4	SENT_296	[p16l1708t3388r2146b3450],
4	2009	CD	DATE	2009	dobj	2	SENT_296	[p16l146t3488r322b3553],
5	;	:	O	;	_	0	SENT_296	[p16l146t3488r322b3553],
6	43	CD	NUMBER	43	num	8	SENT_296	[p16l348t3488r445b3544],
7	:	:	O	:	_	0	SENT_296	[p16l348t3488r445b3544],
8	342-9	CD	NUMBER	342-9	dep	4	SENT_296	[p16l475t3488r692b3544],
9	.	.	O	.	_	0	SENT_296	[p16l475t3488r692b3544],

1	23	CD	NUMBER	23	_	0	SENT_297	[p17l6t24r100b79],
2	.	.	O	.	_	0	SENT_297	[p17l6t24r100b79],

1	Phillips	NNP	PERSON	Phillips	nn	2	SENT_298	[p17l146t18r397b98],
2	E	NNP	O	E	_	0	SENT_298	[p17l420t23r510b90],
3	]	NN	O	]	dep	2	SENT_298	[p17l420t23r510b90],
4	,	,	O	,	_	0	SENT_298	[p17l420t23r510b90],
5	Chung	NNP	PERSON	Chung	nn	6	SENT_298	[p17l535t18r763b98],
6	WH	NNP	PERSON	WH	appos	3	SENT_298	[p17l781t23r945b89],
7	,	,	O	,	_	0	SENT_298	[p17l781t23r945b89],
8	Mockenhaupt	NNP	O	Mockenhaupt	nn	9	SENT_298	[p17l968t18r1443b98],
9	M	NNP	O	M	appos	3	SENT_298	[p17l1465t23r1555b89],
10	,	,	O	,	_	0	SENT_298	[p17l1465t23r1555b89],
11	Roujeau	NNP	PERSON	Roujeau	nn	12	SENT_298	[p17l1580t20r1859b98],
12	IC	NN	PERSON	ic	appos	3	SENT_298	[p17l1881t21r1980b90],
13	,	,	O	,	_	0	SENT_298	[p17l1881t21r1980b90],
14	Mallal	JJ	ORGANIZATION	mallal	amod	15	SENT_298	[p17l2004t23r2141b79, p17l144t111r243b173],
15	SA	NNP	ORGANIZATION	SA	appos	3	SENT_298	[p17l269t115r377b173],
16	.	.	O	.	_	0	SENT_298	[p17l269t115r377b173],

1	Drug	NN	O	drug	nn	2	SENT_299	[p17l406t116r581b193],
2	hypersensitivity	NN	O	hypersensitivity	_	0	SENT_299	[p17l605t111r1152b193],
3	:	:	O	:	_	0	SENT_299	[p17l605t111r1152b193],
4	pharmacogenetics	NNS	O	pharmacogenetic	dep	2	SENT_299	[p17l1181t111r1791b193],
5	and	CC	O	and	_	0	SENT_299	[p17l1820t111r1944b173],
6	clinical	JJ	O	clinical	amod	7	SENT_299	[p17l1970t111r2141b173, p17l146t206r236b267],
7	syndromes	NNS	O	syndrome	dep	2	SENT_299	[p17l258t205r639b287],
8	.	.	O	.	_	0	SENT_299	[p17l258t205r639b287],

1	[	RB	O	[	dep	2	SENT_300	[p17l660t205r941b287],
2	Allergy	NNP	O	Allergy	dep	4	SENT_300	[p17l660t205r941b287],
3	Clin	NNP	O	Clin	nn	4	SENT_300	[p17l963t205r1098b268],
4	Immunol	NNP	O	Immunol	dep	9	SENT_300	[p17l1119t206r1428b267],
5	2011	CD	DATE	2011	num	7	SENT_300	[p17l1448t212r1625b277],
6	;	:	O	;	_	0	SENT_300	[p17l1448t212r1625b277],
7	127	CD	NUMBER	127	dep	4	SENT_300	[p17l1654t212r1787b267],
8	:	:	O	:	_	0	SENT_300	[p17l1654t212r1787b267],
9	S60-6	NN	O	s60-6	_	0	SENT_300	[p17l1814t209r2030b268],
10	.	.	O	.	_	0	SENT_300	[p17l1814t209r2030b268],

1	TNF	NN	O	tnf	nn	2	SENT_301	[p17l6t564r204b618],
2	—	NN	O	—	_	0	SENT_301	[p17l6t564r204b618],
3	oc	NN	O	oc	nn	4	SENT_301	[p17l6t564r204b618],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_301	[p17l229t561r718b633],
5	and	CC	O	and	_	0	SENT_301	[p17l746t561r871b618],
6	ATD-induced	JJ	O	atd-induced	amod	7	SENT_301	[p17l896t561r1344b618],
7	hepatitis	NN	O	hepatitis	dep	2	SENT_301	[p17l1373t561r1670b633],

1	24	CD	NUMBER	24	_	0	SENT_302	[p17l8t809r102b864],
2	.	.	O	.	_	0	SENT_302	[p17l8t809r102b864],

1	Russmann	NNP	PERSON	Russmann	nn	2	SENT_303	[p17l147t808r500b864],
2	S	NNP	PERSON	S	_	0	SENT_303	[p17l530t807r584b874],
3	,	,	O	,	_	0	SENT_303	[p17l530t807r584b874],
4	Ietter	NNP	O	Ietter	nn	5	SENT_303	[p17l615t808r795b875],
5	A	NNP	O	A	appos	2	SENT_303	[p17l821t807r892b874],
6	,	,	O	,	_	0	SENT_303	[p17l821t807r892b874],
7	Kullak-Ublick	NNP	PERSON	Kullak-Ublick	nn	8	SENT_303	[p17l925t803r1401b865],
8	GA.	NNP	O	GA.	appos	5	SENT_303	[p17l1430t807r1555b865],
9	.	.	O	.	_	0	SENT_303	[p17l1430t807r1555b865],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	3	SENT_304	[p17l1588t803r2138b884],
2	—	CD	NUMBER	—	num	3	SENT_304	[p17l1588t803r2138b884],
3	ics	NNS	O	ic	nsubj	7	SENT_304	[p17l147t898r230b957],
4	of	IN	O	of	_	0	SENT_304	[p17l258t896r332b957],
5	drug	NN	O	drug	nn	6	SENT_304	[p17l350t896r812b976],
6	—	NN	O	—	prep_of	3	SENT_304	[p17l350t896r812b976],
7	induced	VBD	O	induce	_	0	SENT_304	[p17l350t896r812b976],
8	liver	NN	O	liver	nn	9	SENT_304	[p17l837t896r984b957],
9	injury	NN	O	injury	dobj	7	SENT_304	[p17l1010t898r1227b976],
10	.	.	O	.	_	0	SENT_304	[p17l1010t898r1227b976],

1	Hepatology	NNP	O	Hepatology	_	0	SENT_305	[p17l1255t896r1628b976],
2	2010	CD	DATE	2010	num	1	SENT_305	[p17l1652t902r1828b966],
3	;	:	O	;	_	0	SENT_305	[p17l1652t902r1828b966],
4	52	CD	NUMBER	52	num	6	SENT_305	[p17l1857t902r1953b957],
5	:	:	O	:	_	0	SENT_305	[p17l1857t902r1953b957],
6	74861	CD	NUMBER	74861	dep	1	SENT_305	[p17l1984t902r2145b957, p17l147t994r241b1049],
7	.	.	O	.	_	0	SENT_305	[p17l1984t902r2145b957, p17l147t994r241b1049],

1	25	CD	NUMBER	25	_	0	SENT_306	[p17l8t1087r102b1142],
2	.	.	O	.	_	0	SENT_306	[p17l8t1087r102b1142],

1	Masson	NNP	PERSON	Masson	nn	3	SENT_307	[p17l146t1086r406b1142],
2	M	NNP	O	M	nn	3	SENT_307	[p17l434t1086r553b1153],
3	]	NN	O	]	_	0	SENT_307	[p17l434t1086r553b1153],
4	,	,	O	,	_	0	SENT_307	[p17l434t1086r553b1153],
5	Collins	NNP	ORGANIZATION	Collins	nn	6	SENT_307	[p17l586t1081r821b1142],
6	LA	NNP	ORGANIZATION	LA	appos	3	SENT_307	[p17l852t1085r965b1152],
7	,	,	O	,	_	0	SENT_307	[p17l852t1085r965b1152],
8	Pohl	NNP	PERSON	Pohl	nn	9	SENT_307	[p17l997t1081r1152b1142],
9	LR	NNP	O	LR	appos	6	SENT_307	[p17l1181t1086r1292b1142],
10	.	.	O	.	_	0	SENT_307	[p17l1181t1086r1292b1142],

1	The	DT	O	the	det	2	SENT_308	[p17l1323t1081r1452b1142],
2	role	NN	O	role	_	0	SENT_308	[p17l1482t1081r1609b1142],
3	of	IN	O	of	_	0	SENT_308	[p17l1639t1081r1713b1142],
4	cytokines	NNS	O	cytokine	prep_of	2	SENT_308	[p17l1734t1081r2048b1161],
5	in	IN	O	in	_	0	SENT_308	[p17l2077t1083r2143b1141],
6	the	DT	O	the	det	7	SENT_308	[p17l145t1174r249b1235],
7	mechanism	NN	O	mechanism	prep_in	4	SENT_308	[p17l302t1174r688b1235],
8	of	IN	O	of	_	0	SENT_308	[p17l741t1174r815b1235],
9	adverse	JJ	O	adverse	amod	11	SENT_308	[p17l858t1174r1105b1235],
10	drug	NN	O	drug	nn	11	SENT_308	[p17l1158t1174r1316b1254],
11	reactions	NNS	O	reaction	prep_of	2	SENT_308	[p17l1367t1176r1687b1235],
12	.	.	O	.	_	0	SENT_308	[p17l1367t1176r1687b1235],

1	Hcmdb	NNP	O	Hcmdb	nn	3	SENT_309	[p17l1741t1174r1969b1235],
2	Exp	NNP	O	Exp	nn	3	SENT_309	[p17l2019t1178r2143b1254],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_309	[p17l144t1267r501b1328],
4	2010	CD	DATE	2010	num	3	SENT_309	[p17l524t1273r700b1338],
5	;	:	O	;	_	0	SENT_309	[p17l524t1273r700b1338],
6	196	CD	NUMBER	196	num	8	SENT_309	[p17l732t1273r864b1328],
7	:	:	O	:	_	0	SENT_309	[p17l732t1273r864b1328],
8	195-231	CD	NUMBER	195-231	dep	3	SENT_309	[p17l900t1273r1191b1328],
9	.	.	O	.	_	0	SENT_309	[p17l900t1273r1191b1328],

1	26	CD	NUMBER	26	_	0	SENT_310	[p17l8t1366r102b1421],
2	.	.	O	.	_	0	SENT_310	[p17l8t1366r102b1421],

1	Diehl	NNP	ORGANIZATION	Diehl	nn	2	SENT_311	[p17l147t1360r330b1421],
2	AM	NNP	ORGANIZATION	AM	_	0	SENT_311	[p17l359t1364r505b1421],
3	.	.	O	.	_	0	SENT_311	[p17l359t1364r505b1421],

1	Cytokine	NN	O	cytokine	nn	2	SENT_312	[p17l543t1360r847b1440],
2	regulation	NN	O	regulation	_	0	SENT_312	[p17l881t1360r1224b1440],
3	of	IN	O	of	_	0	SENT_312	[p17l1258t1360r1332b1421],
4	liver	NN	O	liver	nn	5	SENT_312	[p17l1354t1360r1502b1421],
5	injury	NN	O	injury	prep_of	2	SENT_312	[p17l1534t1362r1738b1440],
6	and	CC	O	and	_	0	SENT_312	[p17l1768t1360r1892b1421],
7	repair	NN	O	repair	conj_and	5	SENT_312	[p17l1925t1362r2139b1440],
8	.	.	O	.	_	0	SENT_312	[p17l1925t1362r2139b1440],

1	Immunol	NNP	O	Immunol	nn	2	SENT_313	[p17l145t1452r452b1513],
2	Rev	NN	O	rev	_	0	SENT_313	[p17l473t1457r595b1513],
3	2000	CD	DATE	2000	num	2	SENT_313	[p17l617t1458r793b1523],
4	;	:	O	;	_	0	SENT_313	[p17l617t1458r793b1523],
5	174	CD	NUMBER	174	num	7	SENT_313	[p17l825t1459r958b1513],
6	:	:	O	:	_	0	SENT_313	[p17l825t1459r958b1513],
7	160-71	CD	NUMBER	160-71	dep	2	SENT_313	[p17l993t1458r1244b1513],
8	.	.	O	.	_	0	SENT_313	[p17l993t1458r1244b1513],

1	27	CD	NUMBER	27	_	0	SENT_314	[p17l8t1552r102b1607],
2	.	.	O	.	_	0	SENT_314	[p17l8t1552r102b1607],

1	Morio	NNP	ORGANIZATION	Morio	nn	2	SENT_315	[p17l146t1548r358b1607],
2	LA	NNP	ORGANIZATION	LA	_	0	SENT_315	[p17l398t1549r511b1616],
3	,	,	O	,	_	0	SENT_315	[p17l398t1549r511b1616],
4	Chiu	NNP	PERSON	Chiu	nn	5	SENT_315	[p17l552t1546r717b1607],
5	H	NNP	PERSON	H	appos	2	SENT_315	[p17l754t1550r833b1617],
6	,	,	O	,	_	0	SENT_315	[p17l754t1550r833b1617],
7	Sprowles	NNP	O	Sprowles	nn	8	SENT_315	[p17l873t1546r1172b1625],
8	KA	NN	O	ka	appos	2	SENT_315	[p17l1210t1550r1334b1616],
9	,	,	O	,	_	0	SENT_315	[p17l1210t1550r1334b1616],
10	et	FW	O	et	nn	11	SENT_315	[p17l1375t1559r1434b1607],
11	al.	FW	O	al.	appos	2	SENT_315	[p17l1463t1546r1535b1607],
12	.	.	O	.	_	0	SENT_315	[p17l1463t1546r1535b1607],

1	Distinct	JJ	O	distinct	amod	2	SENT_316	[p17l1578t1548r1846b1607],
2	roles	NNS	O	role	nsubj	14	SENT_316	[p17l1883t1546r2040b1607],
3	of	IN	O	of	_	0	SENT_316	[p17l2078t1546r2152b1607],
4	tumor	NN	O	tumor	nn	6	SENT_316	[p17l146t1651r360b1700],
5	necrosis	NN	O	necrosis	nn	6	SENT_316	[p17l388t1641r658b1700],
6	factor-alpha	NN	O	factor-alpha	prep_of	2	SENT_316	[p17l687t1639r1098b1719],
7	and	CC	O	and	_	0	SENT_316	[p17l1126t1639r1250b1700],
8	nitric	JJ	O	nitric	amod	9	SENT_316	[p17l1278t1641r1459b1700],
9	oxide	NN	O	oxide	prep_of	2	SENT_316	[p17l1488t1639r1671b1700],
10	in	IN	O	in	_	0	SENT_316	[p17l1699t1641r1765b1699],
11	acute	JJ	O	acute	amod	13	SENT_316	[p17l1794t1651r1969b1700],
12	liver	NN	O	liver	nn	13	SENT_316	[p17l1996t1639r2143b1700],
13	injury	NN	O	injury	prep_in	6	SENT_316	[p17l147t1732r351b1811],
14	induced	VBN	O	induce	_	0	SENT_316	[p17l391t1730r662b1791],
15	by	IN	O	by	_	0	SENT_316	[p17l702t1730r785b1811],
16	carbon	NN	O	carbon	nn	17	SENT_316	[p17l826t1730r1058b1791],
17	tetrachloride	NN	O	tetrachloride	prep_by	14	SENT_316	[p17l1099t1730r1532b1791],
18	in	IN	O	in	_	0	SENT_316	[p17l1576t1732r1640b1791],
19	mice	NNS	O	mouse	prep_in	17	SENT_316	[p17l1683t1732r1859b1791],
20	.	.	O	.	_	0	SENT_316	[p17l1683t1732r1859b1791],

1	Toxicol	NNP	O	Toxicol	nn	3	SENT_317	[p17l1911t1730r2145b1791],
2	Appl	NNP	O	Appl	nn	3	SENT_317	[p17l142t1822r301b1903],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_317	[p17l322t1822r678b1884],
4	2001	CD	DATE	2001	num	3	SENT_317	[p17l701t1829r877b1893],
5	;	:	O	;	_	0	SENT_317	[p17l701t1829r877b1893],
6	172	CD	NUMBER	172	num	8	SENT_317	[p17l909t1829r1042b1884],
7	:	:	O	:	_	0	SENT_317	[p17l909t1829r1042b1884],
8	44-51	CD	NUMBER	44-51	dep	3	SENT_317	[p17l1069t1829r1287b1884],
9	.	.	O	.	_	0	SENT_317	[p17l1069t1829r1287b1884],

1	28	CD	NUMBER	28	_	0	SENT_318	[p17l8t1922r102b1977],
2	.	.	O	.	_	0	SENT_318	[p17l8t1922r102b1977],

1	Yamada	NNP	PERSON	Yamada	nn	2	SENT_319	[p17l144t1916r419b1977],
2	Y	NN	PERSON	y	_	0	SENT_319	[p17l441t1921r508b1987],
3	,	,	O	,	_	0	SENT_319	[p17l441t1921r508b1987],
4	Fausto	NNP	PERSON	Fausto	nn	8	SENT_319	[p17l536t1921r756b1977],
5	N.	NNP	PERSON	N.	nn	8	SENT_319	[p17l782t1921r859b1977],
6	Deﬁcient	NNP	PERSON	Deﬁcient	nn	8	SENT_319	[p17l887t1916r1193b1977],
7	liver	NN	O	liver	nn	8	SENT_319	[p17l1217t1916r1364b1977],
8	regeneration	NN	O	regeneration	appos	2	SENT_319	[p17l1388t1918r1812b1996],
9	after	IN	O	after	_	0	SENT_319	[p17l1837t1916r1988b1977],
10	carbon	NN	O	carbon	nn	12	SENT_319	[p17l2013t1938r2139b1977, p17l144t2007r276b2068],
11	tetrachloride	NN	O	tetrachloride	nn	12	SENT_319	[p17l316t2007r748b2068],
12	injury	NN	O	injury	prep_after	8	SENT_319	[p17l789t2009r993b2088],
13	in	IN	O	in	_	0	SENT_319	[p17l1031t2009r1096b2068],
14	mice	NNS	O	mouse	prep_in	12	SENT_319	[p17l1138t2009r1296b2068],
15	lacking	VBG	O	lack	partmod	14	SENT_319	[p17l1337t2007r1577b2088],
16	type	NN	O	type	dobj	15	SENT_319	[p17l1616t2019r1758b2087],
17	1	CD	NUMBER	1	num	16	SENT_319	[p17l1807t2014r1830b2068],
18	but	CC	O	but	_	0	SENT_319	[p17l1875t2007r1990b2068],
19	not	RB	O	not	_	0	SENT_319	[p17l2030t2019r2143b2068],
20	type	NN	O	type	nn	23	SENT_319	[p17l145t2111r287b2180],
21	2	CD	NUMBER	2	num	23	SENT_319	[p17l322t2105r357b2160],
22	tumor	NN	O	tumor	nn	23	SENT_319	[p17l393t2111r607b2160],
23	necrosis	NN	O	necrosis	dobj	15	SENT_319	[p17l641t2101r910b2160],
24	factor	NN	O	factor	nn	25	SENT_319	[p17l946t2099r1142b2160],
25	receptor	NN	O	receptor	dep	23	SENT_319	[p17l1176t2111r1471b2179],
26	.	.	O	.	_	0	SENT_319	[p17l1176t2111r1471b2179],

1	Am	VBP	O	be	dep	3	SENT_320	[p17l1504t2103r1624b2160],
2	]	CD	NUMBER	]	num	3	SENT_320	[p17l1655t2104r1691b2170],
3	Pathol	NN	O	pathol	_	0	SENT_320	[p17l1716t2099r1931b2160],
4	1998	CD	DATE	1998	dep	3	SENT_320	[p17l1971t2105r2141b2170],
5	;	:	O	;	_	0	SENT_320	[p17l1971t2105r2141b2170],
6	152	CD	NUMBER	152	dep	4	SENT_320	[p17l152t2198r284b2253],
7	:	:	O	:	_	0	SENT_320	[p17l152t2198r284b2253],
8	1577-89	CD	NUMBER	1577-89	dep	6	SENT_320	[p17l319t2198r611b2253],
9	.	.	O	.	_	0	SENT_320	[p17l319t2198r611b2253],

1	29	CD	NUMBER	29	_	0	SENT_321	[p17l8t2289r102b2345],
2	.	.	O	.	_	0	SENT_321	[p17l8t2289r102b2345],

1	Gardner	NNP	PERSON	Gardner	nn	2	SENT_322	[p17l147t2283r427b2345],
2	CR	NN	O	cr	_	0	SENT_322	[p17l458t2287r580b2354],
3	,	,	O	,	_	0	SENT_322	[p17l458t2287r580b2354],
4	Laskin	NNP	PERSON	Laskin	nn	5	SENT_322	[p17l613t2283r831b2344],
5	ID	NNP	O	ID	appos	2	SENT_322	[p17l860t2288r965b2355],
6	,	,	O	,	_	0	SENT_322	[p17l860t2288r965b2355],
7	Dambach	NNP	PERSON	Dambach	nn	8	SENT_322	[p17l998t2283r1323b2344],
8	DM	NN	O	dm	appos	2	SENT_322	[p17l1354t2288r1506b2354],
9	,	,	O	,	_	0	SENT_322	[p17l1354t2288r1506b2354],
10	et	FW	O	et	nn	11	SENT_322	[p17l1539t2296r1598b2344],
11	al.	FW	O	al.	appos	2	SENT_322	[p17l1628t2283r1699b2344],
12	.	.	O	.	_	0	SENT_322	[p17l1628t2283r1699b2344],

1	Exaggerated	JJ	O	exaggerated	amod	2	SENT_323	[p17l1735t2283r2143b2364],
2	hepatotoxicity	NN	O	hepatotoxicity	_	0	SENT_323	[p17l146t2375r634b2455],
3	of	IN	O	of	_	0	SENT_323	[p17l674t2375r748b2436],
4	acetaminophen	NN	O	acetaminophen	prep_of	2	SENT_323	[p17l780t2375r1299b2455],
5	in	IN	O	in	_	0	SENT_323	[p17l1342t2377r1407b2436],
6	mice	NNS	O	mouse	prep_in	4	SENT_323	[p17l1448t2377r1608b2436],
7	lacking	VBG	O	lack	partmod	2	SENT_323	[p17l1648t2375r1889b2456],
8	tumor	NN	O	tumor	nn	11	SENT_323	[p17l1929t2387r2144b2436],
9	necrosis	NN	O	necrosis	nn	11	SENT_323	[p17l146t2470r416b2529],
10	factor	NN	O	factor	nn	11	SENT_323	[p17l450t2467r646b2529],
11	receptor-1	NN	O	receptor-1	dobj	7	SENT_323	[p17l678t2474r1045b2547],
12	.	.	O	.	_	0	SENT_323	[p17l678t2474r1045b2547],

1	Potential	JJ	O	potential	amod	2	SENT_324	[p17l1082t2468r1386b2529],
2	role	NN	O	role	_	0	SENT_324	[p17l1419t2468r1546b2529],
3	of	IN	O	of	_	0	SENT_324	[p17l1581t2467r1655b2529],
4	inﬂammatory	JJ	O	inﬂammatory	amod	5	SENT_324	[p17l1679t2467r2146b2548],
5	mediators	NNS	O	mediator	prep_of	2	SENT_324	[p17l146t2561r501b2622],
6	.	.	O	.	_	0	SENT_324	[p17l146t2561r501b2622],

1	ToxicolAppl	NNP	O	ToxicolAppl	nn	2	SENT_325	[p17l533t2561r945b2641],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_325	[p17l965t2561r1321b2622],
3	2003	CD	DATE	2003	num	2	SENT_325	[p17l1345t2567r1521b2632],
4	;	:	O	;	_	0	SENT_325	[p17l1345t2567r1521b2632],
5	192	CD	NUMBER	192	num	7	SENT_325	[p17l1553t2567r1686b2622],
6	:	:	O	:	_	0	SENT_325	[p17l1553t2567r1686b2622],
7	119-30	CD	NUMBER	119-30	dep	2	SENT_325	[p17l1720t2567r1971b2622],
8	.	.	O	.	_	0	SENT_325	[p17l1720t2567r1971b2622],

1	30	CD	NUMBER	30	_	0	SENT_326	[p17l9t2658r102b2713],
2	.	.	O	.	_	0	SENT_326	[p17l9t2658r102b2713],

1	Abraham	NNP	PERSON	Abraham	nn	3	SENT_327	[p17l144t2652r460b2713],
2	L	NNP	PERSON	L	nn	3	SENT_327	[p17l496t2657r583b2724],
3	]	NN	O	]	_	0	SENT_327	[p17l496t2657r583b2724],
4	,	,	O	,	_	0	SENT_327	[p17l496t2657r583b2724],
5	Kroeger	NNP	PERSON	Kroeger	nn	6	SENT_327	[p17l622t2657r889b2733],
6	KM	NNP	O	KM	appos	3	SENT_327	[p17l925t2657r1069b2713],
7	.	.	O	.	_	0	SENT_327	[p17l925t2657r1069b2713],

1	Impact	NN	O	impact	_	0	SENT_328	[p17l1108t2657r1346b2732],
2	of	IN	O	of	_	0	SENT_328	[p17l1382t2652r1456b2713],
3	the	DT	O	the	det	5	SENT_328	[p17l1482t2652r1586b2713],
4	-308	CD	NUMBER	-308	num	5	SENT_328	[p17l1624t2658r1768b2713],
5	TNF	NN	MISC	tnf	prep_of	1	SENT_328	[p17l1806t2655r1960b2713],
6	promoter	NN	O	promoter	dep	1	SENT_328	[p17l1995t2673r2139b2732, p17l146t2756r350b2806],
7	polymorphism	NN	O	polymorphism	dep	6	SENT_328	[p17l381t2745r882b2825],
8	on	IN	O	on	prep	7	SENT_328	[p17l916t2766r1002b2806],
9	the	DT	O	the	det	11	SENT_328	[p17l1033t2744r1138b2806],
10	transcriptional	JJ	O	transcriptional	amod	11	SENT_328	[p17l1169t2744r1669b2824],
11	regulation	NN	O	regulation	dep	8	SENT_328	[p17l1701t2745r2045b2825],
12	of	IN	O	of	_	0	SENT_328	[p17l2078t2744r2152b2806],
13	the	DT	O	the	det	15	SENT_328	[p17l145t2838r249b2899],
14	TNF	NN	MISC	tnf	nn	15	SENT_328	[p17l278t2840r431b2898],
15	gene	NN	O	gene	prep_of	11	SENT_328	[p17l461t2859r628b2918],
16	:	:	O	:	_	0	SENT_328	[p17l461t2859r628b2918],
17	relevance	NN	O	relevance	dep	11	SENT_328	[p17l661t2838r971b2899],
18	to	TO	O	to	_	0	SENT_328	[p17l999t2850r1065b2899],
19	disease	NN	O	disease	prep_to	17	SENT_328	[p17l1096t2838r1344b2899],
20	.	.	O	.	_	0	SENT_328	[p17l1096t2838r1344b2899],
21	]	SYM	O	]	dep	7	SENT_328	[p17l1371t2842r1406b2909],

1	Leukoc	NNP	O	Leukoc	nn	2	SENT_329	[p17l1426t2838r1655b2899],
2	Biol	NNP	O	Biol	_	0	SENT_329	[p17l1679t2838r1809b2899],
3	1999	CD	DATE	1999	num	2	SENT_329	[p17l1843t2844r2013b2908],
4	;	:	O	;	_	0	SENT_329	[p17l1843t2844r2013b2908],
5	66	CD	NUMBER	66	num	7	SENT_329	[p17l2043t2843r2139b2899],
6	:	:	O	:	_	0	SENT_329	[p17l2043t2843r2139b2899],
7	562-6	CD	NUMBER	562-6	dep	2	SENT_329	[p17l148t2935r364b2990],
8	.	.	O	.	_	0	SENT_329	[p17l148t2935r364b2990],

1	31	CD	NUMBER	31	_	0	SENT_330	[p17l9t3028r102b3083],
2	.	.	O	.	_	0	SENT_330	[p17l9t3028r102b3083],

1	Fontana	NNP	PERSON	Fontana	nn	3	SENT_331	[p17l147t3026r423b3083],
2	R	NNP	O	R	nn	3	SENT_331	[p17l447t3026r543b3093],
3	]	NN	O	]	_	0	SENT_331	[p17l447t3026r543b3093],
4	,	,	O	,	_	0	SENT_331	[p17l447t3026r543b3093],
5	Seeff	NNP	PERSON	Seeff	nn	6	SENT_331	[p17l571t3021r736b3083],
6	LB	NNP	O	LB	appos	3	SENT_331	[p17l751t3026r860b3092],
7	,	,	O	,	_	0	SENT_331	[p17l751t3026r860b3092],
8	Andrade	NNP	PERSON	Andrade	nn	10	SENT_331	[p17l884t3021r1176b3083],
9	R	NNP	O	R	nn	10	SENT_331	[p17l1201t3026r1297b3093],
10	]	NN	O	]	appos	3	SENT_331	[p17l1201t3026r1297b3093],
11	,	,	O	,	_	0	SENT_331	[p17l1201t3026r1297b3093],
12	et	FW	O	et	nn	13	SENT_331	[p17l1324t3034r1384b3083],
13	al.	FW	O	al.	appos	3	SENT_331	[p17l1413t3022r1485b3083],
14	.	.	O	.	_	0	SENT_331	[p17l1413t3022r1485b3083],

1	Standardization	NN	O	standardization	nsubj	10	SENT_332	[p17l1517t3022r2053b3083],
2	of	IN	O	of	_	0	SENT_332	[p17l2079t3021r2153b3083],
3	nomenclature	NN	O	nomenclature	nn	6	SENT_332	[p17l146t3115r615b3176],
4	and	CC	O	and	_	0	SENT_332	[p17l660t3115r784b3176],
5	causality	NN	O	causality	conj_and	3	SENT_332	[p17l828t3115r1120b3195],
6	assessment	NN	O	assessment	prep_of	1	SENT_332	[p17l1162t3127r1527b3176],
7	in	IN	O	in	_	0	SENT_332	[p17l1571t3117r1636b3175],
8	drug	NN	O	drug	nn	9	SENT_332	[p17l1681t3115r2143b3195],
9	—	NN	O	—	prep_in	6	SENT_332	[p17l1681t3115r2143b3195],
10	induced	VBD	O	induce	_	0	SENT_332	[p17l1681t3115r2143b3195],
11	liver	NN	O	liver	nn	12	SENT_332	[p17l145t3208r293b3269],
12	injury	NN	O	injury	dobj	10	SENT_332	[p17l341t3210r559b3288],
13	:	:	O	:	_	0	SENT_332	[p17l341t3210r559b3288],
14	summary	NN	O	summary	dep	12	SENT_332	[p17l613t3229r932b3288],
15	of	IN	O	of	_	0	SENT_332	[p17l979t3208r1053b3269],
16	a	DT	O	a	det	19	SENT_332	[p17l1094t3230r1128b3269],
17	clinical	JJ	O	clinical	amod	19	SENT_332	[p17l1177t3208r1415b3269],
18	research	NN	O	research	nn	19	SENT_332	[p17l1464t3208r1739b3269],
19	workshop	NN	O	workshop	prep_of	14	SENT_332	[p17l1786t3208r2139b3287],
20	.	.	O	.	_	0	SENT_332	[p17l1786t3208r2139b3287],

1	Hepatology	NNP	O	Hepatology	_	0	SENT_333	[p17l144t3300r517b3380],
2	2010	CD	DATE	2010	num	1	SENT_333	[p17l539t3306r715b3370],
3	;	:	O	;	_	0	SENT_333	[p17l539t3306r715b3370],
4	52	CD	NUMBER	52	num	6	SENT_333	[p17l742t3306r838b3361],
5	:	:	O	:	_	0	SENT_333	[p17l742t3306r838b3361],
6	730-42	CD	NUMBER	730-42	dep	1	SENT_333	[p17l868t3306r1124b3361],
7	.	.	O	.	_	0	SENT_333	[p17l868t3306r1124b3361],

1	32	CD	NUMBER	32	_	0	SENT_334	[p17l9t3398r102b3453],
2	.	.	O	.	_	0	SENT_334	[p17l9t3398r102b3453],

1	Holt	NNP	O	Holt	nn	2	SENT_335	[p17l147t3392r300b3453],
2	M	NNP	O	M	nsubj	8	SENT_335	[p17l325t3396r416b3462],
3	,	,	O	,	_	0	SENT_335	[p17l325t3396r416b3462],
4	Iu	NNP	O	Iu	nn	6	SENT_335	[p17l442t3396r514b3463],
5	C.	NNP	O	C.	nn	6	SENT_335	[p17l540t3395r607b3453],
6	Drug	NNP	O	Drug	appos	2	SENT_335	[p17l636t3392r1115b3472],
7	—	NN	O	—	dep	6	SENT_335	[p17l636t3392r1115b3472],
8	induced	VBD	O	induce	_	0	SENT_335	[p17l636t3392r1115b3472],
9	liver	NN	O	liver	nn	10	SENT_335	[p17l1140t3392r1287b3453],
10	injury	NN	O	injury	dobj	8	SENT_335	[p17l1311t3394r1528b3472],
11	.	.	O	.	_	0	SENT_335	[p17l1311t3394r1528b3472],

1	Handb	NNP	O	Handb	nn	3	SENT_336	[p17l1555t3391r1784b3453],
2	Exp	NNP	O	Exp	nn	3	SENT_336	[p17l1807t3396r1930b3472],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_336	[p17l1954t3391r2140b3453, p17l149t3485r341b3546],

1	2010	CD	DATE	2010	_	0	SENT_337	[p17l365t3491r541b3555],
2	;	:	O	;	_	0	SENT_337	[p17l365t3491r541b3555],
3	196	CD	NUMBER	196	num	5	SENT_337	[p17l573t3490r705b3546],
4	:	:	O	:	_	0	SENT_337	[p17l573t3490r705b3546],
5	3-27	CD	NUMBER	3-27	dep	1	SENT_337	[p17l735t3491r910b3546],
6	.	.	O	.	_	0	SENT_337	[p17l735t3491r910b3546],

1	Kim	NNP	PERSON	Kim	_	0	SENT_338	[p18l1845t32r1958b88],
2	et	FW	O	et	nn	3	SENT_338	[p18l1984t38r2048b89],
3	al.	FW	O	al.	dep	1	SENT_338	[p18l2073t31r2137b89],
4	.	.	O	.	_	0	SENT_338	[p18l2073t31r2137b89],

1	Andrade	NNP	PERSON	Andrade	nn	2	SENT_339	[p18l145t259r437b320],
2	RI	NN	O	rus	_	0	SENT_339	[p18l482t264r577b331],
3	,	,	O	,	_	0	SENT_339	[p18l482t264r577b331],
4	Robles	NNP	PERSON	Robles	nn	5	SENT_339	[p18l623t259r846b320],
5	M	NNP	O	M	appos	2	SENT_339	[p18l890t264r981b330],
6	,	,	O	,	_	0	SENT_339	[p18l890t264r981b330],
7	Ulzurrun	NNP	O	Ulzurrun	nn	8	SENT_339	[p18l1027t259r1340b320],
8	E	NNP	O	E	appos	2	SENT_339	[p18l1384t264r1445b330],
9	,	,	O	,	_	0	SENT_339	[p18l1384t264r1445b330],
10	Lucena	NNP	PERSON	Lucena	nn	11	SENT_339	[p18l1492t264r1733b320],
11	MI	NNP	O	MI	appos	2	SENT_339	[p18l1776t264r1894b320],
12	.	.	O	.	_	0	SENT_339	[p18l1776t264r1894b320],

1	Druginduced	JJ	O	druginduced	amod	3	SENT_340	[p18l1941t264r2142b339, p18l147t352r419b413],
2	liver	NN	O	liver	nn	3	SENT_340	[p18l455t352r602b413],
3	injury	NN	O	injury	_	0	SENT_340	[p18l639t354r856b432],
4	:	:	O	:	_	0	SENT_340	[p18l639t354r856b432],
5	insights	NNS	O	insight	dep	3	SENT_340	[p18l897t352r1155b432],
6	from	IN	O	from	_	0	SENT_340	[p18l1193t352r1358b413],
7	genetic	JJ	O	genetic	amod	8	SENT_340	[p18l1396t354r1632b432],
8	studies	NNS	O	study	prep_from	5	SENT_340	[p18l1670t352r1918b413],
9	.	.	O	.	_	0	SENT_340	[p18l1670t352r1918b413],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_341	[p18l1957t352r2143b413, p18l149t447r617b525],
2	2009	CD	DATE	2009	num	1	SENT_341	[p18l641t450r817b515],
3	;	:	O	;	_	0	SENT_341	[p18l641t450r817b515],
4	10	CD	NUMBER	10	num	6	SENT_341	[p18l850t450r941b506],
5	:	:	O	:	_	0	SENT_341	[p18l850t450r941b506],
6	1467-87	CD	NUMBER	1467-87	dep	1	SENT_341	[p18l976t450r1268b506],
7	.	.	O	.	_	0	SENT_341	[p18l976t450r1268b506],

1	Aithal	NNP	O	Aithal	nn	2	SENT_342	[p18l145t538r352b599],
2	GP	NNP	O	GP	_	0	SENT_342	[p18l379t541r499b609],
3	,	,	O	,	_	0	SENT_342	[p18l379t541r499b609],
4	Ramsay	NNP	PERSON	Ramsay	nn	5	SENT_342	[p18l528t543r792b618],
5	L	NNP	PERSON	L	appos	2	SENT_342	[p18l815t543r874b609],
6	,	,	O	,	_	0	SENT_342	[p18l815t543r874b609],
7	Daly	NNP	PERSON	Daly	nn	8	SENT_342	[p18l903t538r1061b618],
8	AK	NNP	O	AK	appos	2	SENT_342	[p18l1081t542r1208b609],
9	,	,	O	,	_	0	SENT_342	[p18l1081t542r1208b609],
10	et	FW	O	et	nn	11	SENT_342	[p18l1238t551r1297b599],
11	al.	FW	O	al.	appos	2	SENT_342	[p18l1327t538r1399b599],
12	.	.	O	.	_	0	SENT_342	[p18l1327t538r1399b599],

1	Hepatic	JJ	O	hepatic	amod	2	SENT_343	[p18l1431t540r1695b618],
2	adducts	NNS	O	adduct	nsubj	9	SENT_343	[p18l1722t538r2000b609],
3	,	,	O	,	_	0	SENT_343	[p18l1722t538r2000b609],
4	circulating	VBG	O	circulate	partmod	2	SENT_343	[p18l2030t540r2142b599, p18l148t631r418b711],
5	antibodies	NNS	O	antibody	dobj	4	SENT_343	[p18l488t631r854b701],
6	,	,	O	,	_	0	SENT_343	[p18l488t631r854b701],
7	and	CC	O	and	dep	9	SENT_343	[p18l928t631r1052b692],
8	cytokine	NN	O	cytokine	nn	9	SENT_343	[p18l1123t631r1407b711],
9	polymorphisms	NNS	O	polymorphism	_	0	SENT_343	[p18l1477t631r2008b711],
10	in	IN	O	in	_	0	SENT_343	[p18l2080t633r2146b691],
11	patients	NNS	O	patient	prep_in	9	SENT_343	[p18l146t726r412b803],
12	with	IN	O	with	_	0	SENT_343	[p18l449t724r599b785],
13	diclofenac	NN	O	diclofenac	nn	14	SENT_343	[p18l637t724r980b785],
14	hepatotoxicity	NN	O	hepatotoxicity	prep_with	9	SENT_343	[p18l1017t724r1519b804],
15	.	.	O	.	_	0	SENT_343	[p18l1017t724r1519b804],

1	Hepatology	NNP	O	Hepatology	_	0	SENT_344	[p18l1559t724r1932b804],
2	2004	CD	DATE	2004	num	1	SENT_344	[p18l1967t730r2144b794],
3	;	:	O	;	_	0	SENT_344	[p18l1967t730r2144b794],
4	39	CD	NUMBER	39	num	6	SENT_344	[p18l148t823r244b879],
5	:	:	O	:	_	0	SENT_344	[p18l148t823r244b879],
6	1430-40	CD	NUMBER	1430-40	dep	1	SENT_344	[p18l279t823r570b879],
7	.	.	O	.	_	0	SENT_344	[p18l279t823r570b879],

1	Carr	NNP	PERSON	Carr	nn	2	SENT_345	[p18l148t915r299b973],
2	DF	NNP	O	DF	_	0	SENT_345	[p18l337t916r456b983],
3	,	,	O	,	_	0	SENT_345	[p18l337t916r456b983],
4	Alﬁrevic	NNP	MISC	Alﬁrevic	nn	5	SENT_345	[p18l494t911r779b973],
5	A	NNP	MISC	A	appos	2	SENT_345	[p18l815t915r887b983],
6	,	,	O	,	_	0	SENT_345	[p18l815t915r887b983],
7	Tugwood	NNP	O	Tugwood	nn	8	SENT_345	[p18l927t911r1250b993],
8	ID	NNP	O	ID	appos	2	SENT_345	[p18l1288t916r1393b984],
9	,	,	O	,	_	0	SENT_345	[p18l1288t916r1393b984],
10	et	FW	O	et	nn	11	SENT_345	[p18l1435t924r1494b973],
11	al.	FW	O	al.	appos	2	SENT_345	[p18l1523t911r1595b973],
12	.	.	O	.	_	0	SENT_345	[p18l1523t911r1595b973],

1	Molecular	JJ	MISC	molecular	amod	4	SENT_346	[p18l1639t911r1983b973],
2	and	CC	O	and	_	0	SENT_346	[p18l2022t911r2146b973],
3	genetic	JJ	O	genetic	conj_and	1	SENT_346	[p18l147t1007r384b1085],
4	association	NN	O	association	nsubj	12	SENT_346	[p18l440t1007r811b1066],
5	of	IN	O	of	_	0	SENT_346	[p18l869t1005r943b1066],
6	interleukin	NN	O	interleukin	prep_of	4	SENT_346	[p18l990t1005r1430b1066],
7	—	CD	NUMBER	—	number	8	SENT_346	[p18l990t1005r1430b1066],
8	6	CD	NUMBER	6	num	6	SENT_346	[p18l990t1005r1430b1066],
9	in	IN	O	in	_	0	SENT_346	[p18l1488t1007r1554b1065],
10	tacrine	NN	O	tacrine	nn	11	SENT_346	[p18l1609t1005r2145b1066],
11	—	NN	O	—	prep_in	4	SENT_346	[p18l1609t1005r2145b1066],
12	induced	VBD	O	induce	_	0	SENT_346	[p18l1609t1005r2145b1066],
13	hepatotoxicity	NN	O	hepatotoxicity	dobj	12	SENT_346	[p18l146t1098r648b1178],
14	.	.	O	.	_	0	SENT_346	[p18l146t1098r648b1178],

1	Pharmdcogenet	NNP	O	Pharmdcogenet	nn	2	SENT_347	[p18l675t1098r1184b1178],
2	Genomics	NNP	O	Genomics	_	0	SENT_347	[p18l1207t1100r1520b1159],
3	2007	CD	DATE	2007	num	2	SENT_347	[p18l1544t1104r1721b1169],
4	;	:	O	;	_	0	SENT_347	[p18l1544t1104r1721b1169],
5	17	CD	NUMBER	17	num	7	SENT_347	[p18l1753t1104r1844b1159],
6	:	:	O	:	_	0	SENT_347	[p18l1753t1104r1844b1159],
7	961-72	CD	NUMBER	961-72	dep	2	SENT_347	[p18l1873t1104r2131b1159],
8	.	.	O	.	_	0	SENT_347	[p18l1873t1104r2131b1159],

1	Phillips	NNP	PERSON	Phillips	nn	2	SENT_348	[p18l147t1191r398b1272],
2	EI	NNP	O	EI	_	0	SENT_348	[p18l444t1196r533b1264],
3	,	,	O	,	_	0	SENT_348	[p18l444t1196r533b1264],
4	Mallal	NNP	O	Mallal	nn	5	SENT_348	[p18l579t1191r791b1253],
5	SA	NNP	O	SA	appos	2	SENT_348	[p18l835t1195r943b1253],
6	.	.	O	.	_	0	SENT_348	[p18l835t1195r943b1253],

1	HLA	NN	O	hlum	nn	4	SENT_349	[p18l991t1195r1154b1252],
2	and	CC	O	and	_	0	SENT_349	[p18l1198t1191r1322b1253],
3	drug	NN	O	drug	nn	4	SENT_349	[p18l1367t1191r1829b1273],
4	—	NN	O	—	nsubj	5	SENT_349	[p18l1367t1191r1829b1273],
5	induced	VBD	O	induce	_	0	SENT_349	[p18l1367t1191r1829b1273],
6	toxicity	NN	O	toxicity	dobj	5	SENT_349	[p18l1872t1193r2142b1273],
7	.	.	O	.	_	0	SENT_349	[p18l1872t1193r2142b1273],

1	Curr	NNP	O	Curr	nn	4	SENT_350	[p18l150t1289r306b1348],
2	Opin	NNP	O	Opin	nn	4	SENT_350	[p18l330t1288r492b1367],
3	Mol	NNP	O	Mol	nn	4	SENT_350	[p18l515t1285r649b1347],
4	Ther	NNP	DATE	Ther	_	0	SENT_350	[p18l677t1285r828b1347],
5	2009	CD	DATE	2009	num	4	SENT_350	[p18l850t1292r1026b1357],
6	;	:	O	;	_	0	SENT_350	[p18l850t1292r1026b1357],
7	11	CD	NUMBER	11	num	9	SENT_350	[p18l1057t1292r1148b1347],
8	:	:	O	:	_	0	SENT_350	[p18l1057t1292r1148b1347],
9	231-42	CD	NUMBER	231-42	dep	4	SENT_350	[p18l1177t1292r1435b1347],
10	.	.	O	.	_	0	SENT_350	[p18l1177t1292r1435b1347],

1	Kindmark	NNP	MISC	Kindmark	nn	2	SENT_351	[p18l147t1380r494b1442],
2	A	NNP	MISC	A	_	0	SENT_351	[p18l520t1384r592b1452],
3	,	,	O	,	_	0	SENT_351	[p18l520t1384r592b1452],
4	Iawaid	NNP	O	Iawaid	nn	5	SENT_351	[p18l625t1380r850b1453],
5	A	NNP	O	A	appos	2	SENT_351	[p18l878t1384r950b1451],
6	,	,	O	,	_	0	SENT_351	[p18l878t1384r950b1451],
7	Harbron	NNP	O	Harbron	nn	8	SENT_351	[p18l983t1380r1276b1442],
8	CG	NNP	O	CG	appos	2	SENT_351	[p18l1309t1383r1436b1451],
9	,	,	O	,	_	0	SENT_351	[p18l1309t1383r1436b1451],
10	et	FW	O	et	nn	11	SENT_351	[p18l1471t1393r1530b1442],
11	al.	FW	O	al.	appos	2	SENT_351	[p18l1560t1380r1632b1442],
12	.	.	O	.	_	0	SENT_351	[p18l1560t1380r1632b1442],

1	Genome	NNP	O	Genome	dep	3	SENT_352	[p18l1670t1380r2145b1442],
2	—	CD	NUMBER	—	num	1	SENT_352	[p18l1670t1380r2145b1442],
3	wide	JJ	O	wide	amod	5	SENT_352	[p18l1670t1380r2145b1442],
4	pharmacogenetic	JJ	O	pharmacogenetic	amod	5	SENT_352	[p18l146t1473r727b1555],
5	investigation	NN	O	investigation	nsubj	16	SENT_352	[p18l764t1475r1197b1555],
6	of	IN	O	of	_	0	SENT_352	[p18l1234t1473r1308b1535],
7	a	DT	O	a	det	10	SENT_352	[p18l1335t1496r1368b1535],
8	hepatic	JJ	O	hepatic	amod	10	SENT_352	[p18l1403t1473r1647b1554],
9	adverse	JJ	O	adverse	amod	10	SENT_352	[p18l1684t1473r1931b1535],
10	event	NN	O	event	prep_of	5	SENT_352	[p18l1968t1485r2146b1535],
11	without	IN	O	without	_	0	SENT_352	[p18l145t1568r412b1629],
12	clinical	JJ	O	clinical	amod	13	SENT_352	[p18l460t1568r697b1629],
13	signs	NNS	O	sign	prep_without	10	SENT_352	[p18l744t1570r907b1649],
14	of	IN	O	of	_	0	SENT_352	[p18l955t1567r1029b1629],
15	immunopathology	NN	O	immunopathology	prep_of	13	SENT_352	[p18l1067t1567r1704b1649],
16	suggests	VBZ	O	suggest	_	0	SENT_352	[p18l1748t1580r2019b1649],
17	an	DT	O	a	det	20	SENT_352	[p18l2067t1590r2146b1629],
18	underlying	JJ	O	underlying	amod	20	SENT_352	[p18l147t1662r514b1742],
19	immune	JJ	O	immune	amod	20	SENT_352	[p18l573t1664r859b1723],
20	pathogenesis	NN	O	pathogenesis	dobj	16	SENT_352	[p18l919t1662r1368b1742],
21	.	.	O	.	_	0	SENT_352	[p18l919t1662r1368b1742],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_353	[p18l1430t1662r2062b1742],
2	I	PRP	O	I	dep	1	SENT_353	[p18l2117t1667r2152b1733],
3	2008	CD	DATE	2008	dep	1	SENT_353	[p18l147t1762r324b1827],
4	;	:	O	;	_	0	SENT_353	[p18l147t1762r324b1827],
5	8	CD	NUMBER	8	num	7	SENT_353	[p18l351t1762r406b1817],
6	:	:	O	:	_	0	SENT_353	[p18l351t1762r406b1817],
7	186-95	CD	NUMBER	186-95	dep	1	SENT_353	[p18l441t1761r692b1818],
8	.	.	O	.	_	0	SENT_353	[p18l441t1761r692b1818],

1	Daly	NNP	PERSON	Daly	nn	2	SENT_354	[p18l147t1850r305b1931],
2	AK	NNP	PERSON	AK	_	0	SENT_354	[p18l329t1854r456b1922],
3	,	,	O	,	_	0	SENT_354	[p18l329t1854r456b1922],
4	Donaldson	NNP	ORGANIZATION	Donaldson	nn	5	SENT_354	[p18l488t1850r859b1912],
5	PT	NN	ORGANIZATION	pt	appos	2	SENT_354	[p18l890t1853r1003b1922],
6	,	,	O	,	_	0	SENT_354	[p18l890t1853r1003b1922],
7	Bhatnagar	NNP	PERSON	Bhatnagar	nn	8	SENT_354	[p18l1035t1850r1379b1932],
8	P	NN	O	p	appos	2	SENT_354	[p18l1408t1855r1470b1922],
9	,	,	O	,	_	0	SENT_354	[p18l1408t1855r1470b1922],
10	et	FW	O	et	nn	11	SENT_354	[p18l1503t1863r1562b1912],
11	al.	FW	O	al.	appos	2	SENT_354	[p18l1592t1850r1664b1912],
12	.	.	O	.	_	0	SENT_354	[p18l1592t1850r1664b1912],

1	HLA	NN	O	hlum	_	0	SENT_355	[p18l1700t1851r2140b1912],
2	.	.	O	.	_	0	SENT_355	[p18l1700t1851r2140b1912],

1	—	NN	O	—	_	0	SENT_356	[p18l1700t1851r2140b1912],
2	.	.	O	.	_	0	SENT_356	[p18l1700t1851r2140b1912],

1	B	NN	O	b	nsubj	12	SENT_357	[p18l1700t1851r2140b1912],
2	*	CD	NUMBER	*	num	1	SENT_357	[p18l1700t1851r2140b1912],
3	5701	CD	NUMBER	5701	num	4	SENT_357	[p18l1700t1851r2140b1912],
4	genotype	NN	O	genotype	nsubj	8	SENT_357	[p18l147t1957r452b2026],
5	is	VBZ	O	be	cop	8	SENT_357	[p18l498t1947r546b2006],
6	a	DT	O	a	det	8	SENT_357	[p18l594t1967r628b2006],
7	major	JJ	O	major	amod	8	SENT_357	[p18l672t1947r872b2026],
8	determinant	NN	O	determinant	rcmod	1	SENT_357	[p18l918t1944r1335b2006],
9	of	IN	O	of	_	0	SENT_357	[p18l1381t1944r1455b2006],
10	drug	NN	O	drug	nn	11	SENT_357	[p18l1492t1944r1955b2026],
11	—	NN	O	—	prep_of	8	SENT_357	[p18l1492t1944r1955b2026],
12	induced	VBD	O	induce	_	0	SENT_357	[p18l1492t1944r1955b2026],
13	liver	NN	O	liver	nn	14	SENT_357	[p18l1999t1945r2146b2006],
14	injury	NN	O	injury	nsubj	15	SENT_357	[p18l147t2040r352b2118],
15	due	JJ	O	due	xcomp	12	SENT_357	[p18l373t2038r495b2099],
16	to	TO	O	to	_	0	SENT_357	[p18l519t2050r585b2099],
17	ﬂucloxacillin	NN	O	ﬂucloxacillin	prep_to	15	SENT_357	[p18l612t2038r1064b2099],
18	.	.	O	.	_	0	SENT_357	[p18l612t2038r1064b2099],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_358	[p18l1089t2043r1222b2099],
2	Genet	NNP	PERSON	Genet	_	0	SENT_358	[p18l1244t2041r1435b2099],
3	2009	CD	DATE	2009	num	2	SENT_358	[p18l1455t2044r1631b2109],
4	;	:	O	;	_	0	SENT_358	[p18l1455t2044r1631b2109],
5	41	CD	NUMBER	41	num	7	SENT_358	[p18l1657t2044r1755b2099],
6	:	:	O	:	_	0	SENT_358	[p18l1657t2044r1755b2099],
7	816-9	CD	NUMBER	816-9	dep	2	SENT_358	[p18l1784t2043r2001b2099],
8	.	.	O	.	_	0	SENT_358	[p18l1784t2043r2001b2099],

1	Wilson	NNP	ORGANIZATION	Wilson	nn	2	SENT_359	[p18l145t2131r388b2193],
2	AG	NNP	ORGANIZATION	AG	_	0	SENT_359	[p18l410t2135r541b2203],
3	,	,	O	,	_	0	SENT_359	[p18l410t2135r541b2203],
4	de	FW	ORGANIZATION	de	appos	2	SENT_359	[p18l569t2131r645b2193],
5	Vries	NNP	ORGANIZATION	Vries	nn	6	SENT_359	[p18l666t2133r840b2193],
6	N	NNP	ORGANIZATION	N	dep	4	SENT_359	[p18l865t2136r943b2203],
7	,	,	O	,	_	0	SENT_359	[p18l865t2136r943b2203],
8	Pociot	NNP	O	Pociot	nn	9	SENT_359	[p18l970t2133r1187b2193],
9	F	NN	O	f	appos	2	SENT_359	[p18l1212t2136r1269b2203],
10	,	,	O	,	_	0	SENT_359	[p18l1212t2136r1269b2203],
11	et	FW	O	et	nn	12	SENT_359	[p18l1298t2144r1356b2193],
12	al.	FW	O	al.	appos	2	SENT_359	[p18l1386t2131r1458b2193],
13	.	.	O	.	_	0	SENT_359	[p18l1386t2131r1458b2193],

1	An	DT	O	a	det	3	SENT_360	[p18l1486t2135r1586b2192],
2	allelic	JJ	O	allelic	amod	3	SENT_360	[p18l1611t2131r1801b2193],
3	polymorphism	NN	O	polymorphism	nsubjpass	15	SENT_360	[p18l1824t2131r2142b2212, p18l146t2224r356b2304],
4	within	IN	O	within	_	0	SENT_360	[p18l382t2224r601b2286],
5	the	DT	O	the	det	9	SENT_360	[p18l628t2225r731b2286],
6	human	JJ	O	human	amod	9	SENT_360	[p18l758t2225r999b2286],
7	tumor	NN	O	tumor	nn	9	SENT_360	[p18l1025t2237r1241b2286],
8	necrosis	NN	O	necrosis	nn	9	SENT_360	[p18l1268t2227r1538b2286],
9	factor	NN	O	factor	nn	12	SENT_360	[p18l1566t2224r1762b2286],
10	alpha	NN	O	alpha	amod	12	SENT_360	[p18l1790t2224r1972b2304],
11	promoter	NN	O	promoter	nn	12	SENT_360	[p18l1998t2246r2142b2304, p18l147t2330r351b2379],
12	region	NN	O	region	prep_within	3	SENT_360	[p18l380t2320r594b2398],
13	is	VBZ	O	be	auxpass	15	SENT_360	[p18l624t2320r672b2379],
14	strongly	RB	O	strongly	advmod	15	SENT_360	[p18l704t2318r978b2398],
15	associated	VBN	O	associate	_	0	SENT_360	[p18l1005t2318r1344b2379],
16	with	IN	O	with	_	0	SENT_360	[p18l1371t2318r1522b2379],
17	HLA	NN	O	hlum	nn	18	SENT_360	[p18l1552t2321r1715b2378],
18	A1	NN	O	a1	prep_with	15	SENT_360	[p18l1741t2321r1853b2388],
19	,	,	O	,	_	0	SENT_360	[p18l1741t2321r1853b2388],
20	B8	NN	O	b8	conj_and	18	SENT_360	[p18l1885t2322r1989b2388],
21	,	,	O	,	_	0	SENT_360	[p18l1885t2322r1989b2388],
22	and	CC	O	and	_	0	SENT_360	[p18l2022t2318r2146b2379],
23	DR3	NN	O	dr3	nn	24	SENT_360	[p18l147t2415r296b2471],
24	alleles	NNS	O	allele	conj_and	18	SENT_360	[p18l324t2410r538b2471],
25	.	.	O	.	_	0	SENT_360	[p18l324t2410r538b2471],

1	I	PRP	O	I	nsubj	2	SENT_361	[p18l560t2415r596b2481],
2	Exp	VBP	O	exp	_	0	SENT_361	[p18l612t2415r736b2490],
3	Med	VBN	O	med	dep	2	SENT_361	[p18l758t2410r909b2471],
4	1993	CD	DATE	1993	dobj	3	SENT_361	[p18l938t2416r1108b2481],
5	;	:	O	;	_	0	SENT_361	[p18l938t2416r1108b2481],
6	177	CD	NUMBER	177	num	8	SENT_361	[p18l1140t2417r1272b2471],
7	:	:	O	:	_	0	SENT_361	[p18l1140t2417r1272b2471],
8	557-60	CD	NUMBER	557-60	dep	4	SENT_361	[p18l1302t2416r1559b2471],
9	.	.	O	.	_	0	SENT_361	[p18l1302t2416r1559b2471],

1	Mallal	JJ	O	mallal	amod	2	SENT_362	[p18l146t2504r358b2566],
2	S	NN	O	s	_	0	SENT_362	[p18l382t2508r436b2576],
3	,	,	O	,	_	0	SENT_362	[p18l382t2508r436b2576],
4	Phillips	NNP	PERSON	Phillips	nn	5	SENT_362	[p18l463t2504r714b2585],
5	E	NNP	O	E	appos	2	SENT_362	[p18l739t2509r800b2576],
6	,	,	O	,	_	0	SENT_362	[p18l739t2509r800b2576],
7	Carosi	NNP	PERSON	Carosi	nn	8	SENT_362	[p18l828t2507r1043b2567],
8	G	NNP	PERSON	G	appos	2	SENT_362	[p18l1069t2508r1141b2576],
9	,	,	O	,	_	0	SENT_362	[p18l1069t2508r1141b2576],
10	et	FW	O	et	nn	11	SENT_362	[p18l1168t2517r1228b2566],
11	al.	FW	O	al.	appos	2	SENT_362	[p18l1257t2504r1328b2566],
12	.	.	O	.	_	0	SENT_362	[p18l1257t2504r1328b2566],

1	HLA-B	NN	O	hla-b	_	0	SENT_363	[p18l1360t2506r1799b2566],
2	*	CD	NUMBER	*	number	3	SENT_363	[p18l1360t2506r1799b2566],
3	5701	CD	NUMBER	5701	num	4	SENT_363	[p18l1360t2506r1799b2566],
4	screening	NN	O	screening	dep	1	SENT_363	[p18l1830t2507r2147b2586],
5	for	IN	O	for	_	0	SENT_363	[p18l147t2598r244b2659],
6	hypersensitivity	NN	O	hypersensitivity	prep_for	4	SENT_363	[p18l278t2598r811b2678],
7	to	TO	O	to	_	0	SENT_363	[p18l843t2610r909b2659],
8	abacavir	NN	O	abacavir	prep_to	6	SENT_363	[p18l946t2598r1241b2659],
9	.	.	O	.	_	0	SENT_363	[p18l946t2598r1241b2659],

1	N	NN	O	n	nn	2	SENT_364	[p18l1277t2602r1345b2658],
2	Engl	NN	O	engl	_	0	SENT_364	[p18l1371t2598r1518b2678],
3	I	PRP	O	I	nsubj	4	SENT_364	[p18l1546t2602r1581b2669],
4	Med	VBD	O	med	rcmod	2	SENT_364	[p18l1607t2598r1758b2659],
5	2008	CD	DATE	2008	dobj	4	SENT_364	[p18l1791t2604r1967b2668],
6	;	:	O	;	_	0	SENT_364	[p18l1791t2604r1967b2668],
7	358	CD	NUMBER	358	dep	2	SENT_364	[p18l2006t2604r2142b2659],
8	:	:	O	:	_	0	SENT_364	[p18l2006t2604r2142b2659],
9	568-79	CD	NUMBER	568-79	dep	7	SENT_364	[p18l149t2697r406b2753],
10	.	.	O	.	_	0	SENT_364	[p18l149t2697r406b2753],

1	Chen	NNP	PERSON	Chen	nn	2	SENT_365	[p18l148t2785r326b2846],
2	P	NN	PERSON	p	_	0	SENT_365	[p18l351t2789r413b2855],
3	,	,	O	,	_	0	SENT_365	[p18l351t2789r413b2855],
4	Lin	NNP	PERSON	Lin	nn	5	SENT_365	[p18l442t2787r552b2845],
5	II	NNP	PERSON	II	appos	2	SENT_365	[p18l578t2789r649b2856],
6	,	,	O	,	_	0	SENT_365	[p18l578t2789r649b2856],
7	Lu	NNP	O	Lu	nn	8	SENT_365	[p18l678t2789r765b2846],
8	CS	NNP	O	CS	appos	2	SENT_365	[p18l792t2788r901b2855],
9	,	,	O	,	_	0	SENT_365	[p18l792t2788r901b2855],
10	et	FW	O	et	nn	11	SENT_365	[p18l930t2797r990b2846],
11	al.	FW	O	al.	appos	2	SENT_365	[p18l1019t2784r1091b2846],
12	.	.	O	.	_	0	SENT_365	[p18l1019t2784r1091b2846],

1	Carbamazepine	NNP	O	Carbamazepine	nn	2	SENT_366	[p18l1124t2784r1954b2864],
2	—	NN	O	—	nsubj	3	SENT_366	[p18l1124t2784r1954b2864],
3	induced	VBD	O	induce	_	0	SENT_366	[p18l1124t2784r1954b2864],
4	toxic	JJ	O	toxic	amod	5	SENT_366	[p18l1980t2787r2146b2846],
5	effects	NNS	O	effect	dobj	3	SENT_366	[p18l148t2878r354b2940],
6	and	CC	O	and	_	0	SENT_366	[p18l399t2879r523b2940],
7	HLA	NN	O	hlum	dobj	3	SENT_366	[p18l566t2880r1010b2940],
8	.	.	O	.	_	0	SENT_366	[p18l566t2880r1010b2940],

1	—	NN	O	—	_	0	SENT_367	[p18l566t2880r1010b2940],
2	.	.	O	.	_	0	SENT_367	[p18l566t2880r1010b2940],

1	B	NN	O	b	_	0	SENT_368	[p18l566t2880r1010b2940],
2	*	CD	NUMBER	*	number	3	SENT_368	[p18l566t2880r1010b2940],
3	1502	CD	DATE	1502	num	4	SENT_368	[p18l566t2880r1010b2940],
4	screening	NN	O	screening	dep	1	SENT_368	[p18l1056t2881r1373b2960],
5	in	IN	O	in	_	0	SENT_368	[p18l1415t2881r1480b2940],
6	Taiwan	NNP	LOCATION	Taiwan	prep_in	4	SENT_368	[p18l1523t2881r1788b2940],
7	.	.	O	.	_	0	SENT_368	[p18l1523t2881r1788b2940],

1	N	NN	O	n	nn	2	SENT_369	[p18l1832t2883r1900b2940],
2	Engl	NN	O	engl	_	0	SENT_369	[p18l1934t2879r2081b2960],
3	I	PRP	O	I	nsubj	4	SENT_369	[p18l2117t2883r2152b2951],
4	Med	VBD	O	med	rcmod	2	SENT_369	[p18l144t2972r295b3033],
5	2011	CD	DATE	2011	dobj	4	SENT_369	[p18l318t2978r494b3042],
6	;	:	O	;	_	0	SENT_369	[p18l318t2978r494b3042],
7	364	CD	NUMBER	364	dep	2	SENT_369	[p18l521t2977r659b3033],
8	:	:	O	:	_	0	SENT_369	[p18l521t2977r659b3033],
9	1126-33	CD	NUMBER	1126-33	dep	7	SENT_369	[p18l694t2977r986b3033],
10	.	.	O	.	_	0	SENT_369	[p18l694t2977r986b3033],

1	Liver	NN	O	liver	nn	3	SENT_370	[p18l1506t3213r1620b3260],
2	International	NNP	O	International	nn	3	SENT_370	[p18l1640t3212r1959b3260],
3	(	NNP	O	(	_	0	SENT_370	[p18l1980t3212r2145b3268],
4	2012	CD	DATE	2012	num	9	SENT_370	[p18l1980t3212r2145b3268],
5	)	CD	NUMBER	)	num	9	SENT_370	[p18l1980t3212r2145b3268],
6	©	CD	NUMBER	©	num	9	SENT_370	[p18l1361t3288r1407b3334],
7	2011	CD	DATE	2011	num	9	SENT_370	[p18l1424t3289r1545b3334],
8	John	NNP	PERSON	John	nn	9	SENT_370	[p18l1572t3287r1689b3334],
9	Wiley	NNP	PERSON	Wiley	dep	3	SENT_370	[p18l1709t3287r1851b3344],
10	&	CC	O	&	_	0	SENT_370	[p18l1869t3289r1905b3334],
11	Sons	NNP	O	Sons	dep	3	SENT_370	[p18l1925t3289r2042b3334],
12	A/S	NNP	O	A/S	dep	3	SENT_370	[p18l2060t3289r2144b3334],

